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Abstract 
 
This body of work presents the research and publications undertaken under a 
general theme of minimal access colorectal surgery. Papers are presented on 
surgery for colon cancer, rectal cancer, splenic flexure, emergency surgery, 
and complications after laparoscopic surgery, outcomes, training in minimal 
access surgery and robotic surgery.  
The work highlights my own personal contributions and publications under 
this theme, as well as collaborations and output emanating from multi-centre 
trials. Presentations include video, oral and poster presentations at national 
and international meetings.  
With my background experience of laparoscopic surgery, the focus has been 
on applications of laparoscopy for the management of colorectal cancer, role 
of laparoscopy in emergency settings, and complications of colorectal 
surgery. With a significant experience in robotics, I have shared the 
published data from management of rectal cancers and the techniques of 
single docking total mesorectal excision and flexure mobilization. A particular 
focus has been on teaching and training in minimal access surgery.  
My publication record comprises; pathfinder and seminal papers; papers from 
co-supervised MD/MSc; international collaborations; technical authorship and 
support; other published contributions; guideline development and technical 
reports and internal briefing papers. 	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Preface 	  	  
 
Minimal access surgery for colorectal disorders is a relatively new field. This 
thesis is divided into sections covering applications of laparoscopy in the 
management of colorectal cancer (colon cancer, rectal cancer, advanced 
rectal cancer, synchronous cancers), emergency laparoscopic surgery, 
(appendicectomy, cholecystectomy, colorectal cancer surgery), splenic flexure 
of the colon (mobilization, cancers of splenic flexure), robotic surgery, 
complications in colorectal surgery (incisional hernia, iatrogenic perforation, 
survival after complications) and training in laparoscopic surgery. 
 
The thesis provides a narrative that combines 19 published peer reviewed 
articles that I have authored or co-authored over a 10-year period. In the 
appendices articles are included in their full text format. Page numbers are 
provided for the full text paper against the references in the commentary.   	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1 Commentary  
1.1 Introduction  
 
Colorectal surgery addresses disorders of the large bowel and a major 
workload of the specialty involves resection of the colon or rectum for benign 
or malignant disease. Traditionally the procedures have been performed in an 
open fashion i.e. a large midline incision extending for a length of 15-30 cm in 
order to carry out the procedure. This allows maximal access but does pose 
challenges in terms of wound healing, increased post-operative pain, limited 
mobility, risk of incisional hernia and sometimes limited exposure. 
 
Minimal access surgery (MAS) involves abdominal access through small port 
sites and under direct camera vision the procedure is performed using 
specialized instruments. The two main sub-divisions of MAS are laparoscopic 
surgery and robotic surgery. 
 
The reported advantages of laparoscopic surgery in terms of smaller scar, 
reduced analgesia requirements, lesser risk of wound complications, earlier 
return of bowel function and routine activities and shorter hospital stay have 
been well documented.1-2 The advent of laparoscopic cholecystectomy 
transformed the management of gall stone disease, however, the uptake of 
laparoscopy in colorectal surgery was rather slow and was not until 1991 
when the first laparoscopic colectomy was performed.3  
 
The risk of port site metastasis, concerns of oncological clearance, longer 
operating times, challenging techniques and expensive equipment were 
among the factors which deterred surgeons from embracing this technique.4-6 
A laparoscopic approach to the management of colorectal cancer is attractive 
due to the associated benefits to the patient and the healthcare system. The 
evidence from early randomised studies suggests that the short-term 
outcomes for laparoscopic colorectal surgery are better than open surgery 
without compromising oncological clearance.7-8 There has been no difference 
in most studies between open and laparoscopic surgery in long-term survival, 
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disease free survival and local recurrence.9 However, the Barcelona series 
showed a significantly better cancer related survival in the laparoscopic 
group.10  
 
This thesis shall begin with a description and flow of my research work over 
the past 10 years. Nineteen peer-reviewed papers published under the theme 
of minimal access surgery are part of this thesis and can be broadly 
categorized as follows: 
 
 
 
 
Colon	  	  cancer	  
Clinical	  outcomes	  of	  laparoscopic	  and	  open	  right	  colectomy	  
Short	  and	  long	  term	  outcomes	  of	  splenic	  >lexure	  tumours	  
Short	  and	  long	  term	  outcomes	  after	  laparoscopic	  versus	  open	  emergency	  resection	  of	  colon	  cancer	  
Laparoscopic	  colorectal	  resection	  in	  patients	  with	  previous	  abdominal	  surgery	  
Rectal	  cancer	  
Laparoscopic	  total	  mesorectal	  excision	  following	  long	  course	  chemoradiotherapy	  for	  locally	  advanced	  rectal	  cancer	  
Urogenital	  function	  after	  laparoscopic	  and	  open	  rectal	  cancer	  resection	  
Laparoscopic	  asssisted	  abdominoperineal	  excision	  for	  low	  rectal	  cancer	  provides	  a	  shorter	  length	  of	  hospital	  stay	  while	  not	  afecting	  the	  recurrence	  or	  survival	  
Four	  percent	  of	  patients	  undergoing	  left	  colon	  or	  rectal	  cancer	  surgery	  have	  synchronous	  appendiceal	  neoplasia	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Robotic	  surgery	  
Robotic	  colorectal	  surgery	  
Three	  step	  standardised	  approach	  for	  complete	  mobilisation	  of	  splenic	  >lexure	  during	  robotic	  rectal	  cancer	  surgery	  
Totally	  robotic	  rectal	  cancer	  resection:	  an	  experience	  of	  the	  >irst	  100	  consecutive	  cases	  
Emergency	  laparoscopic	  surgery	  
Urgent	  cholecystectomy	  for	  acute	  choelcystitis	  
Laparoscopic	  appendicectomy	  has	  reduced	  infection	  rates	  as	  compared	  to	  open	  appendicectomy	  
Is	  routine	  peritoneal	  culture	  during	  appendicectomy	  justi>ied?	  
Complications	  
Iatrogenic	  perforation	  at	  colonic	  imaging	  
Major	  post	  opertive	  complications	  after	  elective	  resection	  for	  colorectal	  cancer	  decreases	  long	  term	  survival	  but	  not	  the	  time	  to	  recurrence	  
Predictive	  factors	  for	  extraction	  site	  hernia	  after	  laparoscopic	  right	  colectomy	  
Miscellaneous	  
Impact	  of	  National	  training	  program	  for	  laparoscopic	  colorectal	  surgery	  on	  training	  opportunities	  for	  trainees	  
The	  selective	  use	  of	  splenic	  >lexure	  mobilisation	  is	  safe	  in	  both	  laparoscopic	  and	  open	  anterior	  resection	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Colorectal cancer is the third commonest cancer and approximately more 
than 40,000 people are diagnosed in the UK each year. I have published 
widely on laparoscopic management of colorectal cancer as outcomes-based 
research and training in MAS has been the focus of my research. 
 
The role of laparoscopic surgery in right colon cancer treatment has been 
debated for a while. I wrote a paper evaluating the role of laparoscopic 
surgery in right colonic cancer.11 (page 73) The study demonstrated better short-
term outcomes in terms of length of stay and reduced post-operative 
complications in patients undergoing laparoscopic right colectomy as 
compared to open procedures. A total of 164 patients were studied (89 in 
laparoscopic arm and 75 in open group). Both groups were matched for 
demographics. Median length of stay was 4 days in lap group versus 8 days 
in open group. Similarly the complication rate was higher in the open group (7 
versus 0). 
 
Splenic flexure colon cancers are rare but pose a different challenge as to 
how best to approach them surgically. There are two main options to choose 
from, an extended right hemicolectomy and a left hemicolectomy. I studied a 
series of 68 cases over a 5-year period and compared the results between 
these two groups. There was a non-significant trend toward left 
hemicolectomy for improved 5-year survival but overall the outcomes between 
the two options were comparable.12 (page 79) 
 
In rectal cancer surgery, the surgeon has to mobilize the splenic flexure to 
achieve a tension free anastomosis. There is a debate whether the splenic 
flexure of colon should be routinely or selectively mobilized. I wrote a paper 
after analyzing our own results of splenic flexure mobilization in 263 
patients.13 (page 238) The results showed no difference in clinical and oncological 
outcomes with or without splenic flexure mobilization and hence we 
recommend of selective use of splenic flexure mobilization in rectal cancer 
surgery. 
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The management of low rectal cancer is challenging due to the difficult 
access, proximity of vital structures and the importance of circumferential 
resection margins. For tumours involving the sphincter complex an 
adominoperineal excision is the only option of surgical management. This has 
been traditionally carried out with open surgery, however, with increasing 
experience in MAS, surgeons are performing this laparoscopically or with the 
use of robot. In my unit I compared the clinical and oncological outcomes of 
abdominoperineal excision performed with open and laparoscopic surgery 
and found no difference in survival or recurrence but a shorter length of stay 
in laparoscopic group again emphasizing the benefit of MAS in quicker 
recovery after complex procedures.14 (page 211) 
 
Locally advanced rectal cancers have been traditionally seen as a 
contraindication for laparoscopic approach. These tumours need prior 
treatment with chemoradiation followed by surgery, which is usually difficult 
due to tissue edema and scarring. I reviewed the results of laparoscopic total 
mesorectal excision for rectal cancer after chemoradiation in 30 patients and 
demonstrated the feasibility and safety of MAS in such setting.15 (page 105) 
 
One of the challenges of rectal cancer surgery is reducing collateral damage 
and in particular nerve damage leading to urogenital dysfunction. Identification 
and preservation of these nerves leads to better functional preservation. My 
work included review of 173 patients with low rectal cancer who underwent 
laparoscopic or open rectal cancer surgery.16 (page 122) Validated questionnaires 
were sent to the patients and symptom scoring was carried out on urogenital 
function. This work clearly showed better nerve preservation and improved 
sexual function after laparoscopic surgery. 
 
Prior abdominal and open colonic surgery has been seen as marker of 
difficulty in successful completion of a laparoscopic procedure. I analyzed the 
results from our own series of 718 patients undergoing colorectal surgery and 
concluded that prior abdominal or colonic surgery does not increase the risk 
of conversion and complications in laparoscopic surgery.17 (page 98) This does, 
however, increase the operative time. 
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Colorectal cancer presenting as emergency are a challenge due to bowel 
obstruction and hence not seen ideal for MAS. We reported a series of 217 
colorectal cancer operated as emergency (181 open and 36 laparoscopic)18 
(page 87) MAS was associated with shorter length of stay. Similarly we also 
demonstrated that the post-operative complications after colorectal cancer 
surgery are an independent predictor of long term survival in these patients.19  
 
I trained in MAS and worked with some the best trainers in the country. This 
allowed me to get equipped with the necessary skills not only for performing 
an operation but sparked my interest in training. I was appointed as a National 
Trainer in LapCo in 2010 in recognition of my skills in this field and have one 
of the largest series of laparoscopic and robotic colorectal cases in the 
country. I have been heavily involved in teaching and training in MAS. I 
trained other consultants in this technique and devised training modules for 
trainees. It has been perceived that by training consultants it will compromise 
opportunities for junior trainees, however, this modular training approach has 
allowed more than one trainee/surgeon to be trained at the same time and 
maximized training opportunities. I published on this topic and showed no 
difference of impact on training of surgeons.20 (page 114)  
 
In addition, I am setting up a trial to evaluate the role of extended lymph node 
dissection in the treatment of colon cancer (CoMET). This will be a multi-
center trial exploring the hypothesis of removing more lymphoid tissue as a 
part of the initial cancer operation. This may change the way we manage 
colon cancer at the moment. I am also part of a trial in rectal cancer surgery 
(TREC trial) where we are evaluating organ preservation by performing local 
excision of the rectal cancer rather than a radical resection. Patients with early 
rectal cancers (T1 and T2 N0) are randomized into receiving TME surgery or 
short course radiotherapy followed by local excision. 
 
I am chief investigator of two clinical trials, have been a principal investigator 
of three trials and have published over 35 papers and given over 100 
international and national presentations.  
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1.2 Laparoscopic colorectal cancer surgery  
 
Laparoscopy also referred to as MAS or keyhole surgery is the performance 
of a procedure through a small 5-10 mm incision and the use of a rigid 
camera system to get a 2D or 3D view of the abdominal cavity. The 
instruments are placed through metallic or plastic cannulae called ports. 
Carbon dioxide gas is used for abdominal insufflation to create 
pneumoperitoneum. The vision is magnified and the key advantages are 
enhanced vision, lesser post-operative pain, reduced blood loss and reduced 
scars for better cosmesis and reduced risk of intra-abdominal adhesions. 
There are, however, some limitations and drawbacks. The lack of tactile 
feedback and 2D view can make depth assessment difficult resulting in errors 
and a steep learning curve. Presence of abdominal adhesions, intestinal 
obstruction and large tumours can make this approach relatively difficult.   
 
In 1901 Georg Kelling, of Dresden, Germany performed the first laparoscopic 
procedure in dogs, and in 1910 Hans Christian Jacobaeus of Sweden 
performed the first laparoscopic operation in humans.21-22 The first clinical 
applications of laparoscopy were mainly by gynaecologists for diagnostic 
purposes. Semm described the technique of laparoscopic appendectomy in 
1981. The big breakthrough was in gall bladder surgery where laparoscopic 
cholecystectomy became the gold standard for the management of gall stone 
disease after the first reported cases in early 1990’s. With the increasing 
confidence of surgeons in laparoscopy and the development of new 
instruments, the application in colorectal surgery has been on the increase. In 
the earlier phase the risk of port site metastasis deterred surgeons from 
adopting this technique in cancer surgery. However the adoption of a sound 
surgical technique and the use of wound protector while extracting specimen 
reduced this risk substantially. In colorectal surgery there is often a need for 
an extraction site with an incision ranging from 4-7 cm on average to remove 
the specimen. In the management of colorectal cancer patients there is an 
added oncological pressure to ensure complete removal of the cancer with 
preservation of tissue layers and achieve resection with clear margins.	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Conversion is the term used to describe when a procedure cannot be 
completed successfully. Different series report a variable conversion rate for 
laparoscopic colorectal surgery ranging between 2-15%. Conversions are 
associated with increased morbidity, increased length of stay and 
complications. A variety of factors responsible for conversion are studied in 
the literature. Surgical experience and the learning curve is directly related to 
conversion rate, however, there are patient factors such as high BMI, large 
tumours, previous surgery, adhesions, bleeding and bowel injury being a few 
common reasons for conversions. 
 
It is helpful to identify some of these factors preoperatively to predict a higher 
conversion rate. For example, previous abdominal surgery is associated with 
adhesions formation and can create difficulty in laparoscopic procedures. 
Furthermore, reduced access, with limited views and the risk of bowel injury 
are associated with higher operative times and increased conversion rates. 
 
Numerous studies have reported that previous abdominal surgery should be a 
contraindication for laparoscopic colorectal surgery.1,6,9,24 We found in our 
practice that previous surgery is associated with adhesions and difficult 
operation, however, adopting a good surgical technique with some technical 
skills for difficult situations can still allow a surgeon to safely use laparoscopic 
surgery in such patients. This facilitates low conversion rates which can be 
achieved resulting in improved surgical outcomes and patient experience. 
 
I analysed a cohort of 718 patients who underwent laparoscopic surgery in my 
unit. Patients were divided into three groups, no previous surgery, previous 
abdominal surgery, and previous colonic surgery. The overall conversion rate 
was 4% and there was no difference in outcomes between the three groups. 
The group with previous colonic surgery took and extra 30 minutes of 
operative time. 17 This is in contrast to the early experience of surgeons in 
1990’s when laparoscopic colorectal surgery was associated with longer 
operating times. Adhesions and previous open surgery were seen as 
contraindications. However, there has been a big professional and cultural 
shift over the last two decades and with improvement in technology and skills 
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a higher proportion of patients are offered minimal access surgery in 
colorectal practice. 	  
     
1.2.1 Right colon cancer                    
 
While the use of laparoscopy in general surgery was revolutionising the 
treatment and outcomes for patients, the appetite for this technique in colonic 
surgery was slow and there were concerns amongst surgeons regarding the 
oncological clearance and risk of pneumoperitoneum with tumour cells 
dissemination and port site metastasis.23-28 Numerous studies have shown the 
advantages of laparoscopic colorectal surgery.29-30 However, it was not until 
the early 1990s when the first cases of laparoscopic colorectal resections 
were reported.31 In 1994, a prospective, randomized trial (COST) comparing 
laparoscopically assisted and open surgery for curable colon cancer was 
begun in multiple, diverse, surgical practices.
32   
  
The conclusion of the COST group was that laparoscopic approach is safer in 
patients with colon cancer, however, the operating times were longer and the 
conversion rate was reported as 21%. The authors of this study 
recommended not to use the approach in locally advanced tumours and 
without prior surgeons training and credentialing in laparoscopic surgery. 
There was no difference in complications, as the main critical steps of the 
procedure remained the same. However, there is a need for an extraction site 
to remove the colonic specimen and hence extraction wound can be 4-10 cm 
long depending upon tumour size. In the UK the National Institute for Health 
and Clinical Excellence (NICE) was not supportive of laparoscopy in 
colorectal cancer until 2000.33 
The work of COST study led the American Society of Colon and Rectal 
Surgeons and the Society of American Gastrointestinal and Endoscopic 
Surgeons to endorse laparoscopic resection for curable colon cancer. The 
long-term results of large multi-centre trials indicated that the laparoscopic 
approach was safe to use in curable colon cancer providing that it is 
undertaken by experienced surgeons adhering to standard oncological 
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principles. In the UK and the US, these encouraging reports have resulted in a 
change in stance of the position statements of the NICE (which sets 
standards within the UK National Health Service), and the Society of 
American Gastrointestinal and Endoscopic Surgeons, supporting laparoscopic 
resections for curable colorectal cancer by suitably experienced surgeons in 
selected patients.34-35  
Recently, the COST study group reported with 5-year data of the prospective 
randomized trial that laparoscopic colectomy for curable colon cancer is not 
inferior to open surgery based on disease-free 5-year survival (open 68.4% 
versus laparoscopic 69.2%, p = 0.94) and overall 5-year survival (open 74.6% 
versus laparoscopic 76.4%, p = 0.93).36 
However, as the scene for laparoscopic surgery for the left and sigmoid colon 
was becoming clearer, there was still confusion about its role in right colon 
cancer surgery. There were a few reports comparing laparoscopic with open 
right colonic resections for cancer, however, the results were conflicting.37-38 
The need for an extracorporeal anastomosis in most right colectomy cases 
and hence the requirement for a sizeable extraction site and the possibility of 
performing an open right hemicolectomy through a relatively small incision led 
the surgeons to doubt if laparoscopic right hemicolectomy was going to offer 
much in comparison to open colectomy. 
The common argument was often anecdotally articulated as “I can perform an 
open right hemicolectomy through a 10 cm incision very well and if one has to 
make a 6-7 cm extraction site, what is the real advantage of laparoscopy?” 
With better post-operative patient controlled analgesia, wound catheters, 
transversus abdominus plane blocks and enhanced recovery programme, 
outcomes equivalent to laparoscopic right hemicolectomy can be achieved in 
open surgery with reduced anaesthetic time.39-40 This approach may not be 
suitable for patients with higher BMI, distal transverse colon tumours, or may 
not be acceptable to some for cosmetic reasons. Furthermore, the clear views 
at laparoscopy ensure safety of surgery and good oncological clearance. 
The diversity of results in the published literature on this issue could be 
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because there is a wide range of procedures labeled as right hemicolectomy 
including right hemi, extended right hemi, transverse colectomy, and variable 
and complex regional anatomy on the right side. 
I held an informed belief that laparoscopic right colectomy is a better 
operation for the patients than an open right colectomy. I practiced a 
technique of laparoscopic right colectomy that I learned in my training and 
after a few years analysed our own data to see if there was any true 
difference in the outcomes for open and laparoscopic right colectomy for 
cancer. In that study I aimed to compare the clinical and oncological 
outcomes for a cohort of patients having laparoscopic right hemicolectomy 
(LRH) with those who had open right hemicolectomy (ORH) during the same 
time period.11 (page 73) 
Data were collected on all right colectomies for colon cancer carried out in the 
3-year study period. Although patients were not randomized they were well 
matched for their demographics and cancer stages. LOS was significantly 
lower (4 versus 8 days) in the laparoscopic group as compared to the open 
group. There was no difference in oncological parameters between the two 
groups. This was certainly a non-randomized study, however, it did establish 
the feasibility, safety and superiority of laparoscopic approach for right-sided 
colon cancers in a busy cancer centre. This work was published in the Annals 
of the Royal College of Surgeons and the full paper is attached below.11 
 
1.2.2 Advanced rectal cancer          
 
 
The multi-disciplinary approach to the management of patients with rectal 
cancer has become the cornerstone for successful outcome.41 Neoadjuvant 
long course chemoradiotherapy (CRT) is now established in the treatment of 
locally advanced rectal cancer.42 Significant tumour downsizing and 
downstaging have been demonstrated and in over 25% cases complete 
clinical and radiological response can be seen. 43-44 	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Surgery has conventionally been performed in these patients at approximately 
six weeks after completion of CRT but it is unclear whether this is the 
optimum time for surgery. Surgeons have encountered technically challenging 
operative fields due to oedema and vascularity associated with neoadjuvant 
therapy. In addition, post-operative morbidity has been shown to be increased 
with wound breakdown after abdominoperineal resection (APR) and 
anastomotic dehiscence following anterior resection (AR) being particular 
problems.45 
 
The optimum timing of surgery is as yet not clearly defined and is a matter of 
conjecture. We worked on the hypothesis that by delaying surgery in these 
patients for another 4-6 weeks, we may see more tumour downsizing and 
increase surgical success rate. I analysed these data at Colchester University 
Hospital NHS Trust and looked at the results of laparoscopic TME for locally 
advanced rectal cancers. 15 (page 105) 
 
Thirty-two patients in that time period received CRT and 25 underwent 
laparoscopic total mesorectal excision (LTME). 60% had restorative surgery. 
There were three conversions and median time to operation from CRT was 11 
weeks. Anastomotic leak was seen in three cases and one patient died of 
cardiovascular complication. This paper proved the concept of feasibility of 
LTME in patients with advanced rectal cancer and after down-staging with 
chemoradiation.15 (page 105) It also provided the basis of the 6 versus 12 trial 
where the traditional operating approach after 6 weeks of CRT was 
challenged and a 12-week wait was introduced in view of ongoing clinical 
response.  
 
With specialist interest in locally advanced rectal cancer I have reviewed my 
own practice since I have been a consultant. I have compared the results of 
rectal cancer surgery in these patients. We defined advanced rectal cancers 
as T4 tumours, circumferential resection margin involvement, and male pelvis 
with T3 tumour and found that laparoscopy was feasible, safe and the 
outcomes were comparable to early rectal cancers. At Portsmouth we had the 
largest dataset for laparoscopic TME surgery (458 patients) between two 
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surgeons with very good clinical and oncological outcomes. The results have 
been written up and a manuscript is submitted to Dis Colon Rectum for peer 
review. 
 
I have also reviewed the role of robotics in locally advanced rectal cancers 
and we have presented our preliminary results at international meetings. 
Robotic surgery is safe, feasible and allows improved access to the true pelvis 
in advanced cancers. Enhanced views in the presence of chemoradiation and 
tissue oedema are critical for safe dissection and the ability to go wide and 
stay clear of the circumferential resection margin is critical to achieve to R0 
resections in these difficult cases.  
 
In a subset analysis of comparing laparoscopic versus robotic surgery in 
locally advanced rectal cancers we found that laparoscopic group (LG, n = 71) 
and robotic group (RG, n = 73) were comparable regarding various risk 
factors, demographics and procedures performed. Operative time 270 versus 
235 minutes, p = 0.11), length of stay in hospital (9 versus 7 day, p = (0.069) 
and post-operative ileus 10 versus 7 (p = 0.58) showed better outcomes in 
RG but did not reached a statistical significance. Blood loss (100 versus 10 
ml, p = 0.001) was statistically less in the RG. There was only one conversion 
to open in LG while no conversion was recorded in RG. Re-operation rate, 
anastomotic leak rate, 30 days mortality and oncological outcomes were 
comparable in both groups. Robotic rectal cancer surgery is safe and feasible 
in a high-risk patient and it may have better impact on perioperative 
outcomes, however, further studies are required to establish its superiority.  	  
 
1.2.3 Low rectal cancer 
 
 
Rectal cancers situated within 6 cm from the anal verge are classified as low 
rectal cancers. They pose a different challenge to the treating clinician due to 
the peculiar position in the pelvis, proximity to important structures including 
sphincters and hence oncologically safe decisions have to be made to prevent 
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local recurrence at the same time with efforts to preserve the sphincter 
function and perform restorative procedures. 
 
There are also particular challenges in the anatomy of the low rectum - there 
is poor access and visibility for the surgeon. There are a number of surgical 
options, but the primary focus is always to provide the best outcomes in terms 
of cancer control for survival, taking into account the patient’s wishes and 
quality of life. For some patients avoiding a stoma is the most important factor, 
though this may not be the best option for oncological clearance. 
 
The range of surgical options for low rectal cancer include: 
 
a- Low anterior resection, which uses the TME plane of surgery, retains 
the sphincters and allows patients to retain function. However, low 
rectal cancer means that the anastomotic join is very low and it carries 
a high risk of feacal incontinence, tenesmus, urgency and leakage 
especially if there has been treatment with neo-adjuvant radiotherapy. 
A low anterior resection offers restorative surgery for patients with 
rectal cancer and may involve partial or full internal sphincter excision 
with intersphincteric dissection. 
 
    b-  Abdomino-perineal excision (APE) removes the rectum, including the 
anus. This means that patients have to have a permanent stoma. 
Although may not be the option of choice by the patient in some cases 
it offers the only and best chance of cancer clearance. There is, 
however, some morbidity associated with these procedures in 
particular delayed healing of perineal wound especially in combination 
with chemo radiation is a very frequent and common complication.46 
        Three different types of APEs are described in the recent literature: 
  
1- Standard APE that follows the anatomy of the rectum with 
excision of both internal and external sphincters. 
 
2- Intersphincteric APE, a middle path, leaving the external 
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sphincter behind, usually done for benign conditions or patients 
with high tumours and poor sphincter function.  
 
 
3- An ‘extended’ procedure, which takes out additional tissue 
including the levators, to remove large tumours – this is called an 
extra-levator abdominoperineal excision or ELAPE. This option 
usually requires reconstruction with a plastic surgical procedure 
or a mesh. 
 
We have published the outcomes from laparoscopic abdomioperineal excision 
of rectum (APER) for low rectal tumours. With a sizable sample of 135 APERs 
(87 open 48 laporscopic), we have shown that with a median follow up of 4.5 
years, the oncological outcomes are similar for between the groups and in 
short term laparoscopic APER is associated with shorter length of stay.14 (page 
211) Comparison was also made for the outcomes of patients treated with a 
low rectal cancer with both APER and low anterior resection. The short-term 
and oncological results were comparable making both options a decent 
choice in these patients. However, the quality of life (QoL) study is now being 
carried out to assess these patients in more detail and we will be publishing 
the results soon. 
 
Depending upon the stage of the rectal cancer, various treatment options can 
be available to the treating surgeon. Local excision in the form of transanal 
endoscopic microsurgery (TEMS) or trans-anal endoscopic operation (TEO) 
can be carried out for early rectal cancer when they are T1 stage. Accurate 
staging is the key in successful management of low rectal cancer. Pelvic MRI 
has been the gold standard in assessing CRM and resectability of rectal 
cancers. Endo-anal ultrasound is another way of assessing the low rectal 
tumours and can complement the findings of MRI in a very useful manner. A 
rectal and endoscopic examination is the key determinant for a surgeon to 
assess the tumour resectability. I proposed a model of triple assessment of 
rectal cancer and set up one stop low rectal cancer clinic at Portsmouth. The 
patients attend a one-stop clinic; have an MRI and flexible sigmoidoscopy and 
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endo-anal ultrasound in the outpatient setting and then a consultation with the 
surgeon. Based on the stage and extent of their cancer, decisions were made 
for suitability of these tumours for TEMS, low anterior resection, 
abdominoperineal excision and the need for neo adjuvant chemotherapy. The 
pathway is outlined below and the concept has been submitted for publication. 
This certainly allows a better patient experience, an improved decision making 
process and reduces delays in treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blue – Standard APER 
Yellow – Intersphincteric APER 
Red – Extralevator APER 
 
Figure 1: Three different types of abdomiperinealexcision (APER). 
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Figure 2: LOREC model for management of low rectal cancer. 
 
 
 
1.2.4 Functional outcomes after pelvic surgery 
 
Total mesorectal excision (TME) remains the gold standard of treatment of 
rectal cancer, however, in a proportion of patients adjuvant treatment in the 
form of neoadjuvant chemoradiotherapy is needed prior to surgery, which may 
result in increased morbidity for the patient. Sexual and urinary function is at 
risk after TME surgery due to the injury risk to the hypogastric and splanchnic 
nerves. Previous studies have demonstrated a higher risk of poor urogenital 
function after laparoscopic surgery.47-48 However, laparoscopic pelvic surgery 
demands advanced laparoscopic skills and these studies evaluated the 
results of surgeons earlier on in their learning curve. 
 
Suspected rectal caner 
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With a significant experience in laparoscopic TME surgery in our unit, I aimed 
to review the urogenital functional outcomes for patients undergoing pelvic 
surgery in both open and laparoscopic groups. Validated questionnaires were 
used for the assessment of sexual and urinary function in both men and 
women. International Prostate Symptom Score (IPSS) and International Index 
of Erectile Dysfunction were used for assessment of male sexual dysfunction 
and for women; King’s Health Questionnaire and Female Sexual Function 
Index were used. 16 (page 122)  
 
One hundred and seventy one patients were eligible for the questionnaire 
survey. Response rate in our series was 89% and there were 78 patients in 
the laparoscopic group and 65 in the open group. Surgery was associated 
with deterioration in urinary and sexual function in both groups. The 
deterioration of urinary function following both laparoscopic and open surgery 
was comparable in both men and women. However, with respect to sexual 
function in men, there was a trend towards increased preservation of all 
sexual functions in the laparoscopic group and a statistically significant 
difference in deterioration of erectile function. Similarly with reference to 
female sexual function, there were statistically significant differences in the 
deterioration of libido, lubrication, orgasm, and dyspareunia between the two 
groups.16 (page 122) 
 
This study has a few limitations, retrospective review, non-randomized groups 
and single snapshot survey of patients’ outcomes should be remembered 
when reviewing the results, however, the large sample size and lack of 
selection bias are the main strengths. The two surgeons performing 
laparoscopic surgery were extremely experienced. I contributed with surgery 
in the laparoscopic group of these patients. I was heavily involved in the 
selection of key questionnaires and writing up of the draft and discussion 
section. I have already planned a more prospective review of these outcomes 
and comparing the open, laparoscopic and robotic TME cases for rectal 
cancer. 
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1.2.5 Synchronous cancers 
 
The incidence of synchronous cancers in colorectal cancer is reported around 
3-5%. There is also a risk of metachronous cancers (developing later in 
patients with previous colorectal cancer) in the range of 2-3 %. This 
necessitates the need for complete colonic imaging at the diagnosis of 
colorectal cancer and subsequent surveillance with CT scans. 
 
Appendicular cancers are rare (1% of colorectal cancer) and unique in the 
way of lack of symptoms, late presentation with pseudomyxoma peritonei and 
their lack of response to chemotherapy and overall poor long-term survival. I 
worked with Brendan Moran at Basingstoke, in a unit, which specializes in 
management of appendix tumours. We believed that the incidence of 
appendix cancers was sufficient enough to warrant a routine appendicectomy 
in patients’ undergoing surgery for colorectal cancer. Over a period of 3 years 
we analysed our data and out of 186 patients who had surgery for colorectal 
cancer and had their appendix removed at the same time, 4.5 % had an 
underlying appendicular neoplasm in a normal looking appendix. This was the 
basis of our recommendation for use of routine appendicectomy in patients 
with colorectal cancers who are otherwise fit and well. This theory was 
received with a huge interest in the surgical community and the paper was 
shortlisted for the BJS prize session in the association of coloproctology of 
great Britain and Ireland meeting in 2006 and the manuscript was published in 
Dis Colon Rectum.49 (page 155)   
 
 
1.3 Laparoscopic emergency surgery  
 
 
The indications for laparoscopy are ever increasing however there are a few 
traditional contraindications including intestinal obstruction, previous 
abdominal surgery, adhesions and emergency presentation. With increasing 
experience in laparoscopy and availability of better tools for the surgeons, 
these are all becoming relative contraindications. More than 15-20% of the 
workload of a general surgeon is emergency work and this big group of 
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patients can also benefit from the use of laparoscopy. A few conditions like 
perforated duodenal ulcer, band adhesions, perforated appendix, acute 
cholecystitis are eminently suitable for laparoscopic management and there is 
enough data to support the use of laparoscopy in this cohort of patients as the 
benefits in term of quicker recovery, less pain, earlier mobilization and 
reduced length of stay are all valuable in the management of such patients. 
However, the application of laparoscopy in acute colorectal conditions is still 
limited. 
 
1.3.1 Emergency colorectal cancer surgery        
  
The proportion of colorectal cancer cases that present as an emergency 
varies in the recent world literature from 6% to 34%.50-52 Emergency 
presentation has been associated with higher morbidity, higher perioperative 
mortality, a longer hospital stay, advanced pathologic stage, and poorer long-
term survival.53-55 In the elective setting, laparoscopic colorectal surgery has 
been shown to be superior to open surgery, resulting in lower wound 
complications, less blood loss, less pain, and earlier gastrointestinal 
recovery.56-58 Emergency surgery poses a different challenge for laparoscopy. 
Cases with bowel obstruction leave little space in the abdomen resulting in 
reduced access and cases with perforation cause adhesions and mass 
formation making laparoscopy difficult, so much so that the earlier data 
considered these as absolute contraindication for laparoscopy. Recent data 
from case series have shown feasibility and enhanced outcomes from 
laparoscopy in emergency setting.  
 
I analysed the short- and long-term outcomes of laparoscopy in the 
emergency management of colorectal cancer in my practice.18 (page 87) This 
was a retrospective case matched observational study on patients having 
emergency colon cancer surgery over a 5 year period. Pre-match baseline 
characteristics were compared by bivariate analysis to assess imbalances of 
covariates. Propensity score matching was performed to minimize selection 
bias. This method allowed for the comparison of treatment effect by 
accounting for the important covariates predicting the selection of laparoscopy 
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versus open surgery. In my current practice we are now able to offer 
emergency laparoscopic surgery to approximately 30% of emergency 
admissions with colorectal cancer. 
 
 
1.3.2 Urgent cholecystectomy     
 
Laparoscopic cholecystectomy has become the gold standard for 
management of gallstone disease. Complications are low and the conversion 
rate in elective setting is around 5-7% in various reported series. However, in 
the setting of acute presentation with cholecystitis, three is a divided opinion 
as to the best time for surgery. Some surgeons advocate an early 
cholecystectomy within 96 hours of onset of symptoms while others are keen 
to wait for at least 6-8 weeks after the acute attack settles down. The latter 
approach minimizes inflammatory response reduces tissue edema and has 
been reported to be associated with reduced risk of postoperative 
complications. 
 
However, one of the drawbacks of this policy is that when the patient is 
waiting for surgery over 25% will get another attack of cholecystitis requiring 
hospital readmission and increased morbidity. I worked in a large district 
hospital in my training and alongside three other consultant surgeons devised 
a pathway of managing these patients with acute cholecystitis. An on call 
system with a rota for acute cholecystectomy was introduced with three 
consultants and a senior registrar. All surgeons were very experienced with 
laparoscopic surgery and various techniques were used to offer a successful 
laparoscopic cholecystectomy service for acute cholecystitis within the same 
admission, regardless of the duration of their symptoms.  
 
Over a period of 8 months 64 patients underwent acute laparoscopic 
cholecystectomy.59 (page 221) The median time from admission to operation was 
3 days and from onset of symptoms to operation was 5 days. Nearly 50% of 
patients had one previous admission with similar symptoms and over a 
quarter had two or more admissions. There were no conversions and no case 
of bile duct injury. We had two patients with bile leak that was managed with 
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ERCP and the cause was leakage from accessory cystic duct and liver bed in 
those cases. High conversion rates and risk of ductal injury has traditionally 
deterred surgeons from adopting laparoscopic acute cholecystectomy at the 
time of index admission. However, this study demonstrated the safety and 
feasibility of urgent laparoscopic cholecystectomy in acute settings. 
 
1.3.3 Appendicectomy         
 
Appendicectomy remains one of the commonest emergency surgical 
procedures since the first description of open appendicectomy by McBurney 
in 1894.60 Since the introduction of laparoscopy interest has developed in its 
application for acute abdominal pain and its use a diagnostic and therapeutic 
option in patients with right iliac fossa pain. In particular in women with the 
diagnostic uncertainty, laparoscopy can be a very useful tool to exclude 
gynecological pathology. Semn described the first laparoscopic 
appendicectomy in 1983 and there has been a rapid uptake in the adoption of 
this technique for managing acute appendicitis.61 Conversion rates are low 
and postoperative complications are limited. Some studies have suggested a 
higher incidence of intra-abdominal abscess formation post operatively after 
laparoscopic appendicectomy and this has deterred a number of surgeons 
from the routine use of this technique.11-13 It has been postulated that in men 
and in patients with perforated appendix an open appendicectomy still 
remains the first choice.62 
 
However, with increasing experience of surgeons and better instruments, this 
argument is debatable. I researched this by comparing open and laparoscopic 
appendicectomy cases and in particular investigated the post-operative 
complications.63 (page 227) We analysed 134 patients who had an emergency 
appendectomy (80 laparoscopic and 54 open) and found no difference in the 
incidence of septic complications. The distribution of perforated appendix 
cases was equal in both groups. A thorough lavage of the abdominal cavity 
and a meticulous technique ensure excellent results with the use of 
laparoscopy in this very common acute surgical emergency. Taking routine 
peritoneal fluid cultures during appendicectomy has been an orthodox 
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practice. I questioned this by analyzing the data and outcomes for patients 
having an emergency appendicectomy and demonstrated that there was no 
significant contribution towards the management of these patients by taking 
routine peritoneal swabs for culture.64 (page 234)   
 
1.4 Splenic flexure  
 
Splenic flexure of the colon is an important area because of the variations in 
the vascular anatomy, location and close proximity to the spleen, stomach 
and pancreas. On one hand is the challenge for the surgeon to mobilize it 
safely for a tension free anastomosis and on the other hand the cancers in 
this area deserve special attention due to lympho-vascular drainage patterns 
and technical difficulties that the surgeon may encounter. 
 
1.4.1 Splenic flexure cancers 	  
Oncology surgery is based on the recognition of tissue planes, keeping the 
mesocolon/mesoresctum intact and removal of the drainage vessels and 
lymph nodes along with removal of the primary tumour. The lymphovascular 
drainage in the colon is variable however the right and left colonic tumours 
have a more predictable drainage as compared to the transverse colon due to 
variations in the vascular anatomy. In particular tumours located at the splenic 
flexure of the colon pose a unique challenge in deciding whether their 
drainage is based on the left or the right side colon. 
 
The incidence of true splenic flexure tumors is low. These tumours present 
late and very often with obstruction and hence the prognosis is generally 
worse than tumours in other locations in the colon.65 Traditionally the surgical 
treatment has involved an extended right hemicolectomy or a left 
hemicolectomy. There are pros and cons of each approach. The extended 
right colectomy allows a tension free anastomosis with well perfused ileum 
joined to the colon, however, necessitates a larger specimen removal and 
remains the preferred option among surgeons. There is, however, no robust 
evidence for this approach. 
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Left colectomy involved either ligations of Inferior mesenteric artery and 
middle colic vessels and anastomosis of the proximal transvers or in some 
instance the right colon to the rectum or preservation of inferior mesenteric 
artery but ligation of left colic artery and preservation of the middle colic artery 
resulting is a colo-colic anastomosis. This is technically a left colic artery 
based resection and is slightly more difficult procedure to perform 
competently. 
 
I aimed to review the short- and long-term outcomes of extended right 
colectomy and left colectomy, in particular on survival and recurrence. Over a 
15-year period 74 patients were identified who were operated for splenic 
flexure tumours.12 (page 79) After excluding stage IV disease, 68 were included 
in this study (LC = 30, RC = 38) There were no significant differences in the 
rate of R0 resections, count of harvested lymph nodes, 30-day mortality, 
anastomotic leak rate, reoperation rate, length of hospital stay, readmission 
rate or need for a stoma. In the LC group, three patients (10 %) had positive 
resection margins, while in the RC group, all cases had clear margins (R0).  
 
A total of six (19.4 %) patients in the LC group and 10 (23.3 %) patients in the 
RC group developed recurrences (p = 0.688); there were two (6.7 %) local 
and five (16.7 %) distant recurrences in the LC group, and no local and 10 
(26.3 %) distant recurrences in the RC group. One patient in the LC group 
developed local as well as distant recurrences. The unadjusted 5-year OS 
was 60 % (95 % CIs 44–83) in the LC group versus 49 % (95 % CIs 35–68) in 
the RC group. The 5-year RFS was 54 % (95 % CIs 39–77) in the LC group 
versus 41 % (95 % CIs 28–61) in the RC group. 
This analysis suggested that there is no significant differences in the short- or 
long-term outcomes between patients treated with left colectomy and 
extended right colectomy for splenic flexure tumours. There was a slightly 
worse trend for RC in OS in univariate analysis (probably due to a higher 
proportion of advanced tumours with emergency presentation in this group) 
but when Cox regression was applied it actually showed an improved trend to 
OS in the RC group.  
	   32	  
1.4.2 Splenic flexure mobilisation 	  
With left sided colorectal resections there is a need for mobilization of the 
splenic flexure of the colon to create a tension free anastomosis, whether that 
is needed in every case is debatable and the actual technique of mobilization 
of splenic flexure of colon varies too. Some believe routine mobilization of the 
splenic flexure for all anterior resections for cancer should be the normal 
practice, to avoid anastomosing thickened sigmoid colon and especially to 
achieve a safe ultra-low anastomosis without tension. The limiting factor for 
length, and therefore anastomotic tension, is the inverted left colic artery. 
There is reasonable evidence that division of the inferior mesenteric artery 
results in partial sigmoid ischaemia, but preservation of the left colic artery 
may overcome this. 
 
Splenic flexure mobilisation (SFM) is a difficult step and can sometimes be 
very challenging. In particular when a surgeon has been operating for over 3 
hours and has done the TME for rectal cancer and thinking that the case is 
over, SFM is still a big task towards the end of a long case. Hence, some 
surgeons recommend to mobilize it early in all cases when one is less tired 
and can avoid potential complications. 
 
In LapCo training model it was felt that SFM is one of tasks that takes longer 
to master and learn effectively and the average number of cases needed for 
the trainee to learn this was over 25. SFM certainly adds an extra operating 
time in the range of 15-45 min. The debate about selective versus mandatory 
mobilization of splenic flexure is very old with both sides having strong 
arguments and reasons to support their view. I had a selective approach 
towards SFM and over the years learned that it was not necessary to mobilise 
the splenic flexure in every case. I then went on to analyse our practice to see 
if there was any difference in outcomes when the flexure was selectively 
mobilized. Our results showed that selective approach towards SFM was safe 
and effective and did not result in any significant complications.13 (page 238) 	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Figure 3: Cusum chart showing average number of cases needed in the 
learning curve for various modules of an anterior resection. 
 
 
1.5 Robotic surgery   
 
Though slower to gain acceptance, laparoscopic colorectal surgery has 
gained in popularity, and in experienced hands is now regarded as a safe and 
feasible alternative to open surgery. Early concerns over oncological 
outcomes have been addressed by several large randomised studies, 
demonstrating comparable results between laparoscopic and conventional 
surgery.67-68 Nevertheless, the long learning curve, together with inherent 
difficulties such as two dimensional imaging, limited dexterity and diminished 
tactile sense have meant the application of laparoscopic surgery to technically 
demanding colorectal procedures continues to present a challenge, in 
particular for restorative resection of mid and low rectal cancers. 
Difficulties inherent to laparoscopy, and in particular, laparoscopic colorectal 
surgery include loss of a 3-dimensional view, use of long, awkward 
instruments with amplified physiological hand tremor, and assistant-
dependent camera manipulation. Additionally, laparoscopy leads to 
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diminished manual dexterity, with only 4 degrees of motion compared to the 7 
degrees achievable with the human wrist at open surgery. Instrument 
movements are also counterintuitive in laparoscopic surgery due to the 
fulcrum effect of the abdominal wall. A further drawback is the significant 
learning curve for laparoscopic colorectal surgery, which has been estimated 
to be as high as 35 to 50 procedures.69 
There are several advantages of a robotic system. Firstly, the operating 
surgeon has a unique 3-dimensional stereoscopic view of the operative field, 
with adjustable magnification (x10) and a stable camera platform, directly 
controlled (using a foot-pedal) and thus not reliant on an assistant. Secondly, 
the surgeon also regains three extra degrees of motion that are lost with 
conventional laparoscopy by using articulated instruments which more closely 
simulate the movements of the human wrist. In addition, the robotic surgeon 
benefits from tremor filtering and motion scaling (up or downscaling). In short, 
the robotic surgeon can achieve an un-paralleled level of precision and control 
during operative dissection.  
It has been postulated that these characteristics of robotic surgery can 
facilitate certain steps in colorectal procedures and thereby reduce conversion 
rate. These include splenic flexure takedown dissection of the inferior 
mesenteric vessels, autonomic nerve preservation, rectal mobilization, ureter 
and gonadal vessel identification, dissection in the narrow pelvis and suturing. 
While intracorporeal anastomosis is not routinely required in colorectal 
surgery, the ability to suture accurately is advantageous in certain instances  
A further proposed advantage may be reduced physical strain for the 
operating surgeon. Conventional laparoscopy often requires the surgeon to 
assume unnatural postures, which may result in fatigue and injury.70 Robotic 
surgery can reduce physical stress, and make the laparoscopic experience 
more ergonomically sound for the surgeon, who sits with his/her forearms 
resting comfortably on a pad.  
Laparoscopic colorectal surgery has a lengthy learning curve and it has been 
suggested that the intuitive controls of robotic systems, more comparable with 
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open surgery, can shorten the learning curve, even in the hands of relatively 
inexperienced laparoscopic surgeons. Ahlering et al. demonstrated a similar 
finding in urological surgery, where a robotic interface allowed a surgeon with 
limited laparoscopic familiarity to perform minimally invasive radical 
prostatectomy, with results comparable to those of an experienced 
laparoscopic surgeon, after only 12 cases.71 The first two cases of robotically 
assisted colectomies were performed in 2001 and since then there have been 
a number of publications on the use of robotic systems in colorectal surgery.72 
               
1.5.1 Single docking robotic TME 
 
TME surgery can be safely and efficiently performed using a robotic system. 
Various techniques of robotic TME have been described including hybrid, 
double docking, reverse hybrid and lap-assisted. The biggest issue with 
robotic surgery is the cost and operative time. In order to reduce both I 
worked on a technique of single docking totally robotic procedure for rectal 
cancers. This was based on the technique I learned while working with 
Professor Seohn-Hahn Kim in Korea. I introduced that in Portsmouth and 
have now got the largest experience in the country with robotic TME 
performed in over 200 cases. 73 (page 178)    
 
We have standardized the technique and adopted a modular approach which 
has made it easier to train surgeons in this technique. I have published the 
result of first 100 consecutive TME cases with very good outocmes.73 (page 178) 
In order to reduce the overall costs of robotic procedures we were able to 
demonstrate that the difference in cost between lap and robotic procedures in 
a head to head intraoperative comparison was not more than £450 in our 
practice.  
 
Using the dual console and a simulator and a modular approach for training in 
robotic surgery I have successfully ran a robotic TME fellowship over the past 
2 years. Steps are broken down into multiple steps and made is simple to 
teach and train other surgeons. 
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1.5.2 Robotic splenic flexure mobilisation 	  
With the increasing interest in the use of robot for colorectal procedures, 
surgeons have explored the techniques and strategies to perform these 
complex cases robotically. One of the key factors in successful splenic flexure 
mobilization (SFM) is the patient set up and accurate port placement with 
good surgical assistance. 
 
In laparoscopic surgery the patient is placed in the Trendelenberg position 
(head down) for vascular division and pelvic dissection. When it comes to the 
SFM, patient is placed in the reverse Trendelenberg position to move the 
small bowel out of the way with the use of gravity and obtain an exposure in 
the left upper quadrant. Some surgeons prefer to mobilise the splenic flexure 
in the Trendelenberg position as explained below. 
 
In order to mobilise the flexure, two main approaches are used i.e. inferior; 
where the surgeon approaches the lesser sac from below under the inferior 
mesenteric vein (IMV) and then dissects along the lower border of pancreas 
to gain access to the lesser sac and superior: where the lesser sac is entered 
from above, after division of the gastrocolic omentum, the lower border of 
pancreas is approached and the mesocolon dissected away from the Gerota’s 
fascia. The inherent risks from SFM are splenic, pancreatic or gastric injury, 
devascularisation of the transverse colon and small bowel injury. 
 
Main limitations with the use of the robot in this context are the lack of tactile 
feedback and the inability to move the operating table once the robot is 
docked (attached to the robotics ports in the patient) This necessitates 
modification of the technique of SFM in order to avoid dual docking and 
change of patients position. I trained in robotic surgery in Korea and then 
applied the principles to develop a single docking technique for SFM, which 
resulted in a reduction of operating time and the need for dual docking.74 (page 
173) It also removed the need for using energy devices and hence allowed us 
to reduce the costs of this procedure. The technique is described as three 
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steps technique for SFM and has been used in a large number of cases 
without any compilations. 
 
1.6 Complications 
 
Complications are part and parcel of surgical practice. Patient factors, 
surgeon factors and pathology can all contribute to the adverse outcomes. 
Postoperative complications are associated with morbidity, increased hospital 
stay, increased healthcare costs, and there is enough data to suggest that 
surgeons and centers, which are better at salvage after complications, have 
better results and outcomes.75 
 
Post-operative complications can be early and late and sometime specific to 
the practice of laparoscopic surgery. Various classification systems for 
complications have been used. Clavien and Dindo postulated a classification 
system based on the severity of complication and its impact on the patient. 
(Table 1). 
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Table 1: Clavien-Dindo Classification System. 
 
Degree 
 
Definition 
I Any deviation from the normal post-operative course without 
the need of intervention beyond the administration of 
antiemetics, antipyretics, analgesics, diuretics, electrolytes 
and physical therapy.  
II Complication requiring pharmacological treatment with other 
medicines beyond the ones used for the complications of 
grade I.  
III Complications requiring surgical, endoscopic or radiological 
intervention. 
III-a Intervention without general anesthesia. 
III-b Intervention under general anesthesia. 
IV Life threatening complications requiring admission to intensive 
care unit.  
IV-a Uni-organ dysfunction (including dialysis). 
IV-b Multi-organ dysfunction. 
V Death. 
 
The commonest complications after colorectal resectional surgery are 
bleeding, infection, anastomotic leak and abscess formation, deep vein 
thrombosis, pulmonary embolism, ileus, bowel injury, and ureteric injury and 
missed injury. Late complications include adhesions, incisional hernia 
formation, and disease recurrence. 
 
1.6.1 Complications in colorectal cancer surgery 
 
Early complications such as bleeding, infection and anastomotic leak and 
abscess formation are associated with high morbidity for colorectal patients. 
They not only delay patient discharge and result in expensive care afterwards 
but are also associated with poor physiological function and a delayed 
recovery. 
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There has been concern whether in the treatment of cancer patients these 
adverse events lead to a difference in the oncology outcomes with reduced 
survival and disease recurrence. We analysed our dataset over a 10-year 
period to analyse the impact of significant post-operative complications 
(Clavien and Dindo grade III/ IV) on overall survival and time to recurrence. 
Out of 868 patients 63 (7%) developed serious complications. Five-year 
overall survival was 78% in the patient group without any complications but 
was reduced to 65% in the group with serious complications. We did not find 
any association with the incidence of serious postoperative complications and 
time to disease recurrence in these cancer patients.19 (page 187)  
 
1.6.2 Complications of colonic imaging 
 
Colorectal cancer (CRC) is the second commonest cause of cancer related 
death in the USA and Europe. The incidence is higher after the age of 50 with 
a lifetime risk of 5%.76 The adenoma-carcinoma theory is a well established 
paradigm for the development of CRC and this has been supported by the 
findings of the US National Polyp Study, where regular endoscopy and polyp 
removal resulted in reduction in cancer incidence. 
 
The options for colonic imaging include colonoscopy, sigmoidoscopy, double 
contrast barium enema and CT pneumocolon also known as virtual 
colonoscopy. All these investigations have their own advantages and 
drawbacks. The most feared complication is colonic perforation. I carried out a 
literature review on iatrogenic complications of all the modalities of colonic 
imaging.77 (page 197) We identified 24 studies with a colonoscopic perforation 
rate of 0.06%. The same for barium enema was 0.02-0.024% and the rate 
was lowest for CT pneumocolon (0.036%) As over more than one million GI 
endoscopies are performed annually the UK, the complications can still occur 
in a significant number of patients.  
 
We were able to describe three different mechanism of perforation: 
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1- Mechanical – direct injury from the tip of the endoscope or from excessive 
torque 
 
2- Pneumatic – increased insufflation with high intraluminal pressure 
 
3- Thermal – damage from diathermy and electrocautrey after polypectomy 
 
The underlying mechanisms for colonic perforation after CT pneumocolon 
include trauma at rectal intubation, over insufflation and/or previous micro-
perforation as a result of incomplete or difficult colonoscopy. Colonic 
perforations can present immediately, early or late as shown in table 2. We 
postulated a pathway for managing colonic perforations based on this 
literature review (Figure 4). 
 
 
 
 
Table 2: Presentations of colonic perforation. 
 
A Immediate Diagnosed at colonoscopy, visualization of fat, 
mesentery and small bowel and inability to 
maintain insufflation. 
 
B Early Post procedural abdominal pain, nausea, 
vomiting, tenderness and guarding, fever, 
tachycardia and leukocytosis 
 
C Late Usually after therapeutic colonoscopy, caused 
by thermal injury the above symptoms can be 
delayed for over 72 h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Protocol for the management of colonic perforation 
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1.6.3 Incisional hernia after colon cancer surgery 
 
Incisional hernia is a common late complication after abdominal surgery. In 
laparoscopic colorectal surgery there is a need for the extraction site to 
remove the specimen and the incision size for the extraction wound can vary 
between 3-12 cm depending upon the specimen and tumour size. Extraction 
site incisional hernia is again a common late complication and the incidence 
varies between 5-15%.78 Risk factors for extraction site herniae after 
laparoscopic surgery are poorly understood. I aimed to analyse a cohort of 
patients operated in my practice for laparoscopic right sided colonic 
resections and followed up to observe the incidence of extraction site 
incisional hernia (ESIH).79 (page 166)  
 
In a series of 282 patients who had a laparoscopic right colectomy and were 
followed up for over a 12 months period with a CT scan, the incidence of 
ESIH was 6.8%. Among the various factors studied as a risk for the 
development of ESIH, incision length and high BMI were the two independent 
factors associated with development of incisional hernia. We recommended 
that in obese patients intra-corporeal anastomosis with reduced incision 
length may prevent this complication in a significant number of patients and 
also choosing an extraction site at the suprapubic region was less likely to be 
associated with the risk of ESIH as compared to midline or upper abdominal 
transverse incisions. Prophylactic use of a mesh in high-risk patients may be 
considered to avoid these complications over a period of time. 
 
1.7 Training in laparoscopic surgery 	  
When I completed my surgical training there were limited opportunities for 
training in laparoscopic colorectal surgery in the UK. I was extremely lucky to 
have the opportunity to work and learn from a master trainer, one of the 
pioneers of laparoscopic colorectal surgery and in particular advanced 
laparoscopic pelvic surgery. I worked as a fellow at Colchester and learned 
the principles of complex laparoscopic surgery. 
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When I started as a consultant I was almost up on my learning curve already 
and then working in a high volume center enabled me to become a national 
trainer in laparoscopic surgery in 2010. This was unique experience of getting 
involved in training and teaching established consultants in laparoscopic 
surgery. Different techniques and methodology for teaching were used and I 
thoroughly enjoyed the challenge.  
 
Training and teaching in laparoscopic surgery has been very close to my 
heart and I devised a modular training programme for training in laparoscopic 
colorectal surgery. A right hemicolectomy operation was divided into three 
modules and a sigmoid colectomy into 4 modules and trainees were taught 
these modules separately. When all modules were taught, it was a question of 
assimilating the modules together in order to completely perform the 
procedure. This approach also offered the opportunity to train more than one 
trainee in a single procedure hence maximizing training opportunities. 
 
With the introduction of national training programme in laparoscopic colorectal 
surgery, selected centres were identified with the skill level and volume of 
work to train established consultants. Portsmouth was one of the centres and 
had two trainers appointed (including myself). There was a huge commitment 
towards training of higher surgical trainees too and the concern was that NTP 
training for the National training program would impact on specialist registrars 
training in laparoscopic colorectal surgery. 
 
We analysed the data over consecutive two years period pre- and post-NTP 
introduction.20 (page 114) The median number for cases for higher surgical 
trainees did not change in this study period and the outcomes of patients 
operated by HST and NTP trainees were very similar as shown below: 
 
Portsmouth       HST   NTP trainee 
Total cases               104    102 
Conversion                3%    1% 
Lymph node      14    13 
R0 rate                 98.9 %   100% 
Major morbidity      1.5%   3% 
LOS                  4 days   4 days 
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1.7.1 National training programme in colorectal 
surgery (NTP) 	  
In 2007 the Department of Health established a national training programme 
for training in laparoscopic colorectal surgery. This programme was supported 
by the cancer action team. NICE (National Institute of Clinical Excellence) in 
2006 produced guidelines on the use of laparoscopic approach in treatment of 
colorectal cancer, which stated that all cases suitable for laparoscopic surgery 
should be offered a choice of a laparoscopic surgeon. In August 2006, NICE 
issued a technology appraisal recommending laparoscopic resection as an 
alternative to open surgery for people with colorectal cancer in whom both 
procedures were suitable. NICE estimated that the surgery would result in 
shorter bed stays and significantly improve the patient experience. On 31 
October 2006, the Department of Health waived the 3-month funding direction 
to implement this appraisal as it was recognised that there were insufficient 
surgeons trained in the procedure.  
  
As part of the Cancer Reform Strategy implementation plans the Department 
of Health and the National Cancer Action Team developed and funded a 
programme to train colorectal surgeons to a level of competence in 
laparoscopic surgery to perform such procedures independently and safely. 
The percentage of colorectal surgeons practicing laparoscopic colorectal 
surgery at that time was dismal and hence this programme was devised to 
increase the skills level and rate of laparoscopic procedures. 
 
Initially 10 centres nationally were selected as training centres and the 
designated surgeons were appointed as National Trainers (NT). I was 
appointed as a NT in 2010 and actively engaged in consultant training in 
laparoscopic surgery. The aim was to get established colorectal surgeons 
competent in performing laparoscopic colorectal producers. 
 
The programme included dry laboratory training, including a number of 
courses, followed by case observations and then hands on training in the 
allocated training centre. This was followed up by independent practice in the 
trainees base hospital, which was supported by extended preceptorship by 
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the trainer travelling to their hospital. A structured feedback session was 
provided at the end of each episode and cases were recorded on both trainee 
and trainer global assessment scale (GAS form). Sign off procedure included 
submission of two DVDs of trainees cases, independently and anonymously 
assessed by two examiners. 
 
I thoroughly enjoyed my participation in this programme as a national trainer 
and assessor. I had extensive training in laparoscopic and open colorectal 
cancer surgery and my appointment as a national trainer in NTP was an 
acknowledgment of my skills and expertise. We had consultants visiting from 
over 25 different Trusts and overall more than 300 training episodes took 
place at Portsmouth Hospital NHS Trust, making Portsmouth the highest 
volume training centre. 
 
This was a unique experience as the mutual exchange of knowledge and 
skills was very useful and rewarding. It was a technical challenge to train 
established surgeons and was different from training junior residents and 
hence different teaching styles and techniques were needed. I completed the 
train the trainer course that greatly emphasized on the use of such methods 
for higher educational gains. 	  
With the increasing number of trainers in laparoscopic surgery, 
advanced fellowships we set up at selected centres in the UK and 
senior trainees or new consultants were offered the opportunity of 
training in a 6 month fellowship program to learn advanced laparoscopic 
surgery. These fellowships were sponsored by industry mainly Johnson 
& Johnson, and over a period of 15 years approximately 150 fellows 
successfully completed the training program. This has enabled the 
appointment of suitably trained and qualified laparoscopic colorectal 
surgeons in most of the UK hospitals. At Portsmouth I trained fellows 
over the last 7 years and they have been successfully appointed as a 
minimal access colorectal surgeon. 	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Figure 5: Percentage of laparoscopic colorectal resections in the UK. 	  	  	  	  	  	  	  
	  	  	  	  
Figure 6: Training activity in LapCo by various centres. 	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1.8 Conclusion 
 
 
This thesis evaluates the role of minimal access surgery in the management 
of colorectal disorders. My experience of laparoscopic and robotic surgical 
management of colorectal cancer, applications of laparoscopy in emergency 
colorectal surgery and complications of colorectal surgery and their 
management is analysed. Working in a high volume centre and having trained 
a significant number of surgeons has allowed me to focus exclusively on 
training in minimal access surgery and development of pathways to reduce 
the learning curve for young surgeons.  
 
The collection of 19 peer reviewed papers that I have coauthored in this 
context is a small contribution and one cannot evaluate fully the complex 
nature of these disorders and their management. However, there are going to 
be exciting developments in this field over the next decade. Patient benefit 
from minimal access surgery in terms of shorter length of stay, quicker 
recovery, less pain and cosmetic superiority have all be proven and the quest 
to minimize surgical scars and reduce the morbidity of complex procedures 
will continue. 
 
The development of better tools and advances in surgical techniques means 
that as a surgical community we will all have to adapt to change as surgical 
practice will evolve and change dramatically over the coming years. Further 
research will be needed in to the possibilities of scar-less surgery, micro-
robots, endoluminal procedures and better diagnostic tests. High quality 
surgical trials will ensure patient safety and improved outcomes remain at the 
heart of all such developments. 
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term outcomes for patients with splenic flexure 
tumours treated by left versus extended right 
hemicolectomy: a retrospective analysis. Surg 
Today. 2014 Nov; 44(11): 2045-51. 
 
Impact Factor: 1.329 
 
 
 
50% 
Paper 3 	  
Odermatt M, Miskovic D, Siddiqi N, Khan J, 
Parvaiz A. Short and long term outcomes after 
laparoscopic versus open emergency resection 
for colon cancer: an observational propensity 
score matched study. World J Surg. 2013 Oct; 
37(10): 2458-67. 
 
Impact Factor: 2.642 
 
 
 
60% 
Paper 4  
Siddiqi N, Zaman Q, Patel K, Odermatt M, 
Khan J, Parvaiz A. Laparoscopic Colorectal 
Resection in patients with previous abdominal 
surgery. J Mini Inv Surg Sci. 2015; 4(3): 
e31968, DOI: 10.17795/minsurgery-31968.	  
 
 
30% 
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Paper 5 
 
Motson RW, Khan JS, Arulampalam TH, 
Austin R, Lacey N, Sizer B. Laparoscopic total 
mesorectal excision following long course 
chemoradiotherapy for locally advanced rectal 
cancer. Surg Endosc. 2011 Jun; 25(6): 1753-
60. 
 
Impact Factor: 3.256 
 
 
 
80% 
 
Paper 6 
 
Hemandas A, Zeidan S, Flashman K, Khan J, 
Parvaiz A. Impact of National training 
programme for laparoscopic colorectal surgery 
on training opportunities for senior colorectal 
trainees. Surg Endosc. 2012 Jul; 26(7): 1939-
45. 
 
Impact Factor: 3.256 
 
 
 
25% 
 
 
Paper 7 
 
McGlone E, Khan O, Flashman K, Khan J, 
Parvaiz A. Urogenital function following 
laparoscopic and open rectal cancer resection: 
a comparative study. Surg Endosc 2012; 26(9): 
2559-65. 
 
Impact Factor: 3.256 
 
 
 
50% 
 
Paper 8 
 
Robotic Colorectal Surgery— review of 
literature and technical update, invited book 
chapter; Colorectal Cancer Diagnostic and 
Surgery Editor “Colorectal Cancer—Surgery & 
Diagnostics”, published by Intech. 
 
 
 
 
90% 
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Paper 9 
Khan MN, Moran B.  Four per cent of patients 
undergoing left colon or rectal cancer surgery 
have synchronous appendiceal neoplasia. Dis 
Colon Rectum. 2007 Nov; 50(11): 1856-9. 
 
Impact Factor: 3.736 
 
 
90% 
 
Paper 10 
 
Parés D, Shamali A, Stefan S, Flashman K, 
O'Leary D, Conti J, Senapati A, Parvaiz A, 
Khan J. Predictive factors for extraction site 
hernia after laparoscopic right colectomy. Int J 
Colorectal Dis. 2016 Jul; 31(7): 1323-8. doi: 
10.1007/s00384-016-2610. 
 
Impact Factor: 2.383 
 
 
 
 
40% 
 
Paper 11 
 
Ahmed J, Kuzu MA, Figueiredo N, Khan J, 
Parvaiz A. Three-step standardized approach 
for complete mobilization of the splenic flexure 
during robotic rectal cancer surgery. Colorectal 
Dis. 2016 May; 18(5):O171-4. doi: 
10.1111/codi.13313. 
 
Impact Factor: 2.452 
 
 
 
50% 
 
 
Paper 12 
 
Ahmed J, Nasir M, Flashman K, Khan J, 
Parvaiz A. Totally robotic rectal resection: an 
experience of the first 100 consecutive cases. 
Int J Colorectal Dis. 2016 Apr; 31(4): 869-76. 
doi: 10.1007/s00384-016-2503-z. 
 
Impact Factor: 2.383 
 
 
 
60% 
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Paper 13 Odermatt M, Miskovic D, Flashan K, Khan J, 
Senapati A, O’Leary D, Thompson M, Parvaiz 
A. Major post-operative complications following 
elective resection for colorectal cancer 
decreases long term survival but not the time 
to recurrence. Colorectal Dis. 2015 Feb; 17(2): 
141-9. 
 
Impact Factor: 2.452 
 
 
30% 
 
Paper 14 
 
Khan JS, Moran BJ. Iatrogenic perforation at 
colonic imaging. Colorectal Dis. 2011 May; 
13(5): 481-93. doi: 10.1111/j.1463-
1318.2009.02147. 
 
Impact Factor: 2.452 
 
 
 
85% 
 
Paper 15 
 
Odermatt M, Flashman K, Khan J, Parvaiz A. 
Laparoscopic assisted abdominoperineal 
resection for low rectal cancer provides a 
shorter length of hospital stay while not 
affecting the recurrence or survival; a 
propensity score matched analysis. Surg 
Today. 2016 Jul; 46(7): 798-806. doi: 
10.1007/s00595-015-1244-x. Epub 2015 Sep 
5. 
Impact Factor: 1.329 
 
 
 
 
50% 
 
Paper 16 
 
Khan MN, Nordon I, Ghauri ASK, Ranaboldo 
C, Carty N.  Urgent cholecystectomy for acute 
cholecystitis in a district general hospital—is it 
feasible? Ann R Coll Surg Engl. 2009; 91(1): 
30-34. 
 
Impact Factor: 1.268 
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Paper 17 
 
Khan MN, Fayyad T, Cecil T, Moran B. 
Laparoscopic Appendicectomy Has Reduced 
Wound Infection Rates Compared To Open 
Appendicectomy. JSLS. 2007 Jul-Sep; 11(3): 
363-7. 
 
 
 
90% 
 
Paper 18 
 
Khan MN, Vidiya R, & Lee R. Is routine 
peritoneal culture during appendicectomy 
justified? Ir J of Med Sci. 2007. (176); 1: 37-40. 
Impact Factor: 1.158 
 
 
 
80% 
 
Paper 19 
 
Marsden M, Conti J, Zeidan S, Flashman K, 
Khan J, O’Leary D, Parvaiz A. The selective 
use of splenic flexure. Mobilization is safe in 
both laparoscopic and open anterior 
resections. Colorectal Dis. 2012 Oct; 14(10): 
1255-61. 
 
 
 
50% 
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2.2 Other papers that are not part of this 
submission but can be provided as a 
supplement if required 
 
1- Khan MN, Davies C, Bhatti K, Strike P, Ghauri AS, Ranaboldo CJ. 
Reduced access aortic exposure (RAAE) technique for infra renal 
abdominal aortic aneurysm (AAA) repair. Int J of Surgery. 2009; 7(2): 
159-162. 
 
2- Khan MN, Rafique S, Boyle J, Ranaboldo CJ. Laparoscopic 
Management of Heterotopic pregnancy—a rare cause of acute 
abdomen in women. Surg Laparo Endo Per. 2009; 19(1): 29-31. 
 
3- Khan MN, Agrawal A, Strauss P. Ileocolic Intussusception–a rare 
cause of acute intestinal obstruction in adults; case report and literature 
review. World J of Emerg Surg. Aug 4; 3: 26. doi: 10.1186/1749-7922-
3-26. 
 
4- Khan MN, Vidya R, Lee RE. Scalp cysts are not always sebaceous in 
origin—two cases of occult renal cell carcinoma presenting with scalp 
nodules. Pak Armed Forces Med J. Mar 2008; 58(1): 115-7. 
 
5- Davies C, Khan MN, Ghauri ASK, Ranaboldo CJ. Blood and body fluid 
splashes during surgery- the need for eye protection and masks. Ann R 
Coll Surg Engl. 2007 Nov; 89(8): 770-2. 
 
6- Khan MN, Naqvi A. Antiseptics and traumatic wound cleansing. J 
Tissue Viability. 2006 Nov; 16(4): 6-10.  
 
7-  Khan MN, Vidya R, & Lee R The limited role of microbial culture and 
sensitivity in the management of superficial soft tissue abscesses. 
Scientific World J. 2006; 6: 1118-23. 
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8-  Moffatt C, Khan MN, Ranaboldo C Diaphragm Disease- Small bowel 
strictures secondary to chronic use of NSAIDs presenting as intestinal 
obstruction Scientific World J. 2006; 6: 1139-43. 
 
9-  Khan M, Davies CG Advances in the management of venous leg 
ulcers—the role of growth factors. Int Wound J. 2006; 3: 113-20. 
 
10- Khan M. Diabetes Mellitus affecting wound healing—the underlying 
mechanisms. Diabet Foot J, 2005; 8(3): 144-53. 
 
11- Khan M, Davie E, Irshad K. Role of White Cell Count & CRP in the 
Diagnosis of Acute Appendicitis. J Ayub Med Coll. 2004 Jul-Sep; 16(3): 
17-9. 
 
12- Khan M, Naqvi A, Irshad K, Chudhary A. Frequency of Abdominal 
Wound Dehiscence at a Tertiary Care Hospital. JCPSP June 2004; 
14(6): 235-40. 
 
13- Khan M, Naqvi A, Lee R. Adeno-carcinoma of sigmoid colon following 
urinary diversion, case report and review of literature World J Surg 
Oncol. 2004, 2:20.    
 
14- Naqvi A, Khan M, Whelan J, Cathal O Ceailaigh. Case report of Port 
Site Metastasis after Laparoscopic Cholecystectomy J Surg Pak. Mar 
2004; 9(1): 56-7. 
 
2.3 Published abstracts 
 
1- S Stefan, A Shamali, D Pares, K Flashman, D O’Leary, J Conti, A 
Senapati, A Parvaiz, J Khan. Predictive factors for incisional hernia 
at the extraction site after laparoscopic right colectomy for cancer: a 
large observational study. DDF 2015 London. Gut 2015; 64:Suppl 1 
A171 doi:10.1136/gutjnl-2015-309861. 
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2- J Ahmed, H Abbass, S Stefan, K Flashman, J Khan, A 
Parvaiz.Robotic colorectal surgery: a single centre experience of 
first 100 consecutive cases. Gut 2015; 64:Suppl 1 A149 
doi:10.1136/gutjnl-2015-309861.310.  
 
3- Singhal T, Khan L, Khan J, Flashman K, Senapati A, O'Leary D, 
Parvaiz A. Short-Term Results of Laparoscopic en-bloc resections 
of Colorectal Cancer: an analysis of 68 cases from a single center. 
Colorectal Dis.  2014; 16(Suppl 3): 37-105.  
 
4- Singhal T, Khan L, Khan J, Flashman K, Parvaiz A. Natural Orifice 
specimen extraction for laparoscopic colorectal surgery: first step 
towards scarless surgery. Colorectal Dis.  2014; 16(Suppl 3): 37-
105. 
 
5- Singhal T, Khan L, Khan J, Flashman K, Abraham-Igwae C, 
Parvaiz A. Laparoscopic complete mesocolic excision for colon 
cancer in over 400 cases. Colorectal Dis.  2014; 16(Suppl 3): 37-
105. 
 
  
6- Miskovic D, Siddiqi N, Dabare D, Conti J, Flashman K, Khan JS, 
Parvaiz AC. Short- and long-term clinical outcomes for supervised 
training in laparoscopic colorectal surgery. Colorectal Dis. 2012; 14 
(Suppl 1): 1-11.  
 
7- Siddiqi N, Miskovic D, Pratt H, Flashman K, Khan JS, Parvaiz AC. 
Is resectional surgery necessary for cancer in polyp? Colorectal 
Dis. 2012; 14 (Suppl 1): 1-11. 
 
8- Miskovic D, Khan JS, Senapati A, O’Leary DP, Thompson M, 
Parvaiz AC. Is postoperative complication a predictor for long-term 
survival after surgery for colorectal cancer? Colorectal Dis. 2012; 14 
(Suppl 1): 12-40.  
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9- Dabare D, Alexander R, Miskovic D, Parvaiz A, Khan J. 
Management of low rectal cancer – variables affecting outcomes. 
Colorectal Dis 2012; 14 (Suppl 1): 12-40.  
 
10- OA Khan, K Flashman, Khan J, A Parvaiz Laparoscopic colorectal 
resections in the obese- are women the fairer sex? Br J Surg. 2011. 
98(S3): 80–217. 
 
11- OA Khan, F Howse, K Flashman, Khan J, A Parvaiz Laparoscopic 
resections for malignant and benign inflammatory diseases of the 
colon- a prospective comparative study Br J Surg 2011. 
12- OA Khan, E McGlone, K Flashman, Khan J, A Parvaiz Functional 
outcomes following laparoscopic and open resection of rectal 
tumours in women   Br J Surg. 2011. 
13- K Patel, N Siddiqi, KG Flashman, DP O'Leary, JS Khan, A Parvaiz. 
Laparoscopic colorectal surgery outcomes for patients with previous 
abdominal surgery. Colorectal Dis. 2011; 13 (Suppl 4): 30. 
 
14- N Siddiqi, S Zeidan, KG Flashman, JS Khan, A Parvaiz. Is 
laparoscopic surgery for colorectal cancer safe in an emergency 
setting? Colorectal Dis. 2011; 13 (Suppl 4): 21. 
 
15- Cantelo A, Flashman KG, Khan JS, Parvaiz A, Senapati A, O'Leary 
DP. Does the patient believe a Nurse Practitioner is good enough? 
Colorectal Dis. 2011; 13 (Suppl 4): 14. 
16- E Maglone, OA Khan, D Cheetham, Khan J, D O'Leary, A 
Senapati, A Parvaiz. Laparoscopic total meso-rectal excision (TME) 
for rectal cancer is associated with significantly better sexual 
function preservation than open surgery Colorectal Dis. 2010; 
12(S3): 8. 
 
17- Howse F, Marsden M, Zeidan S, Khan J, Parvaiz A. Do higher 
expectations of quicker recovery lead to excessive investigations 
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following laparoscopic colorectal surgery? Br J Surg. 2010 97 
(Suppl 2).   
 
18- Howse F, Zeidan S, Flashman K, Khan J, Parvaiz A. Is 
laparoscopic colorectal surgery for benign disease more 
challenging when compared to cancer resection? Experience of 510 
consecutive cases. Br J Surg. 2010; 97 (Suppl 2). 
 
19- Bowles C, Marsden M, Flashman K, Khan J, Parvaiz A. What is the 
significance of CT detected indeterminate pulmonary nodules in 
patients with colorectal cancer? Br J Surg. 2010; 97 (Suppl 2): 2.  
 
20- Khan J, Qureshi TI, Parvaiz A. The feasibility of laparoscopic rectal 
resection for cancer.  Colorect Dis 2008; 10 (Suppl 1): 13. 
 
2.4 National & international presentations: 
 
2.4.1 Video Presentations 
 
1-­‐ Sagias F, Khan J. Laparoscopic ventral mesh rectopexy for obstructed 
defecation syndrome, ACPGBI 2016 Edinburgh. 
2-­‐ Ahmed N, Khan J. Laparoscopic VMR for rectal prolapse, ASCRS LA 
April 2016, selected for the best videos session. 
3-­‐ Ahmed J, Khan J. Single docking robotic Splenic Flexure mobilization 
a standardized technique – CRSA Chicago 2015. 
4-­‐ N Siddiqi, J Ahmed, J Khan, A Parvaiz, Effects of Standardization on 
Laparoscopic and Robotic Total Mesorectal Excision Surgery for Rectal 
Cancer. 15th Turkish Colon and Rectal Surgery Conference, Antalya, 
Turkey, 19th – 23rd May 2015.  
5-­‐ N Siddiqi, J Khan, A Parvaiz, Single Stage Laparoscopic 
Panproctocolectomy and Ileo-anal Pouch. 15th Turkish Colon and 
Rectal Surgery Conference, Antalya, Turkey, 19th – 23rd May 2015.  
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6-­‐ N Siddiqi, J Khan, A Parvaiz. Single Dock Totally Robotic TME 
Surgery for a Re-Grown Rectal Cancer. American College of Surgeons 
(ACS) Chicago, 4th – 8th October 2015. 
7-­‐ N Siddiqi, J Khan, A Parvaiz, Robotic Total mesorectal Excision (TME) 
Surgery in Post Chemo-Radiotherapy Rectum – Standrdized 
Technique. 15th Turkish Colon and Rectal Surgery Conference, 
Antalya, Turkey, 19th – 23rd May 2015. 
8-­‐ Siddiqi N N, Khan L, Alvi S, Khan J, Parvaiz A, Standardised 
Technique of Laparoscopic Panproctocolectomy and Ileoanal pouch for 
Ulcerative Colitis. 14th World Congress of Endoscopic Surgery (EAES), 
Paris. 25th – 28th June 2014. 
9-­‐ Singhal T., Suddiqi N., Khan L., Flashman K., Khan J., Parvaiz A. 
Modular steps of standardised single dock robotic total mesorectal 
excision for rectal cancer. CRSA 2014 San Francisco. 
10-­‐ Siddiqi N, Zeidan S, Barry B, Khan J, Parvaiz A Laparoscopic 
Panproctocolectomy and Ileo-Anal Pouch for Ulcerative Colitis. SAGES 
17th – 20th April 2013, Baltimore, US. 
11-­‐ Siddiqi N, Zeidan S, Barry B, Khan J, Parvaiz A, Laparoscopic Total 
Mesorectal Excision In Post Chemo-Radiotherapy rectum- 
Standardized Technique. SAGES 17th – 20th April 2013, Baltimore, 
US.  
12-­‐ Najaf Siddiqi, Khan J, A Parvaiz. Laparoscopic intersphincteric 
technique of low rectal cancer. ALS Annual Scientific Meeting, Cork, 
Nov 2012 (Best video Prize). 
13-­‐ Miskovic D, Siddiqi N, Khan J, Parvaiz A. Standardized approach in 
Laparoscopic Total Mesorectal Excision. American College of 
Surgeons Clinical Congress, Chicago 2012 and 20th EAES Congress, 
BRUSSELS, Belgium, 2012. 
14-­‐ Khan J, Qureshi T, Parvaiz A. The feasibility of laparoscopic rectal 
resection for cancer. Colorect Dis 2008; 10 (Suppl 1):13 (abstract). 
Video presentation ACPGBI 2008 (Birmingham UK). 
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2.4.2 Oral Presentations 
 
1- Manish Chand, Nathan Curtis*, Nicholas West, Omar Faiz, Steven 
Wexner, Jim Khan. COmplete Mesocolic Excision vs. standard 
right hemicolectomy Trial (COMET). ESCP Milan 2016. 
 
2- Filippos Sagias, Sam Stefan, Roland Fernandes, Vidhi Adhukia, 
Karen Flashman, Emma Lee, Matt Cross, Jim Khan. Portsmouth 
Protocol for triple assessment of colorectal anastomosis in robotic 
surgery reduces anastomotic leak & reoperation rates in rectal 
cancer surgery. ACPGBI 2016 Edinburgh. 
 
3- Sagias F, Khan J. Laparoscopic Right Hemicolectomy with Complete 
Mesocolic Excision for colon cancer. British Association of Surgical 
Oncology BASO - Annual Scientific. Conference, RSM London 2015. 
 
4- F. Sagias, J Ahmed, K Flashman, A Parvaiz & J Khan. R1 
Resections in rectal cancer - incidence and its impact on local 
recurrence and survival, a study in 692 consecutive patients. ESCP 
2015 Dublin. 
 
5- Ahmed J, Siddiqi N, Ramachandra M, Khan J, Parvaiz A.  Robotic 
rectal surgery offers better short-term outcomes in high-risk patients 
as compared to laparoscopy. 7th Annual CRSA meeting, Chicago, 
USA. 2015.  
 
6- Singhal T, Flashman K, Khan J, Parvaiz A. Is there a learning curve 
for robotic total mesorectal excision for experienced laparoscopic 
colorectal surgeons? CRSA 2014 San Francisco. 
 
7- Singhal T, Flashman K, Khan J, Parvaiz A. Colorectal cancer in 
patients over 90 year old: in a disease of the elderly, is it right to be 
ageist. ESSO 2014. 
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8- Singhal T, Khan J, Parvaiz A. Laparoscopic complete mesocolic 
excision for colon cancer in over 400 cases. ESCP Barcelona, 2014. 
 
9- Singhal T, Flashman K, Khan J, Parvaiz A. Laparoscopic 
management of colorectal cancer in the severely obese (BMI >35): a 
safe and reliable technique. ESSO Liverpool, 2014. 
 
10- Singhal T, Khan L, Khan J, Parvaiz A. Short-Term Results of 
Laparoscopic en-bloc resections of Colorectal Cancer: an analysis of 
68 cases from a single center. ESCP Barcelona, 2014. 
 
11- Singhal T, Flashman K, Khan J, Parvaiz A. Natural Orifice specimen 
extraction for laparoscopic colorectal surgery: first step towards 
scarless surgery. ESCP Barcelona 2014. 
 
12- Singhal T, Khan J, Parvaiz A. Strategies to shorten the robotic 
learning curve for colorectal resection: A single centre experience of 
the first 50 cases. ESCP Barcelona 2014. 
13- N Siddiqi, S Zeidan, E Cook, B Reddy, K Flashman, B Barry, D 
O’Leary, A Senapati, J Khan, A Parvaiz. Short term outcomes for 
post radiotherapy laparoscopic rectal cancer surgery: a single centre 
experience. American Society of Colon and Rectal Surgeons 
(ASCRS) April 27 – May 1, 2013 Phoenix, Arizona US.  
 
14- Habib, H; Delisle, T. G; Odermatt, M; Reddy, B; Barry, B; Khan, J; 
Parvais, A. A case-matched study comparing long term outcomes of 
laparoscopic versus open abdominoperineal excision for rectal 
cancers. ASCRS, Arizona 2013. 
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15- S Zeidan, N Siddiqi, L Touzalides, K Flashman, B Reddy, B Barry, D 
O’Leary, A Senapati, J Khan, A Parvaiz. Extra-anatomical 
laparoscopic colorectal en-bloc resections for locally advanced 
cancers - short term outcomes. American Society of Colon and Rectal 
Surgeons (ASCRS) April 27 – May 1, 2013 Phoenix, Arizona US.  
 
16- N Siddiqi, S Zeidan, K Flashman, J Khan, A Parvaiz. Laparoscopic 
Hartman’s Resection – A Safe and Feasible Option. Association Of 
Laparoscopic Surgeons, 2012. 
 
17- Odermatt M., Khan J, Parvaiz A. The role of laparoscopy in 
emergency surgery for obstructive colorectal cancer: a case match 
study. ISLCRS, Hong Kong Nov 2012. 
 
 
18- D Miskovic, M Odermatt, J Khan, A Senapati, D O’Leary, P 
McQuillan, M Thompson, A Parvaiz. Major postoperative 
complications in colorectal surgery have an impact on long-term 
survival. ISLCRS, Hong Kong Nov 2012. 
 
19- E Bracey, M Odermatt, D Miskovic, J Conti, K Flashman, Khan J, A 
Parvaiz. Is laparoscopic surgery feasible for locally advanced low 
rectal tumours? ISLCRS, Hong Kong Nov 2012. 
 
20- Siddiqi N, Miskovic D, Pratt H, Flashman K, Khan J, Parvaiz AC. Is 
resectional surgery necessary for cancer in polyp? ACPGBI, Dublin 
July 2012. 
 
21- Miskovic D, Siddiqi N, Dabare D, Conti J, Flashman K, Khan J, 
Parvaiz AC. Short- and long-term clinical outcomes for supervised 
training in laparoscopic colorectal surgery. ACPGBI, Dublin July 
2012. 
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22- Khan J, Dabare DB, Alexander RA, Pratt HP, Flashman KF, Leek 
EL, Parvaiz A. Management of low rectal cancer at a national training 
colorectal centre. 20th EAES Congress, BRUSSELS, Belgium, June 
2012. 
 
23- Siddiqui N, Zeidan S, Flashman K, Khan J, Parvaiz A. Is 
laparoscopic surgery for colorectal cancer safe in an emergency 
setting? Int. Soc. of Surgery - Int. Surgical week ISW, Yokohama, 
Japan – 2011. 
 
24- Cantelo A, Flashman KG, Khan J, Parvaiz A, Senapati A, O'Leary 
DP. Does the patient believe a Nurse Practitioner is good enough? 
ACPGBI - Birmingham 2011. 
 
25- McGlone E, Khan J, Parvaiz A. Laparoscopic total meso-rectal 
excision (TME) for rectal cancer is associated with significantly 
better sexual function preservation than open surgery. European 
Society of Coloproctology, Sorento- September 2010. 
 
26- Howse F, Marsden M, Zeidan S, Khan J, Parvaiz A. Do higher 
expectations of quicker recovery lead to excessive investigations 
following laparoscopic colorectal surgery? ALSGBI 2010 
(Liverpool). 
 
27- Chand M, Flashman K, Senapati A, Khan J, Parvaiz A, O’Leary D. 
Laparoscopic resection for colorectal cancer improves overall 
outcomes and limits the role of conventional resection in a busy 
colorectal unit. ALSGBI 2010 (Liverpool). ACPGBI 2010 
(Bournemouth). ISLCRS 2010 (Florida). 
 
28- Khan J, J Conti, C Bowles, A Senapati, D O'Leary, K Flashman, A 
Parvaiz. Emergency laparoscopic colorectal cancer surgery is a 
safe and effective option as compared to open surgery. ACPGBI 
2010 (Bournemouth). 
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29- Marsden M, Zeidan S, Hemandas A, Flashman K, Khan J, Parvaiz 
AC. Is the National Training Programme for Consultants 
Detrimental to the Training of higher surgical trainees in 
laparoscopic colorectal surgery? ISLCRS 2010 (Florida). 
 
 
2.4.3 Invited Lectures 
 
1- Robotic TME surgery, Future of rectal cancer surgery, UCLH, 
London, AIS channel live event, 9th December 2016. 
 
2- Robotics in colorectal surgery, DDCRS, Kings College LONDON 
October 2016. 
 
3- Laparoscopic Transverse colon mobilization, Laparoscopic 
Cadaver Course, Christie Hospital, Manchester, October 2016. 
 
4- Robotic TME for rectal cancer, 42nd Check and Slovakian 
Surgical Congress, Prague September 2016. 
 
5- Robotic Colorectal Surgery, European Colorectal Congress, 
Barcelona, August 2016. 
 
6- Robotic TME surgery for rectal cancer, Surgical grand round, St 
Marks Hospital, London, May 2016. 
 
7- The Management of Rectal Polyp; the Big Debate. Portsmouth 
Advanced Endoscopy Symposium 4-5th February 2016. 
 
8- Laparoscopic Ventral mesh Rectopexy- treatment of choice for 
pelvic organ prolapse, Hangzhou, China, October 2015. 
 
9- Robotic surgery- applications and training, University College 
Hospital, London, post graduate course, September 2015. 
 
10- Antisepsis and Infection in colorectal surgery, ECTA- Eurasian 
Colorectal Association Conference, Moscow, May 2015. 
 
11- Changing paradigms in rectal cancer surgery, COLOCON 1st 
Conference, Karachi, May 2015. 
	   72	  
 
12- Robotic Colorectal Surgery, Post graduate students, Anglia-
Ruskin University, Colchester, November 2014. 
 
13- Minimal Invasive Colorectal Surgery, Surgical Grand Round, 
Portsmouth Hospitals NHS Trust, October 2014. 
 
14- Advances & Training in Robotic Surgery. 3rd Robotic Camp for 
colorectal Surgeons in association with the Korean society of 
coloproctology, Daegu, South Korea, October 2014. 
 
15- Pelvic Surgery- hand of a surgeon or the steal hand of the 
robot. From Minimal to maximal, colorectal congress St Petersburg 
Russia, October 2014. 
 
16- How to train a robotic Surgeon. 2nd Controversies in rectal 
cancer surgery meeting, Anglia Ruskin University, Cambridge, 
September 2014. 
 
17- Robotic colorectal surgery, Pelvic oncology Symposium, Christie 
Hospital, Manchester, September 2014. 
 
18- Laparoscopic Colorectal Surgery- a changing paradigm, 
University of Portsmouth, June 2014. 
 
19- Laparoscopic Colorectal Surgery In High Risk patients, 
Intensive Care Joint Meeting, Portsmouth, March 2014.  
 
20- Complete Mesocolic Excision for Colon Cancer, Portsmouth 
Laparoscopic Master Class March 2014. 
 
21- Low Rectal Cancer – management options and pathways. 1st 
Laparoscopic National Conference, April 2013, St Petersburg 
Russia.  
 
22- Laparoscopy in Emergency GI Surgery. 2nd SOLES Conference 
February 2013, Lahore, Pakistan. 
 
23- Block Dissection of pelvic lymph nodes in rectal cancer 
surgery. 2nd International Laparoscopic TME symposium October 
2012 Portsmouth. 
 
24- Laparoscopic Total Mesorectal Excision (TME) in rectal cancer 
surgery, CPSP Golden Jubilee Conference, Lahore 2012. 
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25- Transanal Endoscopic Microsurgery. 6th International Society of 
Laparoscopic Colorectal Surgeons meeting September 2011 
Colchester UK. 
 
26- Technique of Laparoscopic Splenic flexure mobilisation. 1st 
International Laparoscopic TME meeting, Portsmouth 2010. 	   	  	  	  	  	  	  	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  
 
 
 
 
 
 
 
	   74	  
3.0 Set of all publications on which this submission is based 
 
 
 
Paper 1: 	  	  	  
Khan JS, Hemandas A, Flashman K, Senapati A, O'Leary D, Parvaiz A. 
Clinical outcome of laparoscopic and open colectomy for right colonic 
carcinoma. Ann R Coll Surg Engl 2011; 93(8): 603-07.   	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The advantages of laparoscopic surgery in terms of smaller 
scar, reduced analgesic requirements, lower risk of wound 
complications, earlier return of bowel function and rou-
tine activities, and shorter hospital stay have been well 
documented.1,2 The advent of laparoscopic cholecystectomy 
transformed the management of gallstone disease. However, 
the uptake of laparoscopy in colorectal surgery was rather 
slow and it was not until 1991 that the first laparoscopic 
colectomy was reported.3 The risk of port site metastasis, 
concerns of oncological clearance, longer operating times, 
challenging techniques and expensive equipment were 
among the factors that deterred surgeons from embracing 
this technique.4–6
Trials have shown that laparoscopic anterior resection 
and sigmoid colectomy have superior short-term outcomes 
compared to open surgery.7–10 Nevertheless, some reports 
comparing laparoscopic to open right colonic resections for 
cancer have provided conflicting results.11,12 The main rea-
son for this could be the diversity of procedures including 
right hemi- and extended right hemicolectomy, transverse 
colectomy, and variable and complex regional anatomy on 
the right side.
In this study we aimed to compare the clinical and on-
cological outcomes for a cohort of patients having a laparo-
scopic right hemicolectomy (LRH) with those who had an 
open right hemicolectomy (ORH) during the same time 
period.
Methods
Patients with a diagnosis of right or transverse colon adeno-
carcinoma undergoing LRH or ORH between October 2006 
and February 2009 were included in this study. Patients hav-
ing emergency surgery or those who did not have a colonic 
resection were excluded. Data were entered into a prospec-
tive database and patients were followed up routinely. Re-
corded data included patients’ age, sex, American Society 
of Anaesthesiologists (ASA) grade, body mass index (BMI), 
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ABSTRACT
INTRODUCTION Laparoscopic colorectal surgery has gained widespread acceptance. While many studies have compared 
laparoscopic and open left-sided resections, there is limited literature on right colonic resections. We aimed to analyse the 
short-term outcome of laparoscopic (LRH) and open right hemicolectomy (ORH) in our unit.
METHODS Consecutive patients undergoing elective right hemicolectomies over a period of 28 months were included in 
the study. No selection criteria were used to allocate the surgical approach. Study parameters included surgical technique, 
demographic details, ASA grade, body mass index (BMI), length of hospital stay (LOS), post-operative mortality and morbidity, 
readmission rate and histopathological data.
RESULTS A total of 164 patients underwent right hemicolectomies during the study period (LRH: 89, ORH: 75). Both groups 
were comparable in age, sex, BMI, ASA grade, tumour stage and lymph node harvest. Four patients (4.5%) in the laparoscopic 
group required conversion to open surgery. In resections with curative intent, microscopic margins were positive in two patients 
(3%) in the ORH group compared to one (1%) in the LRH group. Seven ORH patients had an adverse post-operative outcome 
(three anastomotic leaks, four deaths); there were no deaths/immediate complications in the LRH group (p<0.05). The median 
LOS for LRH patients (4 days, range: 2–21 days) was significantly shorter than for ORH patients (8 days, range: 3–38 days) 
(p<0.0001, Mann–Whitney U test). By day 5, 77% of LRH patients were discharged compared to only 21% of patients in the 
ORH group. There were two readmissions (2.7%) in the ORH group and nine (10.1%) in the LRH group.
CONCLUSIONS Our findings demonstrate advantages in favour of LRH in terms of a shorter hospital stay and reduced post-
operative major complications. LRH is safe and should therefore be available to all patients requiring colonic resection.
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Table 1 Patient demographics
ORH (n=75) LRH (n=89) p-value
Median age (range) 74 (46–89) 76 (53–92) NS
Male 41 (55%) 37 (42%) NS
Female 34 (45%) 52 (58%) NS
Median BMI (range) 26kg/m2 (18–35kg/m2) 26kg/m2 (17–47kg/m2) NS
ASA grade*
ASA grade 1 7 7 NS
ASA grade 2 43 50
ASA grade 3 18 28
ORH = open right hemicolectomy; LRH = laparoscopic right hemicolectomy; NS = not significant; BMI = body mass index
* There were 11 cases without a record of ASA data.
site of tumour and type of surgery. Operative data included 
operating time, type of operation, conversion to open proce-
dure, extraction site and size of extraction wound.
Following staging and multidisciplinary team discus-
sion, patients were seen in clinic by either a consultant 
surgeon or a colorectal specialist nurse. The oncologic 
aspects of a radical right hemicolectomy were explained 
and the patients were advised that this could be achieved by 
either a conventional or a laparoscopic approach. Patients 
were informed that the unit was aiming to perform increas-
ing amounts of this surgery laparoscopically but that this 
would not be possible for all patients. The chances of having 
an open or laparoscopic operation were dependent on list 
availability and cancer target breach dates. There was no 
case selection at this stage. A few patients requested laparo-
scopic operations but most were happy to go along with the 
policy as described.
All open operations were performed by five colorectal 
consultant surgeons or by senior trainees under direct su-
pervision of a consultant surgeon. LRH was performed by 
two of the five consultant surgeons as well as a third new 
consultant in the latter part of the series. A consultant was 
present in all open and laparoscopic cases (scrubbed in 87% 
[65/75] of the ORH cases and in 99% [88/89] of the LRH cas-
es). No selection criteria were employed to allocate patients 
to a laparoscopic or open resection. The surgeon and the 
patient decided on the choice of approach after discussing 
the risks and benefits of the procedure in detail.
Open surgery was performed with either a midline or 
transverse incision. The procedure for LRH included the 
standard Lloyd-Davies position for the patient, open inser-
tion for establishing pneumoperitoneum and a four-port 
technique routinely. No bowel preparation was admin-
istered. The oncological principles of en bloc resection, 
clear resection margins and ligation of vascular pedicles 
with lymphadenectomy were adhered to in both open and 
laparoscopic groups. At laparoscopy, dissection was carried 
out using the monopolar diathermy or ultrasonic dissector. 
The ileocolic or middle colic vascular pedicle was isolated 
and divided using either absorbable clips or an endovascu-
lar stapler. The right branch of the middle colic was ligated 
routinely during laparoscopic procedures. A combination of 
medial-to-lateral and subileal dissection was carried out to 
mobilise the right colon and terminal ileum. The specimen 
was delivered through a small transverse or paraumbili-
cal extraction wound (median length: 5cm) after placing a 
wound protector.
After resection of the specimen, an ileocolic anastomosis 
was performed by either a hand sewn or stapling technique 
according to the surgeon’s preference. Patients in both 
groups were managed in an enhanced recovery programme, 
modelled on the practice of Kehlet and Kennedy,13,14 apart 
from selective rather than routine use of epidural anaesthe-
sia and omission of pre-operative carbohydrate loading. Pa-
tients were discharged after meeting the criteria set in the 
enhanced recovery programme. The follow-up included a 
six-week clinic visit followed by six-monthly cancer follow-
up as part of local protocol.
Statistical comparisons of clinical outcomes were made 
between the laparoscopic and open groups. Variables ana-
lysed included patient demographics, type of surgery, lymph 
node yield, readmission rates, length of post-operative hos-
pital stay (LOS), morbidity and 30-day mortality. Continu-
ous data were expressed as a median (range). To compare 
treatment groups, the Mann–Whitney U test was applied to 
continuous data and the chi-square test to categorical data. 
A p-value of <0.05 was considered statistically significant. 
All analyses were performed using the GraphPad Prism® 5 
(GraphPad Software Inc, La Jolla, CA, US).
Results
Between October 2006 and February 2009, 164 patients (78 
male) underwent an elective right-sided colonic resection. 
Eighty-nine patients (54%) were in the LRH and seventy-
five in the ORH group. Patients in both groups were well 
matched for age, sex, BMI and ASA grade (Table 1).
Operative details, site of tumour, major complications, 
30-day reoperation rate and mortality are shown in Table 
2. There were no anastomotic leaks or deaths in the LRH 
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ORH (n=75) LRH (n=89) p-value
Tumour site NS
Caecum 33 (44%) 39 (44%)
Ascending colon 15 (20%) 30 (34%)
Hepatic flexure 7 (9%) 11 (12%)
Transverse colon 16 (21%) 7 (8%)
Splenic flexure 3 (4 %) 2 (2%)
Appendix 1 (1%) 0 (0%)
Type of incision
Midline 27 (36%)
Transverse 42 (56%)
Conversion 4 (4%)
Dukes’ staging NS
A 6 (8%) 20 (22%)
B 39 (52%) 44 (49%)
C1 23 (31%) 21 (24%)
C2 7 (9%) 4 (5%)
Tumour staging NS
pT1 3 (4%) 1 (1%)
pT2 4 (5%) 20 (22%)
pT3 50 (67%) 54 (61%)
pT4 18 (24%) 13 (15%)
Lymph node yield 13 (range: 1–37) 15 (range: 3–34) NS
Median hospital stay (days)
Primary 8 (range: 3–38) 4 (range: 2–21) <0.0001
Total (includes readmission) 8 (range: 3–38) 4 (range: 2–48) <0.0001
Mortality 4 (5%) 0 (0%) 0.0418
Major morbidity 4 (5%) 0 (0%) 0.0418
30-day reoperation 3 (4%) 1 (1%) NS
Readmission within 30 days 2 (3%) 9 (10%) NS
ORH = open right hemicolectomy; LRH = laparoscopic right hemicolectomy; NS = not significant
group. However, one patient developed a port site hernia 
and required an operation to repair this. Three patients in 
the ORH group had an anastomotic leak and required reop-
eration. Two of the three had standard resections for caecal 
and hepatic flexure tumours and the third had an extended 
resection for a proximal transverse colon tumour. All three 
were T3 tumours. There were four deaths in the ORH group: 
three patients died of cardiopulmonary causes and one pa-
tient of septicaemia following an anastomotic leak. None 
of these patients had extended resections and all were T2/
T3 cancers. In addition, three of the four patients were ASA 
grade 2 while the fourth patient was grade 3 with cardiac 
co-morbidity.
In the laparoscopic group, 38 patients (43%) had previ-
ous abdominal surgery. Four patients were converted to an 
open procedure. Adhesions resulting in difficult dissection 
were responsible for two of these conversions. A difficult 
dissection and oncological uncertainty were responsible 
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for the other two. The decision to convert was made early 
during the LRH. The converted patients were included in 
the LRH group on an intention-to-treat basis. The median 
LOS in the converted group was 7 days (range: 3–16 days). 
No major morbidity was recorded in any of these converted 
patients.
The median lymph node yield was 13 in the ORH and 
15 in the LRH group. This difference was not statistically 
significant. The R0 resection margins were achieved in 97% 
of ORH and 99% of LRH patients. The majority of patients 
were staged as Dukes’ B in both groups (52% in ORH, 49% 
in LRH). In the ORH group, 91% of patients were staged as 
pT3/4. For LHR patients the figure was 76%. A detailed dis-
tribution of Dukes’ and pathology tumour staging is shown 
in Table 2. For T3 and T4 cancers there was no difference in 
distribution between the ORH and LRH groups.
The median LOS was 4 days (range: 2–21 days) in the 
LRH group and 8 days (range: 3–38 days) for ORH cases 
(p<0.0001). In terms of type of incision for ORH patients, the 
median LOS was 8 days for both midline (n=27, 36%) and 
transverse (n=42, 56%) (6 unrecorded). Altogether 77% of 
LRH patients were discharged by day 5 compared to only 
21% patients in the ORH group. Eleven patients were read-
mitted within 30 days of surgery (2 ORH, 9 LRH), the median 
total length of post-operative stay (including readmission) 
remained at 4 days in the LRH and 8 days in the ORH group. 
Of these 11 readmissions, 4 were admitted due to infective 
wound complications, 2 for pain management and 3 with 
nausea, vomiting and diarrhoea. Two patients had sub-
phrenic abscesses requiring radiological drainage.
The median operating time for LRH was 120 minutes 
(range: 70–230 minutes) and the median length of incision 
for LRH was 5cm (range: 4–8cm).
Discussion
The last decade has seen a rapid development in laparo-
scopic colorectal surgery. A laparoscopic approach to the 
management of colorectal cancer is attractive due to the 
associated benefits to the patient and the healthcare system. 
The evidence from early randomised studies suggests that 
the short-term outcomes for laparoscopic colorectal surgery 
are better than for open surgery without compromising on-
cological clearance.7,15 There has been no difference in most 
studies between open and laparoscopic surgery in long-
term survival, disease free survival or local recurrence.16 
However, the Barcelona series showed a significantly better 
cancer related survival in the laparoscopic group.17
The uptake for laparoscopic/extended right hemicolec-
tomies has been slow compared to left-sided resections. 
More variable and complex anatomy on the right side, the 
need for extracorporeal anastomosis and the steep learning 
curve may have been responsible for this hesitation among 
surgeons.18,19
Most of the trials comparing open and laparoscopic 
colorectal surgery include a heterogeneous group of pa-
tients undergoing a variety of procedures including right, 
extended right, transverse and left hemicolectomies and 
sigmoid resections. A few studies have compared the open 
and laparoscopic approach for right-sided colon cancers.20–23 
One could argue that, in selected patients, ORH can be 
performed through a small (8–10cm) transverse incision. 
With better post-operative analgesia (patient controlled 
anaesthesia, wound catheters, transversus abdominis plane 
blocks) and an enhanced recovery programme, outcomes 
equivalent to those for LRH can be achieved.24,25 This ap-
proach, however, may not be suitable for patients with a 
higher BMI or distal transverse colon tumours and it may 
not be acceptable to some for cosmetic reasons. Further-
more, the clear views at laparoscopy ensure safety of sur-
gery and good oncological clearance.
In this study we have shown that major morbidity, mor-
tality and length of hospital stay were significantly less in 
the LRH than in the ORH group (Table 2). We have reported 
major morbidity and reoperation rates for laparoscopic and 
open surgery. There were four major complications in the 
open group (three leaks and one bleed) with no major com-
plications in the laparoscopic group (p<0.04). Although the 
method of anastomosis was extracorporeal for both groups, 
it may be that the lower immune and stress response insti-
gated with a laparoscopic technique could have contributed 
to reduced leak rates and fewer major complications. This 
has been hypothesised previously in a randomised control-
led trial.7
The median hospital stay for a right hemicolectomy in 
the COST (Clinical Outcomes of Surgical Therapy) trial was 
six days.26 We have shown that it can be reduced further to 
four days. Even in the group of patients who were converted 
in the LRH group, the median hospital stay was less than for 
the ORH group (7 vs 8 days).
The oncological safety of laparoscopic colorectal cancer 
surgery has been well established and the results of our study 
are in agreement with this. We did not find any difference 
between ORH and LRH in terms of lymph node yield or R0 
resection. The conversion rate for LRH in this study was 4%, 
which compares favourably with the published literature.21 
The reasons for conversion were locally advanced disease 
and adhesions due to previous surgery. The outcomes for 
converted patients were good. The median length of stay in 
this group was seven days.
This study is not without limitations. The patients were 
not randomised and this may have caused a degree of selec-
tion bias. Nevertheless, the two groups are well matched 
in terms of patient demographics, tumour site, ASA grade 
and BMI. There was no mortality in the LRH group although 
there were four deaths (5%) in the open group. The cause 
of death was cardiopulmonary (n=3) and multiple organ 
failure following an anastomotic leak (n=1). None of these 
patients had either locally advanced disease or an extended 
resection. The lymph node yield and circumferential mar-
gins were also comparable.
The comparison of open and laparoscopic colorectal 
surgery has been reported in various case controlled and 
randomised controlled studies. However, one could argue 
that ORH with a transverse incision offers similar short-
term clinical outcomes compared to the laparoscopic ap-
proach. Although there are a few case controlled series20,22 
that have compared the clinical and oncological outcomes 
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between LRH and ORH, there is no level one evidence in 
the literature. We have in particular focused on the issue of 
LRH versus ORH, demonstrating that the laparoscopic ap-
proach still offers better short-term outcomes compared to 
ORH, regardless of whether transverse or midline incisions 
were used.
Conclusions
Only a prospective randomised controlled trial can settle the 
debate of superiority between ORH and LRH. However, in 
the present era with increasing evidence of safety and good 
outcomes for LRH, some will argue that it is not ethical to 
design such a trial. It is envisaged that over 90% of right-
sided tumours may be suitable for laparoscopic intervention 
although open surgery would remain an option for bulky 
tumours or multivisceral en bloc resections necessitating a 
larger extraction site.
This study shows that LRH is surgically safe and has sim-
ilar oncological outcomes to ORH. There is also significant 
benefit to patients in terms of lower morbidity and mortality 
rates and a shorter hospital stay.
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Abstract
Purpose To compare the outcomes of colonic splenic
flexure tumours treated by extended right colectomy versus
left colectomy.
Methods Stage I–III splenic flexure tumours, treated
either by extended right colectomy or left colectomy
between 1996 and 2011, were identified in a prospective
database, and the short- and long-term outcomes compared.
The survival analyses were performed using the Kaplan–
Meier method and adjusted using a Cox-proportional haz-
ard model.
Results A total of 30 (44 %) splenic flexure tumours were
resected by left colectomy and 38 (56 %) by right colec-
tomy. Emergency operations were more common (74 versus
20 %, p\ 0.001) in the right colectomy group. In the uni-
variate analysis, the 5-year overall survival (55 % for right
colectomy versus 60 % for left colectomy, p = 0.197) and
5-year recurrence-free survival (41 versus 54 %, p = 0.180,
respectively) showed a trend towards a non-significant sur-
vival benefit for left colectomy. However, when adjusted for
age, gender, ASA classification, tumour stage, urgency and
year of surgery, this trend disappeared.
Conclusion Patients undergoing extended right or left
colectomy for splenic flexure tumours seemed to have
comparable short- and long-term outcomes.
Keywords Splenic flexure tumour ! Right
colectomy ! Left colectomy ! Colorectal cancer
Introduction
Colon tumours arising at the splenic flexure are relatively
rare and represent only 2–8 % of all colon cancers treated
by surgery [1–3]. They tend to more frequently be
obstructive and to present at a more advanced stage, thus
resulting in a poorer prognosis than that for tumours arising
at other sites in the left colon [3]. The topography of the
splenic flexure is ill-defined, and the blood supply and
lymphatic drainage show heterogeneity [4]. The extent of
resection chosen by surgeon is often arbitrary rather than
based on evidence; to avoid this, lymph road mapping has
been proposed as a method to better target the extent of
resection, particularly to avoid unnecessary resection of the
middle colic artery [5]. However, although of potential
value for colonic flexure tumours, this technique has not
been widely adopted [6] due to the procedure being labour-
intensive. The most appropriate surgical approach contin-
ues to be debated [7]; one option is to perform an extended
right colectomy which, in most cases, allows a tension-free
ileo-colic anastomosis to be made, and provides the anas-
tomosis with a good blood supply [8]. The alternative is a
left colectomy, consisting of either a high tie of the inferior
mesenteric artery and ligation of the left branch of the
middle colic artery, followed by a transverse-rectal anas-
tomosis [9], or the selective ligation of the left colic artery
with a transverse-sigmoid anastomosis [10]. However, for
extended left colectomies, a right colonic transposition
may be necessary to achieve a tension-free anastomosis
[11, 12]. The evidence in the literature regarding the
advantages and disadvantages of either approach is sparse.
The aim of this study was to investigate if there is a dif-
ference in the short- and long-term outcomes for patients
with splenic flexure cancers treated by left (LC) versus
extended right (RC) colectomy.
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Materials and methods
This was a retrospective analysis of a prospective database
of consecutive patients with colorectal cancer (CRC) who
underwent colorectal resections for cancer between 1996
and 2011 in the colorectal unit at Queen Alexandra Hos-
pital in Portsmouth, UK. All patients C18-year old
undergoing elective or emergency resection for stage I–III
splenic flexure tumours were included in the analysis. As
there is no exact definition of the splenic flexure, tumours
were classified as splenic flexure tumours according to the
operating surgeon’s clinical judgment. The selection of the
surgical procedure (LC versus RC) was also at the
attending surgeon’s discretion. Emergency operations were
defined as surgery within 48 h of admission to the emer-
gency department. Both colorectal and general surgeons on
call performed emergency operations.
Outcome measures
The patients were divided into either LC or extended RC
groups based on the type of procedure performed. The
baseline characteristics evaluated were the patient age,
gender, body mass index (BMI), American Society of
Anaesthesiologists (ASA) grade, American Joint Commit-
tee on Cancer (AJCC) tumour stage [13], adjuvant therapy,
urgency (elective versus emergency surgery) and surgical
method (open versus laparoscopic). The long-term out-
comes were defined as the 5-year overall survival (OS) and
recurrence-free survival (RFS) rates. OS was defined as the
time from the date of surgery to the date of death. RFS was
defined as the time from the date of surgery to the date of
recurrence or death from any cause. Recurrence was
defined as radiological or histological evidence of recurrent
disease. The short-term outcomes were the completeness of
resection (R-stage), number of lymph nodes harvested,
complications (30-day mortality, anastomotic leakage,
reoperation and readmission rates), length of hospital stay
and need for a stoma. Anastomotic leaks were defined as
those that required reoperation. Reoperation was defined as
every intervention performed in the operating theatre under
regional or general anaesthesia following primary surgery
during the same hospitalisation, or within the 30 days
following the operation.
Surgical technique
Both open and laparoscopic techniques were used, with
laparoscopic resections introduced in 2006. Extended right
colectomy was defined as a resection of the right and
transverse colon, as well as parts of the descending colon,
performed to achieve a distal tumour-free margin of at least
5 cm. The ligation of the ileocolic, right (if present) and
middle colic artery was performed centrally. The left-sided
approach was usually a left colectomy with ligation of the
left branch(es) of the middle colic artery. No right colonic
transpositions were used to achieve anastomosis [11].
Adjuvant treatment
Postoperatively, all patients were discussed at the inter-
disciplinary tumour board meeting. Patients with stage III
tumours or those with stage II tumours and unfavourable
histopathological features were offered adjuvant chemo-
therapy unless contraindications, such as multiple comor-
bidities or a lack of consent, were present.
Postoperative follow-up
All patients were invited for follow-up appointments for
5 years. The standard follow-up consisted of clinical
examinations after 3, 6 and 12 months, followed by yearly
appointments for the remaining 4 years, including three CT
scans and two colonoscopies. Patients presenting with
symptoms suggestive of recurrence were investigated
immediately. Patients lost or discharged to active follow-up
were traced by passive follow-up (the last review of the
death registry was performed June 11, 2013). The median
follow-up was calculated using the Kaplan–Meier estimate
of the potential follow-up (reverse Kaplan–Meier method)
[14].
Statistical analysis
Categorical variables were analysed using the Chi-squared
or Fisher’s exact test, as appropriate. The median (range)
values were calculated for continuous data and compared
using the non-parametric Mann–Whitney U test. The OS
and RFS were analysed using Kaplan–Meier curves and
compared using the log-rank test. To adjust for confound-
ers, a multivariate analysis (Cox-proportional hazard
model) was performed. A p value\0.05 was considered to
be statistically significant. All statistical analyses were
performed using the SPSS! IBM!, version 20 (SPSS,
Chicago, IL, USA) and the Survival Package [15] of R [16]
software programs.
Results
From 1996 to 2011, a total of 3290 patients underwent
elective (n = 2630) or emergency (n = 660) resections for
CRC. A total of 74 (2.2 %) patients had tumours localised
at the splenic flexure (LC: n = 31, RC: n = 43). After the
exclusion of stage IV tumours, a total of 68 splenic flexure
tumour resections were included in the analysis (LC:
2046 Surg Today (2014) 44:2045–2051
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n = 30, RC: n = 38). The baseline characteristics of these
cases are shown in Table 1.
In the univariate analysis, there were significantly more
emergency operations in the RC group than the LC group
(74 versus 20 %, p\ 0.001). There were other non-sig-
nificant inter-group differences in the baseline character-
istics, for example, in the RC group, more ASA III and IV
patients and stage III tumours were noted. There were 10
(33 %) T4 tumours in the LC group and 10 (26 %) in the
RC group (p = 0.873).
With respect to the short-term outcomes, there were no
significant differences in the rate of R0 resections, count of
harvested lymph nodes, 30-day mortality rate, anastomotic
leak rate, reoperation rate, length of hospital stay, read-
mission rate or need for a stoma (Table 2). The mean
number of harvested lymph nodes was 12.3 in the LC
group and 12.5 in the RC group (p = 0.93), with positive
lymph nodes in 40 and 53 % of patients (p = 0.30),
respectively. However, the proportion of patients with
fewer than 12 harvested lymph nodes was 47 % in the LC
group and 55 % (p = 0.48) in the RC group. There was a
positive but weak correlation between the lymph node
count and year of surgery (Pearson correlation 0.24,
p = 0.039).
In the LC group, three patients (10 %) had positive
resection margins (R positive), while in the RC group, all
cases had clear margins (R0). Of the R-positive tumours,
two were T4 and one was a T3 tumour; the two patients
with T4 tumours had open operations, and the patient with
the T3 tumour was treated laparoscopically. All tumours
with positive margins received adjuvant therapy. The
patient with the R-positive T3 tumour did not develop
recurrence or die within an observation period censored at
4.7 years. In contrast, both patients with R-positive T4
tumours developed distant recurrences.
A total of six (19.4 %) patients in the LC group and 10
(23.3 %) patients in the RC group developed recurrences
Table 1 Baseline data of the patients treated for splenic flexure
tumours by left colectomy or extended right colectomy (n = 68)
Left
colectomy
(n = 30)
Extended right
colectomy
(n = 38)
p
Gender 0.233a
Male 13 (43.3 %) 22 (57.9 %)
Female 17 (56.7 %) 16 (42.1 %)
Age in yearsb 71.5 (51–86) 74.5 (42–95) 0.145c
BMIb 25 (20–34) 25.5 (19–29) 0.462c
ASAd score 0.254e
I 6 (20.0 %) 4 (10.5 %)
II 18 (60.0 %) 18 (47.4 %)
III 5 (16.7 %) 13 (34.2 %)
IV 1 (3.3 %) 3 (7.9 %)
TNM AJCCf stage 0.526e
I 4 (13.3 %) 5 (13.2 %)
II 14 (46.7 %) 13 (34.2 %)
III 12 (40.0 %) 20 (52.6 %)
Chemotherapy 0.528a
None 20 (66.7 %) 28 (73.7 %)
Adjuvant 10 (33.3 %) 10 (26.3 %)
Urgency \0.001a
Elective 24 (80.0 %) 10 (26.3 %)
Urgent/emergency 6 (20.0 %) 28 (73.7 %)
Method 0.318e
Open 24 (80.0 %) 34 (89.5 %)
Laparoscopic 6 (20.0 %) 4 (10.5 %)
a Chi-square test
b Median; range in parentheses
c Mann–Whitney U test
d American Society of Anesthesiologists
e Fisher’s exact test
f American Joint Committee on Cancer
Table 2 Short-term outcomes of patients treated for splenic flexure
tumours by left colectomy or extended right colectomy
Left
colectomy
(n = 30)
Extended right
colectomy
(n = 38)
p
R0 resection 27 (90.0 %) 38 (100.0 %) 0.081a
Number of lymph nodes
harvestedb
12 (2–25) 11 (4–40) 0.926c
\12 lymph nodes 14 (46.7 %) 21 (55.3 %) 0.481d
C12 lymph nodes 16 (53.3 %) 17 (44.7 %) 0.481d
30-day mortality 1 (3.3 %) 3 (7.9 %) 0.624a
Anastomotic leaks 1 (3.3 %) 4 (10.5 %) 0.374a
Reoperation 2 (6.7 %) 4 (10.5 %) 0.452a
Length of hospital stay
(LOS) in daysb
11 (2–61) 14 (3–79) 0.124c
LOS for open operation 11 (2–61) 16.5 (3–79)
LOS for laparoscopic
operation
4 (3–13) 3.5 (3–7)
Readmission within 30 days 4 (13.3 %) 4 (10.5 %) 0.724a
Stoma 0.318d
Primary anastomosis
without stoma
26 (86.7 %) 35 (92.1 %)
Temporary ileostomy 1 (3.3 %) 2 (5.3 %)
Temporary colostomy 2 (6.7 %) 0 (0 %)
Permanent ileostomy 0 (0 %) 1 (2.6 %)
Permanent colostomy 1 (3.3 %) 0 (0.0 %)
a Fisher’s exact test
b Median (range)
c Mann–Whitney U test
d Chi-squared test
Surg Today (2014) 44:2045–2051 2047
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(p = 0.688); there were two (6.7 %) local and five
(16.7 %) distant recurrences in the LC group, and no local
and 10 (26.3 %) distant recurrences in the RC group. One
patient in the LC group developed local as well as distant
recurrences.
The results of the uni- and multivariate survival analyses
are summarised in Table 3. The median follow-up was 6.2
(95 % CIs 4.9–11.0) years. The unadjusted 5-year OS was
60 % (95 % CIs 44–83) in the LC group versus 49 %
(95 % CIs 35–68) in the RC group (Fig. 1a). The 5-year
RFS was 54 % (95 % CIs 39–77) in the LC group versus
41 % (95 % CIs 28–61) in the RC group (Fig. 1b). There
were no statistically significant differences in the OS
(p = 0.197) and RFS (p = 0.180) between the groups.
When adjusted for age, gender, the ASA score, AJCC
tumour stage, urgency, procedure type and year of surgery,
the predicted OS and RFS were similar for both groups
(Table 3), although there was a non-significant trend
towards a better survival for the extended right colectomy
group, as shown in Fig. 1c, d. In the Cox-proportional
hazard model (Table 3) predicting OS, only the age
(p = 0.001) and ASA score (p = 0.010) were significant
predictors of survival; for predicting the RFS, the age
(p = 0.002), ASA score (p = 0.049) and urgency of sur-
gery (p = 0.030) were significant cofactors.
Discussion
This analysis suggests that there are no significant differences
in the short- or long-term outcomes between patients treated
with left colectomy and extended right colectomy for splenic
flexure tumours. With regard to the overall survival, Nakagoe
et al. [17] came to a similar conclusion after comparing 27
patients with splenic flexure tumours resected either by
subtotal colectomy (n = 20) or left colectomy (n = 7). The
small number of patients in the left colectomy group ana-
lysed in the Nakagoe study, however, reflects the paucity of
data available on splenic flexure tumours in general.
In terms of surgical quality surrogates, the number of
harvested lymph nodes and R0 rate were similar in the RC
and LC groups. The proportion of patients with more than
12 lymph nodes harvested (regarded as the minimum
number for accurate pathological staging) was not signifi-
cantly different, but in both groups, was inadequately low.
However, a population-based study showed that 12 or more
lymph nodes were examined in only 37 % of resected
colon cancers [18]. The exact relationship between the
lymph node count and survival is still under debate [19].
Since the extended right colectomy is a more radical
operation with regard to resection of the middle colic
artery, one would have expected a higher lymph node yield
in the RC group. It has previously been demonstrated that
the proportion of specimens with at least 12 nodes har-
vested was significantly higher in right-sided tumours and
longer specimens [20].
In a multivariate analysis of a cohort of 2879 patients
reported by Nedrebo et al., male sex, age[ 75 years,
sigmoid tumours, pT category 1–2, failure to use a
pathology report template and a distance of B 5 cm from
the bowel resection margin were identified as predictors of
a poor lymph node harvest [21]. In our series, no special
lymph node harvesting techniques were applied by
pathologists. Therefore, it remains unclear whether the
technique of the surgeons or the efforts of the pathologist
were inadequate. The significantly positive correlation
Table 3 The results of the uni- and multivariate overall and recurrence-free survival analyses for the impact of the type of procedure (left versus
extended right colectomy)
Overall survival (OS) Recurrence-free survival (RFS)
Kaplan–Meier Cox regression Kaplan–Meier Cox regression
5-year OS rate (%) pa HR pb 5-year RFS rate (%) pa HR pb
Procedure 0.197 0.633 0.180 0.373
LC (n = 30) 60 (44–83) 1.00 54 (39–77) 1.00
RC (n = 38) 49 (35–68) 0.80 (0.32–1.99) 41 (28–61) 0.68 (0.30–1.58)
Values in parentheses are 95 % confidence intervals
Significant cofactors predicting OS: age (HR 1.09, CIs 1.04–1.15, p = 0.001), ASA score (p = 0.010): ASA 1 (HR 1), ASA 2 (HR 0.95, CIs
0.172–5.20), ASA 3 (HR 2.64, CIs 0.42–16.54) and ASA 4 (HR 6.34, CIs 0.98–40.91). Significant cofactors predicting RFS: age (HR 1.07, CIs
1.03–1.12, p = 0.002); ASA score (p = 0.049): ASA 1 (HR 1), ASA 2 (HR 0.87, CIs 0.20–3.72), ASA 3 (HR 1.81, CIs 0.38–8.69) and ASA 4
(HR 4.10, CIs 0.80–21.07), urgency of surgery (HR 2.71, CIs 1.10–6.68, p = 0.030)
OS overall survival, RFS recurrence-free survival
a Log-rank test
b Cox proportional hazard model adjusted for the procedure, age, gender, ASA (American Society of Anesthesiologists) score, tumour stage,
urgency and year of surgery
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between the number of lymph node harvested and the year
of surgery may reflect an improvement in both the surgical
and pathological techniques. A further reason for the poor
lymph node harvest may be the high proportion of emer-
gency procedures, which led to an increased number of
non-colorectal specialist surgeons performing the proce-
dures while on call. However, the impact of the pathologist
on lymph node harvest has been shown to be more
important than the specialty of the surgeon [22]. Further-
more, emergency surgery itself has not been associated
with a poor lymph node harvest so far [23].
Concerning the R stage, only the LC group included
patients with positive resection margins, although both
groups had an equal number of T4 tumours. This may reflect
the fact that the extended right colectomy is a more radical
resection with respect to the transverse colon and its vas-
cular pedicle. In addition, the fact that the T3 case with
positive margins was laparoscopically resected may support
our personal experience that the left-sided laparoscopic
approach is technically more challenging, especially the
selective dissection of the left-sided branch(es) of the middle
colic artery; this carries the potential risk of compromising
the radicality. However, there has been no study to date that
has compared laparoscopic extended colectomies and lapa-
roscopic left colectomies for splenic flexure tumours.
The rate of primary anastomosis without a stoma and the
leak rate were similar between the LC and RC groups.
However, significantly more RCs were performed as
emergency procedures. The rationale for favouring an
extended right-sided resection or subtotal colectomy in the
emergency setting may be due to the fact that the ileocolic
anastomosis rarely causes perfusion or tension problems.
For LC, a recent review highlighted that primary anasto-
moses are performed less frequent in emergency than in
either elective or interventionally bridged colectomies [24].
The less sub-specialised surgeon performing emergency
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Fig. 1 The uni- and multivariate survival plots. The non-significant
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operations may find a formal left colectomy technically
more challenging than an extended right colectomy, where
a safe primary anastomosis can be performed in most cases.
Both LC and RC can be performed laparoscopically, the
safety and feasibility of which have been demonstrated in
previous studies [25, 26]. The small number of laparo-
scopic procedures performed in our study was due to the
fact that, as already mentioned, laparoscopic resections of
splenic flexure tumours are technically demanding, and the
procedure has only been practiced in our centre more
recently. In our study, the laparoscopic RC was performed
less frequently than the laparoscopic LC (11 % RC versus
20 % LC). More RC cases seemed to be unsuitable for
laparoscopy due to massive bowel dilatation or perforation
in cases of emergency presentation. Furthermore, a high
proportion of emergency cases was treated by non-colo-
rectal surgeons without sufficient experience with laparo-
scopic colon surgery, which was in contrast to elective
cases, which was only treated by colorectal surgeons who
were more likely to perform laparoscopic procedures.
Local recurrences were only observed in the LC group,
even though the number of T4 and stage III tumours was
similar to that in the RC group. The 100 % R0 rate in the
RC group was associated with long-term local tumour
control. As already mentioned, this may be explained by
the central dissection of the middle colic artery and asso-
ciated lymph node clearance achieved by RC. The positive
impact on local recurrence of central vessel ligation leading
to a specimen with a long vascular pedicle containing the
draining lymph nodes has previously been shown [27].
With respect to the long-term survival outcomes, the
type of procedure was not a significant predictor even
when adjusted for other influencing factors like the age,
ASA score, tumour stage, urgency and year of surgery in
the multivariate analysis. Kim et al. [28] found that the
patient age, tumour stage and emergency procedures were
significant predictors of survival in an analysis of 167
splenic flexure tumours treated by LC. In an analysis of
627 colon cancer resections, tumours presenting as
emergencies were shown to have a poorer prognosis [29].
Likewise, Slim et al. [30] identified emergency surgery
and age as important independent factors associated with
postoperative mortality in patients undergoing colorectal
surgery. The poor prognosis of splenic flexure tumours in
general may be related to the fact that they frequently
present at a more advanced stage and with acute
obstruction compared with other colonic tumours [28]. In
our analysis, the trend towards a worse survival for
patients undergoing extended right colectomy in the uni-
variate analysis was likely to be due to the fact that this
procedure was predominately chosen for high risk emer-
gencies and in patients with higher ASA scores; indeed,
when adjusted in the Cox-regression model, this trend
converged to the opposite; showing a trend toward a
better survival in the RC group. This trend may also be
explained by the more radical approach to the middle
colic vessels, since this is the most distinct difference
between the two procedures. Hohenberger et al. [31]
reported the benefit of the high tie and generous lymph
node clearance on both the recurrence and overall sur-
vival. In addition, the more extensive lymph node dis-
section around the middle colic artery in the RC group
might have led to stage migration, resulting in more
patients receiving adjuvant treatment. This association,
however, is still under debate [32–34]. Furthermore, one
must bear in mind that the adjusted survival differences in
our study were not statistically significant and larger case
numbers are required to confirm or refute these trends.
This study has some limitations due to its retrospective
and non-randomised nature. The study was underpowered
due to the small sample sizes, as reflected by the large
confidence intervals. However, the combination of the uni-
and multivariate analyses provides an idea of the impact of
the surgical procedure for splenic flexure tumours. As no
stronger evidence is currently available in the literature,
especially concerning the long-term results, neither pro-
cedure can be considered to be superior. A randomised
controlled trial would be required to evaluate the optimal
surgical technique for splenic flexure tumours.
In summary, left and extended right colectomies for the
curative resection of splenic flexure tumours seem to pro-
vide similar short- and long-term outcomes. In the future,
preoperative radiological studies on the vascular supply
type, as well as lymph road mapping, may help to further
guide the surgeon’s choice of the most appropriate surgical
approach.
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Abstract
Background Case series suggest the feasibility and safety
of emergency resection of colon cancer by laparoscopy.
The present study compares short- and long-term outcomes
of laparoscopic and open resection for colon cancers trea-
ted as emergencies.
Methods The study was a propensity score-matched
design based on a prospective database. From October 2006
to December 2011, emergency laparoscopic colon cancer
resections were 1:2 propensity score-matched to open cases.
Covariates for match-estimation were age, gender, Ameri-
can Society of Anesthesiologists grade, procedure type,
tumor site, and reason for emergency surgery. Short-term
outcomes included oncological quality surrogates (lymph
node harvest and R stage), need for a stoma, length of
hospital stay, and postoperative complications. For long-
term outcomes, overall and recurrence-free survival rates
were analyzed with Kaplan–Meier curves.
Results During the study period, a total of 217 colon
cancers were resected (181 open and 36 laparoscopic) as
emergencies. The laparoscopic cases were matched to 72
open cases. Median follow-up was 3.6 [95 % confidence
interval (CI) 2.3–4.3] years. The overall 3-year survival
rate was 51 % (95 % CI 35–76) in the laparoscopic group
versus 43 % (95 % CI 32–58) in the open group
(p = 0.24). The 3-year recurrence-free survival rate in the
laparoscopic group was 35 % (95 % CI 20–60) versus
37 % (95 % CI 27–50) in the open group (p = 0.53).
Median lymph node harvest (17 vs. 13 nodes; p = 0.041)
and median length of hospital stay (7.5 vs. 11.0 days;
p = 0.019) favored laparoscopy.
Conclusions Our data suggest that selective emergency
laparoscopy for colon cancer is not inferior to open surgery
with regard to short- and long-term outcomes. Laparoscopy
resulted in a shorter length of hospital stay.
Introduction
In the elective setting, laparoscopic colorectal surgery has
been shown to be superior to open surgery, resulting in
lower wound complications, less blood loss, less pain, and
earlier gastrointestinal recovery [1–4]. However, the role of
laparoscopy in emergency resections for obstructive colo-
rectal cancer remains unclear [5]. Despite a trend toward
decreasing mortality rates for elective colorectal cancer
surgery, emergency resections remain at a high risk for
perioperative death [6]. Because of the high-risk patient
profile and level of operative technical difficulties due to
dilated and vulnerable bowel, colonic obstruction has often
been considered a contraindication for minimally invasive
surgery [7, 8]. Hence, the endo-laparoscopic approach
consisting of endoscopic stenting followed by planned
laparoscopic resection has become an important alternative
to immediate open emergency surgery [9–11]. However,
results from recent case series and comparative studies on
short-term results suggest that laparoscopy is also feasible
and safe as a primary approach in the emergency setting
[8, 12–15]. To date, evidence is based on case series, and
no data on long-term results are available. Furthermore,
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cases with free abdominal perforation have been excluded
in previous studies. The aim of the present study was to
compare short- and long-term outcomes of emergency
laparoscopic versus open colon surgery for cancer.
Methods
Inclusion criteria and follow-up
This was a retrospective case-matched observational data-
base study of patients who underwent colonic resection for
cancer from October 2006 to December 2011 in a high-
volume surgery unit (200–250 colorectal cancer resections
per year) at Queen Alexandra Hospital in Portsmouth, UK.
The unit is one of the training centers for the National
Training Programme for Laparoscopic Colorectal Surgery
in the UK [16, 17]. Data from patients C18 years old who
underwent emergency resection for colonic (and rectosig-
moid junction) tumors were extracted from a prospective
database. Because these were emergency cases, in most
instances no preoperative endoscopy was available, and
therefore classification of tumors as rectal was mainly
based on intraoperative assessment alone. Tumors below
the peritoneal reflection were classified as rectal and were
excluded, whereas those just above the reflection were
classified as rectosigmoid and were included. Emergency
operations were defined as surgery within 48 h of admis-
sion to the emergency department for symptoms of
obstructing, perforated (peritonitis), or bleeding colorectal
tumors. Preoperatively, patients were managed by the
surgical emergency team for diagnostic work-up, including
a computed tomography scan in stable patients. Patients
who were unstable due to sepsis were resuscitated and
transferred to the operating room as soon as possible
without imaging. Postoperatively, patients were routinely
transferred to the surgical high care unit or, in cases of
circulatory or respiratory instability, to the intensive care
unit. In contrast to elective cases, patients after emergency
open and laparoscopic resections were not enrolled in a
standardized enhanced recovery program; instead, pain
management, diet, and mobilization were decided on an
individual basis. After discharge, all patients were enrolled
in a 5-year follow-up program that consisted of clinical
examinations after 3, 6, and 12 months, followed by
appointments on a yearly basis. During this time three
computed tomography scans and two colonoscopies were
performed to screen for local and distant recurrences.
Patients with symptoms suggestive of recurrence were
investigated at the time of such presentation. Patients lost
or discharged from active follow-up were tracked by pas-
sive follow-up through the death registry database. The end
of the review period date was 1 October 2012. Prospective
data collection and data quality management were per-
formed by an independent full-time research assistant.
Adjuvant therapy
Postoperatively, all patients were discussed at the multi-
disciplinary team meeting. Patients with stage III tumors
were generally advised to have adjuvant chemotherapy. For
those with stage II tumors, adjuvant therapy was recom-
mended if poor histopathologic features (such as lympho-
vascular invasion, high-grade tumor, or serosal
involvement) were present. In patients with stage IV
tumors, potentially resectable metastatic lesions were dis-
cussed with the appropriate specialists. Patients with dif-
fuse metastatic disease were offered palliative
chemotherapy. However, acute presentation and its asso-
ciated morbidity and generally poorer prognosis were taken
into account during decision making. All adjuvant or pal-
liative therapy recommendations were discussed with the
patient.
Baseline variables
Prospectively collected baseline characteristics included
age, gender, body mass index (BMI), American Society of
Anesthesiologists (ASA) grade, type of procedure, site of
tumor, reason for emergent surgery, tumor-node-metastasis
(TNM) American Joint Committee on Cancer stage, and
specialty of surgeon. Procedures were categorized as right,
left, subtotal, and sigmoid colectomies. The right colec-
tomy category included ileo-cecal resections, right colec-
tomies, and extended right colectomies. The sigmoid
colectomy category included resections of the rectosigmoid
colon and Hartmann procedures (rectosigmoid resection
with closure of the rectal stump and formation of an end-
colostomy). With respect to classification of tumor site,
tumors were categorized as right- and left-sided tumors.
The right colon category included tumors from the cecum
to the transverse colon, whereas the left colon category
included tumors from the splenic flexure to the rectosig-
moid junction. For example, splenic flexure tumors were
classified as left-sided tumors and treated by either exten-
ded right colectomy or left colectomy.
Outcomes
Long-term outcomes included overall and recurrence-free
3-year survival rates. Overall survival was measured from
the date of operation to the date of death. Recurrence-free
survival was measured from the date of operation to the
date of confirmed recurrence or death from any cause.
Short-term outcomes were completeness of resection
(R-stage), lymph node harvest, complications (30-day
World J Surg (2013) 37:2458–2467 2459
123
	   91	  
	  	  	  	  	  	  
mortality and surgical complications needing re-interven-
tion), wound infection, length of stay, need for a stoma, and
readmissions. Anastomotic leaks were defined as leaks that
required treatment by interventional drainage or reopera-
tion. Reoperation was defined as every intervention in the
operating room under regional or general anesthesia fol-
lowing primary surgery during hospitalization or within
30 days after an operation.
Selection of operative method and technique
All operations were performed by both specialist colo-
rectal and general surgeons. Patients admitted on an
emergency basis were managed by the on-call consultant,
who either performed the operation or supervised it, in a
dedicated emergency operating room. When additional
operating room capacity was available during the day-
time hours, colorectal cases could be handed over from
non-colorectal on-call surgeons to colorectal-specialist
consultants. Some cases were referred to laparoscopic
specialists by surgeons practicing mainly open surgery;
however, this parameter could not be quantified because
it was not specified in the database. Two experienced
laparoscopic colorectal surgeons who had performed
several hundred individual elective laparoscopic resec-
tions performed or supervised a high proportion of the
emergency laparoscopic cases. However, specialized
laparoscopic surgeons also performed or supervised open
procedures, for example when staff without appropriate
laparoscopic expertise were available. No formal proto-
col defining the selection criteria for laparoscopic colo-
rectal surgery existed. However, those patients who were
persistently unstable in spite of resuscitation, or in whom
there was serious anesthesia concern with respect to
pneumoperitoneum or tolerating the Trendelenburg
position, were considered to be unsuitable for laparo-
scopic surgery. Polymorbidity alone was not considered
to be a contraindication. During the whole study period,
a total of 14 different regular or locum consultant sur-
geons operated, eight of whom were specialist colorectal
surgeons. Acknowledged principles of colorectal tumor
surgery, such as central ligation and mesocolic excision,
were the aim in both open and laparoscopic surgeries.
However, whereas the laparoscopic procedures were
highly standardized, open procedures were not. Only
traditional laparoscopic (i.e., no single-port or hand-
assisted) techniques were used. Every unplanned exten-
sion of an incision for any task other than retrieving the
specimen was considered to be a conversion [18]. Lap-
aroscopic operations that had to be converted to open
surgery were analyzed according to the intention-to-treat
principle.
Matching
Pre-match baseline characteristics were compared by
bivariate analysis to assess imbalances of covariates.
Propensity score matching was performed to minimize
selection bias. This method allowed for the comparison
of treatment effect by accounting for the important
covariates predicting the selection of laparoscopy versus
open surgery. In contrast, an exact match only would
only account for a relatively small number of covariates
without weighting their impact, and therefore not taking
into account the complexity of decision making in this
setting. Propensity scores were estimated using logistic
regression. Age, gender, ASA grade, type of procedure,
site of tumor, and reason for emergent surgery were
selected as covariates in the regression model. These
covariates were chosen as they were known to the sur-
geon before the operation and may have influenced the
surgeon’s decision making with respect to choice of open
versus laparoscopic surgery. Although of potential
importance, BMI was not included in the model because
of a high rate of missing values (45 %). Furthermore,
there were significantly more missing BMI values in the
open group than in the laparoscopic group (50 vs. 17 %),
which would have introduced an unacceptable bias in the
case of imputation or loss of power in the case of list-
wise deletion. The operative modality (laparoscopy yes/
no) was entered into the regression model as a dependent
variable. A 1:2 ‘‘nearest neighbor’’ case–control match
without replacement was used due to considerable sam-
ple size differences. A laparoscopic patient was matched
with two patients treated by open surgery who had the
closest estimated propensity scores. After matching, the
relative multivariate imbalance measure L1 (Iacus et al.)
[19] was calculated. A decrease in the relative multi-
variate imbalance measure L1 signifies a better overall
balance of covariates in comparison to pre-match data.
Additionally, the mean standardized differences of
covariates or interactions among covariates greater than
–0.25/? 0.25 were calculated. The standardized mean
difference was defined as the mean difference of
covariates or interactions between the case and control
groups divided by the standard deviation of the control
group. Post-match baseline characteristics, including
covariates not entered into the propensity score model,
were compared between the groups using bivariate
analysis. Furthermore, an alternative propensity score
model was constructed by entering the specialty of the
surgeon as covariate into the logistic regression. This
second model was intended to reveal any bias caused by
different grades of specialization among operating
surgeons.
2460 World J Surg (2013) 37:2458–2467
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Statistics
For bivariate two-sided comparisons between the laparo-
scopic and the matched open surgery groups, the Chi
square test or Fisher’s exact test (expected cell count\5)
for categorical variables, and the Mann–Whitney U test for
continuous variables, were used. Continuous data were
recorded as a median and range (minimum to maximum).
Missing or unspecified values of categorical data were
handled as a separate category and listed in the tables.
Missing values of continuous data were addressed by list-
wise deletion in descriptive statistics and reported where
missing values were [2 %. Continuous data used for
matching had no missing values. Median follow-up was
calculated using the Kaplan–Meier estimate of potential
follow-up (reverse Kaplan–Meier) [20]. Survival and
recurrence-free survival were analyzed using the Kaplan–
Meier method. Survival curves were compared using the
log-rank test. A p value\0.05 was considered to be sta-
tistically significant. Statistical analyses were performed
with SPSS (Statistical Package for Social Science, IBM
SPSS Statistics, Version 20) and the open source statistical
software platform R in version 2.15.1 [21]. For survival
analysis the R Survival package [22] was used. The
matching procedure was performed using Propensity Score
Matching for SPSS (Version 1.0, by Felix Thoemmes,
2011) [23]. Underlying R packages included MatchIt [24,
25], RItools [26, 27], and CEM [28].
Results
Pre-match study population
From October 2006 to December 2011, a total of 231
operations for colorectal cancers were performed as
emergencies. Of these, 14 were performed for rectal can-
cers and were excluded. The remaining 217 cases met the
inclusion criteria and were 36 (17 %) laparoscopic cases
and 181 (83 %) open cases. Baseline characteristics of the
pre-match groups are outlined in Table 1. There were
considerable imbalances between the groups: the propor-
tion of right-sided tumors was significantly higher in the
laparoscopic group than in the open group (72 vs. 54 %,
respectively, p = 0.045), and the rate of free abdominal
perforation was significantly higher in the open group than
in the laparoscopic group (34 vs. 11 %, respectively,
p = 0.003).
Post-matching baseline characteristics
Details of the 1:2 matching procedure are summarized in
the Methods section and in Fig. 1. After matching, the
accuracy of the model was tested. The relative multivariate
imbalance measure L1 was 0.790 before and 0.694 after
matching, indicating an increase in overall balance. No
post-match covariates had a standardized mean difference
[0.25 between the two groups. The average absolute
standardized mean difference of covariates and interactions
in the post-match group was 0.07 (range: 0.00–0.20) com-
pared to 0.29 (range: 0.01–0.61) in the pre-match group.
Bivariate analysis after matching is shown in Table 2.
There were no significant differences in baseline parameters
included in the logistic regression between the laparoscopic
cases and the open control group. In particular, the rate of
T4 tumors was similar in both groups (54 % in the open
group vs. 53 % in the laparoscopic group). There were also
no significant differences between patients receiving adju-
vant chemotherapy (33 % in the laparoscopic vs. 40 % in
the open group) or palliative chemotherapy (8 % in the
laparoscopic vs. 6 % in the open group) (p = 0.72). In the
open group, one patient with a T4N2M0 tumor additionally
received postoperative radiotherapy.
Extended analysis
Of the laparoscopic procedures, 89 % of the cases were
performed by colorectal specialists. Of these, two surgeons
with a special interest in laparoscopic surgery performed
67 % of the laparoscopic procedures. Because there was a
significant difference in the proportion of specialist sur-
geons between the groups, the matching process was
repeated including the specialty as a covariate. To reduce
the overall imbalance caused by adding a highly imbal-
anced covariate, 1:1 matching was performed. This resul-
ted in a balanced number of procedures performed by
colorectal specialists with 32 cases (88.9 %) in both the
matched open and the laparoscopic group (p = 1.000).
However, six interactions or covariates had a standardized
mean difference of more than 0.25, which indicated an
unacceptable increase in imbalance. Effects of the sur-
geon’s specialty and type of surgery seemed to be too
strongly confounded to be disentangled by matching.
Because of its imbalances, this model was rejected.
Long-term outcomes
Long-term outcomes showed no overall or recurrence-free
survival advantage in either group (Table 3). The estimated
3-year overall survival rate was 51 % in the laparoscopic
group and 43 % in the open group (p = 0.24; Fig. 2). The
3-year recurrence-free survival rates were 35 and 37 %
(p = 0.53), respectively (Fig. 3). Because the median
overall follow-up was only 3.6 (95 % confidence interval
2.3–4.3) years, no 5-year survival rates could be estimated
reliably.
World J Surg (2013) 37:2458–2467 2461
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Short-term outcomes
Short-term outcomes are summarized in Table 3. In the
laparoscopic (vs. open) group, median lymph node counts
were significantly higher (17 vs. 13, respectively;
p = 0.041) and median length of hospital stay shorter (7.5
vs. 11.0, respectively; p = 0.019). There was also a trend
toward a lower R0 resection rate in the laparoscopic group
(72 % in the laparoscopic vs. 89 % in the open group,
p = 0.052). Of the 36 laparoscopic cases, three cases (8 %)
had to be converted to open surgery. In two cases, the
reason for conversion was the finding of advanced T4
tumors (in the sigmoid colon and cecum) needing extensive
open resections. One of these cases resulted in a R1
resection (T4N2M0). Both cases were performed by a
specialist laparoscopic colorectal surgeon. The third con-
version was in a patient with a tumor of the transverse
colon (T3N0M0) operated on by an on-call general sur-
geon. The reason for conversion was a lack of expertise in
treating transverse tumors laparoscopically. According to
the intention-to-treat principle, all three converted cases
were analyzed as belonging to the laparoscopic group.
Table 1 Baseline
characteristics before matching
(n = 217)
BMI body mass index,
ASA American Society of
Anesthesiologists, TNM tumor-
node-metastasis
a Mann–Whitney U test
b Chi square test
c Fisher’s exact test
d Missing values of 50 % in the
open group and 17 % in
laparoscopic group
Open (n = 181) Laparoscopic (n = 36) p value
Age, years [median (range)] 74 (30–94) 74 (32–93) 0.367a
Gender 0.191b
Male 97 (53.6 %) 15 (41.7 %)
Female 84 (46.4 %) 21 (58.3 %)
BMI [median (range)]d 25 (15–42) 24 (16–41) 0.709a
ASA score 0.934c
1 24 (13.3 %) 4 (11.1 %)
2 80 (44.2 %) 17 (47.2 %)
3 66 (36.5 %) 14 (38.9 %)
4 11 (6.1 %) 1 (2.8 %)
Type of procedure 0.713c
Right colectomy 104 (57.5 %) 25 (69.4 %)
Left colectomy 10 (5.5 %) 1 (2.8 %)
Subtotal colectomy 15 (8.3 %) 2 (5.6 %)
Sigmoid colectomy 52 (28.7 %) 8 (22.2 %)
Right versus left colon 0.045b
Right colon tumor 98 (54.1 %) 26 (72.2 %)
Left colon tumor 83 (45.9 %) 10 (27.8 %)
Reason for urgency 0.003c
Pericolic abscess or
contained perforation
3 (1.7 %) 2 (5.6 %)
Free perforation 61 (33.7 %) 4 (11.1 %)
Intestinal obstruction 88 (48.6 %) 17 (47.2 %)
Unspecified 29 (16.0 %) 13 (36.1 %)
TNM stage 0.122c
1 1 (1.1 %) 2 (5.6 %)
2 55 (30.4 %) 15 (41.7 %)
3 97 (53.6 %) 16 (44.4 %)
4 27 (14.9 %) 3 (8.3 %)
Postoperative chemotherapy 1.000c
No chemotherapy 99 (54.7 %) 21 (58.3 %)
Adjuvant chemotherapy 61 (33.7 %) 12 (33.3 %)
Palliative chemotherapy 19 (10.6 %) 3 (8.4 %)
Speciality of surgical team \0.001b
Non-colorectal consultants 94 (51.9 %) 4 (11.1 %)
Colorectal consultants 87 (48.1 %) 32 (88.9 %)
Colorectal consultants with
special interest in laparoscopy
22 (12.2 %) 24 (66.7 %)
2462 World J Surg (2013) 37:2458–2467
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Discussion
We found that laparoscopic resections of colon cancers
presenting as emergencies were not only feasible and safe
but also provided long- and short-term outcomes similar to
open surgery. Laparoscopic surgery led to a significantly
shorter hospital stay.
Emergency surgery is not only an independent risk
factor for perioperative mortality but also poses a risk for
decreased long-term survival, especially in the first year
after surgery [29–31]. Preliminary survival analysis of our
unmatched study collective suggested a long-term survival
benefit for laparoscopic surgery. However, further analysis
revealed that more severe cases, such as free perforation,
were more likely to be operated via open surgery, whereas
cases of uncomplicated obstruction and contained perfo-
ration were treated by both methods. Previous investiga-
tions have reported risk factors affecting conversion rate
and outcome. A retrospective multivariate analysis by
Thorpe et al. found that T stage, male gender, tumor site,
and ASA grade were significant predictive factors for
conversion to open surgery [32]. A multivariate analysis of
perioperative mortality and its risk factors in large bowel
surgery for obstructive cancer identified ASA grade, pre-
operative renal failure, and colon lesions proximal to the
tumor as the main predictors of postoperative mortality
[33]. In a retrospective analysis, Chen et al. [34] reported a
perioperative mortality rate of 5 % for obstruction alone,
9 % for perforation at the site of the tumor, and 33 % for
perforation proximal to the tumor. In a national cohort
study, Storli et al. [35] identified TNM stage, lymph node
ratio in stage III tumors, gender, and old age as adverse
factors for overall survival. These data were the rationale
behind including age, ASA grade, tumor site, and tumor
stage as covariates in the logistic regression analysis for
matching in the present study. As a result, the alleged long-
term survival benefit of emergency laparoscopy disap-
peared completely, which is consistent with results repor-
ted in the elective setting [36]. Also, no significant
postoperative 30-day mortality differences were detected in
the laparoscopic versus open groups. Similarly, in a non-
matched study by Stulberg et al. [37] the comparison of 42
laparoscopic emergency colectomies and 25 open cases
showed no short-term survival benefit differences. For the
elective setting, a recent meta-analysis also failed to
demonstrate a lower perioperative mortality risk for lapa-
roscopy [38]. Although the postoperative mortality rate in
our laparoscopic group (8 %) was under the UK national
average of 11 % and the open group (13 %) was above
(Bowel Cancer Audit Report 2011 [39]), this difference
was not statistically significant.
The quality of surgical resection represented by R0
resection and lymph node yield showed no significant
inferiority of laparoscopy. In fact, lymph node harvest was
significantly higher in the laparoscopic group. Although a
higher number of negative lymph nodes has been associ-
ated with improved survival [40], this was not the case in
our laparoscopic collective. Moreover, our result is in
contrast to 24 randomized controlled trials, in which no
differences in lymph node counts between laparoscopic
and open surgery were found, at least not in the elective
setting [41]. A possible explanation for this is that the
laparoscopic technique was highly standardized and mainly
performed by colorectal specialists, whereas the open
technique was not standardized and in 57 % of cases per-
formed by non-colorectal surgeons. In our experience, the
inability to stay in the correct plane is a common cause of
intraoperative hazards and, ultimately, conversion. In our
collective only three cases (8 %) had to be converted,
suggesting that most cases in the laparoscopic group could
be operated according to our standardized technique; ide-
ally this results in a specimen consisting of a colon with an
intact mesocolon and the maximum possible distance
between colon and high tie. Complete mesocolic excision
with central vascular ligation has been shown to signifi-
cantly increase the number of harvested lymph nodes when
compared to series not systematically following these
principles [42]. An attempt has been made to reduce this
Fig. 1 Sample sizes and propensity score matching
World J Surg (2013) 37:2458–2467 2463
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bias by including the surgeon’s specialty as a covariate into
the matching. However, no sufficient balance between the
groups could be reached to allow for statistical interpreta-
tion. By additionally matching for the specialty, several
other covariates became unbalanced ([0.25 standardized
mean difference) with a trend to a more unfavorable risk
profile and outcome in the open group. Specialist colorectal
surgeons often were involved in open cases because of the
complexity or unfavorable risk profile. Only when match-
ing for the specialty was not performed, open cases with a
similar risk profile to the laparoscopic cases were included.
With respect to completeness of resection (R stage), there
was a trend toward a higher R1/2 rate in the laparoscopic
group (28 %) compared to the open group (11 %), which
may be related to the high proportion of T4 tumors in
patients presenting as emergencies. In the past, T4 tumors
were considered to be a contraindication for laparoscopy.
Although Bretagnol et al. [43] showed that laparoscopy for
T4 colorectal tumors was feasible and concluded that T4
tumors are not an absolute contraindication for laparos-
copy, their rate of incomplete resections and conversions
was relatively high. In advanced T4 tumors, the standard
Table 2 Baseline
characteristics after 1:2
matching (n = 108)
a Mann–Whitney U test
b Chi square test
c Fisher’s exact test
d Missing values of 56 % in
open and 17 % in the
laparoscopic group
Open (n = 72) Laparoscopic (n = 36) p value
Age, years [median (range)] 77.5 (30–92) 74.0 (32–93) 0.865a
Gender 0.413b
Male 36 (50.0 %) 15 (41.7 %)
Female 36 (50.0 %) 21 (58.3 %)
BMI [median (range)]d 26 (15–38) 24 (16–41) 0.662a
ASA score 0.841c
1 11 (15.3 %) 4 (11.1 %)
2 33 (45.8 %) 17 (47.2 %)
3 24 (33.3 %) 14 (38.9 %)
4 4 (5.6 %) 1 (2.8 %)
Type of procedure 0.978c
Right colectomy 48 (66.7 %) 25 (69.4 %)
Left colectomy 4 (5.6 %) 1 (2.8 %)
Subtotal colectomy 4 (5.6 %) 2 (5.6 %)
Sigmoid colectomy 16 (22.2 %) 8 (22.2 %)
Right versus left colon 0.658b
Right colon tumor 49 (68.1 %) 26 (72.2 %)
Left colon tumor 23 (31.9 %) 10 (27.8 %)
Reason for urgency 0.686c
Pericolic abscess or
contained perforation
1 (1.4 %) 2 (5.6 %)
Free perforation 9 (12.5 %) 4 (11.1 %)
Intestinal obstruction 37 (51.4 %) 17 (47.2 %)
Unspecified 25 (34.7 %) 13 (36.1 %)
TNM stage 0.328c
1 1 (1.4 %) 2 (5.6 %)
2 22 (30.6 %) 15 (41.7 %)
3 42 (58.3 %) 16 (44.4 %)
4 7 (9.7 %) 3 (8.3 %)
Postoperative chemotherapy 0.721c
No chemotherapy 39 (54.2 %) 21 (58.3 %)
Adjuvant chemotherapy 29 (40.3 %) 12 (33.3 %)
Palliative chemotherapy 4 (5.5 %) 3 (8.4 %)
Speciality of surgical team \0.001b
Non-colorectal consultants 41 (56.9 %) 4 (11.1 %)
Colorectal consultants 31 (43.1 %) 32 (88.9 %)
Colorectal consultants with
special interest in laparoscopy
5 (7.0 %) 24 (66.7 %)
2464 World J Surg (2013) 37:2458–2467
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laparoscopic technique seems to have its limitations. Blunt
dissection in predefined embryological planes has to be aban-
doned in favor of awide excision,whichoften leads to bleeding
and uncontrolled actions. Furthermore, the extent of tumor
infiltration may be more difficult to assess laparoscopically
than in open surgery, where digital palpation helps to guide the
resection. The benefit of laparoscopy in locally advanced
tumors needs to be explored in further studies.
Although the rate of serious complications needing re-
intervention was similar in both groups, the laparoscopic
group surprisingly showed a trend toward more wound
infections (17 vs. 4 %, p = 0.057), which is in contrast to
the situation that exists in elective surgery. A possible
explanation for this is that port site incisions and extraction
site were routinely primarily closed, whereas laparotomy
wounds were closed on a more selective basis according to
the grade of the contamination.
In the elective setting, a shorter length of hospital stay
has been reported as one of the major benefits of laparo-
scopic surgery [44–46]. Likewise in the emergency setting
Table 3 Long- and short-term
outcomes after 1:2 matching
Propensity score matched for
age, gender, ASA score, type of
procedure, site of tumor, reason
for emergent surgery
a Log rank test
b Chi-square test
c Fisher’s exact test
d Mann–Whitney U test
e Denominator of percentages
in parenthesis is total number of
anastomoses performed in
corresponding group
Open (n = 72) Laparoscopic (n = 36) p value
Long-term outcomes
3-year overall survival rate (95 % CI) 43.2 % 51.1 % 0.239a
(32.3–57.9) (34.5–75.7)
3-year recurrence-free survival rate (95 % CI) 36.6 % 34.9 % 0.528a
(26.6–50.3) (20.4–59.5)
Recurrence
Local recurrence 5 (6.9 %) 4 (11.1 %) 0.478c
Distant recurrence 16 (22.2 %) 10 (27.8 %) 0.524b
Short-term outcomes
30-day mortality 9 (12.5 %) 3 (8.3 %) 0.747c
R0 resection 64 (88.9 %) 26 (72.2 %) 0.052c
Lymph node harvest [median (range)] 13 (3–39) 17 (5–55) 0.041d
Surgical complications needing re-intervention 6 (8.3 %) 5 (13.9 %) 0.668c
Abscess 3 (4.2 %) 3 (8.3 %)
Leaks/cases with anastomosise 1/57 (1.8 %) 1/30 (3.3 %)
Bleeding 0 (0.0 %) 0 (0.0 %)
Other 2 (2.8 %) 1 (2.8 %)
Wound infection 3 (4.2 %) 6 (16.7 %) 0.057b
Length of stay, days [median (range)] 11.0 (1–61) 7.5 (2–45) 0.019d
Stoma 0.565c
No stoma 50 (69.4 %) 28 (77.8)
Ileostomy temporary 7 (9.7 %) 2 (5.6)
Ileostomy permanent 3 (4.2 %) 1 (2.8 %)
Colostomy temporary 1 (1.4 %) 2 (5.6 %)
Colostomy permanent 11 (15.3 %) 3 (8.3 %)
Readmission 5 (6.9 %) 3 (8.3 %) 1.000c
Fig. 2 The Kaplan–Meier curves show no significant difference in
overall survival between the open and laparoscopic post-match group
(p = 0.24, log rank test)
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of the present study, length of hospital stay was signifi-
cantly shorter in the laparoscopic group, which may have
implications for the effort to reduce hospital-related costs
[47, 48].
Although selection bias has been addressed by a pro-
pensity score-matched design, this study has limitations
due to its non-randomized design and retrospective nature.
With a relatively small sample size and short follow-up,
especially in the laparoscopic group, the study may be
underpowered such that smaller but significant differences
may not be evident. Furthermore, outcomes were mainly
based on experienced laparoscopic surgeons and are
therefore not generalizable without reservation. This con-
founder could not be addressed by the study design because
not every surgeon was able to offer both laparoscopic and
open methods. Therefore, it is important to highlight the
fact that the study results are based on a selected patient
collective and laparoscopically experienced specialist
colorectal surgeons. Keeping this in mind, laparoscopy
may be an alternative to open surgery and may become
even more important as expertise in laparoscopy increases.
However, only a multi-center study with randomized
treatment allocation can answer whether laparoscopy in the
emergency setting can challenge the gold standard of open
surgery.
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Abstract
Background: Previous abdominal surgery and its related adhesions are usually a relative contraindication for laparoscopic surgery or reason for conversion.
Objectives: This study aim to identify patients with previous abdominal surgery and compare the clinical outcomes in patients with and without previous abdominal surgery.
Patients and Methods: Data was collected prospectively from September 2006 to Dec 2010 of all laparoscopic colorectal resections done for both benign and malignant diseases.
Results: Out of 718 patients 476 had no previous abdominal surgery (Group A), whilst 190 patients had previous abdominal surgery not involving colonic surgery (Group B), and 52 had previous bowel surgery (Group C). The conversion rate was 4% for all groups, the re-admission rate was 11.8% for Group A, 12.6% for Group B and 9.6% for Group C, the median length of stay was 4 days for Groups A and B and 5 days for Group C. There was no statistically significant diﬀerence between groups for any of the above measures. However, there was a statistically significant diﬀerence in the length of operative time between groups. Patients in Group A and Group B requiring a median of 180 minutes, whilst Group C required a median of 210 minutes of operative time. (P = 0.026 and 0.002, respectively).
Conclusions: Previous abdominal surgery, including previous colonic surgery, confers no added risk of conversion to an open operation, morbidity or mortality for patients undergoing laparoscopic colorectal surgery. The operative time however is longer (30 minutes) for patients with previous colonic surgery.
Keywords: Laparoscopic Surgery, Conversion Rates, Previous Abdominal Surgery, Previous Colonic Surgery
Copyright © 2015, Minimally Invasive Surgery Research Center and Mediterranean & Middle Eastern Endoscopic Surgery Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. BackgroundSince Jacobs et al. (1) described the first laparoscopic colectomy in 1991, the use of laparoscopic approaches to benign and malignant colorectal disease has increased dramatically. Despite initial concern over surgical learn-ing curves and port site recurrence, several large multi-centre trials have shown that laparoscopic surgery is safe and has comparable surgical outcomes and com-plication rates when compared with open surgery (2) and in particular can improve return to function of GI tract, reduce length of hospital stay and shorten time oﬀ work.However, concern remains over laparoscopic conver-sion rates, which vary wildly in the published literature (3, 4). Indeed, patients who have conversion to open sur-gery are more likely to have increased length of stay (2), decreased survival (5) and increased complication rates (6). Therefore attention has turned to identifying sub-groups of patients who are thought to be particularly high risk for conversion to open surgery (7-10). Patients with previous abdominal surgery and therefore are pre-
disposed to having intra-abdominal adhesions, are one such group (11).Adhesions are a common consequence of previous sur-gery. Indeed, reports suggest that 90% of patients with previous abdominal surgery will have adhesions on post-mortem (12) or on subsequent laparotomy (13). Morbidity from adhesions range from periodic abdominal pain, in-fertility to intestinal obstruction requiring adhesiolysis or bowel resection (14-16) and are a significant cause of readmission to the surgical acute take. In addition, adhe-sions may cause concern for the laparoscopic colorectal surgeon. Curet (11) describes how adhesions can cause increased risk of bowel injury, inadequate operative field exposure and a restricted view of the operative field and subsequent operative series found an increased conver-sion rate (17), re-operation and higher complication rates (10). This led many surgeons to avoid laparoscopic ap-proaches in patients with previous abdominal surgery or, opt for early conversion upon demonstrating intra-abdominal adhesions.
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2. ObjectivesOur study aim is to examine the eﬀects of previous abdominal surgery on clinical outcomes. In addition, patients previously undergone open colonic resections were also included.
3. Patients and MethodsWe describe a prospective series of 718 unselected pa-tients. From 2006 to 2010, patients undergoing elective and emergency laparoscopic colonic surgery for benign and malignant disease at Queen Alexandra hospital, Portsmouth, U.K., were enrolled in our study.Data collected includes, Patient’s demographic details, previous abdominal procedures, indication for surgery, type of surgery, conversion to open surgery, length of op-eration, length of hospital stay, readmissions within 30 days following surgery, postoperative major complica-tions and 30 days mortality.
3.1. Operative TechniqueLaparoscopic colorectal surgery was performed un-der general anaesthetic, with the patients positioned in modified Lloyd Davies position. Pneumoperitoneum was established using Hassan’s open technique or blunt port insertion. Surgeon stands on the opposite side of the co-lon to be resected. The standard 4 - 5 ports techniques was used with extraction of the specimen carried out using either transverse or paraumblical incision of approxi-mately 3 - 5 cm. Mobilisation of the colon and ligation of supplying vessels were performed intra-corporeally and specimens were extracted according to onco-surgical principles using wound protector. Right-sided resections were followed with extracorporeal anastomosis, while all 
left sided resections were completed using intra corpo-real anastomosis techniques (18).All patients had DVT prophylaxis with subcutaneously administered clexane. All patients with rectal cancer underwent bowel preparation while all other patients including the emergency resection were not given bowel preparation. Post operatively, all elective resection pa-tients were managed with enhance recovery protocol as described by Kehlet and Wilmore (19) with an exception of selective use of epidural catheter and avoidance of pre-operative glucose loading.
3.2. Statistical AnalysisMicrosoft access Database was used to collect and store data. Continuous data was expressed as median (range). To compare treatment groups, the Mann-Whit-ney U test was applied to the continuous data and the Chi square test to categorical data. P < 0.05 was consid-ered as statistically significant. All analyses were per-formed using Graphpad prism 5. (Graphpad software Inc., San Diego, CA).
4. ResultsFor the comparison of outcomes, patients were divided into three groups based on their previous surgical histo-ry. Patients in Group A (n = 476) did not have previous ab-dominal surgery. Patients included in Group B had previ-ous abdominal surgery, but not colonic surgery (n = 190) and Group C patients had previously undergone colonic surgery (n = 52). Details of the laparoscopic procedures performed during are listed in Table 1 details of previous operative abdominal procedures for Groups B and C are listed in Table 2.
Table 1. Patient Demographics of the Diﬀerent Patient Groups, Including Indication of Surgery and Laparoscopic Procedure at the Time of Studya
Patient Demographics No Previous Surgery Previous Abdominal Surgery Previous Colonic Surgery
Elective laparoscopic lower GI surgery 476 (66) 190 (26) 52 (7)
Male 280 (59) 74 (39) 32 (62)
Age (median, range) 68 (18 - 92) 69 (24 - 89) 58 (22 - 90)
Current ProcedureAnterior resection 223 (46.8) 89 (46.8) 9 (17.3)Right Hemicolectomy 131 (27.5) 54 (28.4) 8 (15.4)Other 7 (1.5) 1 (0.5) 21 (40.4)Sigmoid colectomy 28 (5.9) 22 (11.6) 0 (0.0)Proctectomy 0 (0.0) 0 (0.0) 7 (13.5)Panproctocolectomy 9 (1.9) 3 (1.6) 4 (7.7)Extended right Hemicolectomy 20 (4.2) 6 (3.2) 0 (0.0)Hartmann’s procedure 7 (1.5) 4 (2.1) 1 (1.9)APER 27 (5.7) 4 (2.1) 1 (1.9)Subtotal colectomy 13 (2.7) 4 (2.1) 1 (1.9)Left Hemicolectomy 11 (2.3) 3 (1.6) 0 (0.0)
Other current procedureReversal Hartmann’s 0 (0) 0 (0.0) 11 (21.2)Ileo-colic resection 0 (0) 0 (0.0) 8 (15.4)Ileo-rectal resection 0 (0) 0 (0) 1 (1.9)
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Rectal resection 0 (0) 0 (0) 1 (1.9)Excision rectovaginal septum 3 (0.6) 0 (0) 0 (0.0)Small bowel resection 4 (0.8) 1 (1) 0 (0.0)Anastomosis 430 (90) 179 (94) 46 (88)
DiagnosisColorectal cancer 368 (77.3) 155 (81.6) 19 (36.5)Diverticular disease 25 (5.3) 14 (7.4) 6 (11.5)Colitis 13 (2.7) 4 (2.1) 12 (23.1)Other 13 (2.7) 5 (2.6) 6 (11.5)Crohn’s disease 32 (6.7) 4 (2.1) 7 (13.5)Adenoma 16 (3.4) 2 (1.1) 2 (3.8)Volvulus 6 (1.3) 3 (1.6) 0 (0.0)Carcinoid 3 (0.6) 3 (1.6) 0 (0.0)aData are presented as No. (%) except age (median, range).
Table 2. The Previous Abdominal Surgeries for Patients in Groups B and Ca
Previous Abdominal Surgery Previous Colonic Surgery
Previous Abdominal ProcedureUnrecorded 27 (14) 0 (0)Hysterectomy 59 (31) 0 (0)Appendicectomy 52 (27) 0 (0)Laparotomy 14 (7) 0 (0)Hartmann’s 0 (0) 12 (23)Other 15 (8) 5 (10)Subtotal colectomy 0 (0) 10 (19)Right Hemicolectomy 0 (0) 10 (19)Cholecystectomy 10 (5) 0 (0)Anterior resection 0 (0) 7 (13)Bowel resection (unknown detail) 0 (0) 6 (12)Caesarian 9 (5) 0 (0)AAA repair 4 (2) 0 (0)Sigmoid colectomy 0 (0) 2 (4)Total 190 52
Other previous abdominal procedureSterilisation 3 0Pyeloplasty 2 0Liver resection 4 0Nephrectomy 1 0Stoma 0 3Splenectomy 1 0Umbilical hernia repair 2Twisted bowel 0 1Adhesiolysis 1 0Perforated colon after polyp removal 0 1Perforated diverticulum 1 0Total 15 5aData are presented as No. (%) or No.
During our series, overall conversion rate was 4.0% (29/718) and 30 days mortality rate of 0.6% (5) was seen. Post-operative morbidity was 12.5% (90/718), of which 30 patients (4.2%) required re-operation < 30 days following surgery. Overall, median length of stay in hospital was 4 days (range 1 - 74).
There were no significant differences detected be-tween groups for conversion rates (P = 0.954), post-op-erative re-admission rate (P = 0.852), re-operation (P = 0.701) rate or mortality (P = 0.281). This is shown below in Table 1. Indications for conversion are given in Table 3. Clinical outcomes, readmission rate and reopera-
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tion rate with reasons for reoperations are displayed in Table 4.
Table 3. The Conversion Rate and Indication of Conversiona
Conversion or Complete No Previous Surgery Previous Abdominal Surgery Previous Colonic Surgery
Laparoscopic complete 456 (96) 183 (96) 50 (96)
Conversion to open surgery 20 (4) 7 (4) 2 (4)
Adhesions 0 (0) 3 (2) 2 (4)
Oncological 9 (2) 3 (2) 0 (0)
Obese 1 (0) 1 (1) 0 (0)
Technical 2 (0) 0 (0) 0 (0)
Diﬃcult operation 5 (1) 0 (0) 0 (0)
Bleed 1 (0) 0 (0) 0 (0)
Other 2 (0) 0 (0) 0 (0)aData are presented as No. (%).
Table 4. Outcomes and Complication Rates for the Three Patient Groupsa
Outcomes No previous surgery Previous Abdominal Surgery Previous colonic surgery
Length of hospital stay: median, range 4 (1 - 74) 4 (2 - 50) 5 (2 - 43)
Readmission < 30 days surgery 56 (11.8) 24 (12.6) 5 (9.6)
Postoperative mortality 5 (1.1) 0 (0) 0 (0)
Reoperation < 30 days surgery 22 (5) 6 (3) 2 (4)
Reoperation for anastomotic leak 14 (3) 2 (1) 1 (2)
Reoperation for abscess 0 (0) 0 (0) 1 (2)
Reoperation for bleed 0 (0) 1 (1) 0 (0)
Reoperation for obstruction 0 (0) 1 (1) 0 (0)
Reoperation for revision of stoma 2 (0) 2 (1) 0 (0)
Reoperation for small bowel injury 1 (0) 0 (0) 0 (0)
Reoperation for wound dehiscence 1 (0) 0 0 () 0 (0)
Reoperation for exploration port site 2 (0) 0 (0) 0 (0)
Reoperation for exploratory investigation 2 (0) 0 (0) 0 (0)aData are presented as No. (%) except median, range.
In addition, length of hospital stay was not significantly diﬀerent between groups A and B (P = 0.07) and groups A and C (P = 0.22). However, median length of operating time did diﬀer between groups. Surgery for patients in Group A took 180 minutes (SD = 79.2 minutes), Group B took 180 minutes (SD = 69.2 minutes) and Group C took 210 minutes (SD = 86.4 minutes) on average to complete. The diﬀerence between Groups A and C was statistically significant (P = 0.026), as was the diﬀerence between groups B and C, (P = 0.002)
5. DiscussionExperience in minimally invasive surgery has rapidly increased and adhesions due to previous abdominal sur-gery are not considered to be contra-indication for lapa-roscopy (20).In our series of 718 unselected patients, the overall con-version rate was 4%. This is lower than previously pub-lished conversion rates in laparoscopic colorectal sur-gery, which ranged from 5% in selected patient groups to in excess of 20% in unselected groups (3, 4, 21).Postoperative mortality and morbidity was low and hospital length of stay was only 4 days, further corrobo-rating the findings of randomised control trials of lapa-
roscopic surgery (2, 22, 23). Therefore, we too conclude that laparoscopic surgery is a safe approach for colorectal surgery with few postoperative complications.There were more women in the previous abdominal surgery group and this is likely to be due to previous abdominal hysterectomies. However, there was no sta-tistical diﬀerence in the number of males with no previ-ous surgery and those with previous colonic surgery (P = 0.809).In patients with no previous abdominal surgery, the commonest cause for conversion was oncological clear-ance. However, the reason for conversion in groups with previous abdominal and colonic surgery was abdominal adhesions. Our study revealed no statistically significant diﬀerence in conversion rates between all three groups of patients with no previous abdominal surgery (4 %), those with previous abdominal surgery (3.8%) and even be-tween patients with previous colonic surgery (4%). These results show that having previous abdominal or colonic surgery confers no added risks for conversion to open surgery or worse clinical outcomes.Previous studies have also shown that conversion rates are unaﬀected by previous surgery (24). However, Gon-zalez (17) described a 20% increase (P = 0.02) and Vignali 
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(25) an 8% increase (P = 0.001) in conversion rates for pa-tients with previous abdominal surgery compared with patients with a “virgin abdomen”. However, the num-bers involved in these studies were smaller (n = 86 and n = 182, respectively) and additionally, having found no diﬀerence in complication rates, both Gonzalez (17) and Vignali (25) concluded that laparoscopic surgery was safe in patients with previous colonic surgery.Complications encountered are included in Table 4. Of note, no statistically significant diﬀerence in complica-tion rates was detected between patients with and with-out prior surgery, even those who have had prior colonic surgery (P = 0.852). These findings are consistent with previously published studies (17, 26).Concerning operative time, previous studies have shown little consensus over whether patients with previ-ous abdominal surgery require more operative time. In-deed, Vignali (25), found that approximately 26 minutes extra were needed for laparoscopic resections in patients with previous abdominal surgery, whilst Gonzalez (17) found no significant diﬀerence in operating times, be-tween these groups. Our results show that laparoscopic colectomies on patients with previous abdominal but not colonic, surgery does not take longer. However, lapa-roscopic resections on patients with previous colonic surgery take approximately 30 minutes longer than for patients with virgin abdomens or with other previous abdominal surgeries. In addition, patients with protec-tive ileostomies in Group C resulted in increase length of stay by one day due to stoma competencies. We therefore suggest that previously contradicting studies’ findings in patients with previous abdominal surgery may have been due to not taking account of whether patients had previous colonic surgery or not.A surgeon experience in laparoscopy plays an impor-tant role in patients with previous abdominal surgery. Low conversion rate in our study is due to the fact they are heavily experienced in laparoscopic surgery. In litera-ture authors have used diﬀerent sites for port insertion but in our experience the best approach is to either use umblical port, but if this is not possible we have used right upper quadrant or left upper quadrant 5mm port with an oﬀ centre 5mm camera which enable us to create pneumoperitoneum and division of adhesions.Our study found no diﬀerence in conversion rate and short term clinical outcomes including major morbidity, re operation rate, readmission rates, length of hospital stay and 30 days mortality for patients undergoing lapa-roscopic colorectal surgery with or without previous ab-dominal surgery. Previous colonic surgery does require additional operating time but other previous abdominal surgeries confers no added risk for this too. We conclude that previous abdominal surgery and previous colonic surgery confer no added risk to laparoscopic colonic sur-gery and therefore, should not be considered contra-in-dication for a laparoscopic approach. However extensive experience with laparoscopic technique makes the sur-
gery safe and possible with very low rate of conversions. Additionally, with recent publications showing a reduced rate of adhesion formation in laparoscopic surgery (27), it is likely that future surgeons will be able to operate on patients with previous abdominal and previous colonic surgery with even greater confidence.
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Abstract
Purpose Laparoscopic total mesorectal excision (TME)
of locally advanced rectal cancer after long-course che-
moradiotherapy (LCRT) is surgically and oncologically
challenging. We have assessed the feasibility, timing, and
short-term oncological outcome of laparoscopic TME after
LCRT.
Methods Between 2004 and 2006, 30 patients were
selected for LCRT based on clinical examination and MRI.
Patients received 3/4 field radiotherapy, 45–50.4 Gy in
25–28 fractions during 5 weeks with either 5-fluorouracil
or Uftoral. Clinical assessments were made 4 weeks after
completion of radiotherapy and then 2 weekly with
sequential 4 weekly MRI, to individualize the timing of
surgery at maximal response. Laparoscopic TME was
performed using a standard technique.
Results Thirty patients received LCRT and 26 patients
(21 men; median age, 63 years) underwent laparoscopic
TME at 11 weeks (median) after LCRT. Median operating
time was 270 min. Sixteen patients had LAR and ten had
APR. There were three conversions. Three patients devel-
oped anastomotic leak (18.7%): one was managed con-
servatively and one patient died of septicemia. Morbidity
was seen in 19% of patients. There were 25 (96%) R0
resections with a complete response in 5 (19%) cases and
microscopic tumor in lakes of mucin (Tmic) in another 6
(23%). Two patients (7.6%) developed local recurrence
(median follow up, 34 months). The median time interval
between radiotherapy and surgery was 11 (range, 7–13)
weeks, which was based on serial MRI scans after LCRT.
Conclusions Laparoscopic TME after LCRT is feasible
and safe both oncologically and surgically. Serial MRI
helps to determine the optimum timing of surgery.
Keywords Laparoscopic total mesorectal excision !
Locally advanced rectal cancer ! Long-course
chemoradiotherapy
The multidisciplinary approach to the management of
patients with rectal cancer has become the cornerstone for
successful outcome [1]. Neoadjuvant long-course chemo-
radiotherapy (LCRT) is now established for the treatment
of locally advanced rectal cancer [2, 3]. Significant tumor
downsizing and downstaging has been demonstrated with
reports of complete clinical and radiological response in up
to 25% of cases [4–7]. Delivery of radiotherapy (RT) as a
short course followed by total mesorectal excision (TME)
surgery has been favored by the Dutch Colorectal Cancer
Group [8]. However, there are strong arguments in favor of
delivering RT as a long course with a delay between the
end of RT and definitive surgery [9].
Surgery has conventionally been performed in those
deemed operable at approximately 6 weeks after comple-
tion of CRT, but it is unclear whether this is the optimum
time for surgery. Surgeons have encountered technically
challenging operative fields due to edema and vascularity
associated with neoadjuvant therapy. In addition, postop-
erative morbidity has been shown to be increased with
wound breakdown after abdominoperineal resection (APR)
and anastomotic dehiscence following anterior resection
(AR) being particular problems [10, 11]. It has been
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postulated that surgery may, in these cases, be deferred by
a period of time that will allow the tissue reaction in the
pelvis to settle down. The optimum timing of surgery is as
yet not clearly defined.
The advent of powerful gradient systems and the
development of high-resolution phased array surface coils
in recent years has greatly improved the staging of rectal
cancer with respect to local spread into the mesorectum and
associated lymphatic tissue by MRI [12, 13]. The advan-
tages and accuracy of MRI for preoperative staging of
rectal cancer are not in doubt [14, 15]. It is, however,
possible that the full potential of preoperative MRI has not
been utilized, particularly in optimizing the timing of sur-
gery following CRT.
There remains uncertainty regarding the management of
patients with rectal cancer who successfully undergo CRT
and have a complete radiological and pathological response
(CR). Habr-Gama and colleagues have adopted a success-
ful policy of careful follow-up, high-quality imaging, and
frequent examination under anesthesia [16]. Many would
argue that resection of the scar would be the minimum that
one should offer such patients. The availability of transanal
endoscopic microsurgery (TEMS) allows such an option.
In the 75% or so of patients who require radical resection,
we have argued that a laparoscopic approach to resection of
the rectum should be considered [17].
The authors of UK MRC CLASICC raised concern
about the application of laparoscopic anterior resection for
rectal cancer due to a nonstatistically significant increased
risk of involved circumferential resection margins in the
laparoscopic group [18]. However, data from further pub-
lished studies have shown the safety and feasibility of
laparoscopic anterior resection for rectal carcinoma [19–
21]. The goal of this study was to assess a new clinical and
radiological method to optimize timing of surgery after
LCRT and to assess the safety and feasibility of the lapa-
roscopic approach in patients with rectal cancer who
undergo LCRT.
Materials and methods
Study design
This was a prospective audit of consecutive patients who
underwent laparoscopic TME for LARC. Since 2003, 30
patients with histologically proven, locally advanced ade-
nocarcinoma of the rectum have been analyzed. Rectal
cancer was defined as any tumor arising in the rectum up to
15 cm from the anal verge on rigid sigmoidoscopy.
Patients were selected for neoadjuvant treatment based on
pelvic MRI scan. T3[ 5 mm into perirectal fat, T4
tumors, multiple enlarged lymph nodes in the mesorectum,
and threatened or involved CRM were the criteria for
preoperative long-course chemoradiotherapy.
Demographic, operative, and postoperative data were
recorded. All patients with rectal cancer were seen in a
follow-up clinic by a single senior surgeon who kept a
prospective database of complications, recurrence, and
mortality. In addition, case notes were retrieved to obtain
details of postdischarge complications and follow-up. All
patients gave fully informed consent for their treatment.
All operations were performed by three experienced lapa-
roscopic colorectal surgeons (RWM, RA, and TA) and
senior colorectal trainees under their direct supervision.
Chemotherapy and radiology protocol
Patients received two-phase, conformal, external beam
radiotherapy (45–50.4 Gy/25–28 fractions/5 weeks), con-
currently with their choice of oral UFT, 240 mg/m2/d days
1–28 with Leucovorin (LV) 90 mg/d or iv bolus 5-FU
(n = 6) 300 mg/m2 days 1, 8, 15, 22, and 29 with LV
20 mg/m2. Clinical reassessment was done twice weekly
from 4 weeks post-CRT, with serial MRIs 4-weekly, from
6 weeks onwards.
Technical and operative specifications
Patients who underwent anterior resection of the rectum
(AR) were given bowel preparation at the beginning of the
study period. Patients received 20 mg of enoxaparin
(Clexane!) at 1800 on the day before surgery and 1.5 g of
cefuroxime and 500 mg of metronidazole. Enhanced
Recovery Programme (ERP) was the standard of care for
patients undergoing elective colorectal resections, which
was modelled on the practice of Kehlet and Kennedy et al.
[22, 23].
Pneumoperitoneum was obtained using the previously
described standard Colchester technique with a blunt 5-mm
reusable trocar placed in the right flank, which accommo-
dated a 5-mm 30" laparoscope [24]. A 5-mm port was
placed in the epigastrium just to the right of the midline
and a further 10-mm port was placed in the right iliac fossa.
Another 5-mm port was placed in the left flank for
retraction and splenic flexure mobilisation. The 10-mm
right iliac fossa port was exchanged later for 10/12 dis-
posable port (Ethicon Endosurgery, UK) if the bowel was
to be transected using an Endoscopic stapling device.
Dissection was performed using the Harmonic Scalpel
(Ethicon Endosurgery, Cincinnati, OH). Before any dis-
section, the small intestine was displaced into the right
upper abdomen by a combination of lateral tilt and reverse-
Trendelenburg position. A medial to lateral dissection was
performed commencing at the sacral promontory and
continued in a cranial direction toward the origin of the
1754 Surg Endosc (2011) 25:1753–1760
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inferior mesenteric artery, which was divided using Lapa-
roclips (Covidien, Gosport, UK). The left ureter was
identified. Dissection proceeded along the fascia of Toldt to
the lateral peritoneal attachments and cranially toward the
spleen. The inferior mesenteric vein (IMV) was preserved
until the lateral dissection was completed and then divided
between Laparoclips. Where necessary the splenic flexure
was mobilized via an approach through the lesser sac above
the pancreas with dissection continued laterally to join up
with the previous lateral dissection. Laparoscopic TME
was performed down to the pelvic floor. Autonomic nerves
were identified and preserved. The rectal tube was tran-
sected using a linear stapler cutter (Ethicon Endosurgery).
The segment to be resected was extracted through a 5–6-cm
vertical transumbilical incision with a wound protector in
situ (3M Steri-DrapeTM Wound Edge Protector).
Data and statistical analysis
Analysis of correlation between imaging and pathology
was determined by Cohen’s unweighted Kappa coefficient.
Data on overall morbidity from the present study was
compared with that from other centres by Chi-square test;
Fisher’s exact test was used to compare individual outcome
measures of morbidity and mortality with data from other
centers.
Results
Thirty patients were treated with LCRT. Laparoscopic
TME was attempted in 26 patients. Four patients were
excluded from the analysis. Two had progressive inopera-
ble disease and two patients developed large-bowel
obstruction requiring emergency surgery. There were 21
men and 5 women patients with a median age of 63 (range,
39–81) years. The majority of patients (n = 15) were ASA
grade II (Table 1).
Timing and nature of surgery
The timing of surgery was based on clinical and radio-
logical assessment. The median time to surgery was
11 weeks after completion of CRT. Although initially
digital rectal examination, sigmoidoscopy, and a single
posttreatment MRI (MRI 2) was standard practice, the
continued clinical response led to the introduction of an
additional MRI scan (MRI 3) before surgery (Fig. 1A, B).
Eleven patients in total had MRI 3. No patients developed
metastatic disease between diagnosis and surgery.
Sixteen (61.5%) patients underwent anterior resection of
the rectum and ten (38.4%) underwent APR. These figures
compare to a rate of 13% of patients with rectal cancer
undergoing laparoscopic APR in the unit since 1994. These
ten patients all had low (\5 cm from the anal verge)
tumors that were not amenable to sphincter-saving surgery.
Twelve patients had a defunctioning loop ileostomy. The
median length of operation was 270 min for patients who
underwent laparoscopic TME after CRT (Table 2). The
mean operating time for patients undergoing laparoscopic
TME in the unit is 220 min. There were three conversions
to open surgery (2 for APR and 1 for low anterior resec-
tion). All conversions were in male patients. The reason for
conversion in these three patients was a difficult pelvic
dissection in a narrow pelvis with inability to progress. In
these cases a lower midline incision was made to complete
the rectal dissection.
Complications of surgery and mortality
There were five complications (19%) and one death (3.4%)
within 30 days. The patient who died was a 67-year-old
man who underwent low AR for a T3N1M0 tumor. On
postoperative day 3, he developed clinical signs of anas-
tomotic leak, which was confirmed with a CT scan. He
underwent emergency laparotomy, peritoneal washout, and
formation of an end colostomy because the anastomosis
was not salvageable. Unfortunately, he developed multiple
organ failure secondary to the sepsis and died 4 days later.
Overall, the rate of anastomotic leakage was 18.7% (3/26
patients). One of these patients had a leak with a small
abscess cavity. He was already defunctioned with a loop
ileostomy and was managed conservatively with uncom-
plicated recovery.
Major morbidity is listed in Table 3. Interestingly, the
rate of wound breakdown for APR was 20%, much lower
than expected figure of 50–60% [25, 26]. Two patients
with postoperative small-bowel obstruction underwent
Table 1 Patient demographics
Age (year)
Median 63
Range 39–81
Sex
Male 21
Female 5
ASA grade
Grade I 5
Grade II 15
Grade III 6
Tumor location
Lower rectum (\5 cm from anal verge) 11 (42%)
Mid rectum (5–10 cm from anal verge) 14 (53%)
Upper rectum (11–15 cm from anal verge) 1 (4%)
Surg Endosc (2011) 25:1753–1760 1755
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laparoscopy and adhesiolysis with good recovery. Four
patients had bladder dysfunction and were managed suc-
cessfully with a period of catheterisation.
Pathological findings
Eight patients had pathological staging of T3N0M0, five
were T3N1M0, two patients had T1N1M0 and T4N1M0
each, and there was one patient in T2N0M0 and one in
T4N0M0 stage. Two patients had N2 disease (T2N2 and
T3N2). Five patients had pathological complete response
(T0N0M0). The median lymph node yield was 5 (range,
0–14). One patient had a R1 resection (1/26, 4%) with a
T4N1M0 Dukes C1 tumor with the cancer cells extending
up to\1 mm from the CRM. He remains disease-free after
a follow-up of 30 months.
In five patients, there was a pathological complete
response. In addition, there were six patients classified as
Tmic, in whom microscopic islands of tumor cells were
seen within lakes of mucin. The overall disease free sur-
vival after a mean follow-up of 19 months was 84%
(Fig. 1C). One patient had a local recurrence. He was a
67-year-old man who underwent laparoscopic APR for a
carcinoma 4 cm from the anal verge. The procedure was
converted to open surgery due to technical difficulty
because of a narrow pelvis. The histology was T3N1M0
and he developed local recurrence on follow-up of
18 months. One patient developed recurrent systemic
Fig. 1 Sagittal section MRI pelvis with a low rectal carcinoma, demonstrating ongoing radiological response to CRT: Pre-LCRT (T3N1) (A),
6 weeks post-LCRT (T3N1) (B) and 10 weeks post-LCRT (T2N0) (C)
1756 Surg Endosc (2011) 25:1753–1760
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disease. This patient was a 57-year-old woman who had
rectal cancer at 7 cm from the anal verge. The histology
was a T3N0 Dukes B cancer; however, she developed
hepatic metastases during her follow-up.
Correlation between imaging and pathology
There was good correlation between the last preoperative
MRI and final pathology. MRI 3 showed a high correlation
for T stage (k = 0.56; 95% CI 0.10–0.93) and N stage
(k = 0.41; 95% CI 0.01–1.0) respectively. The concor-
dance for combined T and N stage also was high (k = 0.44;
95% CI 0.08–0.81). The second MRI scan (performed
6 weeks post-CRT) showed that a full T downstage
occurred in 19% of patients. This figure increased to 42%
for the N stage. A further downstaging for N stage was seen
in 11% of patients on MRI 3. In those patients who had two
post-CRT MRIs, the second MRI had a more accurate
correlation with final pathology. The presence or absence
of vascular invasion was correctly predicted in 73% on the
MRI 3. Vascular invasion was correctly predicted in only
53% of cases following MRI 2 (Figs. 2, 3).
Discussion
Neoadjuvant CRT is now established in the treatment of
patients with LARC. The traditional approach to timing of
surgery has been to delay definitive resection until
approximately 6–8 weeks after CRT [27]. More recently it
has been suggested that surgery can be delayed or even
postponed indefinitely [28]. We have reported earlier that
there is a radiologically documented ongoing response to
CRT beyond 6 weeks [29]. Delaying surgery until
11 weeks after CRT has had no deleterious consequences
in this series. Our experience suggests that the optimum
timing of surgery may be at approximately 3 months as a
result of the ongoing response to CRT and may account for
the high rate of pCR and Tmic seen in the final histology.
Pelvic surgery after CRT can be challenging due to the
tissue fibrosis and scarring. The tissue planes can be more
difficult to follow compared with non-irradiated. Occa-
sionally they are less distinct and edematous. The use of a
sucker and harmonic scalpel is helpful to continue dissec-
tion in the TME plane. The back of the mesorectum is not
as smooth as seen in a nonirradiated pelvis. Increased
postoperative morbidity in patients receiving neoadjuvant
CRT has been published. The anastomotic leak rate in
these patients has been reported as approximately 11–15%
Table 2 Operative and postoperative data
Type of surgery
Anterior resection 16 (61.5%)
APER 10 (38.4%)
Stoma (ileostomy) 12
Median operative time (min) 270 (range, 180–410)
Conversion 3 (12%)
Median length of stay (days) 8 (range, 5–17)
Median no. of lymph nodes 5 (0–14)
Dukes staging
Dukes A 5 (19.2%)
Dukes B 10 (38.4%)
Dukes C1 10 (38.4%)
Dukes C2 1 (3.8%)
CRM (mm) Median 5.5 (range\ 1–15)
Median follow-up (mo) 34 (range 10–61)
Local recurrence 2 (7.6%)
Table 3 Outcomes comparison with other series
Outcome measures Colchester series
(n = 26)
German rectal
CA group [2] (n = 799)
Japanese experience [35]
(n = 1,057)
Strasbourg series [36]
(n = 99)
Procedure-related mortality 1 (3.8%) 8 (1%)
P = 0.243
0
P = 0.023
2 (2%)
P = 0.494
Overall morbidity 5 (19%) 287 (36%)
P = 0.841
235 (22%)
P = 0.119
27 (27%)
P = 0.53
Anastomotic leak 3 (18.7%) 93 (12%)
P = 0.573
84 (9.1%)
P = 0.324
17 (17.3%)
P = 0.388
Postoperative small bowel obstruction 2 (7.6%) 24 (3%)
P = 0.185
38 (3.6%)
P = 0.235
5 (5%)
P = 0.43
Local recurrence 2 (7.6%) 53 (6%)
P = 0.821
162 (15.3%)
P = 0.08
6 (6%)
P = 0.43
Median follow up months 34 46 30 36
Complete response 5 (19%) 8/415 (2%)
P B 0.001
n/a n/a
Surg Endosc (2011) 25:1753–1760 1757
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[2, 10, 30]. In this study the anastomotic breakdown rate
was 18.7%.
Similarly there is a high risk of perineal wound com-
plications in these patients. The reported risk of perineal
wound infection is approximately 25% and there is a
50–60% risk of delayed wound healing with dehiscence
[25, 26]. The rate of perineal wound breakdown in this
study was 20%. We do not know the exact cause for a
lower risk of wound complications in this group of patients.
However, the slightly younger age (median age, 59 years)
and the delayed interval between completing radiotherapy
and surgery (median interval, 11 weeks) may have
contributed.
It is possible that the timing of surgery may have con-
tributed to these findings. Delaying surgery by 4–6 weeks
compared with standard practice may have allowed the
edema associated with RT to decrease. This may explain
why the laparoscopic approach was possible in all but a
single patient. There is no doubt that normal anatomical
planes within the pelvis are distorted, but not to such an
extent that the laparoscopic approach was impossible. The
technically more demanding challenge of laparoscopic
TME in patients after CRT is borne out by the longer
operating time. The median operating time for laparoscopic
TME after CRT in our unit has been 270 min compared
with 210 min in patients without CRT.
Studies have shown good correlation between the pre-
operative MRI and final histology [31]. MRI also is widely
used to assess response and determine operability post-
chemoradiotherapy in patients with previously inoperable
Fig. 2 Coronal section MRI pelvis with a low rectal carcinoma demonstrating ongoing radiological response to CRT. Pre-LCRT (T3N1) (A),
6 weeks post-LCRT (T3N1) (B) and 10 weeks post-LCRT (T2N0) (C)
1758 Surg Endosc (2011) 25:1753–1760
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rectal tumors, with a reported accuracy of 77% for CRM
involvement [32]. In our institution, following multidisci-
plinary discussion, a third MRI has been performed in a
subset of patients with locally advanced rectal cancer who
had undergone CRT and had appeared to show little or no
response on their follow-up MRI. The authors have earlier
presented data documenting the ongoing response to RT as
seen on serial MRI [33] and higher correlation with final
histology [34]. There is a potential that the use of serial
MRI scans may prove to be very useful in determining the
optimal timing of surgery [33, 34]. We have found a close
correlation between the final pathology and the final, pre-
operative MRI scan.
In this study, five patients (19%) had a pathological
complete response to CRT. This is an interesting cohort of
patients because they require very careful evaluation for
ongoing management in the light of experience in the large
series by Habr-Gama et al., where 10.1% (24/262) patients
had pathological complete response [16]. Habr-Gama from
Brazil has published the largest series of nonoperative
treatment of patients with rectal cancer with a complete
clinical response following CRT. In her group of 361
patients with distal rectal cancer, complete clinical
response was seen in 34% (n = 122) at 8 weeks. After a
follow-up of 12 months, there were five local recurrences
and seven distant metastases.
These findings reiterate the importance of a well-coor-
dinated MDT in the management of rectal cancer. In the
United Kingdom, surgery remains the choice for young, fit
patients; however, there is a growing consensus that a
‘‘watch and wait’’ approach may be a valid alternative for
particularly elderly or frail patients. In those requiring
APR, a complete clinical response may save them from
major surgery with avoidance of a stoma and all associated
complications or may make them suitable for local exci-
sional surgery, such as transanal endoscopic microsurgery.
This study demonstrates that delaying definitive surgery
in patients with LARC who have undergone CRT does not
have deleterious effects and results in greater downstaging
and a wider CRM. The surgical morbidity and mortality is
not significantly higher than non-RT cases. A laparoscopic
approach for TME after long-course radiotherapy is pos-
sible when performed by experienced surgeons.
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Abstract
Background There is growing concern that the recently
introduced National Training Programme for consultants in
laparoscopic colorectal surgery will have a negative impact
on the training of senior colorectal trainees by minimizing
the opportunities available. This study aimed to determine
the impact that local implementation of the National
Training Programme has had on the operating experience
of senior colorectal trainees.
Methods A prospective study was conducted at a desig-
nated national training center for laparoscopic colorectal
surgery based in a large district general hospital in Eng-
land, United Kingdom. All patients undergoing laparo-
scopic colorectal surgery in our unit between October
2006–September 2008 and October 2008–September 2010
were included in the study. The study variables included
number and type of procedure, patient demographics,
American Society of Anesthesiology grade, body mass
index, conversion rates, previous abdominal surgery, and
median operating time. The main outcome measure was the
number of procedures performed by senior colorectal
trainees before and after commencement of National
Training Programme training in October 2008.
Results A total of 746 laparoscopic colorectal resections
were performed. Senior colorectal trainees performed 175
cases before commencement of the National Training
Programme and 184 cases afterward. The difference was
not significant. National Training Programme consultants
performed 126 cases. Data were analyzed using Fisher’s
exact test and the Mann–Whitney U test. The study groups
were found to be well matched. The median operating time
was significantly longer after commencement of the
National Training Programme. The study was limited in
terms of ability to extrapolate results to smaller units
wishing to participate in training programs.
Conclusion Implementation of the National Training
Programme in our hospital has not had a negative impact
on the training opportunities for senior colorectal trainees.
However, any unit wishing to participate in the National
Training Programme must ensure that an adequate opera-
tive caseload and extra resources for operative lists are
available for training.
Keywords Colorectal cancer ! Education ! GI cancer !
Training courses
Laparoscopy is being offered to increasing numbers of
patients undergoing colorectal cancer surgery. The supe-
rior short-term outcomes and oncologic safety associated
with this technique and recommendations from the
National Institute for Health and Clinical Excellence
(NICE) guidelines in 2006 have led to a rapid rise in
service demands for laparoscopic colorectal surgery
across the National Health Service (NHS) trusts [1–5].
The result has been a large mismatch in service provision
and number of adequately trained laparoscopic colorectal
surgeons. Recognition of this mismatch led to an initiative
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launched by the Department of Health (DoH) in England
to promote and accelerate the adoption of this technique.
Through an application and interview process, National
Training Centres (NTC) were set up to deliver training in
laparoscopic colorectal surgery for established colorectal
surgeons in England [6].
The National Training Programme (NTP) for laparo-
scopic colorectal surgery started in 2008 with the selection
of 10 NTCs across England. The selection criteria for the
NTCs included the availability of an expert laparoscopic
surgeon with a declared interest and background in training
and who had performed at least 200 laparoscopic colorectal
resections. In addition, other facilities for training such as
well-staffed, fully-equipped operating theaters and an
adequate volume of suitable cases for training also were
desired.
The NTP is set up to train consultant colorectal surgeons
at substantive posts in English NHS trusts who require
training in this method. Currently, senior colorectal train-
ees (SCTs) are not permitted to participate in the NTP.
The NTCs had the option of providing training as stand-
alone hospitals or merging with other hospitals in the
region to form a consortium. Training within the NTP
began in September 2008 in the form of either an in-reach
or an out-reach preceptorship [6]. With the in-reach model,
consultant preceptees trained at the designated NTC, and
occasionally, the preceptee’s own patients traveled to the
preceptor’s hospital to undergo surgery there. In such
cases, wherein the patients were brought with the visiting
consultant preceptee, immediate postoperative care was
carried out at the preceptor’s hospital until the time of
discharge. With the out-reach model, the trainer traveled to
the consultant preceptees’ hospital to supervise their
training. The three different modules proposed for training
within the NTP were aimed at ring fencing the training
cases for SCTs.
Training in laparoscopic colorectal surgery for SCTs in
the UK has been confined to a few centers that have ade-
quately trained surgeons and case volumes. The SCTs are
increasingly expected to be competent in laparoscopic
colorectal surgery before taking up independent practice as
consultants. With the introduction of NTP, a concern may
arise about the training opportunities available to SCTs in
centers participating in this initiative. Before implementa-
tion of the NTP, these very centers would have been ideal
training grounds for SCTs. Hence, it is easy to envisage the
negative impact that such a program may have on the
training opportunities for SCTs in a center that has taken
this role.
The purpose of this article is to report on the conse-
quences from the introduction of the NTP in our hospital in
September 2008 and the implications it had for the training
of SCTs.
Methods
Our colorectal unit is in a large district general hospital
serving a population of more than 600,000. The unit sees
more than 320 colorectal cancers, manages approximately
250 cases per annum, and was awarded NTC status in
2008. Within the NTP, our center committed to all three
modules of training: in-reach, out-reach, and patients
traveling to our unit with NTP preceptees.
Data were collected for all patients undergoing elective
laparoscopic colorectal resections performed by SCTs and
consultants in training between October 2006 and September
2010 from a prospectively maintained database in our unit.
The 4-year study period was split into an index period of
24 months (October 2008–September 2010) and a pre-index
periodof24 months (October 2006–September2008).During
the index period, training was undertaken by SCTs rotating
through the unit at the time (group A) and by consultant pre-
ceptees in the NTP (group B), and this was compared against
the pre-indexperiodwhen the trainingwasundertakenonlyby
SCTs (group C). Analysis included patients’ demographic
details, American Society of Anesthesiologists (ASA) grade,
body mass index (BMI), diagnosis, and operative details
including typeof surgery, operating surgeon, conversion rates,
operating time, and histopathologic data where relevant.
Trainer profile
The trainer (Prof. Amjad C. Parvaiz) had undergone formal
laparoscopic colorectal surgical training including a
National Fellowship before appointment as a consultant in
September 2006. The trainer has an exclusively laparoscopic
practice with more than 95% of resections completed lapa-
roscopically and is on the national preceptor register main-
tained by the Association of Laparoscopic Surgeons of Great
Britain and Ireland (ALSGBI) and Lapco [6]. Although the
trainer had overall responsibility for trainingNTP preceptees
and SCTs, two other surgeons in the department contributed
to training of SCTs after 2008.
Profile of trainees
Data on laparoscopic colorectal resections were obtained
for 9 NTP preceptees and 10 SCTs. Two of the SCTs were
on a sponsored national fellowship, and the remaining eight
SCTs were final year specialist registrars (SpR) of the
Wessex Specialist Registrar training scheme assigned to
our unit during the study period.
NTP trainees
The NTP trainees all were established colorectal consul-
tants with variable but limited or no prior laparoscopic
1940 Surg Endosc (2012) 26:1939–1945
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colorectal surgical experience and who had undergone
various preparatory courses, including 2-day advanced
laparoscopic wet lab workshops and cadaver training. In
addition, all the NTP preceptees had attended a Laparo-
scopic Colorectal Masterclass with their respective theater
staff and anesthetist before starting training in our unit.
SCTs
The specific experiences of the SCTs were varied. How-
ever, all SCTs had been performing several basic to
intermediate laparoscopic procedures such as appendecto-
mies, cholecystectomies, and hernia repairs with adequate
exposure to open colorectal resections, which they had
been performing independently or under supervision as
appropriate. The SCTs also had experience assisting in a
limited number of laparoscopic colorectal operations at
other hospitals of the region before their placement to our
unit. Apart from basic and intermediate laparoscopic skills
courses, the SCTs had attended 2-day advanced laparo-
scopic wet lab workshops.
Resection technique
All laparoscopic resections were performed mainly using
standard four-port technique and a transverse incision of
approximately 5 cm for extraction of the specimen, as
described previously [7]. A standardized medial-to-lateral
approach was used for isolation and ligation of vessels,
with extracorporeal anastomosis used for right-sided
resections. The left-sided resections were followed by
intracorporeal anastomosis to restore bowel continuity.
Postoperatively, patients were managed according to an
enhanced recovery program as described by Kehlet and
Wilmore [8], with minor modifications, and were allowed
discharge to home when discharge criteria were met. The
modifications were selective use of epidural analgesia and
omission of preoperative glucose loading.
Statistical analysis
Statistical comparisons were made between the operations
performed by SCTs (group A), those performed by the
NTP preceptees (group B) during the index period, and
those performed by SCTs in the pre-index period (group
C). The variables analyzed included the number of proce-
dures performed in each group, patient demographics, type
of surgery, and operating time. Continuous data were
expressed as median and range. To compare treatment
groups, the Mann–Whitney U test and the Kruskal–Wallis
test were applied to continuous data. v2 and Fisher’s exact
test were used for categorical data. A P value less than
0.050 was considered to indicate statistical significance.
All analyses were performed using Graphpad Prism 5
(Graphpad Software Inc., San Diego, CA, USA).
Results
Of the 746 elective laparoscopic colorectal resections per-
formed during the study period, 60 were performed at either
out-reach hospitals (n = 26) or private hospitals (n = 34),
and these were excluded from the analysis. An additional
201 cases performed by trainers also were excluded (Fig. 1).
Of the 423 laparoscopic resections during the index
period, 310 (73.5%) were performed by trainees: 184
(43.5%) by SCTs (group A) and 126 (29.5%) by NTP
preceptees (group B). The five SCTs in group A performed
an average 36 resections each. The five SCTs in group C
performed a similar number of resections proportionately
(n = 175/263, 66.5%) during the pre-index period when
there were no NTP preceptees. The average number of
resections performed by each SCT in this group (n = 32)
was similar, and the difference was not significant. A small
number of resections (n = 19) were performed by the
remaining seven junior specialist registrars, who were
mostly in the early years of their training rotation.
Fig. 1 Study flow chart showing distribution of cases across different
study groups
Surg Endosc (2012) 26:1939–1945 1941
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The patient characteristics and indications for surgery in
the three groups of patients were found to be similar
(Table 1). Group A had a greater number of extended right
hemicolectomies, subtotal colectomies, anterior resections,
and panproctocolectomies, whereas group C had a greater
number of sigmoid colectomies and abdominoperineal
excisions of the rectum (APERs), but these differences did
not achieve statistical significance (Table 2). The operating
time, however, was significantly longer for the group A and
B patients (P\ 0.0027).
Pathologic evidence of resection quality (Table 3)
Altogether, 370 laparoscopic cancer resections were per-
formed across all the study groups. The proportions of
resections for cancer in the groups were similar (Table 3).
The R0 resection rates and median lymph node yields also
were not significantly different across the groups for pro-
cedures performed with curative intent.
Discussion
This study evaluated the impact that introduction of the
NTP for laparoscopic colorectal surgery had on the training
of specialist registrars in a busy district general hospital.
The principal finding of this study was that the number of
opportunities SCTs had for laparoscopic colorectal surgical
training was not affected by introduction of the NTP.
The SCTs were able to perform adequate numbers of
procedures and to complete their training before moving
on to independent practice as laparoscopic colorectal
surgeons.
The DoH in the UK set a goal that 50% of resections for
colorectal cancer should be completed laparoscopically by
2012. Currently, there is a large untrained consultant
workforce and therefore an urgent requirement to train
more surgeons in laparoscopic colorectal surgery to meet
the progressively increasing demand on the service. The
Cancer Action Team of the DoH launched the NTP ini-
tiative in 2007 to provide laparoscopic colorectal surgery
training to consultants in English NHS trusts. However, a
well-known difficulty commonly encountered in super-
vised operative training for SCTs is lack of training time
compounded by pressures to meet waiting list and cancer
targets. Current legislation limits the number of hours a
trainee can work per week, resulting in a further reduction
in the time available for elective training episodes during
the workweek. The need for targeted training is therefore
critical. Among the many requirements of a successful
training scheme is an adequate number of opportunities
available for supervised operations on suitable patients.
Training in laparoscopic colorectal surgery for SCTs in
the UK has been very variable because until recently, only
a small proportion of units performed laparoscopic colo-
rectal surgery routinely [9]. In general, most SCTs seek a
specialized period of training in the form of a national or
international fellowship in established laparoscopic centers
toward the end of their training rotation or at completion of
the rotation.
Table 1 Patient characteristics
and indications for surgery
across the groups
BMI body mass index,
ASA American Society of
Anesthesiology classification,
UK unknown
Index Pre-index
Group A
(n = 184)
Group B (NTP)
(n = 126)
Group C
(n = 175)
n (%) n (%) n (%)
Median age: years (range) 69 (18–93) 66 (24–90) 70 (27–92)
Sex ratio–male 96 (52) 68 (54) 82 (47)
Median BMI (range) 26 (16–42) 26 (17–44) 26 (18–52)
ASA 1 29 (16) 29 (16) 22 (13)
2 104 (57) 71 (56) 98 (56)
C3 40 (22) 32 (25) 51 (29)
UK 11 (6) 3 (2) 4 (2)
Previous abdominal surgery 59 (32) 31 (25) 71 (41)
Diagnosis
Adenoma 5 (3) 6 (5) 5 (3)
Carcinoid 1 (0.5) 0 (0) 2 (1)
Colitis 15 (8) 4 (3) 5 (3)
Carcinoma 135 (73) 99 (79) 136 (78)
Crohn’s 14 (8) 10 (8) 10 (6)
Diverticular disease 12 (6.5) 6 (5) 3 (2)
Other 2 (1) 1 (1) 14 (8)
1942 Surg Endosc (2012) 26:1939–1945
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The DoH currently has no specific initiatives to promote
the development of specialized training skills among SCTs
required to perform these highly specialized procedures.
However, the medical industry has been magnanimous in
this respect and has provided generous grants to support the
training of SCTs via provision of funding for several fel-
lowships of 6- to 12-month duration in nationally and
internationally recognized centers to enable trainees to gain
the necessary laparoscopic colorectal training. Increas-
ingly, SCTs are expected to be competent in laparoscopic
colorectal surgery before taking up a consultant post.
At implementation of the NTP in our hospital, the
prospect of a negative influence on SCT training was
realized. Specifically, the competition for cases deemed
suitable for laparoscopic training could detract from the
surgical experience of SCTs. Interestingly, the number of
cases managed by SCTs increased during the index year
when the NTP was introduced compared with the previous
year, whereas the overall proportion of cases managed by
SCTs remained similar.
These findings have four potential explanations. First,
the main preceptor continued to train SCTs on his usual
weekly allocated list and was awarded a separate operating
list for training the NTP preceptees, thus allowing the SCT
training to continue uninterrupted.
Second, appointment of an additional laparoscopic sur-
geon meant that a greater number of resections were being
performed laparoscopically, with the result that SCTs had
access to a greater number of operating lists than previously.
Additionally, the other two senior surgeons in our depart-
ment also had been trained to undertake laparoscopic colo-
rectal surgery, thus contributing to the progressive increase
in the number of laparoscopic resections in the unit.
Third, active efforts were made to provide NTP training
at out-reach hospitals. This approach permitted the use of
cases from the local hospital of the NTP preceptee, thus
leaving suitable training cases in the preceptor’s unit for his
or her own SCTs. It also had the added benefit of an out-
reach model of training such as informal training of theater
staff and anesthetists.
Finally, where possible, efforts were made to plan
training lists around the availability of SCTs to maximize
training opportunities.
The learning curve for acquiring laparoscopic skills in
colorectal surgery is steep and has variously been reported
as ranging between 15 and 70 cases [10–13], and as greater
for rectal resections. In our study, trainees in groups A and
C were able to perform an average of 36 and 32 colonic
resections, respectively. These figures are on par with the
stipulated number of resections required to achieve com-
petence in this advanced technique. All trainees have since
been able to complete their training and have gone on to
independent practice as laparoscopic colorectal surgeons.
Implementation of the NTP should be seen as a long-
term investment because more existing workforce should
become competent in the technique of laparoscopic colo-
rectal surgery. Consequently, the very surgeons trained
Table 2 Type of procedure and
operating times across groups
APER abdominoperineal
excision of the rectum
Procedure Index Pre-index
Group A
(n = 184)
Group B (NTP)
(n = 126)
Group C
(n = 175)
n (%) n (%) n (%)
Right hemicolectomy 44 (24) 35 (28) 53 (30)
Extended right hemicolectomy 11 (6) 10 (8) 3 (2)
Anterior resection 84 (46) 60 (48) 63 (36)
APER 5 (3) 0 (0) 12 (7)
Hartmann’s 4 (2) 2 (2) 4 (2)
Sigmoid colectomy 11 (6) 5 (4) 24 (14)
Left hemicolectomy 1 (0.5) 6 (5) 3 (2)
Subtotal colectomy 8 (4) 6 (5) 5 (3)
Proctectomy 5 (3) 0 (0) 1 (1)
Panproctocolectomy 7 (4) 2 (2) 5 (3)
Other 4 (2) 0 (0) 2 (1)
Median operating time: min (range) 185 (45–410) 175 (80–380) 155 (65–410)
Table 3 Pathologic evidence of oncologic quality for cancers
resected with curative intent
Index Pre-index
Group A Group B
(NTP)
Group C
n = 115 n = 82 n = 124
R0 resection: n (%) 112 (97) 79 (96) 121 (98)
Median lymph node yield:
n (range)
14 (0–41) 14 (2–31) 12 (0–45)
Surg Endosc (2012) 26:1939–1945 1943
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within the NTPwould provide the grounds for training SCTs
in the future. With an increasing number of centers per-
forming routine laparoscopic colorectal surgery, the need
for dedicated fellowships also would become redundant.
This study had some limitations. We recognize that ours
is a particularly busy district general hospital serving a
population exceeding 600,000, with more than 320 colo-
rectal cancers managed annually, and that this limits the
ability to extrapolate the reported results to most other
centers dealing with a smaller volume of cases per annum.
Despite the large volume of cases available, many of which
were considered suitable for training purposes, NTP pre-
ceptees were nevertheless encouraged to bring their
patients, and the trainer frequently traveled to the precep-
tees’ hospital to supervise their training (out-reach model).
Data from other centers participating in the NTP would
perhaps provide further useful insights into this aspect.
The other limitation of the study pertains to its relevance
outside the English NHS. The NTP is a unique training
initiative that has resulted in a successful increase in the
number of laparoscopic resections performed, from 11% at
the time of its inception to 33%. The international surgical
community has a growing interest to bring in similar pro-
grams for training of consultants in Europe and the Asia–
Pacific [6]. Our study is the first to address the issue of a
potential negative impact of training for consultants on the
education of surgical trainees, and we hope our findings
will stimulate further discussion and debate.
We believe that centers wishing to participate as training
hubs within the NTP while simultaneously having
responsibilities to train regional SCTs must make sure
mechanisms are in place to ensure that the training of
preceptees in either group is not compromised. A greater
degree of flexibility is required among theater management
staff to provide extra capacity for undertaking a larger
volume of work, to enable administrative bodies to host
patients from the NTP preceptee’s hospital (in-reach
model), and to allow travel of the preceptor to the NTP
preceptee’s hospital (out-reach model).
Additionally, studies have shown that amodular approach
is an effective way to maximize training opportunities [14,
15] in low- or medium-volume units while providing train-
ing opportunities for patients who might otherwise not be
deemed suitable for training. Standardization of technique
and prior experience of the trainees in basic laparoscopic
procedures with a good grounding in open colorectal surgery
would help to shorten the learning curve.
Conclusion
Our experience has shown that implementation of the NTP
in our hospital did not have a negative impact on the
number of training opportunities for SCTs. This was pos-
sible by having dedicated operating lists for training,
appointing a fully trained laparoscopic surgeon, and being
prepared to travel to the perceptee’s hospital to provide
training in an out-reach model. Any unit wishing to par-
ticipate in the NTP must ensure that an adequate operative
caseload and extra resources for operative lists and per-
sonnel are available for training both SCTs and NTP
trainees.
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Abstract
Background Sexual and urinary dysfunction is an estab-
lished risk after pelvic surgery. Studies examining sexual
and urinary function following laparoscopic and open
rectal surgery give conflicting evidence for outcomes. The
purpose of this study was to analyse the impact of the
surgical technique on functional outcomes following lap-
aroscopic or open resection for rectal cancer patients in a
high-volume laparoscopic unit.
Methods All patients who underwent elective laparo-
scopic or open surgery for rectal cancer between Septem-
ber 2006 and September 2009 were identified from a
prospectively collated database. Validated standardized
postal questionnaires were sent to surviving patients to
assess their postoperative sexual and urinary function. The
functional data were then quantified using previously val-
idated indices of function.
Results A total of 173 patients were identified from the
database, of whom 144 (83 %) responded to the ques-
tionnaire-based study. Seventy-eight respondents had
undergone laparoscopic rectal resection (49 men and 29
women), and 65 had an open procedure (41 men and 24
women). Both open surgery and laparoscopic surgery were
associated with deterioration in urinary and sexual func-
tion. With regard to urinary function, there was no differ-
ence in the deterioration in open and laparoscopic groups in
either gender. With regard to sexual function, in males one
component of sexual function, namely, the incidence of
successful penetration, showed less deterioration in the
laparoscopic group (p = 0.04). However, in females, lap-
aroscopic surgery was associated with significantly better
outcomes in all aspects of sexual activity, specifically
sexual arousal (p = 0.005), lubrication (p = 0.001),
orgasm (p = 0.04), and the incidence of dyspareunia
(p = 0.02).
Conclusion Laparoscopic total mesorectal excision for
rectal cancer is associated with significantly less deterio-
ration in sexual function compared with open surgery. This
effect is particularly pronounced in women.
Keywords Colorectal cancer ! Urogenital function
Although surgical resection with total mesorectal excision
(TME) is the optimum therapy for rectal cancer [1, 2],
surgery is associated with considerable morbidity and
mortality. This procedure in particular is associated with a
high incidence of disturbances in sexual and urinary
functions which may be attributed to inadvertent damage of
the hypogastric and splanchnic nerves in the pelvis during
dissection [3–6].
Laparoscopic colorectal cancer resection now offers
shorter recovery times than open resection, in addition to
comparable morbidity and oncological outcomes [3]. With
reference to urinary and sexual function after surgery, it
has been argued that the laparoscopic approach may enable
better visualisation of autonomic nerves, contributing to
their preservation and thereby reducing the incidence of
urinary and sexual dysfunction postoperatively [7]. A
conflicting view, however, proposes that nerve preservation
is less achievable with laparoscopic methods due to
reduced tension on tissue planes [8]. Previous large-scale
trials [8, 9] have demonstrated that laparoscopic resections
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are associated with poorer postoperative sexual function in
males than open surgery; however, these studies were
performed in the early part of the laparoscopic era. In
addition, there is very limited data on female sexual and
urinary function following rectal resection.
The purpose of this retrospective clinical study was to
compare the changes in urinary and sexual function fol-
lowing open and laparoscopic resection of rectal tumours
in both men and women in a high-volume laparoscopic
colorectal centre.
Methods
Background
Our institution is a high-volume district general hospital
serving a population of 550,000. Between September 2006
and August 2009, all patients who underwent potentially
curative elective surgical resection for rectal cancer
(defined as cancer present within 15 cm from the anal
verge) were identified from a prospectively collated
database.
Prior to surgery all patients underwent an oncological
and physical assessment of their suitability for surgery.
Fitness for surgery was assessed using a variety of tech-
niques, including clinical examination, electrocardiogra-
phy, and, where indicated, echocardiography and exercise
tolerance testing. Preoperative oncological staging was
achieved by colonoscopy (or flexible sigmoidoscopy fol-
lowed by CT pneumocolon), computed tomography of
chest and abdomen, and magnetic resonance imaging
(MRI) of the pelvis. Preoperative radiotherapy was given
according to the recommendations of the multidisciplinary
team. In general, preoperative long-course chemoradio-
therapy was reserved for T4 rectal cancers or those where
the circumferential resection margin (CRM) appeared
threatened on MRI, whilst short-course radiotherapy was
advised for rectal cancers that approached but did not
threaten the CRM. Radiotherapy was not used where rectal
cancers were considered resectable by TME with a good
likelihood of clear margins.
Operative techniques
Open rectal resections were performed using a midline
incision. Laparoscopic resections were performed using a
4-port technique with a transverse incision of approxi-
mately 5 cm for extraction of the specimen. A standardised
laparoscopic technique of medial to lateral mobilization
with isolation and ligation of main vessels using clips or
vascular stapler was used, whilst TME was performed as
previously described using monopolar diathermy [10, 11].
It should be noted that neither ultrasonic nor bipolar
coagulation devices were routinely used in open or lapa-
roscopic procedures. The extraction site was protected
using a wound protector and stapled anastomoses were
performed intracorporeally. Mid and low rectal anasto-
moses were routinely defunctioned with a loop ileostomy
in both groups. Postoperatively, all patients were managed
using a modification of the enhanced recovery program
described by Kehlet and Wilmore [12], with selective use
of epidural analgesia and omission of preoperative glucose
loading. Patients were allowed to go home when discharge
criteria were met.
Patient selection
During the period of this study, resections were undertaken
by a total of six consultant surgeons. No selection criteria
were used to allocate patients to a laparoscopic or an open
operation; patients were assigned to individual surgeons by
a multidisciplinary team according to their target dates for
treatment as determined by national cancer targets and
availability of operating theatre slots. Although it was left
to the operating surgeon to decide on the appropriate
operative approach, four of the surgeons performed open
rectal resections exclusively, whilst only laparoscopic
resections were undertaken by two of the surgeons.
Moreover, it should be noted that these two surgeons
attempted almost all of their cases laparoscopically [during
the period of the study, these two surgeons performed a
total of 441 elective colorectal resections of which only 9
(2 %) were performed open and the remaining 432 (98 %)
were attempted laparoscopically].
Functional data collection
Anonymous and confidential questionnaires were sent to all
surviving patients in February 2010, a minimum of
6 months after surgery, as part of their follow-up protocol.
These standardised questionnaires were gender- and
symptom-specific, requiring patients to rate their urinary
and sexual functions preoperatively and postoperatively.
Urinary symptoms in men were quantified using a ques-
tionnaire based on the validated International Prostatic
Symptom Score [13] and sexual function was rated with a
questionnaire based on the International Index of Erectile
Dysfunction [14]. The female questionnaire was based on
validated measures of female urogenital health, specifically
the King’s Health questionnaire [15] and the Female Sex-
ual Function Index [16]. In addition, women were also
asked if they had previously had a hysterectomy. In par-
ticular, the questionnaires were used to assess and quantify
the following components:
2560 Surg Endosc (2012) 26:2559–2565
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1. Male urinary function: frequency, nocturia, urgency,
straining, flow, and incomplete bladder emptying
2. Male sexual function: libido, erection, stiffness for
penetration, and ejaculation/orgasm
3. Female urinary function: frequency, nocturia, urge,
and stress incontinence
4. Female sexual function: libido, lubrication, orgasm,
and dyspareunia
Scoring was standardised and quantified for all ques-
tions using the following scale: not at all/not applicable;
less than half the time; about half the time; more than half
the time; and almost always, with 0 reflecting normal
function and 4 reflecting poor function. In order to maxi-
mise the response rate, follow-up telephone calls were
made by a same-gender health professional to those
patients who had not responded 4 weeks after they
received the initial letter.
Statistical analysis
Statistical analysis was performed using commercially
available software packages. Data are expressed as
mean ± standard error or median with interquartile range.
Intergroup comparisons were made using a t-test or Mann-
Whitney U test for continuous variables and a v2 test or
Fisher’s exact test for categorical variables.
Results
Baseline demographics and characteristics
Of 211 patients who had undergone elective resection for
rectal cancer, 171 were alive in February 2010 and there-
fore eligible to participate in this study. Of these, 143
(84 %) completed questionnaires: 90 men and 53 women.
Of this cohort, 78 patients (49 men and 29 women) had
laparoscopic resections whilst 65 patients (41 men and 24
women) had open resections. There were four conversions
that were included with the open procedures for the pur-
pose of analysis.
The questionnaire response rate was 88 % for the lap-
aroscopic group and 77 % for the open group. At the time
of the questionnaire, 26 patients in the laparoscopic group
and 32 patients in the open group had a permanent or a
temporary stoma in situ.
The clinical and demographic details of the two groups
are summarised in Table 1. The baseline characteristics of
the two groups were broadly comparable; however,
patients in the open group were significantly more likely to
require an end colostomy, to have a more distal tumour,
and to have an R1 resection. With respect to postoperative
complications, four patients in the open group required
reoperation: one each for perineal wound dehiscence, one
prolapsed stoma, one ischaemic stoma, and one perineal
abscess debridement. Similarly, there were four patients in
the laparoscopic group who required reoperation: one each
for refashioning of stoma, a delayed formation of stoma, a
prolapsed stoma, and a leak which required washout.
Preoperative urinary and sexual function
The preoperative urinary and sexual function of the two
groups were quantified as previously described and sum-
marised in Table 2 (males) and Table 3 (females). The
overall preoperative urinary and sexual functions of the
patients in both groups were comparable. There were fewer
preoperatively sexually active men in the open group (51
vs. 73 %) but more sexually active women in the open
group (38 vs. 31 %). It should also be noted that the pro-
portion of females who had previously undergone a hys-
terectomy was comparable in the laparoscopic [6 (20 %)
patients] and open [9 (37 %) patients] groups.
Postoperative urinary and sexual function
In the laparoscopic and open groups, surgery was associ-
ated with deterioration in urinary and sexual function. The
degree of change in both genders is quantified and sum-
marised in Tables 4, 5, 6, and 7. The deterioration of uri-
nary function following both laparoscopic and open
surgery was comparable in both men and women. How-
ever, with respect to sexual function in men, there was a
trend towards increased preservation of all sexual functions
in the laparoscopic group and a statistically significant
difference in deterioration of erectile function (see
Table 5). Similarly, with reference to female sexual func-
tion, there were statistically significant differences in the
deterioration of libido, lubrication, orgasm, and dyspareu-
nia between the two groups, as seen in Table 7).
Discussion
In common with the published literature, this study has
demonstrated that open and laparoscopic surgery for rectal
cancer is associated with a significant deterioration in uri-
nary and sexual function in both men and women. With
respect to urinary function, a comparison of laparoscopic
and open approaches showed no significant differences in
the deterioration of outcomes in either gender. However,
this pattern is not seen with regard to sexual dysfunction. In
males, there was a trend towards increased preservation of
most aspects of sexual function following laparoscopic
surgery than after open surgery, and there was a significant
Surg Endosc (2012) 26:2559–2565 2561
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Table 1 Baseline clinical and
pathological characteristics of
the laparoscopic and open
groups
Bold values indicate statistically
significant
Laparoscopic (n = 78) Open (n = 65) p value
Gender
Male 49 (63 %) 41 (63 %) 0.86
Female 29 (37 %) 24 (37 %) 0.86
Age (years)
Median 70 67 0.53
Interquartile range 63–75 60–76
Mean body mass index
Male 26 27 0.47
Female 28 26 0.39
ASA grade
1 12 (15 %) 9 (14 %) 0.94
2 51 (65 %) 42 (65 %) 0.86
3 15 (19 %) 14 (22 %) 0.81
Type of surgery
Total anterior resection (AR) 63 (81 %) 37 (57 %) 0.04
Male AR 38 (76 %) 23 (56 %) 0.05
Female AR 25 (86 %) 14 (58 %) 0.05
Covering ileostomies
Male AR with ileostomy 36 (95 %) 23 (100 %) 0.74
Female AR with ileostomy 20 (80 %) 12 (86 %) 0.97
Total APER 14 (18 %) 21 (32 %) 0.08
Male APER 10 (20 %) 16 (39 %) 0.08
Female APER 4 (14 %) 5 (21 %) 0.76
Total Hartmann’s 1 (1 %) 7 (11 %) 0.03
Male Hartmann’s 1 (2 %) 2 (5 %) 0.84
Female Hartmann’s 0 (0 %) 5 (21 %) 0.03
Distance from anal verge (cm)
Median 10 (7–12) 7 (4–10) 0.0003
T stage
Tx 4 (5 %) 2 (3 %) 0.86
T1 6 (8 %) 3 (5 %) 0.70
T2 26 (33 %) 20 (31 %) 0.94
T3 36 (46 %) 36 (55 %) 0.37
T4 6 (8 %) 4 (6 %) 0.89
Radiotherapy
Preoperative short course 9 (12 %) 12 (18 %) 0.44
Preoperative long course 5 (6 %) 12 (18 %) 0.05
Postoperative 0 (0 %) 2 (3 %) 0.41
Chemotherapy
Neoadjuvant 7 (9 %) 12 (18 %) 0.18
Adjuvant 18 (23 %) 14 (22 %) 0.95
Postoperative complications
Anastomotic leak 3 (4 %) 1 (2 %) 0.84
Need for reoperation 4 (5 %) 4 (6 %) 0.91
Median lymph node yield 12 12 1
Circumferential resection margin status
R0 77 (99 %) 54 (83 %) 0.002
R1 0 (0 %) 9 (14 %) 0.002
R2 1 (1 %) 2 (3 %) 0.80
2562 Surg Endosc (2012) 26:2559–2565
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difference in one component of sexual function: erectile
function. In women this effect was even more pronounced,
with the laparoscopic group reporting significantly less
deterioration in all aspects of sexual function studied:
arousal, lubrication, orgasm, and dyspareunia. These
results are in contrast to those reported by a number of
other authors. For example, Quah et al. [8] demonstrated
significantly worse sexual outcomes for males who
underwent laparoscopic as opposed to open excision of
rectal cancer. Similarly, Jayne et al. [9] have shown in a
Table 3 Preoperative female sexual and urinary function
Mean score
for open
group
(n = 24)
Mean score for
laparoscopic
group
(n = 29)
p value
Urinary function
Frequency 1.12 1.66 0.23
Nocturia 1.83 1.79 0.92
Urgency 0.33 0.76 0.12
Stress incontinence 0.5 1.1 0.06
Sexual function
Number of sexually
active
9 (38 %) 9 (31 %)
Libido 0.56 0.89 0.53
Lubrication 1.44 1.44 1
Orgasm 0.89 0.44 0.35
Dyspareunia 0.78 0.44 0.51
Table 4 Comparison of change in male urinary function in laparo-
scopic and open groups
Mean change
in open group
(n = 41)
Mean change
in laparoscopic
group (n = 49)
p value
Change in frequency
after operation
0.55 ± 0.23 0.57 ± 0.16 0.939
Change in nocturia
after operation
0.78 ± 0.21 0.63 ± 0.17 0.599
Change in urgency
after operation
0.88 ± 0.22 0.69 ± 0.21 0.554
Change in straining
after operation
0.25 ± 0.16 0.39 ± 0.12 0.491
Change in poor flow
after operation
0.53 ± 0.28 0.73 ± 0.18 0.531
Change in incomplete
bladder emptying
after operation
0.20 ± 0.18 0.16 ± 0.20 0.890
Table 5 Comparison of change in male sexual function in laparo-
scopic and open groups
Mean change
in open group
(n = 21)
Mean change
in laparoscopic
group (n = 36)
p value
Change in libido
after operation
2.19 ± 0.43 1.56 ± 0.28 0.222
Change in ability to
sustain erection
after operation
2.43 ± 0.36 1.53 ± 0.29 0.056
Change in erection
firmness after
operation
2.52 ± 0.37 1.39 ± 029 0.020
Change in orgasm/
ejaculation after
operation
2.67 ± 0.37 1.78 ± 0.31 0.073
Bold value indicates statistically significant
Table 6 Comparison of change in female urinary function in lapa-
roscopic and open groups
Mean change in
open group
(n = 24)
Mean change in
laparoscopic group
(n = 29)
p value
Change in
frequency after
operation
0.83 ± 0.26 0.62 ± 0.25 0.558
Change in nocturia
after operation
0.5 ± 0.39 0.69 ± 0.27 0.693
Change in urgency
after operation
0.5 ± 0.21 0.48 ± 0.16 0.948
Change in stress
incontinence
after operation
0.42 ± 0.24 0.10 ± 0.11 0.248
Table 2 Preoperative male sexual and urinary function
Mean score
for open
group
(n = 41)
Mean score for
laparoscopic
group
(n = 49)
p value
Urinary function
Frequency 1.50 1.63 0.69
Nocturia 1.68 2.06 0.26
Urgency 0.55 0.59 0.87
Straining 0.15 0.16 0.91
Poor flow 0.78 0.69 0.77
Incomplete bladder
emptying
0.88 0.92 0.89
Sexual function
Number sexually active 21(51 %) 36 (73 %)
Libido 0.05 0.31 0.10
Erection 0.43 0.69 0.30
Stiffness for penetration 0.48 0.86 0.20
Ejaculation/orgasm 0.17 0.19 0.87
Surg Endosc (2012) 26:2559–2565 2563
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randomised controlled trial an increased tendency for
poorer male sexual function following laparoscopic as
compared to open resection, but no difference in functional
outcomes in females. The explanation for our contrasting
findings is unclear but may be related to our increased
experience with laparoscopic surgery. It is notable that both
surgeons who performed laparoscopic resections in our
study were national trainers in laparoscopic colorectal
surgery and that laparoscopic resections accounted for
almost all of their elective rectal cancer surgery practice.
It should be noted that within our cohort, the baseline
preoperative urinary function for our male patients was
much poorer than those reported in other studies. For
example, in a recent retrospective study of 50 men fol-
lowing laparoscopic TME, Morino et al. [7] reported mean
a preoperative nocturia score of 0.74 as compared with a
score of 2.06 in our laparoscopic group. The high incidence
of preoperative urinary dysfunction in our study may be
partly attributed to our wide inclusion criteria. For exam-
ple, unlike Morino et al. [7], we did not exclude patients
over the age of 75. Indeed, our cohort had a significant
number of ‘‘high-risk’’ cases as evidenced by the fact that
85 % of our patients had an ASA grade of 2 or above and
over half the cancers were T3 or T4 tumours. Interestingly,
some recent studies [17, 18] have suggested that high-risk’’
patients with significant comorbidities benefit from a lap-
aroscopic approach more than low-risk patients and our
study suggests that such benefits may include functional
outcomes.
In common with previous studies, surgery appeared to
have a more significant impact on sexual than bladder
function. For example, Morino et al. [7] reported that 31 %
of patients developed severe erectile dysfunction following
laparoscopic TME as compared with a 14 % incidence of
postoperative urinary dysfunction. Similarly, open series of
TMEs quote rates of erectile dysfunction ranging from 11
to 55 % [2, 3]. Although data on functional outcome of
TME in women is limited, a recent small-scale study
concluded that sexual but not urinary function was affected
by colorectal surgery [19]. The differential impact of sur-
gery on urinary and sexual function may be attributed to
the fact that sexual function is mainly dependent on auto-
nomic pathways, whilst urinary function is affected by
many other mechanical factors such as prostatic size in
men and pelvic floor function following childbirth in
women. In addition, changes to bowel function and psy-
chological factors may also be more relevant to sexual than
to urinary function, and given our finding of the superiority
of laparoscopic over open surgery in the preservation of
sexual function, it is tempting to hypothesize that this
advantage may in part be related to smaller scar sizes and a
faster recovery.
We acknowledge that this study does suffer from a
number of limitations. For a start, this study was nonran-
domised and retrospective in nature. Although the baseline
clinical and pathological characteristics of the open and
laparoscopic groups were broadly comparable, it should be
noted that the open group had a higher incidence of an end
colostomy, a lower incidence of R0 resections, and a lower
proportion of patients who were sexually active preopera-
tively. Although, as previously detailed, there was no
systematic selection bias in the allocation of patients for
open or laparoscopic surgery, we accept that these differ-
ences, as well as the relative technical skills of the open
and laparoscopic surgeons, may be significant confounding
factors. In addition, the fact that the patients retrospectively
reported their preoperative urogenital function postopera-
tively may limit the interpretation of the data; however, this
factor occurred for both the laparoscopic and open groups
and should not affect the comparative data. Moreover, we
accept that although our overall cohort size was large, the
numbers in our subgroup analyses (particularly with regard
to sexual function) were relatively small. Finally, we also
accept that by sending questionnaires at a single time point,
the data obtained represent merely a snapshot of patients’
functional status and that their status may alter over time.
Nonetheless, despite these provisos, the lack of any sys-
tematic selection bias and high response rates to our
questionnaires add weight to the validity of our findings.
In summary, we have shown that laparoscopic TME for
rectal cancer is associated with significantly less deterio-
ration in sexual function than open surgery, and this effect
is particularly pronounced in women. These findings
require confirmation in a large-scale randomised controlled
trial.
Disclosures Ms. E. R. McGlone, Mr. O. Khan, Ms. K. Flashman,
Mr. J. Khan, and Professor A. Parvaiz have no conflicts of interest or
financial ties to disclose.
Table 7 Comparison of change in female sexual function in lapa-
roscopic and open groups
Mean change
in open group
(n = 9)
Mean change
in laparoscopic
group (n = 9)
p value
Change in libido
after operation
2.78 ± 0.52 0.67 ± 0.37 0.005
Change in lubrication
after operation
2.33 ± 0.50 0 ± 0.17 0.001
Change in orgasm
after operation
2.44 ± 0.53 0.89 ± 0.42 0.036
Change in dyspareunia
after operation
2.78 ± 0.76 0.44 ± 0.47 0.021
Bold values indicate statistically significant
2564 Surg Endosc (2012) 26:2559–2565
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Chapter 7
Robotic Colorectal Cancer Surgery
Ray Swayamjyoti, Jim Khan and Amjad Parvaiz
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/58350
1. Introduction
A robot is a mechanical or virtual agent, usually an electro-mechanical machine that is guided
by a computer program or electronic circuitry. Robots have been linked with the future and
modern civilization but have been around for more than 2000 years since ancient Greek
automata. Their real surgical application has been in the last 20 years [1, 2].
Robots were first used in medicine to help people with disabilities to aid in their rehabilitation
process. The Edinburgh Modular Arm System [3] was one of the first bionic arm which was
engineered by Dr. David Gow in the early eighties.
The National Aeronautics and Space Administration (NASA) developed the first telemanipu‐
lator robot in 1985 at the behest of the Defense Department of the United States of America
with the aim to decrease war casualties using telerobotic surgery [4].
It was believed that robots could have prevented more than a third of the soldiers from dying
during the Vietnam War secondary to haemorrhage [5].
Robotic colorectal operations have gained considerable interest after successful implementa‐
tion in the field of urology and gynaecology. The advantages of a stable platform, better vision
and better access has made this an attractive tool in many specialities. [6] Pelvic and rectal
resections are best suited for robotic operations [6].
2. The Da Vinci surgical robotic system
The Federal Drug and Administration approved the use of the da Vinci robotic system for
surgical treatment in 2000 and it was first used at the Ohio State University Hospital for
oesophageal and pancreatic surgery [22].
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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At present it is extensively used throughout the world and has sold over 2000 units worldwide
in 2013. It is estimated then more than 200,000 operations have been performed in 2012 [23, 24].
The initial model of da Vinci was released in the year 1999, later this was updated to “S” in
2007 and in 2009 Si was released with improved functions and better performance. The author
uses the da Vinci “Si” robotic system for his colorectal operations.
The da Vinci system consists of a surgeon’s console and four interactive robotic arms attached
to the robotic cart controlled by the surgeon from the console. One of the arms carries an
endoscopic camera via a 12mm port. The camera has two lenses, which gives a 3D image with
stereoscopic vision when the surgeon looks through the eyepiece in the console. The three
other arms are used to hold tools and tissues i.e. scissors, bovies, electrocautery. The arms are
maneuvered using two-foot pedals and two hand controllers.
Year Milestones
1985 • PUMA 560 was used under computerised tomography guidance to orient a needle for brain biopsy [7]
1992 • PROBOT - developed at Imperial College, London and was used to perform prostatic surgery at Guy's and St
Thomas' Hospital, London [8]
• The ROBODOC developed by Integrated Surgical Systems was used to curve out accurate fittings in the
femur for hip replacement [8]
1998 • Zeus robotic surgical system – used for reconstruction of the Fallopian tube performed at the Ohio State
University Medical Center [9]
1999 • Robotics assisted closed chest bypass on a beating heart was performed at the London Health Sciences
Centre [10]
2000 • FDA approval of da Vinci robotic system[11]
2002 • Robotic cholecystectomy [12]
• Robotic Right Hemicolectomy [13]
• Robotic bowel resections [14]
2006 • Unassisted robotic surgery using artificial intelligence to correct atrial fibrillation at a hospital in Milan [15]
2007 • Denervation of spermatic cord for testicular pain using robotic assisted microsurgery performed at Winter
Haven Hospital and University of Florida [16]
2008 • Magnetic Resonance guided neurosurgical procedure performed at University of Calgary [17]
• Microsurge developed by German Aerospace Center [18]
2010 • Sophie Surgical System developed by Eindhoven University of Technology [19]
• Femoral reconstruction [20]
• World’s first all robotic operation i.e. prostatectomy using the da Vinci robot along with McSleepy robot
used for anaesthesia at McGill University Hospital, Canada [21]
Table 1. Development of Robotics to aid in Surgical Procedures.
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Unlike laparoscopy the da Vinci system allows the surgeon to perform operation seated at the
console, with the hands and eyes positioned in line with the instruments. The operating
surgeon is able to control the movements of the camera using the foot pedal rather than relying
on an assistant. The system is able to filter and decipher surgeon’s hand movements into steady
and precise micro movements.
Figure 1. [25]: showing the robotic stack/cart and the monitor used by the assistant to follow the operation
Figure 2. [26] : showing robotic and vision carts and the surgeon’s console with an additional teaching console
Robotic Colorectal Cancer Surgery
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3. Evidence of robotics in colorectal surgery
Robotic colorectal surgery is gaining widespread interest worldwide and in the continent. Data
collected in 2012 suggests that most of the reported or published data shows that majority of
the robotic colorectal operations have been performed in the United States (32%) followed by
South Korea (20%), Italy (15%), Canada, Germany and Netherlands accounted for 5% and the
rest of the world less than 2% [13].
The first colorectal surgical publication was published by Weber et al in 2002 [27] and since
then there has been a tenfold rise in publication in colorectal surgery [13]. The important
landmark studies are summarized in table 2.
Laparoscopic colorectal operations have many advantages over conventional open operations.
The benefits in terms of short term outcomes are well established and include shorter hospital
stay, faster return to work, better cosmesis, less post operative pain, less risk of bleeding and
ileus. Long term outcomes including cancer specific and disease free survival have been subject
of many well-designed trials.
The COLOR (COlon cancer Laparoscopic or Open resection) trial (330 stated that laparoscopic
colectomy was associated with less significant blood loss, earlier recovery of bowel function,
use of fewer analgesics and with a shorter hospital stay when compared with open colectomy.
It however took half an hour longer than open operations and had 19% chances of converting
to open operation. The reasons for conversion were mainly attributed to tumour size of more
than 6cms and in patients who had involvement of adjacent structures.
There were concerns regarding tumour recurrence associated with laparoscopic colectomy.
The meta-analysis of four randomized control trials (CLASICC trial, COST trial, Barcelona trial
and COLOR trial) where patients with colonic cancers were randomised to either open or
laparoscopically assisted colectomy concluded that the positive margins were found in
specimens after open operations were 2.1% as compared to 1.3% after laparoscopic operation.
The overall disease free survival at three years was 83.5% for open operations and 82.2% for
laparoscopic operations [34]. Hence, the evidence shows that laparoscopic colonic operation
is oncologically safe and viable with comparable outcomes to open surgery [34, 35].
The safety and viability for rectal cancers is still less clear especially with the higher circum‐
ferential margin (CRM) involvement with laparoscopic rectal operations when compared to
open rectal operations as mentioned in the CLASSIC trial [34]. There was however, no
difference in local recurrence at three years [36]. There was a higher conversion rate in the
laparoscopic rectal subgroup (34%) in comparison to laparoscopic colonic group (25%).
Conversions to open operations led to higher mortality and morbidity [34, 37]. Conversions
were mainly attributed to bulky tumours [33] and increased technical difficulty [37]. The robot
promises to abolish some of these technical problems faced during dissection of rectal tumours
using laparoscopy and the ROLARR (RObotic versus LAparoscopic Resection for Rectal
cancer) trial results are awaited. It is an international, multicentre, prospective, randomised,
and controlled, unblinded, parallel-group trial of robotic-assisted versus laparoscopic surgery
for the curative treatment of rectal cancer [37].
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Year Reference Country Study type Number of
patients
2002 Weber et al. USA Case series 2,
3,
Hashizume et al. Japan 18
Talamini et al. USA
2003 Vibert et al. France Case series 3,
Giulianotti et al. Italy 16
2004 Hubens et al. Belgium Case series, 8,
Anvari et al. Canada Prospective Comparative 10,
D'Annibale Italy Comparative 53
2005 Woeste et al. Germany Comparative, 6,
Bonder et al. Austria Case series, 14,
Ruurda et al. Holland Case series 23
2007 Heemskerk et al. Netherlands Comparative 19
2008 Baik et al. Korea, Randomized trial, 18,
Spinoglio Italy, Comparative, 50,
Huettner et al. USA, Comparative, 70,
Soravia et al. Switzerland Case series 40
2009 Baik et al. Korea Comparative, 56,
DeHoog et al. Netherlands Case control 20
2010 Tsoraides et al. USA, Retrospective, 102,
Kim and kang Korea, Comparative, 100,
Bianchi et al. Italy, Comparative, 56,
Pernazza and Morpurgo Italy, Case series, 50,
DeSouza et al. USA, Case control, 40,
Zimmern et al. USA, Case series, 131,
Popescu et al. Romania Comparative 122
2011 Kang and kim Korea Retrospective 204
2012 Antoniou SA et al [28] Germany Case series 39
2013 Casillas MA Jr et al [29] USA Case series 344
Germain A et al [30] France Case Series 77
Barrie J et al [31] UK Comparative 34
Wormer BA et al [32] USA Comparative 1809
Table 2. [13]
Robotic Colorectal Cancer Surgery
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The skills required for laparoscopic operations are different to open operations.
Limitations of laparoscopic surgery include loss of depth perception, reduced tactile feedback
and a declined range of motion [33]. The author believes that limited space in the pelvis, with
two-dimensional visions and a bulky specimen can make laparoscopic operations very
difficult.
Laparoscopic TME rectal resections have a steep learning curve [38], requiring precise pelvic
dissection with preservation of autonomic nerves. There is higher incidence of male sexual
dysfunction due to inadvertent injury to the nerves following TME resections [39]. It is
estimated that 50% of colorectal surgeons perform laparoscopic colorectal operations in the
UK and only a quarter of them perform laparoscopic TME resections [40]. Approximately 50-70
cases are needed to surmount the laparoscopic colorectal learning curve [35, 38, 41].
The COREAN trail [42] trial compared open surgery with laparoscopic surgery for mid or low
rectal cancer after neoadjuvant chemoradiotherapy. There was a conversion rate of 1.2% in the
COREAN trial as compared to 34% in the CLASSIC trial. The low conversion rate in the
COREAN trial was attributed to greater experience of the surgeons who has performed an
average of seventy laparoscopic operations as compared to twenty per average surgeon in the
CLASSIC trial [43].
The learning curve for performing robotic colorectal operations is shorter and is achieved after
15-20 cases [37, 38]. There are three phases that has been identified in the learning curve for
robotic colorectal operations [44, 45, 46]
• Phase 1 – initial learning (1-15 cases)
• Phase 2 – increased competence (15-25 cases)
• Phase 3 – period of highest skill (>25 cases)
The other advantages of robotic colorectal resections are that
• It is superior in narrow areas like the pelvis and it’s safe and feasible [47] with good three
dimensional view and zoom magnification [37]
• It has 7 degrees of freedom of movement [37]
• It is associated with lower conversion rates to open operation [48]
• It has better pathologic and functional outcomes. It is associated with less complication rates,
shorter duration of hospital stay, time to recover to normal bowel function or first flatus and
time to start diet. It also causes less postoperative pain [49].
• Hospitals who perform high-volume robotic colorectal operations have significantly lower
rates of postoperative bleeding and ileus [50]
• the double console that comes with the robotic cart allow trainees to take part actively at the
surgical procedure and learn from it [51]
• simulators are available than can be attached to the console which provides a platform for
surgical trainees to practice their skills before actually performing the procedures
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There are however some limitations of the da Vinci system. In particular
• there is a definite learning curve for this technique
• loss of tactile feedback although partly compensated by better vision, still can have its effects
on the performance and outcomes
• Hospitals that perform less robotic colorectal operations had more complications with
longer length of hospital stay causing higher cost for the hospital. [19]
• High cost of purchasing as well as maintaining the robotic system [22]
LNs (mean N) Distal margin(mean, cm) Positive CRM (%)
ROB LAP p ROB LAP p ROB LAP p
Park et al, 2010 17.3 14.2 0.06 2.1 2.3 ns 4.9 3.7 0.5
Kim et al, 2010 14.7 16.6 ns 2.7 2.6 0.09 3 2 ns
Kwak et al, 2011 20 21 0.7 2.2 2.0 0.8 1.7 0 >0.9
Baek et al, 2011 13 16 0.07 3.6 3.8 0.6 2.4 4.9 1
Bianchi et al, 2010 18 17 0.7 2 2 1.0 0 4 0.9
Baik et al, 2009 18.4 18.7 0.8 4 3.6 0.4 7 8 0.7
Patriti et al, 2009 10.3 11.2 >0.05 2.1 4.5 >0.05 0 0 ns
(LNs: lymph nodes, CRM: circumferential resection margin, ns: not significant, ROB: robotic procedure, LAP: laparo‐
scopic procedure.)
Table 3. Oncologic results of robotic and laparoscopic surgery for rectal cancer [52].
LNs (mean) Distal margin (mean, cm) Positive CRM (%)
ROB OPEN p ROB OPEN p ROB OPEN p
De Souza et al], 2011 15 16.8 0.26 na na 0 3 0.25
Kim et al, 2012 20 19.6 0.7 2.7 1.9 0.001 1 1 1
Park et al, 2011 19.4 18.5 0.06 2.8 2.3 0.002 1 2 0.9
(LN: lymph nodes, CRM: circumferential resection margin, na: not assessed, ROB: robotic procedure, OPEN: laparoscop‐
ic procedure.)
Table 4. Oncologic results of open and robotic surgery for rectal cancer [52].
Robotic Colorectal Cancer Surgery
http://dx.doi.org/10.5772/58350
147
	   139	  
	  	  	  
4. Patient selection
Patient selection is the key especially in the early stages of the learning curve. The author would
recommend choosing patients with
• ASA grade 1-3
• BMI <30
• Age <75 years
• No previous pelvic or intra-abdominal surgery
• T1/T2 tumours
• Tumors that are at or just above the peritoneal reflection of the rectum
• Avoid patients who received neo-adjuvant chemo-radiotherapy and
• Avoid patients who for medical reasons will not be able to tolerate Trendelenburg position
5. Patient preparation
• Bowel preparation – phosphate enema for left sided operations. Bowel preparation not
necessary for right sided colonic operations.
Bowel preparation is controversial in colorectal surgery. Surgeons differ in their approach.
Mechanical bowel preparation results in a colon that is clear of feces. However, it can leave
liquid stool in the bowel that is more likely to contaminate the operative field and the pelvis
in the event of an anastomotic leak. In our experience, bowel preparation also results in small
bowel distension that can make operations more difficult. The authors do not use bowel
preparation for right-sided colonic resections. Two-phosphate enemas are used for left sided
colorectal resections.
• low residue diet 3-4 days before operation
• 4 high calorie drinks to be taken the night before operation
• Eating and drinking normally up to 6 hours before operation
• 2 high calorie drinks to be taken up to 2 hours before operation
• Intra-operative fluids are restricted to 500 mL per hour as tolerated by the patient. This
minimizes the risk of edema of the face and neck that can occur due to the steep Trende‐
lenburg position and excessive fluids. Goal directed therapy is the standard approach using
esophageal Doppler.
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6. Operating room configuration
Figure 3. [53]: showing operating room set up during colectomy
7. Positioning
• Patient is positioned supine in a modified lithotomy position with legs wrapped around
adjustable stirrups
• Legs are abducted and slightly flexed at the knees
Robotic Colorectal Cancer Surgery
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• Patient's arms are wrapped alongside the body to reduce possibility of shoulder injury and
additional shoulder harness can be placed to support Trendelburg’s position
• Pressure points and bony prominences are padded and the body position is secured with
vacuum-mattress device, especially lateral on the right side.
• Secure the patient to the table to avoid any shifting with the Trendelenburg position.
• Patient is tilted right side down and adjust the angle during initial exposure
• A body warmer (bear hugger) is applied to prevent patient hypothermia.
• Sequential compression devices (Flowtrons) are applied to the legs for DVT prophylaxis.
• After positioning, padding, securing and preparing the patient in the supine position, the
table is then placed in a Trendelenburg position, whereby the steepness should be adjusted
as per exposure needs during the initial exposure step.
Image 1. Showing positioning of patient
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8. Right-sided operations
R2 
R1 
Optical 
R3 
Image 2. Showing marking for Right Colonic resections. Insufflation via Veress needle at LUQ.
9. Port placements
9.1. Preparing for port placement
• Port placement is the key for a successful robotic procedure. Narrow space between the
ports will result in clashing of the arms and poor ergonomics. We recommend marking of
the abdomen for port placement after CO2 insufflation.
• The initial pneumopertioneum can be established with a Veress needle or Hassan’s techni‐
que at LUQ or at camera port site.
• Initial assessment of entire anatomy of the abdomen focusing on adhesions, peritoneal
seedlings and liver metastasis is carried out once the camera port is inserted. Place remaining
ports under endoscopic vision avoiding injury to the inferior epigastric vessels.
Robotic Colorectal Cancer Surgery
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9.2. Instrument port placements for left sided colorectal operations [54]
Diagram 1 Showing post placements for left sided colorectal operations
• Robotic camera port, 12 mm (Blue): Place the port 3-4 cm right and 3-4 cm above umbilicus.
Distance to symphysis pubis should be ~22-24 cm.
• Robotic instrument arm port, 8 mm (Yellow): Place the port a minimum of 8 cm from the
camera port, on the right spinoumbilical line (SUL) at the crossing of the mid-clavicular line
(MCL). Distance to symphysis pubis should be ~14-16 cm. Linear stapler can be used from
this port.
• Robotic instrument arm port, 8 mm (Green): Place the port a minimum of 8 cm from the
camera port, on the left spinoumbilical line (SUL) at the crossing of the mid-clavicular line
(MCL). The distance to the symphysis pubis should be ~14-16 cm.
• Robotic instrument arm port, 8 mm (Red): Place the port ~ 3 cm sub-xyphoid and ~ 2 cm
medial to the right MCL
• Robotic instrument arm port, 8 mm (Green-Red): Place the port 7-8 cm below the left costal
margin, slightly medial to the left MCL. Place the port a minimum of 8 cm from the other
instrument ports and the camera port.
• Assistant port, 5 mm (White): Place the port 8-10 cm cephalad to the instrument arm port
and ~ 4 cm lateral to the right MCL (a minimum of 8 cm from the camera port). This port is
used for suction/irrigation, ligation and retraction.
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Image 3. Showing port placements for left sided colorectal operations
Robotic Colorectal Cancer Surgery
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9.3. Port placement for right sided colonic resections
Image 4. [74]: showing port placements for right sided colonic resections
9.4. Instrument port placements for right sided colorectal operations
• Camera port 12mm, at left spinoumbilical line (SUL)
• Robotic arm port 1, 8mm, at left mid-clavicular line (MCL) 8cms below costal margin
• Robotic arm port 2, 8mm, is placed in at right SUL 2cms lateral to right MCL
• Robotic arm port 3, 8mm, is placed in midline 3 cms from pubic symphysis
• Assistant port, 5mm, place at LIF lateral to left MCL
9.5. Operative steps for left sided colorectal operations
• Initial exposure is acquired by cephalad retraction of the omentum to expose the transverse
colon and by moving the small bowel out of the pelvis. Loops of small bowel can be stacked
in the right upper quadrant to expose the Inferior Mesenteric Vein (IMV). A small swab
placed against the small bowel loops can sometimes help by preventing the bowel from
slipping into the operative area.
• Primary vascular control is achieved by ligating the Inferior Mesenteric Artery (IMA) and
IMV earlier in the operation. Disposable locking clips are used to secure these vessels before
division.
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• Medial to lateral mobilization of sigmoid and descending colon is carried out towards the
left sidewall and superiorly towards the spleen. The plane between mesocolon and Gerota’s
fascia is developed. Left ureter and gonadal vesssels should be identified at this stage.
• Splenic flexure mobilization (SFM) is not mandatory. However, if the anastomosis is likely
to be at tension, SFM is strongly recommended. If SFM is needed, IMV is divided high and
the plane above the pancreas is developed which can lead the surgeon into the lesser sac.
Gastrocolic omental division from above can complete this step safely.
• Rectal dissection and division – Total Mesorectal Excision (TME) is carried out to the pelvic
floor for a mid to low rectal cancer or to the peritoneal reflection for an upper rectal cancer.
Great care is taken to avoid injury to the parasympathetic nerves.
• Anastomosis - Rectal division and anastomosis is performed using surgical staplers. Care
should be taken not to damage the pelvic floor at this stage. For rectal division, stapler can
be inserted through the assistant port or the R1 can be disabled and undocked and the port
changed to a 12 mm port to allow the stapler to pass through. In patients with a very narrow
pelvis, a supra-pubic port can be used to divide the rectum anteroposteriorly. We perform
a routine flexible sigmoidoscopy to check for anastomotic bleeding, viability of the colon
and rectum and at the same time perform a leak test to check for anastomotic leak.
9.6. Operative steps for right sided colonic resections
• The patient is positioned in modified Lloyd –Davis position with slight Trendelenberg tilt.
The ileocolic and Superior Mesenteric Artery (SMA) pedicles are exposed by retraction of
the small bowel and appropriate traction and counter traction on the mesentry. Dissection
along the Superior Mesenteric Vein (SMV) will expose the ileocolic vein and artery that are
then divided after clipping. Duodenum is identified early and dissection carried out towards
the liver to enter the lesser sac.
• Lateral to medial mobilization allows the right colon to be freed up. Sub ileal dissection
completes this dissection allowing the whole specimen to come to the midline. Gastrocolic
omental division results in complete mobilization of the heaptic flexure.
• Ileocolic anastomosis can be performed intra or extra corporeally depending upon the
surgeons preference. Specimen is extracted either through a midline or suprapubic incision.
9.7. Post-operative management — (Enhanced Recovery Programme [55])
Day of operation:
• Pain management with epidural followed by PCA and then oral/IV/IM analgesia
• Post-operatively the patients are transferred to Surgical High Care for close monitoring
• All patients should have DVT (unless contraindicated) and antibiotic prophylaxis
• Patients encouraged to sit out of bed and encouraged to drink straight after the operation
including 2 protein drinks
Robotic Colorectal Cancer Surgery
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First post-operative day:
• The patient will have an epidural and urinary catheter
• Will be encouraged to drink 2 litres of fluid and drink 4 high protein drinks
• Will be encouraged to eat normal food
• Will be encouraged out of bed for 8 hours and take 3 walks of 50 meters each with help from
the physiotherapists
Second post-operative day:
• Epidural and urinary catheter removed. Pain management using PCA.
• Will be encouraged to drink 2 litres of fluid and drink 4 high protein drinks
• Will be encouraged to eat normal food
• Will be encouraged out of bed for 8 hours and take 3 walks of 50 meters each with help from
the physiotherapists
Post-operative days 3-5:
• The patient is discharged from the hospital if stable in three to five days i.e. passed flatus
and or opening bowels
• Pain controlled with oral medications
• Able to mobilize and physiotherapists happy with progress
Outpatient follow-up:
• Follow up at OPD 2-3 weeks post-operatively
• All Cancer patients are discussed at Multidisciplinary Team Meeting, regarding additional
therapy or adjuvant radiation with or without chemotherapy as indicated.
10. Future developments
10.1. Role of ICG in bowel anastomosis and lymph node mapping using da Vinci robot
Indocyanine green (ICG) is a cyanine fluorescent dye that absorbs near infrared wavelengths
of light. It binds to plasma proteins and travels in the vascular system [56]. ICG emits an
infrared signal when excited by laser light in situ, which can be detected with near-infrared
fluorescence camera system (NIRF) [57].
The image from NIRF gives visual assessment of blood vessels, blood flow, and tissue
perfusion. ICG has been widely used by the ophthalmologists to visualise retinal blood vessels
[58] and the technique has been amalgamated into the da Vinci Si robotic system.
Water soluble ICG can be given intravenously during surgical procedure. The surgeon is able
switch into fluorescence imaging modes from normal white light mode by pressing pedals in
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the console and is able to view infrared images of blood flow in the microvasculature as well
as tissue perfusion in real time. This is particularly useful during bowel anastomosis and
improving patient outcomes [59].
Lymph nodes harvesting can be a difficult procedure to perform in cancer surgery.
The use of ICG is an attractive method to facilitate visualisation of lymphatic vessels, sentinel
nodes, and metastatic lymph nodes. It was first introduced by Lim and Soter [60].
ICG has been used in the recent past to harvest lymphnodes for cutaneous rectal carcinoma
metastasis [61] and cutaneous Kaposi's sarcoma [62] with successful outcome.
It has also been used in transcutaneous Sentinel Lymph Node detection in vulvar cancer
patients [63] and for identification of lymphatic pathway involved in the spreading of prostate
cancer [64].
10.2. Robotic Single Incision Laparoscopic Surgery (SILS) or Colectomy (SILC)
Single incision laparoscopic colectomy (SILC) is well established. SILC is associated with
shorter post-operative length of hospital stay and smaller skin incision. There is no difference
in operating time or in conversion rate when compared to multiport laparoscopic colorectal
operations [65]. The main drawback with SILC is exposure, conflict of instruments, ease of
instrumentation, camera operation and ergonomics [66].
Robotic single incision laparoscopic surgery may be the answer to some of the problems
associated with SILC. The author believes that robotic single incision colectomy will result in
less abdominal wall trauma, less pain, needing fewer analgesics, early mobilisation and
decreased length of hospital stay. It will have better cosmetic result due to fewer numbers of
incisions. There is good evidence to suggest that multiple laparoscopic port incisions can cause
port site hernias even with 5mm ports [67, 68].
Early experience with robotic SILC performing right hemicolectomy is safe and feasible [69].
We need more studies to validate robotic SILC for left sided operations.
Other surgical specialties where robotic SILS is gaining interest are listed below:
• Spinioglio G et al mentioned that it took them less time to perform robotic single port
laparoscopic cholecystecomies than laparoscopic SILS [70].
• Robotic single-port trans-umbilical total hysterectomy is technically feasible in selected
patients with gynaecological disease [71].
• Hahn Tran et al have successfully performed robotic single-port inguinal hernia repair
without any complications [72].
• The authors believe that robots will also play a role in natural orifice endoscopic surgery
and specimen retrieval via the natural orifice in the near future
The perfect robotic platform should have a low external profile,  which can be deployed
through a single access site. It should be able to restore intra-abdominal triangulation while
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maintaining  the  maximum degree  of  freedom for  accurate  maneuvers  and  strength  for
reliable traction. Several purpose-built robotic prototypes for single-port surgery are being
tested [73].
The author believes that robots will also play a role in natural orifice endoscopic surgery and
specimen retrieval via the natural orifice in the near future.
11. Summary
In summary the developments of surgical robotics over the last decade has been very exciting.
The technology is improving rapidly. Robots certainly allow the surgeons to perform better
operations with improved safety. In colorectal surgery robotics will find its place in pelvic and
rectal cancer surgery. The cost of instruments and the system are the biggest barrier to the
widespread uptake of robotic surgery by the surgical community. The future applications of
this technology may result in further benefits that will offset the cost issue.
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Four Percent of Patients Undergoing
Colorectal Cancer Surgery may have
Synchronous Appendiceal Neoplasia
Muhammad Najm Khan, F.R.C.S.(Glasg.), Brendan J. Moran, M.Ch., F.R.C.S.I.
Department of Colorectal Surgery, North Hampshire Hospital NHS Trust, Basingstoke, United Kingdom
PURPOSE: An individual with colorectal cancer has a 3
percent risk of synchronous colonic neoplasia and further 2
to 3 percent risk of metachronous cancer, a risk that has
prompted colonic surveillance. The appendix has a similar
mucosal pattern to the colon and it has been hypothesized
that appendicular adenocarcinoma may account for 1
percent of all colorectal malignancies. A special interest of
the senior author in appendiceal and rectal cancer has
prompted routine removal of the appendix in all cases
undergoing surgery for colorectal cancer. METHODS:
Consecutive patients undergoing left colectomy or anterior
resection for colorectal cancer had coincidental appendec-
tomy with the specimen pathologically analyzed. A retro-
spective review of the case notes and histopathology was
performed. Data also were collected for patients who had
right hemicolectomy for colonic carcinoma. RESULTS: In
total, 169 patients under the care of a single surgeon had
colorectal cancer resection between April 2002 and April
2005: 63 patients had right hemicolectomy, 29 had left
hemicolectomy, and 77 had rectal cancer resection. Seven
of 169 appendices had abnormalities: 3 mucinous cystade-
nomas, 2 cystadenocarcinomas, 1 carcinoid tumor, and 1
villous adenoma. CONCLUSIONS: Patients having colorec-
tal cancer resection for adenocarcinoma should have
appendicectomy performed. Synchronous pathology was
found in 4.1 percent in this series. Metachronous neoplasia
is a risk in the retained appendix in patients with colorectal
cancer. Routine postoperative surveillance cannot assess
the appendiceal mucosa, so there is little justification for
not taking the opportunity to eliminate the possibility of
future appendicitis or neoplasia. [Key words: Colorectal
cancer; Appendix tumors; Synchronous cancer]
M ore than 70 percent of colorectal cancers arethought to originate from adenomatous polyps in
what has been termed the adenomacarcinoma se-
quence.1 Synchronous colorectal neoplasia has been
reported in 3 to 5 percent and metachronous neoplasia
in 2 to 3 percent, a risk that has prompted complete
preoperative colonic imaging and postoperative colon-
ic surveillance.2, 3 The appendix is derived embryolog-
ically from the large intestine and has a similar mucosal
pattern to the colon and hence any neoplastic condi-
tion of the colon can affect the appendix.4
Appendiceal adenocarcinoma may account for 1
percent of all colorectal malignancies.5 Many appen-
diceal tumors present with pseudomyxoma perito-
nei, a condition that we, among others, have
reported as predominantly arising from a perforated
cystadenoma, or adenocarcinoma, of the appendix.6
We hypothesized that patients with colorectal cancer
might have a similar risk of synchronous and
metachronous appendiceal tumors to that of the
colon and rectum. The appendix was removed
routinely at colorectal cancer resection because of
the small but real risk of appendiceal pathology,
which is demonstrated in this case series, and the low
risk of adding appendectomy to a colectomy.
MATERIALS AND METHODS
This case series is a retrospective study. Consecu-
tive patients undergoing left colectomy or rectal
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resection for cancer under the care of a consultant
surgeon had incidental appendicectomy. The appen-
dix was submitted separately for histopathologic
assessment. Case notes and histopathology records
of all such patients between April 2002 and April
2005 were reviewed and the data were analyzed. In
patients having a right hemicolectomy for cancer, the
appendix was part of the specimen, and the results
for this group also were analyzed for comparison.
Patients who had a previous appendicectomy were
excluded from the study.
The site of the primary tumor, index operation,
stage of the cancer, and lymphatic involvement were
noted. Macroscopic and microscopic features of the
appendix were recorded. Postoperative course, hos-
pital stay, and complications also were recorded for
these patients.
RESULTS
Between April 2002 and April 2005, 182 consecu-
tive patients had surgery for colorectal cancer.
Thirteen patients had previous appendicectomy and
hence were excluded. In total, 169 patients were
included in this study (93 males; male-to-female
ratio, 1.2:1; median age, 67 (range, 20–91) years).
Of these 63 underwent right or extended right
hemicolectomy, 29 had left hemicolectomy, and 77
had surgery for rectal cancer. The appendix was part
of the specimen in patients having right hemicolec-
tomy and was removed separately in patients under-
going left hemicolectomy or rectal resection. Seven
patients (4.1 percent) had epithelial appendiceal
tumors (Table 1). Five patients had rectal cancer
surgery and the other two had right hemicolectomy.
There was one case of carcinoid tumor of the
appendix.
There was no specific morbidity that could be
attributed to appendicectomy in any of the seven
cases. One patient who had an abdominoperineal
excision after chemoradiotherapy had delayed peri-
neal wound healing, and one other patient had a
superficial wound infection. The patient character-
istics, including site of primary tumor, index opera-
tion, staging, and lymphatic involvement are outlined
in Table 1.
DISCUSSION
The appendix derives embryologically from the
cecum and histologically is similar to the colorectum.7
Epithelial tumors of the appendix are rare but could
be more common in individuals with colorectal
neoplasia. A recent review suggested that 33 percent
of individuals with appendiceal tumors had coinci-
dental synchronous or metachronous neoplasms
predominantly of the gastrointestinal tract.8 The
adenoma–carcinoma sequence for the sequential
development of cancer may be similar in appendi-
ceal as in colon cancer.9
A mucocele is the commonest presentation of
benign adenomas of the appendix; however,
adenocarcinomas also may be associated with
excessive production of mucin.10 There are no
Table 1.
Patient Characteristics, Operative Findings, and Histologic Results in Patients with Appendiceal Tumors
Age (yr) Gender
Primary
Tumor
Primary
Operation
Appendix
Abnormality
Stage of
Primary
Tumor
No. of
Nodes
Involved
67 F Upper rectum Anterior resection Mucinous
cystadenoma
Dukes A
(pT2N0)
0
77 M Upper rectum Anterior resection Mucinous
cystadenocarcinoma
Dukes C1
(pT3N2)
11
74 M Lower rectum Abdominoperineal
resection
Mucinous
cystadenocarcinoma
Dukes B
(pT3N0)
0
69 F Lower rectum Ultra low anterior
resection
Mucinous
cystadenoma
Dukes A
(pT2N0)
0
69 F Upper rectum Anterior resection Villous adenoma Dukes B
(pT4N0)
0
83 F Ascending
Colon
Right hemicolectomy Mucinous
cystadenoma
Dukes C1
(pT3N1)
2
79 M Cecum Right hemicolectomy Carcinoid tumor Dukes A
(pT2N0)
0
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pathognomonic symptoms or signs of appendiceal
tumors, and tumors are difficult to detect preopera-
tively. In a series published from the Mayo Clinic, no
patient with an appendiceal tumor was correctly
diagnosed preoperatively and even at operation only
30 percent were suspected.5 In our study, all the
appendices were macroscopically normal with no
preoperative or perioperative suggestion of an
appendiceal tumor.
Preoperative colonic imaging by colonoscopy and
postoperative colonic surveillance allows detection
of synchronous and metachronous neoplasms and
prophylactic polypectomy.11 The National Polyp
Study reported that colonoscopic polypectomy and
surveillance colonoscopy reduced the incidence of
colorectal cancer by two-thirds compared with the
reference population.12 Some authors have sug-
gested that the presence of a benign adenoma of
the appendix should be considered as a marker for
future development of colorectal cancer and such
patients should be screened and followed up.10 The
detection of these synchronous abnormalities at the
time of primary operation is important because,
the majority of these synchronous lesions are early
cancers (carcinoma in situ or Stage I).13,14
In our study, synchronous appendiceal neoplasia
was found in 4.1 percent of 169 patients with
colorectal cancer, similar to previous reports of
synchronous colonic pathology.2 Patients with rectal
cancer had more appendiceal tumors than those with
right colon cancer, although this may be biased by
more accurate pathology in the separately submitted
appendix specimens in patients with rectal cancer. In
a recent review of 7,500 appendicectomy specimens,
the authors reported ten cases of adenocarcinoma of
the appendix and two of them had synchronous
rectosigmoid cancers.15 Metachronous neoplasia is a
known risk (2–3 percent) in colorectal cancer
patients and could develop in a retained appendix.
Some studies have reported a much higher risk (up
to 5 percent) for the development of metachronous
tumors. This is particularly important because not
every tumor is detected in these patients as a result of
diagnostic difficulties or inadequate follow-up.16
Postoperative surveillance colonoscopy is now rou-
tine after colorectal cancer resection. Although an
excellent method for colonic surveillance, the appen-
diceal mucosa is inaccessible.
Incidental appendicectomy with cholecystectomy,
herniorrhaphy, and other abdominal procedures has
been associated with an increased risk of infection
and abscess formation, presumably from the addition
of an intestinal operation to a clean procedure.17
Appendicectomy is unlikely to be an additional
infective risk in major bowel resection. There was
no added morbidity or mortality related to appen-
dectomy in this study.
CONCLUSIONS
The results of this study suggest that there is little
justification for omitting the opportunity to remove
synchronous and to eliminate the possibility of
metachronous, appendiceal neoplasia in patients
undergoing colorectal cancer resection. Further,
larger series are needed to explore this proposed
routine addition of appendicectomy in surgery for
colorectal cancer.
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Abstract
Purpose Incisional hernia at the extraction site (ESIH) is a
common complication after laparoscopic colorectal resec-
tions. The aim of this study was to evaluate the prevalence
and potential risk factors for ESIH in a large cohort study
having standardized technique.
Methods A cross-sectional study was performed including all
patients who underwent elective laparoscopic right or extend-
ed right colectomy for cancer from November 2006 to
October 2013 using a standard technique. All patients have
been followed up for a minimum of 1 year with abdominal CT
scan.
Results A total of 292 patients were included with a median
follow-up of 42 months. Twenty patients (6.8 %) developed
ESIH. Obesity (odds ratio (OR) = 3.76, 95 % confidence
interval (CI) 1.39–10.15; p = 0.009) and incision length (OR
2.86, 95 % CI 1.077–7.60; p = 0.035) significantly
predisposed to the development of ESIH.
Conclusion This study identified that the risk of ESIH is sig-
nificant after colonic resections and there are several risk fac-
tors responsible for the development of ESIH.
Keywords Laparoscopic right colectomy . Incisional hernia .
Predictive factors
Introduction
Laparoscopic resection is now the standard surgical treatment
for colon cancer [1, 2]. For cancer of the right colon, this
comprises right or extended right hemicolectomy according
to the location of the tumor [3, 4]. Mostly, the specimen is
removed via an extraction site wound in the abdominal wall.
Incisional hernia at the extraction site (ESIH) appears
to be one of the most frequent complications after lap-
aroscopic colorectal resection with an incidence of 5–
20 % in published series [5–7].
An understanding of risk factors for ESIH would provide a
useful basis for consenting patients before operation and for
designing interventions to prevent this complication.
Published series have been mostly heterogeneous with regard
to pathology, operation performed, or duration of follow-up,
making it difficult to draw firm conclusions [8, 9].
The aim of this study was to analyze the risk factors and
prevalence of ESIH on CT scan at a minimum follow-up of
1 year in a cohort of patients, all of whom have undergone
laparoscopic resection for right-sided colon cancer.
Methods
A retrospective analysis was undertaken of patients data col-
lected prospectively on our colorectal surgery database from
November 2006 to October 2013. This is a cross-sectional
study of patients who underwent elective laparoscopic right
or extended right colectomy for cancer in the study period.
Inclusion and exclusion criteria
All consecutive patients with cancer in the right colon (cecum,
ascending colon, hepatic flexure, and transverse colon) who
This work was presented on the DDF meeting in London, UK, 23–25
June 2015.
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underwent elective laparoscopic right hemicolectomy or ex-
tended right hemicolectomy during an 8-year study period were
included in the analysis. Patients underwent standard CT stag-
ing of the chest, abdomen, and pelvis preoperatively and again
at a minimum 1 year postoperatively using a multislice CT
scanner (Siemens™) with a slice of 3 mm. Operative data were
recorded on a proforma, which included the location and length
of the extraction site wound. All CT scans were reported by a
consultant radiologist and reviewed for evidence of ESIH
(Fig. 1). Exclusion criteria were as follows: conversion to lap-
arotomy, surgical reintervention through a laparotomy, natural
orifice extraction of specimen, follow-up less than 1 year,
and/or without a follow-up abdominal CT scan. No single-
incision surgical procedure (SILS) was included in the study.
Surgical technique and postoperative management
All cancer resections were performed by experienced laparo-
scopic consultant surgeons or by higher surgical trainees un-
der direct supervision using a standardized technique which
we have previously published [10]. Laparoscopic mesocolic
excision was performed in all cases adhering to oncological
principles of cancer resection. No bowel preparation was used.
Port placement for right colonic resections included the use of
four trocars (two 12 mm and two 5 mm). Primary vascular
ligation was followed by medial to lateral dissection and then
division of colon with clear margins. The location of the ex-
traction site wound was decided by the surgeon, and in all
cases, we used a wound protector. Fascial closure used a run-
ning suture of loop B0^ PDS in one or two layers, for midline
incision or other sites, respectively. The 12-mm port site was
also closed with an interrupted absorbable suture. The skin
was closed with an absorbable subcuticular suture. Patient-
controlled analgesia (PCA) or local blocks were the preferred
option for pain relief, although epidural analgesia was used in
a minority. Postoperatively, patients were managed in an en-
hanced recovery program.
Study variables
The principal endpoint was the presence or absence of an
incisional hernia at the extraction site (ESIH) on CT scan at
a minimum of 1 year after surgery. The following variables
were analyzed: age, gender, BMI, American Society of
Anesthesiologists (ASA) grade, operative data (including
technique and operative time, length and site of extraction
incision), and postoperative complications. Pathological char-
acteristics of the specimen were included in the study. Tumors
were staged according to the seventh edition of the TNM
staging system [11].
Statistical analysis
All results and variables were logged on a specially designed
database. Continuous variables are presented as
mean ± standard deviation, ranges, and categorical variables
as absolute numbers or percentages. Chi-square tests were
used to compare differences in categorical variables (Fisher’s
exact tests were used as needed), and Student’s t tests were
used for continuous variables. Univariate analysis and multi-
variate logistic regression analysis were performed to identify
independent predictive factors for the development of ESIH.
Adjusted odds ratios (ORs) were calculated using logistic re-
gression. Variables achieving statistical significance in the
univariate analysis were considered for multivariate analysis.
ORs with 95 % confidence intervals (CIs) are presented for
each studied variable. Differences were considered to be sig-
nificant at the 5 % level. All p values reported were two sided.
Statistical analyses were performed using SPSS version 20.0
(SPSS™, Inc., Chicago, IL, USA).Fig. 1 Flow chart of patients included in the study
Laparoscopic right colectomy or extended right colectomy  
From October 2006 to August 2014 
N=352 
Included in the final analysis 
N=292 
Excluded (N=60) 
- Converted to open procedure N=16 
- Vaginal extrac!on of specimen N=2 
- Less than 1 year follow-up or reoperated N=42 
Fig. 2 Imaging of CTscan showing an incisional hernia at the extraction
site after laparoscopic right colectomy
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Results
From November 2006 to August 2014, we per-
formed 352 laparoscopic right or extended right
hemicolectomies. Figure 2 provides the flow chart of
all patients included in this series. After several exclu-
sions, the data of 292 patients were included in the final
analysis.
There were 127 males (43.5 %) and 165 females (56.5 %),
with a mean age of 73.3 ± 10.46 years and a mean BMI of
Table 1 Characteristics of
patients according to
development of incisional hernia
after a minimum follow-up of
1 year
Patients with incisional hernia in extraction
site N = 20
No hernia
N = 272
p value
General characteristics
Age (years)a 75.15 ± 6.9 73.21 ± 10.7 73.21 ± 10.7
0.258b
Genderc
Male
Female
8 (40 %)
12 (60 %)
119 (43.7 %)
153 (56.3 %)
0.818d
BMI (kg/m2)a 30.40 ± 6.0 25.91 ± 4.5 0.004b
ASA riskc
I
II
III
IV
0
8/20 (40 %)
12/20 (60 %)
0
20/265
(7.5 %)
161/265
(60.8 %)
82/265
(30.9 %)
2/265 (0.8 %)
0.132d
Previous abdominal
surgeryc
11/20 (55 %) 94/272
(34.5 %)
0.900d
Technique at extraction site
Site of extraction
incisionc
Midline
Others sites
16 (80 %)
4 (20 %)
119 (43.7 %)
153 (56.3 %)
0.062d
Length extraction site
(cm)a
5.90 ± 1.2 5.40 ± 0.9 0.023b
Postoperative data
Hospitalization (days)e 5.0 4.0 0.145b
Postoperative wound
infectionc
1/20 (5 %) 17/272
(6.2 %)
1.0d
Postoperative ileusc 0/20 11/272 (4 %) 0.9d
Characteristics of tumor
Tumor sitec
Cecum
Ascending colon
Hepatic flexure
Transverse colon
5 (25 %)
6 (30 %)
6 (30 %)
3 (15 %)
114 (41.9 %)
91 (33.4 %)
28 (10.3 %)
39 (14.4 %)
0.136d
Max diameter of tumor
(mm)a
46.85 ± 17.4 48.79 ± 19.3 0.664b
Dukes classificationc
A
B
C1
C2
2 (10 %)
11 (55 %)
7 (35 %)
0
48 (17.7 %)
134 (49.2 %)
76 (27.9 %)
14 (5.2 %)
0.549d
aMean ± SD
b Student’s t test
c Absolute numbers (percentages)
d Chi-square’s test
eMedian
Int J Colorectal Dis (2016) 31:1323–1328 1325
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26.2 ± 4.74 kg/m2. Overall, 35.9 % of patients had previous
abdominal surgery and 32.8 % an ASA grade greater than III.
During a median follow-up of 42 months (range 12–96),
20 patients (6.8 %) developed ESIH. Table 1 shows the
characteristics of patients who developed ESIH versus
those who did not. There were no significant differences
between groups in the characteristics of tumor, surgical
technique, or postoperative data. The rate of ESIH ap-
peared to be significantly greater in those with a higher
BMI (p = 0.004) or a longer extraction site wound
(p = 0.023). There was also a greater prevalence of ESIH
in patients with a periumbilical midline extraction site
(9.1 %) compared with other sites (3.4 %), but this did
not reach statistical significance (p = 0.062) (Table 1).
On multivariate analysis, a BMI >30 (odds ratio
[OR] = 3.76, 95 % confidence interval (CI) 1.39–10.15;
p = 0.009) and an incision length more than 5 cm (OR 2.86,
95 % CI 1.077–7.60; p = 0.035) were significant independent
predictors of ESIH (Table 2).
Of the 20 patients with ESIH, 6 of them underwent surgical
repair because of symptoms or cosmetic concerns. The re-
maining 14 are awaiting surgery, or surgery is not warranted
for several reasons (i.e., comorbidities).
Discussion
We report that approximately 7 % of patients developed an
extraction site incisional hernia after standardized laparoscop-
ic resection for right-sided colon cancer as evidenced by CT
scan at a year or more postoperatively.
The strength of this study is that it is the largest
analysis of incisional hernia in a homogenous series of
patients who had a laparoscopic procedure for a right-
sided colon cancer with a standardized technique. A
limitation is that although the data was collected pro-
spectively, this is a retrospective analysis and some con-
founders were not studied as diabetes mellitus or
smoking habit.
There is some controversy regarding the most appro-
priate method of detecting ESIH. The yield of incisional
hernias on CT is perhaps double the clinical rate of
detection [7]. However, while many hernias detected
on CT may never become clinically significant, CT is
more accurate than clinical examination in detecting the
presence or absence of a hernia and is therefore more
valuable in the research setting. However, the cross-
sectional design based on yearly CT scan hampered
identification of the specific time after surgery at which
hernia occurred.
Across the spectrum of laparoscopic colon resections,
ESIH is recognized as one of the most common compli-
cations [5]. The incidence of this clinical condition ranges
from 5 to 20 % of patients in some series [7, 12]. Apart
from our series, the largest published experience included
1057 cases [13]. However, that was a retrospective series,
including open and laparoscopic procedures. In their re-
sults from 137 laparoscopic right colonic resections
followed up, 15.9 % developed incisional hernia (includ-
ing port site hernia) and specifically 5.1 % on the midline
incision for the laparoscopic right colectomies. The pres-
ent study in patients undergoing right-sided colonic resec-
tion for bowel cancer reports ESIH in 6.8 %.
Previous studies have reported a range of factors associated
with ESIH. Sadava et al. [8], in a series of patients operated for
cancer and benign diseases, found BMI and surgical site in-
fection to be significant predictors of ESIH. Compared with
standard laparoscopic surgery, single-incision technique
(SILS) has been reported to increase the risk of ESIH [9].
Interestingly, in a recent study, in a series of 193 patients
operated for colorectal cancer with open or laparoscopic tech-
niques, visceral obesity measured by CTscan rather than BMI
was a significant predictor of incisional hernia [12].
One of the most controversial issues is whether there is
any benefit in using a midline incision vs. other sites for
specimen extraction after colonic resection. Lim et al. [14]
compared midline and transverse incisions in 147 left
sided laparoscopic procedures (sigmoid and rectal cancer
resections). They did not find any differences between
clinical complications (transumbilical incision 2/92 vs.
left transverse incision 0/55, p = 0.810). Williams et al.
[15] demonstrated, in a prospective series of 15 patients,
the benefit of using a transverse right incision and preser-
vation of rectus abdominis muscle. There is no control
arm, but in their experience, none of the patients in a
24-month follow-up developed any incisional hernia.
However, Singh et al. [16] in 2008 reporting on 208
laparoscopic colonic resections observed a 7.8 % ESIH
Table 2 Results of univariate and
multivariate analyses of the study
of predictive factors for incisional
hernia in overall series
Univariate analysis Multivariate analysis
OR, 95 % CI p value OR, 95 % CI p value
BMI >30 kg/m2 4.30 (1.64–11.27) 0.003 3.76 (1.39–10.15) 0.009
Length of incision >5 cm 3.54 (1.36–9.20) 0.009 2.86 (1.07–7.60) 0.035
OR odds ratio, 95 % CI 95 % confidence interval
1326 Int J Colorectal Dis (2016) 31:1323–1328
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rate for midline extraction wound versus 0 % for other
extraction sites. In our experience, the rate of ESIH was
higher in the group of patients with midline incision, but
the difference did not reach statistical significance. It is
important to note that our study included a relatively ho-
mogeneous group of patients undergoing a standardized
operation. The only real variables introduced by the sur-
geon were the location of extraction site and length of the
wound.
Non-controlled trials have proposed intracorporeal
anastomosis in laparoscopìc right colectomy to diminish
the size of the extraction site incision and potentially re-
duce the rate of abdominal wall complications [17–20].
However, it is usually the specimen size rather than the
extracorporeal anastomosis that determines the length of
the extraction wound (except for NOTES). Finally, use of
prophylactic mesh has been suggested to prevent
incisional hernia in patients at risk [21]. The scientific
evidence is scarce, but recently, a RCT has published its
benefits in colorectal surgery when an open procedure
was carried out [22]. We are not aware of any published
data on use of prophylactic mesh in laparoscopic colorec-
tal surgery except in the prevention of port site incisional
hernias in laparoscopic cholecystectomy [23].
Patients undergoing laparoscopic colon resection need
to be informed that although their surgery is planned as a
minimally invasive procedure with associated benefits,
nonetheless, an extraction site through the abdominal wall
is usually required and this is associated with a significant
risk of hernia which may require further surgery in due
course. This risk is especially high in patients who are
overweight, and they need to be so advised.
Regarding surgical technique, the risk of ESIH may be
reduced by using extraction sites away from the umbilicus
(possibly NOTES) and by keeping the extraction wound
short.
In conclusion, increased BMI, longer extraction wound
length and possibly periumbilical extraction site all increase
the risk of ESIH after standardized laparoscopic right
hemicolectomy for cancer.
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Abstract
Aim The aim of this technical note is to describe a
three-step technique for expeditious and complete
mobilization of the splenic flexure (CMSF) during sin-
gle docking totally robotic rectal cancer surgery.
Method A prospectively maintained database was
searched for all patients who underwent single docking
totally robotic rectal cancer surgery with CMSF through
a stepwise technique.
Results We studied 89 patients underwent CMSF dur-
ing single docking totally robotic lower anterior resec-
tion for rectal cancer.
Conclusion The technique demonstrates that CMSF can
be performed with a standardized approach using the nat-
ural embryological planes of surgery. Moreover, this tech-
nique does not involve any change in patient’s position
on the operating table or undocking the robotic system.
We have included an intra-operative video recording to
demonstrate the technique.
Keywords Colorectal cancer, robotic surgery, educa-
tion, flexure mobilization
Introduction
Complete mobilization of the splenic flexure (CMSF)
during minimally invasive rectal cancer surgery may be a
difficult step [1], but it is an important step to achieve a
tension-free anastomosis after anterior resection for lower
rectal cancer [2,3]. A modular system is an effective
approach for learning complex surgical techniques [4].
We have developed a three-step technique for mobilizing
the splenic flexure during a single dock totally robotic
approach for rectal surgery. The technical steps of CMSF
are illustrated in the accompanying video recording.
Position of the patient and deployment of
ports
All colorectal resections are performed using a standard-
ized technique developed through a modular approach.
The operating theatre layout is shown in Fig. 1. Robotic
port configuration for left colonic and CMSF is shown in
Fig. 2. After insertion of robotic ports (R1, R2, R3 and
C, each 8mm) and an assistant port (10 mm), patient is
placed in a maximal Trendelenburg position with at least
a 15° rotation to the right. The robotic cart is docked
from the patient’s left side at a 45° angle (Fig. 3). It is
important to note that once the robotic cart is docked,
the patient remains in the same position till the comple-
tion of whole procedure (i.e. anterior resection).
Operative technique
The procedure is commenced from the medial to lateral
approach. The inferior mesenteric artery is isolated,
clipped and divided at its origin. Further dissection is
carried out towards the lateral abdominal wall and
above the Gerota’s fascia. The subsequent dissection is
a part of CMSF and this is carried out in the following
three critical steps.
Step one
As a first step towards CMSF, while staying between
the embryological planes, the inferior mesenteric vein is
Correspondence to: Amjad Parvaiz, MBBS, FRCS FRCS (Gen), Professor of
Surgery, Director of Minimally Invasive Colorectal Unit, Director of VIMAS,
QA Hospital NHS Trust, Cosham, Portsmouth, UK, and Head of
Laparoscopic and Robotic Programme, Colorectal Cancer Unit,
Champalimaud Clinical Foundation, Lisbon, Portugal.
E-mail: apcheema@yahoo.com
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Surgery Association (CRSA) 2015, Chicago, Illinois, USA.
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identified as an anatomical landmark. The upper border
of the pancreas is identified at 2 cm lateral and above
the origin of the inferior mesenteric vein. A surgical
plane is developed above the pancreas aiming towards
the lesser sac. At this stage, for better access and safe
dissection, the inferior mesenteric vein is divided at the
Robot cart
Operating table
Vision cartLap stack
Anaesthesia
Assistant
Scrub
Console surgeon
M I
C U
Figure 1 Operating theatre set-up.
MCL- Mid clavicle line,
A- Assistant (10 mm port)
ML- Midline, SUL- Spinoumbilical line
C- Camera
R1
A
R3
M
CL
M
L
M
CL
R2
C
SUL
SUL
Figure 2 Left colonic and splenic flexure
configuration.
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level of the lower border of the pancreas. Further dis-
section is continued cephalad towards the splenic flex-
ure above the pancreas. The pancreas is exposed and a
protective swab is placed above it, which acts as land-
mark during lateral (step 2) and superior (step 3)
dissection.
Step two
During this step, lateral colonic mobilization is com-
menced by dividing the lateral peritoneal reflection.
Traction and countertraction are provided by robotic
arms and the patient side assistant. Dissection is contin-
ued towards the splenic flexure till the splenocolic
attachment is divided. At this stage, the previously
placed swab can be seen which facilitates dissection in
this area.
Step three
The robotic arm R2 is disengaged at the start of this
step to minimize collision of the robotic arms and to
provide better access. Dissection is carried out using R1
and R3 while an assistant provides countertraction with
the bowel grasper. Dissection starts at the distal trans-
verse colon. The aim is to separate the embryological
plane that exists between the greater omentum and the
transverse colon. The lesser sac is entered from the
above and dissection is continued towards the spleen
where the previously placed swab over the pancreas is
identified. The plane of dissection is joined laterally to
the previous dissection performed developed during left
colonic mobilization in step two. This final step results
in CMSF and further pelvic dissection is performed to
complete the procedure.
Results
The three-step technique for CMSF was used in 89
consecutive patients who underwent single docking
robotic resection for rectal cancer. Demographics and
peri-operative are shown in Table 1. There were no
intra-operative complications such as bleeding or injury
to the pancreas or bowel. Postoperatively three patients
returned to theatre, one with anastomotic leakage and
two with small bowel obstruction. There was no 30-day
mortality and all morbidities are listed in Table 1. The
median total time for the robotic anterior resection
including CMSF was 240 (130!456) min.Figure 3 Patient position and docking.
Table 1 Patients undergoing anterior resection and complete mobilization of the splenic flexure.
n = 89 Percentage (%)
Patiets (anterior resection) 89 100
Male:female 64:25 !
Age, median (range) 65 (35–92) !
Body mass index (kg/m2), median (range) 27 (20–46) !
ASA Grade I 8 8.9
ASA Grade II 64 71.9
ASA Grade III 17 19.1
Total operation time (min), median (range) 240 (130!456) !
Blood loss (ml), median (range) 10 (0!200) !
Postoperative outcomes
Hospital stay (days), median (range) 6 (3!48) !
30-day mortality 0 0.0
30-day postoperative reoperation 3 3.3
Readmission (30-day) 10 11.2
Wound infection 12 13.4
Postoperative ileus 8 8.9
Urinary tract infection 7 7.8
ASA, American Society of Anesthesiologists.
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Discussion
CMSF may be difficult and is not routinely performed
for every left-sided colorectal resection. A number of
studies support selective mobilization of the splenic flex-
ure [5–7], but in patients with mid to low rectal cancer
it is important to perform splenic mobilization to
achieve an appropriate length to create a tension-free
anastomosis. Various approaches have been described to
perform CMSF laparoscopically [8,9], but they require
intra-operative repositioning and/or re-draping of the
patient which is time consuming.
Robotic mobilization is even more difficult as the
patient’s position is not changed due to docking. For
this reason various methods such as hybrid or laparo-
scopic assisted or dual docking techniques have been
described [10–12]. These techniques are also time con-
suming and may pose more difficulty, particularly dur-
ing the early learning phase. Additionally a hybrid
technique requires using laparoscopic instruments and
an energy device, which confer extra cost.
It is important to consider the anatomical variations
of the splenic flexure. A high flexure is more difficult to
mobilize and in our experience a stepwise approach is
more useful in this situation. For example, if most of
the dissection is performed during step one the next
two steps become easier if the lesser sac is entered from
below over the pancreas.
The authors (JK and AP) have completed the three-
step technique for CMSF successfully in 89 cases with no
intra-operative or postoperative complications related to
CMSF. The technique is feasible and less time consum-
ing and does not involve use of a laparoscope, undocking
the robot or a change in patient’s position. We recom-
mend that all steps should be performed in the same
order as each step facilitates dissection during the next
step. The technique can be performed safely in a stan-
dardized way using the natural embryological planes,
and the whole procedure of robotic anterior resection
including CMSF can be performed through a single
docking without change in the patient’s position.
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Abstract
Introduction Robotic surgery provides an alternative option
for a minimal access approach. It provides a stable platform
with high definition three-dimensional views and improved
access, which enhances the capabilities for precise dissection
in a narrow surgical field. These distinctive features
have made it an attractive option for colorectal surgeons.
Aim The aim of this study was to present a standardised
technique for single-docking robotic rectal resection and to
analyse clinical outcomes of the first 100 robotic rectal proce-
dures performed in a single centre between May 2013 and
April 2015.
Method Prospectively collected data related to 100 consecu-
tive patients who underwent single-docking robotic rectal sur-
gery was analysed for surgical and oncological outcomes.
Results Sixty-six patients were male, the median age was
67 years (range-24–92). Eighteen patients had neo-adjuvant
chemoradiotherapy whilst 23 patients had BMI >30.
Procedures performed included anterior resection (n=74),
abdominoperineal resection (n=10), completion proctectomy
(n=9), restorative proctectomy with ileal pouch–anal anasto-
mosis (IPAA) (n=5) and Hartmann’s procedure (n=2). The
median operating time was 240 min (range-135–456), and
median blood loss was 10 ml (range 0–200). There was no
conversion or intra-operative complication. Median length
of stay was 7 days (range, 3–48) and readmission rate was
12 %. Thirty-day mortality was zero. Postoperatively, two
patients had an anastomotic leak whilst two had small
bowel obstruction. The median lymph node harvest was 18
(range, 6–43).
Conclusion The single-docking robotic technique should be
considered as an alternative option for rectal surgery. This
approach is safe and feasible and in our study it has demon-
strated favourable clinical outcomes.
Keywords Colorectal . Minimally invasive surgery . Robotic
surgery . Pelvic surgery
Introduction
Rectal cancer surgery has undergone significant evolution
over last few decades. Although the original concept was
centred on radicality, it came at the cost of both higher mor-
bidity and mortality. With the paradigm shift from radical
surgery to precision surgery, organ and functional preservation
also become a vital part in clinical outcomes.
Laparoscopy now has become a standard approach for co-
lorectal surgery [1–3]. Various studies have shown that it is
safe and has good oncological outcomes. Laparoscopy is also
associated with improved short-term outcomes, less morbidity
and better cosmetic results [4–6].
The data from this article was presented in the annual meeting of Clinical
Robotic Surgery Association (2015) held in Chicago, USA
What does this paper add to the literature? There is limited data about
the single-docking robotic rectal resection. This series shows that the
single-docking approach is a feasible and has been applied successfully
in 100 consecutive cases.
This article adds to the evidence to support the potential of robotic rectal
surgery as important alternative option for patients with colorectal cancer.
* J. Ahmed
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Conversely, the laparoscopic approach has various inherent
technical challenges particularly associated with rectal resec-
tions. These include limited views with restricted range of
movement and dexterity of straight surgical instruments as
well as, an assistant dependant, unstable and two dimensional
view [7, 8]. It is also associated with a steep learning curve [9,
10]. These challenges have prompted the use of innovative
new technology such as a robotics system, which has gained
popularity in a number of specialities including colorectal
surgery.
Robotic colorectal surgery (R-CRS) using the da Vinci®
surgical system (Intuitive Surgical Inc., Sunnyvale, CA, USA)
has technical advantages. It provides a stable platform with
high definition three-dimensional view. It also improves ac-
cess and allows sophisticated movements due to Endowrist®
instruments [11, 12]. This approach enhances the capability of
precise dissection in a narrow surgical field with minimal fa-
tigue for the operating surgeon [13, 14].
Since the first robotic resection by Weber in 2002, a num-
ber of case series have shown that the R-CRS is feasible and
safe [15–20]. Most of the robotic cases are reported from
South Korea, Japan, USA and a few from Europe [18–21].
Though the R-CRS is a promising alternative to overcome the
challenges faced by the laparoscopic approach, its widespread
adaptation is still in its infancy. We believe that a standardised
surgical technique can facilitate the training for the R-CRS,
which can bridge this gap [22]. Currently, various robotic
approaches such as hybrid, double docking, reversed hybrid
and laparoscopic-assisted methods have been described for
rectal surgery [23–25].
We have adopted a Bmodified flip arm^ technique for
single-docking robotic rectal resection in our practice. The
aim of this study was to present our standardised technique
and to analyse the clinical outcomes of the first 100 robotic
rectal procedures.
Patients and methods
The data related to 100 consecutive patients who underwent
robotic rectal resection surgery fromMay 2013 till April 2015
was analysed from a prospectively maintained database for
surgical and oncological outcomes.
Preoperative workup
All patients with a known diagnosis of rectal cancer
underwent standard preoperative staging with computed to-
mography (CT) and pelvic magnetic resonance imaging
(MRI). Patients with low rectal cancer (5 cm from anal verge)
underwent additional staging with the help of endoanal
ultrasound. Each colorectal cancer patient was discussed in
multidisciplinary team meeting prior to any treatment.
The neo-adjuvant chemoradiotherapy (NCRT) was recom-
mended to patients with T4 rectal cancer or patients with
threatened circumferential margins (CRM) of <2mm. Surgery
was planned within 8–12 weeks after completing the NCRT.
Patient selection of robotic approach
All patients with potential curative rectal surgery were
offered the robotic approach. Patients who were deemed
unsuitable for laparoscopic approach were not considered for
robotic surgery. Patients with pelvic reoccurrence or needing
multi-visceral resection were excluded from a robotic
approach.
Perioperative care and bowel preparation
All patients underwent standard enhanced recovery pro-
gramme during their perioperative period. The bowel prepa-
ration comprising a fibre-free diet for 2 days and two sachets
of piclolax ® were given 1 day prior to surgery.
Every patient given a prophylactic dose of antibiotics at
induction of general anaesthesia and received a mechanical
and chemical thrombo-prophylaxis for venous thromboembo-
lism (VTE) unless contraindicated.
Theatre setup
The da Vinci® Si robotic system is used for colorectal
resections. A single-dockingmethod with Bmodified flip arm^
technique was applied for all procedures. The splenic flexure
mobilisation and pelvic dissection were performed with only a
slight change in port configuration without changing either the
patient’s position or undocking the robot. The patient’s posi-
tion, placement of ports and surgical approach for rectal sur-
gery is illustrated below.
Patient position
The patient is placed supine in a modified Lloyd Davies po-
sition with arms wrapped beside the body. The vacuum bean
mattress is used to prevent anymigration of patients during the
procedure whilst in Trendelenburg position. A protective
cross bar is used over the patient’s face to prevent any injury
by the robotic arm 3 during the abdominal part of the surgery.
The patient is placed in steep Trendelenburg position with 15°
right tilt to facilitate the exposure. Fig. 1 The room setup along
with robotic cart position is shown in Fig. 2.
870 Int J Colorectal Dis (2016) 31:869–876
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Port placement
Placement of ports for both abdominal and pelvic part of the
procedure are shown in Figs. 3 and 4.
Abdominal configuration
The 12 mm robotic camera port is placed with open technique
at 3–4 cm above and lateral to the right of the umbilicus. The
ideal distance between the camera port and symphysis pubis
should be 22–24 cm. The 8mm robotic arm R1 is placed at the
right spinoumbilical line (SUL) at the crossing of the mid-
clavicle line (MCL). The 8 mm robotic arm R2 is placed about
8 cm below the left costal margin, slightly medial to the left
MCL. The 8 mm robotic arm R3 is placed at 2–3 cm sub-
xyphoid and about 2 cm medial to the right MCL.
A 10mm assistant port A, is placed cephalad to R1 port and
about 4 cm lateral to the right MCL. This port is used for
suction/irrigation, ligation and retraction (Fig. 3).
Pelvic configuration
The robotic arm R2 is moved to R2A (lateral to the left SUL
at the crossing of theMCL) and R3 is moved to R2 port site. A
5 mm port is inserted at the R3 port site, which is also used as
second assistant port (Fig. 4).
Standardised surgical technique
Robotic left colonic and splenic flexure mobilisation
The principle of standardised technique developed for laparo-
scopic colorectal surgery was also applied for the robotic ap-
proach [26]. The omentum and small bowel is moved cepha-
lad to achieve optimal view of the vessels. Procedure
Fig. 1 Robot docked at about a 45° angle at the left side of the patient
after ports insertion
Fig. 2 Theatre setup
Fig. 3 Abdominal configuration. MCL mid-clavicle line, ML midline,
SUL spinoumbilical line, A assistant (10-mm port), C camera
Int J Colorectal Dis (2016) 31:869–876 871
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is commenced from medial to lateral dissection. Primary vas-
cular control is achieved by ligating the inferior mesenteric
artery (IMA) at 1 cm from its origin in order to prevent injury
to hypogastric nerves and by dividing inferior mesenteric vein
(IMV) at the lower boarder of the pancreas. The disposable
locking clips (Hem-o-lok®) are used to secure these vessels
before division. The medial dissection is carried out towards
the left sidewall and superiorly towards the spleen. A plane
between the mesocolon and the Gerota’s fascia is developed.
For splenic flexure mobilisation, a stepwise approach is used.
These steps included, firstly, dissection over the lower border
of pancreas and access to the lesser sac, secondly, the lateral
mobil isat ion of the lef t colon up to splenocol ic
attachments and finally separation of the omentum from the
transverse colon and entry in to the lesser sac from the above.
During the omental separation from the transverse colon, of-
ten the robotic arm R2 is disengaged to minimise the arm
clashing.
Robotic total mesorectal excision
For pelvic dissection and total mesorectal excision (TME)
arrangement is changed to pelvic configuration as shown in
Fig. 4. The TME dissection starts posteriorly and proceeds to
laterally and anteriorly in a stepwise manner. For a better view,
the uterus or base of the bladder (male patient) is hooked up to
the anterior abdominal wall through a stitch using a straight
needle. Great care is taken during the whole procedure to
avoid injury to the pelvic nerves.
The rectum is divided using Endo GIA 45 mm purple
(Covidien’s Tri-Staple™) through either assistant port A or
R1 port site. Following its division, the specimen
is extracted through a 4–5 cm suprapubic incision using a
wound protector. The robot is undocked and a standard anas-
tomosis is performed using circular stapling device. A flexible
endoscope is routinely used to check the integrity of the anas-
tomosis or bleeding, viability of the colon and the rectum.
Patients following low rectal cancer surgery or ileo-anal
pouch are de-functioned using loop ileostomy. A liner stapler
(GI80) with refills is used for extracorporeal J-pouch forma-
tion during pouch surgery.
Statistical analysis
Parametric variables were reported as medians (range). All
statistical analyses were performed using IBM SPSS Statistics
software for Windows, version 18 (SPSS Inc., Chicago, IL,
USA)
Results
Demographics
Sixty-six patients were male and 34 were female. The median
age was 67 years (range 24–92). Eighteen (21.7 %) patients
had neo-adjuvant chemoradiotherapy whereas 23 patients had
BMI>30. The majority of resections were for cancer (n=83),
with 17 for benign conditions. Forty patients had previous
laparoscopic or open abdominal surgery. The detail of previ-
ous procedures is shown in Table 1.
Operative outcomes
The commonest procedure was anterior resection (n=74),
followed by abdominoperineal resection (n=10), completion
proctectomy (n = 9), restorative proctectomy with IPAA
(n=5) and Hartmann's procedures (n=2). The median oper-
ating time was 240 min (range, 135–456), with a median
blood loss of 10 ml (range 0–200). Median length of stay
was 7 days (range, 3–48). There was no mortality within 30
day after procedure whilst readmission rate was 12 %. There
were no intra-operative complications with no conversion to
laparoscopy or open surgery. (Table 2).
Four patients required re-operation within 30 day after the
index procedure, two for anastomotic leak and two for small
bowel obstruction. All complications were managed
laparoscopically. Other morbidities included prolonged ileus
Fig. 4 Pelvic configuration. MCL mid clavicle line, ML midline, SUL
spinoumbilical line, A assistant (10-mm port), A1 secondnd assistant port,
C Camera
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n=11, urinary tract infection n=9, chest and wound infection
n=17 (Table 3)
Oncological outcomes
Preoperative staging showed the majority of patients had T2
or T3 disease. Five patients had nodular involvement (N2)
whilst four had distant metastases (M1) disease during preop-
erative staging. 18 out of 83 (21.7 %) patients had neo-
adjuvant chemoradiotherapy (Table 4).
The postoperative histology showed that 42 patients had
tumour stage T3 or T4 and the median lymph node harvest
was 18 (range, 6–43). The median distal resection margin was
2.7 cm (range, 0.4–8.0 cm). In three cases (3.6 %), circumfer-
ential resection margin (CRM) was reported as positive
(<2 mm) (Table 5).
Discussion
Although minimal access surgery has become the goal
standard for colorectal cancer, penetration of laparoscopy for
rectal surgery remains limited. Furthermore, with inherent
difficulties associated with laparoscopy, robotic approach to
rectal resection is certainly very appealing [27, 28]. The da
Vinci robotic® system provides a three-dimensional view,
using a stable platform for precise dissection. The endowrist
provides an unprecedented range of movement allowing 7
degrees of freedom, 180° articulation and 540° rotation [11,
12]. The robotic wristed instruments allow a much more so-
phisticated range of movements compared to straight laparo-
scopic instruments, especially during dissection on the right
pelvic sidewall.
A systemic review quotes several studies that show the
robotic approach in colorectal surgery is safe and feasible
(21). In our series, the largest single centre series to our knowl-
edge, we also confirm the feasibility and safety of single-
docking robotic surgery for rectal resection. The robotic ap-
proach is associated with low conversion rate as reported by
many authors [17, 29, 30]. In our series of 100 consecutive
cases, there was no conversion to open or laparoscopic sur-
gery. Similarly there was no intra-operative complication in
our series of patients. The median length of stay in hospital
was 7 days whereas readmission rate was 12 % without any
mortality in 30 days after operation. These findings are also
comparable to the published data [25].
We used Bmodified flip arm technique^ for single-docking
approach for our entire procedure using the da Vinci Si ®
system as discussed above. A similar approach of single-
docking technique such as Bflip arm technique^ and Bone step
Table 2 Operative details
n= 100 Procedures Malignant Benign Total
Anterior resection 70 4 74
Abdominoperineal resection 10 0 10
Completion proctectomy 0 9 9
Hartmann procedures 2 0 2
Restorative proctectomy with IPAA 1 4 5
Operation time 240 (135–456) 230 (105–360) 240 (105–456)
Blood loss (ml) 10 (0–200) 20 (0–200) 10 (0–200)
Conversion rate 0 0 0
Total cases 83 17 100
NB Values are given as number or median (range)
Table 1 Patient characteristics n = 100
Total (n= 100) Percentage (%)
Adenocarcinoma 83 83 %
Benign 17 17
Sex:male:female 66:34 (2:1)
Age (years)—median 67 (range 24–92)
Body mass index (kg/m2) 27 (range 19–41)
ASA grade
I 9
II 77
III 14
IV 0
Previous abdominal surgery 40 %
Appendectomy 11 27.5
Total abdominal hysterectomy 7 17.5
Caesarean section 3 7.3
Subtotal colectomy 9 22.5
Bowel resection 1 2.5
Cholecystectomy 5 12.5
Laparotomy 3 7.5
Other 1 2.5
NB values are given as number or median (range)
Int J Colorectal Dis (2016) 31:869–876 873
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setup^ has been reported in the past [31, 32]. For the flip arm
technique, authors reported only four resections (two left
colectomies and two anterior resections) whilst the Bone step^
approach was used only in three cases (one human cadaver
and two involving patients). Our technique includes further
modification in the single-docking approach and helps to
overcome the shortcomings of previously reported ap-
proaches. In our series of patients, no technical difficulties
relating to dissection in the various compartments of abdom-
inal cavity were recorded. We believe that the single docking
is safe and practice. It is also probably easy to learn, if
the standardised approach is adopted, especially during the
initial phase of learning. It also reduces operating time as
compared to hybrid or double docking approaches [24, 25].
The principle of a standardised approach developed for the
laparoscopic colorectal surgery, previously published, was ap-
plied for robotic resections [22, 33]. Therefore, advanced lap-
aroscopic skills can be considered as a key factor for smooth
adaptation of the R-CRS [34, 35].
The median operating time was 240 minutes (range, 128–
456), with blood loss of 10 ml (range, 0–200). These findings
are comparable to various reports published related to the
R-CRS [36]. It is important to highlight that our last 50 pro-
cedures were performed as part of teaching workshops, where
national and international delegates had demonstration of live
robotic surgery. This resulted in slightly prolonged operative
duration as more time was set aside for the discussion and
delegates’ interaction during the live surgery.
The short-term results from various studies have
reported comparable oncological outcomes amongst the ro-
botic and laparoscopic groups. In a sub-group analysis of pa-
tients with higher BMI, male pelvis and mid to low rectal
cancer, a robotic approach was more advantageous [37]. We
concur with this statement. In our series, 66 patients weremale
and more than 23% had BMI>30 whilst over 21.7 % patients
had neo-adjuvant chemoradiotherapy. Our oncological out-
comes such as lymph node count and R0 resection rates were
also comparable to the robotic and the laparoscopic rectal
cancer resections reported in the literature [38].
A number of factors are accountable for the limited uptake of
the R-CRS. The higher capital cost and the use of consumable
instruments are amongst those key factors [39]. However, it is
likely that competition for the robotic system would drive this
Table 4 Preoperative staging (cancer only) n = 83
Number Percentage
Preoperative T staging
T no data 2 2.4
T1 3 3.6
T2 38 45.8
T3 36 43.4
T4 4 4.8
Preoperative N staging
N no data 2 2.4
N0 53 63.9
N1 24 28.9
N2 5 4.8
Preoperative M Staging
Mo 79 95.2
M1 3 3.6
Neo-adjuvant Chemoradiotherapy 18 21.7
Table 5 Pathological results n= 83
Number %
Total cases 83
TME cases 83 –
pTNM stage
T0 2 2.2
T1 15 18.9
T2 24 31.1
T3 38 44.4
T4 4 3.3
Number of harvested nodes 18 (6–43)
Tumour size (cm) 3.5 (0.3–7.0)
Quality of mesorectum
Distal resection margin (cm) 2.7 (0.4–8.0) %
R0 76 91.1
R1 3 3.6
R2 0 0
NB Values are given as number or median (range)
Table 3 Postoperative and morbidity outcome
Number %
Total surgery 100
30 Days postoperative mortality 0 0
30 Days back to theatre for surgery 4 4
30 Days readmission 12 12
Median postoperative hospital stay (day) 7 (3–48)
Anastomotic leakage 2 2
Bowel obstruction needed operation 2 2
Anastomotic bleeding 0 0
Prolonged ileus 11 11
Urinary tract infection 9 9
Wound infection 17 17
Chest infection 4 4
Total major complications 4 4
Values are given as median (range)
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down in the near future. Another factor is the lack of structured
training and mentorship, which may result in poor clinical out-
comes during the initial phase of the robotic surgery. The pro-
fessional bodies such as the European Academy of Robotic Co-
lorectal Surgery (EARCS) are aiming to provide a structured and
supervised training for the robotic colorectal surgery. This will
help to monitor both clinical outcomes and trainees’ pathways to
minimise the consequences of the learning curve [40]. These
incentives may also improve the uptake for the R-CRS in future.
Similarly, we believe that the development of a standardised
approach is also important in mastering the skills and shortening
the learning curve.
Our study was limited as it did not compare the outcomes
of the R-CRS to other approaches. Though during this period
of the R-CRS, the laparoscopic colorectal resections were also
performed, and there was no selection bias. Patients were al-
located to an operating list based on cancer breach dates or if
patients wanted to have the R-CRS. To our knowledge, this is
the first large series from the UK to report this approach and
the short-term clinical and oncological outcomes.
We believe that the R-CRS will find its place in pelvic and
rectal cancer surgery. The future applications of this technology
and the development of new generations of robotic system like
da Vinci Xi robotic system may overcome some of the
challenges faced by the current robotic approach. Similarly,
the clear view of surgical planes and the conservation of pelvic
nerves due to the precise dissection may have a significant
impact on clinical outcomes and the quality of life after rectal
surgery due to better bladder and sexual function [41]. Though
further data are required to establish this notion.
Conclusion
A minimal access surgery has provided the perfect mix for
both precision and organ preservation. The robotic platform
has pushed that boundary even further due to better views and
articulated instruments.
The single-docking robotic rectal resection can be consid-
ered as an alternative approach. This approach is safe, feasible
and can be adopted in surgical practice without compromising
the clinical and the oncological outcomes.
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Abstract
Aim The aim of the study was to determine the effect
of major complications after colorectal cancer surgery
on survival and time to recurrence.
Method Patients having a curative colorectal cancer
resection and a follow-up of at least 3 years were identi-
fied from a prospective database. Major complications
were defined as Clavien–Dindo Grades 3b or 4 and
their impact on time to recurrence and mortality was
analysed by univariate and multivariable analysis. Post-
operative death within 30 days or during the initial hos-
pitalization (Clavien–Dindo Grade 5) was a priori
excluded.
Results From 2003 to 2012, 868 colorectal cancer
resections resulting in 63 (7%) major postoperative
complications including deaths (Clavien–Dindo ≥ 3b)
were identified. After exclusion of Grade 5 complica-
tions (postoperative or in-hospital deaths), 844 resec-
tions with 39 (5%) major complications remained for
analysis. Median follow-up time was 5.7 years. Using
the Kaplan–Meier method, the estimated crude 5-year
overall survival probability was 78% (95% CI 75–81) in
the group without and 65% (95% CI 51–83) in the
group with major complications (P = 0.009, log-rank
test). Major complications were a significant negative
predictor for overall survival (hazard ratio 2.42, 95% CI
1.41–4.14) when adjusted for sex, age, American Soci-
ety of Anesthesiologists grade, tumour site (colon vs
rectum), R stage and tumour stage. However, in both
univariate and multivariable analysis, major complica-
tions were not a significant predictor for time to recur-
rence (hazard ratio 1.29, 95% CI 0.56–2.99).
Conclusion Non-lethal major postoperative complica-
tions seem to have a negative long-term impact on sur-
vival but not on time to recurrence.
Keywords Postoperative complications, colorectal, sur-
vival, recurrence
What does this paper add to the literature?
In contrast to the available data (a single study), major
postoperative complications had no significant indepen-
dent impact on time to recurrence after colorectal can-
cer surgery in curative intent. This study used the
increasingly popular Clavien–Dindo classification for
grading of postoperative surgical complications.
Introduction
Postoperative complications worsen the short-term out-
come in colorectal surgery [1,2]. Additionally, there is
evidence that postoperative complications may indepen-
dently affect long-term survival for a range of cancers [3–
11], but interpretation of this evidence is hindered by a
lack of standardization in classifying and reporting com-
plications. One retrospective study has shown a signifi-
cant adverse impact of postoperative complications on
long-term overall survival and on time to recurrence after
curative colorectal cancer resection [9], but a negative
impact on recurrence has not consistently been reported
for other tumours and the topic remains controversial
[6]. While the impact of complications on overall
survival may partly reflect pre-existing comorbidity, an
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independent effect on time to recurrence after resection
for bowel cancer is difficult to explain as recurrence is
predominately dependent on stage and pathological
tumour characteristics [12]. The object of this study was
to systematically classify major complications after colo-
rectal cancer resections and to investigate their impact on
time to recurrence and survival.
Method
Study design
This was a retrospective analysis of a prospectively col-
lected database of consecutive patients who underwent
elective open or laparoscopic resection for colorectal
cancer with curative intent from January 2003 to
December 2010. Date for censoring was 7 April 2012.
All surgical operations were performed in a high-vol-
ume specialist colorectal unit (Queen Alexandra Hospi-
tal, Portsmouth, UK) which is community based and
covers a population of about 600 000 people. Patients
were staged by CT scanning of chest, abdomen and pel-
vis with MRI for rectal cancers. Operations were per-
formed by specialist colorectal surgeons and trainees
under supervision.
Entry criteria
Inclusion criteria for the study were patients of 18 years
or more who had open or laparoscopic elective resec-
tion for colorectal cancer with curative intent [American
Joint Committee on Cancer (AJCC) 1–3], did not die
within 30 days or during the primary hospitalization
and had a potential postoperative observation period
from date of surgery to date of censoring of at least
3 years.
Adjuvant treatment
All patients were discussed in the colorectal multidisci-
plinary team meeting where management was recom-
mended on the basis of histopathology and staging
characteristics as well as clinical factors. These decisions
were made according to Network Guidance (National
Cancer Intelligence Network, UK) and in line with
National Guidelines (National Institute for Health and
Care Excellence, UK). The Portsmouth colorectal multi-
disciplinary team meeting has been running since 1999.
Follow-up
All operated patients were enrolled in a 5-year follow-
up programme which consisted of outpatient clinic
review 6 monthly for a year and annually thereafter to
5 years supplemented by CT scans of chest, abdomen
and pelvis at 1 and 2 years (recently 5 years as well).
Colonoscopy was scheduled according to indication but
at a minimum of 5 years. Patients discharged or lost
from regular surveillance were tracked by passive follow-
up consisting of yearly checks of death registries and
patient notes. There was also a virtual follow-up clinic
from 2008 led by specialist cancer nurses where patients
were called at 6 monthly to yearly intervals to detect
any clinical concerns and to coordinate imaging and
colonoscopy follow-up. Patients could access the virtual
clinic with concerns of their own and working from an
advice sheet. Continuous data collection and data qual-
ity management were accomplished by a full-time
research assistant.
Variables
Baseline variables were patient characteristics [age, gen-
der, American Society of Anesthesiologists (ASA) grade],
operative characteristics (type of procedure, method),
oncological characteristics [tumour site, lymph node
yield, resection grade (R0, R1, R2), tumour stage, neo-
adjuvant and adjuvant radiotherapy or chemotherapy]
and complications (mortality, readmissions, major com-
plications). Complications were graded according to the
classification evaluated and proposed by Dindo et al.
[13]. Only major complications defined as Clavien–Dindo
Grade 3b or 4 were analysed. Postoperative 30-day or
primary in-hospital deaths (Clavien–Dindo 5) were a
priori excluded from the statistical analyses.
Outcome variables were time to recurrence and over-
all and recurrence-free survival. Overall survival was
defined as the time from date of surgery to date of
death from any cause. Recurrence-free survival was
defined as the time from date of surgery to date of his-
tologically or radiologically confirmed local or distant
recurrence or death from any cause.
The quantitative variables length of stay and lymph
nodes were analysed as continuous data. Age was cate-
gorized for univariate and multivariable analysis. Some
patient and tumour characteristics were considered as
potential confounders and adjusted for in the multivari-
able analyses.
Data sources and data management
Data sources for the database included preoperative
assessment forms for patient characteristics, standardized
forms in the case of laparoscopic procedures and opera-
tion notes in the case of open procedures, summaries of
the multidisciplinary team meeting and histology
Colorectal Disease ª 2014 The Association of Coloproctology of Great Britain and Ireland. 17, 141–149142
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reports for oncological data, patient notes for postoper-
ative complications and follow-up reports. The research
assistant was responsible for completeness of data collec-
tion, entry of data in a structured database and data val-
idation. She was also responsible for passive follow-up
(death registries) and tracking of readmissions. Prospec-
tively, complications were identified in all patients who
had any variance from the expected postoperative course
such as delay of discharge, re-operation, unplanned
imaging or involvement of other specialties. Retrospec-
tively, these cases were analysed and the grading of their
complications was performed. Complications not need-
ing re-operation or intensive treatment unit transfer
were collected inconsistently and therefore not further
analysed. Thus, medical complications such as for exam-
ple pulmonary embolism not needing intensive care unit
treatment were not considered to be severe surgical
complications according to our definition. In the case
of more than one major complication in a single
patient, the higher graded complication was used for
further analysis.
Statistical methods
Categorical data were summarized using absolute num-
bers and percentages. Continuous data were summarized
using the median and range (minimum and maximum).
Baseline variables with missing data were reported.
Patients who died during primary hospitalization or
within 30 days after operation were excluded from the
analysis as the main focus was on long-term effects of
major complications once patients had survived peri-
operative complications. Median potential follow-up
time was estimated using the inverse Kaplan–Meier
method [14]. Cumulative incidences of recurrence with
death as the competing event were calculated and the
effect of each independent variable was tested according
to the methods presented by Gray [15]. For univariate
estimation of overall and recurrence-free survival, Kap-
lan–Meier curves were used [16]. Groups were com-
pared using the log-rank test. To estimate the impact of
major complications on time to recurrence and overall
and recurrence-free survival, Cox proportional hazards
models were constructed adjusting for tumour and
patient characteristics. The ‘rule of 10’ recommending a
minimum of 10 outcome events per included predictor
variable was applied in the Cox regression models to
ensure reliable model estimates [17,18]. A univariate
regression screening process was undertaken for each
Cox regression model. Those variables with a P value
> 0.5 in the univariate model, showing no evidence of
an association with the outcome, were considered for
omission from the multivariable model. However, clini-
copathologically important factors (e.g. R stage) were
retained in order to ensure that they do not act as con-
founding factors [19]. The proportional hazards
assumption for the Cox regression model was tested by
creating a plot of the Schoenfeld residuals vs log time for
each of the predictors. A significant non-zero slope was
considered to be a violation of the proportional hazards
assumption. The visual method was complemented by a
residual-based test statistic described by Grambsch and
Therneau [20]. Upon violation of the proportional haz-
ards assumption, the model was modified using stratifi-
cation. The effect of each predictor on the dependent
variable was reported via hazard ratios (HRs) with 95%
confidence intervals (CIs) and a global P value assessing
the statistical significance of the variable (likelihood ratio
test). P ≤ 0.05 was considered to be significant (i.e. a
5% significance level). All statistical analyses were con-
ducted in R (version 2.15.1) using the ‘Survival’ and
‘cmprsk’ packages [21–23].
Results
From 2 January 2003 to 20 December 2010, 1131
elective resections for colorectal cancer AJCC Stages
1–3 were performed. Of these, 868 had a postoperative
follow-up of at least 3 years at the date of censoring.
Postoperative mortality (Clavien–Dindo 5) occurred in
2.8% of patients (23 deaths within 30 days postopera-
tively and one death after 69 days during the same hos-
pitalization) with 83.3% (20/24) of these cases due to
medical conditions. Patients with postoperative mortal-
ity were excluded prior to analysis and there were there-
fore 844 cases who met the inclusion criteria.
Descriptive data
Baseline characteristics as well as operative and oncolog-
ical parameters are summarized in Table 1. Major com-
plications with grading according to the Clavien–Dindo
classification are specified in Table 2. The incidence of
major complications excluding postoperative mortality
(3b, 4a or 4b) was 4.6% (39/844). Anastomotic leakage
was the most common surgical complication responsible
for re-intervention and organ failure occurring in 22
(2.6%) patients. The median follow-up time was
5.7 years (interquartile range 4.2–7.2) and did not sig-
nificantly differ between the groups with and without
major complications (P = 0.91, log-rank test).
Main results
Of the 844 patients, recurrence occurred in 129 (15%)
including 123 (15%) of 805 in the group without major
Colorectal Disease ª 2014 The Association of Coloproctology of Great Britain and Ireland. 17, 141–149 143
M. Odermatt et al. Long-term impact of major surgical complications
	   186	  
	  
	  
	  
	  
complications and 6/39 (15%) in the group with major
complications. When looking at the non-censored
3-year period after operation, the overall recurrence
proportion was 12% (104 recurrences), with 12% (98
recurrences) in the group without major complications
vs 15% (six recurrences) in the group with major com-
plications.
In the Cox regression model with time to recurrence
(censoring for no recurrence or death) as the dependent
variable, four control variables [age, tumour site (rec-
tum vs colon), AJCC tumour stage and R stage] were
included in addition to the primary variable of interest
(major complications). The model included eight factor
levels (i.e. coefficients to be estimated) and the ‘rule of
Table 1 Patient characteristics (n = 844). Major complications
defined as Clavien–Dindo Grade 3b and 4. Postoperative 30-
day or primary in-hospital deaths (n = 24) are excluded (Cla-
vien–Dindo 5).
No major
complications
n = 805
Major
complications
n = 39
Age (median, range),
years
72 (25–93) 70 (51–89)
< 65 233 (28.9%) 11 (28.2%)
65–74 251 (31.2%) 17 (43.6%)
75–84 268 (33.3%) 6 (15.4%)
≥ 85 53 (6.6%) 5 (12.8%)
Gender
Male 372 (46.3%) 15 (38.5%)
Female 432 (53.7%) 24 (61.5%)
ASA
1 112 (13.9%) 5 (12.8%)
2 487 (60.5%) 23 (59.0%)
3 172 (21.4%) 10 (25.6%)
4 5 (0.6%) 0 (0.0%)
Missing 29 (3.6%) 1 (2.6%)
Operative characteristics
Procedure
Ileocolic resection 2 (0.2%) 0 (0.0%)
Right hemicolectomy 243 (30.2%) 3 (7.7%)
Extended right
hemicolectomy
25 (3.1%) 1 (2.6%)
Transverse colectomy 4 (0.5%) 0 (0.0%)
Left hemicolectomy 26 (3.2%) 1 (2.6%)
Sigmoid colectomy 40 (5.0%) 1 (2.6%)
Anterior resection 392 (48.7%) 25 (64.1%)
Abdominoperineal
resection
58 (7.2%) 8 (20.5%)
Hartmann procedure 5 (0.6%) 0 (0.0%)
Subtotal colectomy 5 (0.6%) 0 (0.0%)
Panproctocolectomy 5 (0.6%) 0 (0.0%)
Method
Open 536 (66.5%) 28 (71.8%)
Laparoscopic
Laparoscopic
completed
257 (31.9%) 10 (25.6%)
Laparoscopic
converted
12 (1.5%) 1 (2.6%)
Oncological characteristics
Tumour site
Colon
Caecum 126 (15.7%) 1 (2.6%)
Ascending colon 77 (9.6%) 2 (5.1%)
Hepatic flexure 26 (3.2%) 0 (0.0%)
Transverse colon 40 (5.0%) 1 (2.6%)
Splenic flexure 12 (1.5%) 0 (0.0%)
Descending colon 14 (1.7%) 1 (2.6%)
Sigmoid colon 223 (27.7%) 9 (23.1%)
Table 1 (Continued).
No major
complications
n = 805
Major
complications
n = 39
Recto/sigmoid 7 (0.9%) 0 (0.0%)
Rectum 280 (34.8%) 25 (64.1%)
Rectum vs colon
Rectum 280 (34.8%) 25 (64.1%)
Colon 525 (65.2%) 14 (35.9%)
Lymph node harvest
(median, range)
12 (0–50) 12 (3–34)
R stage
R0 781 (97.0%) 37 (94.9%)
R1 24 (3.0%) 2 (5.1%)
T stage
T1 67 (8.6) 3 (7.7%)
T2 175 (21.7%) 12 (30.8%)
T3 477 (59.3%) 23 (59.0%)
T4 86 (10.7%) 1 (2.6%)
Tumour stage AJCC
Stage 1 (T1,T2 N0) 202 (25.1%) 13 (33.3%)
Stage 2 (T3,T4 N0) 343 (42.6%) 17 (43.6%)
Stage 3 (any T, N1–2) 260 (32.3%) 9 (23.1%)
Radiotherapy in rectal cancer
Short course preoperative 19 (2.4%) 2 (5.1%)
Long course preoperative 22 (2.7%) 3 (7.7%)
Postoperative 10 (1.2%) 2 (5.1%)
Chemotherapy
Neoadjuvant (rectal
cancers)
22 (2.7%) 3 (7.7%)
Adjuvant 186 (23.1%) 3 (7.7%)
Postoperative
Length of stay (median,
range), days
8 (2–112) 23 (2–118)
Readmissions 30 (3.7%) 9 (23.1%)
ASA, American Society of Anesthesiologists; AJCC, American
Joint Committee on Cancer.
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10’ recommending at least 80 recurrence events was
satisfied as 129 recurrences were available to model
[17]. All the variables included in this model did not
significantly violate the proportional hazards assump-
tion. Of all the covariates included in the Cox model,
only tumour stage was found to be a significant nega-
tive predictor for time to recurrence (P < 0.001, likeli-
hood ratio test), with greater risk of recurrence for
higher stages (Stage 1 vs Stage 2, HR 2.03, 95% CI
1.09–3.81; Stage 1 vs Stage 3, HR 5.57, 95% CI 3.07–
10.10). In contrast, no evidence was found of major
postoperative complications having a significant effect
on time to recurrence in this model (P = 0.560, likeli-
hood ratio test).
The results of the cumulative incidence (Gray) analy-
sis and multivariable (Cox) analysis concerning time to
recurrence are summarized in Table S1. Taking into
account that death and recurrence are competing
events, the time to recurrence was similar in the groups
with and without major complications, as shown in the
cumulative incidence plot in Fig. 1. With respect to
overall survival, a total of 216 (26%) deaths were
observed in the 844 patients surviving the early postop-
erative period. The estimated crude (Kaplan–Meier)
5-year overall survival probability was 78% (95% CI
75–81) in the group without major complications and
65% (95% CI 51–83) in the group with major complica-
tions (P = 0.009, log-rank test). Recurrence-free 5-year
survival probability was 73% (95% CI 70–76) and 65%
(95% CI 51–83), respectively (P = 0.096, log-rank test).
The corresponding Kaplan–Meier curves are shown in
Fig. 2(a,b). In the Cox proportional hazards model
with death as the dependent variable (recurrence cen-
sored) and major complication as the primary variable
of interest, a total of six binary or categorical control
variables (sex, age, ASA grade, tumour site, AJCC
tumour stage, R stage) were included. This resulted in a
total of 13 factor levels (i.e. coefficients to be esti-
mated), and the ‘rule of 10’ recommending at least 130
events was satisfied as 216 deaths were available to
model. Evaluation of the model showed that AJCC
tumour stage was a highly predictive factor but did not
fulfil the proportional hazards assumption. Therefore
the model was stratified for the tumour stage variable.
For the Cox model with recurrence-free survival as the
dependent variable, the same set of control variables as
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Figure 1 The cumulative incidence of recurrence (death as
competing event) in patients with and without major complica-
tions was similar. Comparison conducted using Gray’s test.
Table 2 Specification and classification of major complications (highest graded complication 3b or 4 per patient) according to Cla-
vien–Dindo with deaths (Grade 5) excluded (N = 844).
Clavien–Dindo grade
Total3b* 4a† 4b‡
Wound infection/dehiscence 2 1 0 3 (0.4%)
Anastomotic leak 16 5 1 22 (2.6%)
Abscess 1 1 0 2 (0.2%)
Bleeding (internal/external) 2 0 0 2 (0.2%)
Ileus/obstruction not stoma related 0 1 0 1 (0.1%)
Stoma dysfunction/necrosis 3 2 1 6 (0.7%)
Port site hernia 1 0 0 1 (0.1%)
Medical conditions 0 1 1 2 (0.2%)
Total 25 (3.0%) 11 (1.3%) 3 (0.4%) 39 (4.6%)
*Clavien–Dindo 3b: re-intervention under general anaesthesia.
†Clavien–Dindo 4a: intermediate care/intensive care unit with single organ failure.
‡Clavien–Dindo 4b: intensive care unit with multi-organ failure.
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in the previous model were included. Likewise, stratifi-
cation for the AJCC tumour stage variable with non-
proportional hazards was performed.
The effect of major complications on overall and
recurrence-free survival is summarized in Tables S2 and
S3, respectively, where the results of the Kaplan–Meier
method and Cox proportional hazards models are
given. The occurrence of non-lethal major postoperative
complications was an independent negative predictor
for overall survival (HR 2.42, CI 95% 1.41–4.14,
P = 0.0036) and recurrence-free survival (HR 1.77, CI
95% 1.05–2.99, P = 0.048). Age and ASA grade were
also found to be statistically significant independent pre-
dictors for both overall and recurrence-free survival.
Whether the procedure was performed by an open or
laparoscopic operation was not a statistically significant
predictor of time to recurrence (HR 1.11, 95% CI
0.77–1.61, P = 0.58), overall survival (HR 1.04, 95%
CI 0.76–1.42, P = 0.80) or recurrence-free survival
(HR 1.08, 95% CI 0.82–1.41, P = 0.60) in univariate
regression analyses when screening for noise variables.
Therefore this variable was not included in the final
multivariable models. However, method of surgery was
tested by reintroducing this variable in each of the final
models and was again found to have no association with
the outcome in each case.
Discussion
In this study, major surgical complications had an
adverse effect on long-term survival but not on recur-
rence. Whereas the impact on overall survival is consis-
tent with previous investigations, the lack of an effect
on time to recurrence remains controversial.
The complication rate in this study (4.6% Clavien-
Dindo 3b or 4) seems to be small in comparison with
16% in laparoscopic and 21% in open colorectal cancer
resections found in a recent meta-analysis [24], but in
this study only major complications Clavien–Dindo 3b
or 4 and patients in an elective setting were analysed.
Rather than only classifying complications according to
their clinical manifestation, the Clavien–Dindo classifica-
tion is based on the extent of measures which have to
be taken to treat them. We defined major complications
as adverse events which led to interventions under gen-
eral anaesthesia (Grade 3b) or intensive care admission
because of single (Grade 4a) or multi-organ dysfunction
(Grade 4b). Similarly, severe complications were defined
as Clavien–Dindo 3b or 4 in a recently published study
by Petermann et al. [25] investigating the impact on
survival after pancreatic tumour surgery. In the multi-
centre validation study of the Clavien–Dindo classifica-
tion, Grade 3b complications were reported in 4.0%,
Grade 4a in 1.6% and Grade 4b in 0.7% of patients
[13]. In the present study, the respective incidences of
3.0%, 1.3% and 0.4% were slightly lower which could be
due to the fact that emergencies and palliative opera-
tions as a high risk group for major complications were
excluded [26]. In our study, patients with major com-
plications tended to be older and to have more rectal
cancers and abdominoperineal resections.
In a retrospective analysis of 1316 colorectal resec-
tions by Kirchhoff et al. [27], age over 75 years and
complexity of surgery were also found to be significant
predictors of postoperative complications. The number
of patients who underwent neoadjuvant treatment was
small in our study (46, 5.5%) due to the exclusion of
patients with potentially resectable metastatic disease
and those presenting as emergencies often having locally
advanced high risk tumours. This and the relatively
small number of T4 tumours (87, 10.3%) may also
explain the generally favourable long-term outcome of
the patients included. Less adjuvant chemotherapy was
given to the group with severe complications although
tumour stage distribution was similar. Most likely this is
because major complications made patients unfit for
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Figure 2 Kaplan–Meier curves for overall
(a) and recurrence-free (b) survival
(comparison by log-rank test) for patients
with (MC) and without (NMC) major
complications (Clavien–Dindo 3b or 4).
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adjuvant therapy or delayed the time at which they
would be fit beyond the time at which its benefit is pro-
ven, that is 8–12 weeks postoperatively. Lesser use of
adjuvant therapy in patients with major postoperative
complications could partly explain their decreased long-
term survival. Besides major complications, only age
and ASA grade were significant independent predictors
for overall survival in the multivariable analysis. One has
to bear in mind, however, that the influence of tumour
stage on survival was not quantified in this study as
stratification for this variable was necessary to avoid vio-
lation of the proportional hazards assumptions. Regard-
ing time to recurrence, neither age nor comorbidity
classified by ASA proved to have an independent influ-
ence. Expectedly, length of stay, which is often consid-
ered as a surrogate for postoperative morbidity, was
longer in the major complication group. Due to its col-
linearity with postoperative complications, length of stay
was not included in the Cox models. Significant adverse
long-term effects of major complications on survival
have been reported following surgery for oesophageal
cancer [28], pancreatic cancer [3], non-small-cell lung
cancer [4], hepatocellular carcinoma [6], colorectal liver
metastases [5,8,11] and colorectal cancer [9]. In these
studies, major complications seemed to irreversibly and
independently reduce life expectancy. This association
has been shown in detail for infective complications and
anastomotic leaks [29–31]. The mechanism of the cor-
relation between major complications and survival is
debatable. It remains unclear whether complications
reduce immunological response, prevent patients from
having adjuvant therapy or whether patients with unfa-
vourable predisposition/comorbidity are simply more
susceptible to developing surgical complications. Tan
et al. [32], for example, demonstrated that a higher
ASA class was correlated independently with a higher
rate of colorectal anastomotic leakage. Similarly, in our
study the highest leak rate (3.8%) was found in ASA 3
patients. However, Law et al. [9] adjusted the influence
of complications on survival for a variety of medical
comorbidities by multivariable analysis with the result
that complications still remained a significant indepen-
dent predictor for decreased survival. In our study, the
influence of complications on survival has been adjusted
for age, gender and ASA grade, among other factors,
leading to the same conclusion. Thus, the impact of
major complications on survival in the present study
was significant, relevant and in accordance with results
of previous studies.
Previous reports concerning lung, metastatic liver
and colorectal tumour surgery [4,5,8,9,11] have sug-
gested a link between major complications and
increased risk of recurrence. Proposed mechanisms have
included immunosuppression following septic complica-
tions leading to proliferation of metastatic tumour cells
and dysregulation of immune response after physical
stress [9,33,34]. In particular after re-operations, as for
complications and in the presence of comorbidity, the
immunological response may become exhausted [35],
although these changes in immunological parameters
normally return to baseline values within 3 weeks [36].
In contrast, we could not demonstrate any significant
impact of major complications on recurrence. In our
study, all patients had a follow-up of at least 3 years.
Because 80% of recurrences occur within 2 years after
primary resection [37,38], our data, at a minimum of
3 years’ observation time and a median 5.7 years post-
operative follow-up, probably accurately reflect true
recurrence rates as only minimal censoring was neces-
sary in the time to recurrence analysis.
The study has its limitations. No formal power
calculation was performed for this retrospective analysis
and preoperative assessment of morbidity was by ASA
classification alone rather than by a more sophisticated
morbidity risk assessment tool. Despite these limita-
tions, the independent impact of major complications
on survival could be clearly demonstrated.
In conclusion, major complications after resection for
colorectal cancer are associated with decreased long-term
survival. Whether better preoperative assessment and
peri-operative care could increase long-term survival is
unclear. Major complications seem not to be associated
with increased risk of recurrence of colorectal cancer.
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Abstract
Aim Adequate colonic imaging is generally an invasive
procedure with attendant risks, particularly perforation.
Endoscopy, barium enema and computed tomographic
colonography (CTC) are the main techniques for inves-
tigating patients with symptoms of, or screening for,
colorectal cancer. The potential complications of these
investigations have to be weighed against the benefits.
This article reviews the literature on the incidence,
presentation and management of iatrogenic colonic
perforation at colonic imaging.
Method A literature review of relevant studies was
undertaken using PubMed, Cochrane library and per-
sonal archives of references. Manual cross-referencing was
performed, and relevant references from selected articles
were reviewed. Studies reporting complications of endos-
copy, barium enema and CT colonography were included
in this review.
Results Twenty-four studies were identified comprising
640 433 colonoscopies, with iatrogenic perforation
recorded in 585 patients (0.06%). The reported perfora-
tion rate with double-contrast barium enema was
between 0.02 and 0.24%. Serious complications with
CTC were infrequent, though nine perforations were
reported in a case series of 24 365 patients (0.036%)
undergoing CTC.
Conclusion Perforation remains an infrequent and al-
most certainly under-reported, complication of all colonic
imaging modalities. Risk awareness, early diagnosis and
active management of iatrogenic perforation minimizes
an adverse outcome.
Keywords Iatrogenic colonic perforation, colonic ima-
ging, colonoscopy
Introduction
Colorectal cancer (CRC) is the second leading cause of
cancer-related death in the USA and Europe [1]. Most
cases occur over 50 years of age, with a 50-year-old
individual having a 5% lifetime risk of developing CRC
and a 2.5% chance of dying from it [2]. Overall, the death
rate has been dropping steadily for the last two decades,
with the suggestion that this may be attributable to
prevention by colonoscopic polypectomy, early detection
by screening and greater public awareness of relevant
symptoms. The ‘adenoma–carcinoma’ sequence is a well-
recognized paradigm for the sequential development of
CRC [3]. The National Polyp Study from the USA has
shown a two-third reduction in the incidence of CRC in
people undergoing surveillance colonoscopy and polyp-
ectomy as compared with the reference population [4].
Colonoscopy and double-contrast barium enema
(DCBE) have been the main colonic investigative tech-
niques. Recently, computed tomographic colonography
(CTC) (also known as CT pneumocolon and virtual
colonoscopy) has been introduced for colonic assessment.
Data from well-conducted case–control studies sup-
port the use of sigmoidoscopy and colonoscopy in
reducing the incidence and mortality from CRC in the
screened population [5–8]. Likewise, there is favourable
evidence for DCBE or CTC in screening asymptomatic
individuals [2,9,10]. The potential risks of investigating
asymptomatic individuals have to be weighed against the
benefits. Hence, an understanding of the main potential
complications, especially if life threatening, and manage-
ment strategies of any adverse events are of paramount
importance for healthcare professionals. A major, serious,
and life-threatening complication of any technique for
colonic imaging is an iatrogenic perforation.
The purpose of this review was to analyse the literature
on the incidence, presentation and management of
complications associated with investigative techniques
for assessing the colon and rectum, focussing in particular
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on colonic perforation. The main diagnostic modalities,
namely endoscopy [rigid sigmoidoscopy, flexible sig-
moidoscopy (FS) and colonoscopy], DCBE and CTC,
were reviewed.
Method
Electronic literature searches using MEDLINE, EM-
BASE, CINAHL and Cochrane library were performed.
The following Medical Subject Headings (MeSH) terms
were used: ‘endoscopy complications’, ‘colonoscopy
complications perforation’, ‘bleeding, endoscopy’, ‘man-
agement colonoscopy perforation’, ‘barium enema com-
plication’, ‘CT colonography, CT pneumocolon, virtual
colonoscopy, complications’. Potentially suitable articles
were retrieved and reviewed for relevance. In addition to
the Cochrane library, the general search engine Google
was also used for searching for the above terms. Manual
cross-referencing was performed, and relevant references
from selected articles were reviewed.
The search included the published literature in
English between 1966 and 2008. Studies that reported
the incidence of colonic perforation and mortality were
included. Where multiple studies describing the same
patient population were identified, the most recent
publication was included. The eligibility of included
studies was agreed mutually by the authors. The follow-
ing data were extracted: authors, year of publication,
study period, study setting, number of patients, cases of
iatrogenic colonic perforation, mortality and manage-
ment of these patients whether operative or conservative
and the differential mortality in each arm. Studies were
assessed for methodological quality and validity and
graded on strength of evidence using the revised grading
system of Scottish Intercollegiate Guidelines Network.
The search identified 44 eligible studies. In total, two
duplicate and 11 nonrelevant abstracts were excluded
(Fig. 1). After further evaluation of the remaining 31
references, one editorial and one commentary were
excluded. In five studies, the relevant clinical outcomes
(perforation rate and ⁄ or mortality) were not reported
and so they were excluded. Eventually, 24 studies were
analysed in this review (Table 1).
Results
Rigid sigmoidoscopy
Rigid sigmoidoscopy is an outpatient procedure, usually
performed without bowel preparation, and has limited
accuracy (approximately 50%) in detecting rectal pathol-
ogy [11]. Rigid scopes are 25–30 cm in length and thus
capable of assessing the complete rectum (15 cm) and the
distal sigmoid in some cases. However, views are often
limited to the lower rectal mucosa as a result of faecal
contamination. The findings at rigid sigmoidoscopy are
operator dependent and, as reported in a recent review,
lesions were missed in 25% of patients [12].
Publications identified through
literature search (n = 44)
Publications retrieved for detailed
evaluation (n = 31)
Publications excluded (duplicates n = 2,
abstract not relevant to the study n = 11)
Publications included in the review
(n = 24)
Publications excluded (studies not reporting
clinical outcomes for colonoscopy n = 5,
editorial/commentary n = 2)
Figure 1 Trials flow diagram.
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Flexible sigmoidoscopy
There is good evidence that FS is superior to rigid
sigmoidoscopy for patients with bowel symptoms sug-
gestive of cancer [13]. Generally, 45–60 cm of the colon
and rectum can be visualized at FS and hence theoret-
ically 60% of colorectal carcinomas and adenomas could
be diagnosed [14]. Flexible sigmoidoscopy has been
suggested as an initial CRC screening test. The UK FS
trial included > 40 000 patients, using FS at 14 centres,
with an overall CRC detection rate of 0.35%, and long-
term results are awaited [7]. Flexible sigmoidoscopy can
be performed without sedation, and by either doctors or
specialist nurses, hence maximizing resources [15].
Colonoscopy
Colonoscopy is a primary diagnostic investigation in
symptomatic patients, those with positive faecal occult
blood test and in clarifying abnormalities on DCBE.
Colonoscopy has revolutionized the diagnosis and
treatment of colorectal disease and has been recom-
mended as an initial screening tool for CRC in high-risk
individuals [2]. Fibre-optic colonoscopy has been in
clinical practice since 1969, with numerous technological
developments over the past four decades. High-resolu-
tion views have recently been enhanced by chromo-
endoscopic dye-spray techniques to identify smaller
lesions and for dysplasia surveillance [16].
A complete colonoscopic examination involves visual-
ization of the caecum, identified by the triradiate fold,
appendicular orifice, ileocaecal fold and ⁄ or ileal intuba-
tion. The reported completion rates vary between 55 and
97%, depending upon the difficulty of the examination
and operator experience, with 95% completion rates
suggested as optimal practice [17]. It is likely that
publication bias is a major factor, both in completion
rates and major complication reports, because of the
widespread use of colonoscopy by many endoscopists
with varying case volume, case mix, endoscopy facilities
and experience. In the UK, the Joint Advisory Group on
Gastrointestinal Endoscopy (JAG) recommends that
Table 1 Colonoscopic perforation rates, management and outcome.
Authors Year Study period Institution
No. of
patients
Perforation
(%)
Mortality
(%)
Management (number who
died in parentheses)
Operative Nonoperative
Rogers et al. [137] 1975 1972–1973 M 31512 27 (0.08) 7.4 21 (2) 6 (0)
Smith et al. [138] 1976 N ⁄ S M 20130 72 (0.35) 2.7 47 (2) 25 (0)
Macree et al. [37] 1983 1971–1980 S (TH) 5000 6 (0.12) 0 5 (0) 1 (0)
Carpio et al. [65] 1989 1977–1987 S 5424 14 (0.25) 21.4 8 (2) 6 (1)
Soon et al. [68] 1990 S (TH) 1832 7 (0.38) 42.8 7 (3) 0
Christie & Marazo [35] 1991 1979–1989 S 4784 7 (0.14) 0 2 (0) 5 (0)
Hall et al. [66] 1991 4–15 years M 17500 15 (0.08) 0 14 (0) 1 (0)
Waye et al. [31] 1992 1988–1990 S (COM) 2097 2 (0.09) 0 2 (0) 0 (0)
Lo & Beaton [132] 1994 1986–1992 S 26708 12 (0.04) 16 6 (2) 6 (0)
Jentschura et al. [133] 1994 1982–1990 S (TH) 29695 31 (0.1) 6.4 24 (2) 7 (0)
Farley et al. [51] 1997 1980–1995 S (TH) 57028 45 (0.07) 0 42 (0) 3 (0)
Anderson et al. [41] 2000 1987–1996 S 10486 20 (0.19) 10 20 (2) 0
Aragizadeh et al. [52] 2000 1970–1999 S 34620 31 (0.08) 0 20 (0) 11 (0)
Tran et al. [40] 2001 1994–1999 S 26162 21 (0.08) 4.7 21 (1) 0 (0)
Wexner et al. [44] 2001 1998–1999 M 13580 10 (0.07) 0 5 (0) 5 (0)
Gatto et al. [42] 2003 1991–1998 M 39286 77 (0.19) 5.1 n ⁄ a n ⁄ a
Korman et al. [140] 2003 1999–1999 M 116000 37 (0.03) 0 35 (0) 2 (0)
Cobb et al. [53] 2004 1997–2003 S (TH) 43609 14 (0.03) 0 11 (0) 3 (0)
Ker et al. [139] 2004 1988–2003 S 5120 6 (0.11) 0 0 6 (0)
Iqbal et al. [56] 2005 1994–2000 S (TH) 78702 72 (0.09) 8.3 62 (5) 10 (1)
Rathgaber & Wick [134] 2006 2002–2004 S (COM) 12407 2 (0.01) 0 2 (0) 0 (0)
Tulchinsky et al. [135] 2006 1994–2001 S (TH) 12067 7 (0.05) 0 6 (0) 1 (0)
Levin et al. [33] 2006 1994–2002 M 16318 15 (0.09) 6.6 n ⁄ a n ⁄ a
Luning et al. [138] 2007 1990–2005 S 30366 35 (0.11) 8.5 35 (3) 0 (0)
Total 640433 585 (0.09) 5.8 395 (24) 6% 98 (2) 2%
S, single centre; M, multicentre; S (TH), single centre teaching hospital; S (COM), single centre community setting; n ⁄ a, not available.
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approved endoscopy units should achieve completion
rates > 90%, without excessive sedation [18]. It is likely
that these standards will be applied, in due course, to all
colonoscopists, a laudable aim but perhaps with potential
downsides. There are now anecdotal reports of an
increase in the perforation rate as a consequence of
attempting to achieve completion in patients with unfa-
vourable anatomy or significant pathology (particularly
diverticular disease). A caecal intubation rate of > 90% is
recommended for trainees [19], and the current curric-
ulum for higher medical training in gastroenterology
suggests that trainees should demonstrate this level of
expertise at completion of specialist training [20].
Published series from the USA have reported com-
pletion rates > 97%, with low complication rates, and
detection of significant pathology in asymptomatic pop-
ulations [21,22]. Specialist centres in the UK report
similar results but are unlikely to be representative of the
overall national standards, as more than one million
gastrointestinal endoscopies are performed annually in
the UK, with an increasing proportion of therapeutic
examinations [23].
Complications of endoscopy
Endoscopy is an invasive investigation with potential for
serious life-threatening complications. Fortunately, the
incidence of these complications is low. Bleeding and
iatrogenic colonic perforation are perhaps the most
feared, challenging and potentially life-threatening com-
plications of endoscopy. There are a number of other,
often numerically more important, complications, such as
cardiopulmonary events, which are responsible for more
than 50% of endoscopy-associated deaths. Problems with
oversedation, abdominal distension, vasovagal episodes,
thrombophlebitis, splenic rupture and postpolypectomy
coagulation syndrome have also been reported [24,25].
There are a few sporadic case reports of transmission of
hepatitis B and C virus via contaminated endoscopes
[26]. Small bowel obstruction is another rare complica-
tion [27], seen in patients with an incompetent ileocaecal
valve culminating in insufflation of the small bowel and
abdominal distension. Splenic rupture is rare, with
around 30 case reports in the literature [28].
Postpolypectomy syndrome (PPS)
Postpolypectomy syndrome, or postcoagulation syn-
drome, is characterized by abdominal pain, fever and an
increase in the white cell count, following a colonoscopic
polypectomy. The syndrome is caused by transmural
thermal colonic damage resulting in serosal inflammation.
The electric current used during snare polypectomy
can result in transmural thermal damage [29], and
involvement of the muscularis propria and serosa results
in clinical signs of localized peritonitis without perfora-
tion. The clinical features are localized pain, tenderness,
rigidity and guarding. An erect chest X-ray can be helpful
in ruling out free intraperitoneal air (even though CT is
more sensitive). Occasionally, the situation can be pro-
gressive, and a deep thermal burn may result in necrosis
of the bowel wall and delayed free perforation.
The symptoms begin 6 h to 5 days after colonoscopy
and usually settle in 2–5 days [30]. The management is
conservative, with bowel rest, intravenous fluids and
antibiotics, and hence recognition is important to avoid
an unnecessary laparotomy. Joint care by a gastroenter-
ologist and surgeon is recommended, and serial reviews
are helpful to ascertain the progress. The incidence of
PPS is reported to be around 0.5–2% of patients
undergoing colonoscopic polypectomy [31–33], and
significantly higher (3.7%) for polyps larger than
25 mm [34]. Postpolypectomy syndrome mainly presents
after removal of large polyps (> 20 mm), using long
application of thermal current, inadvertently catching the
adjacent mucosa in the snare and alternatively when a
large polyp is touching the opposite colonic wall resulting
in ‘contre-coup’ thermal damage [35].
Perforation
The incidence of perforation varies with the indications
and type of endoscopy. The risk also depends upon
patient characteristics, experience of the endoscopist and
underlying disease state. The reported rates are 0.03–
0.65% for diagnostic and 0.07–2.14% for therapeutic
colonoscopies [36–40]. The risk of perforation for FS is
between 1 in 25 000–50 000 [41,42].
Rigid sigmoidoscopy also carries the potential for
iatrogenic perforation. Robinson et al. reported five cases
(0.001%) of rectal perforation in a series of 328 815 rigid
sigmoidoscopies [43]. Personal experience and anecdotal
reports suggest that the greatest dangers of perforation
are in patients with diverticular disease being examined
under general anaesthetic.
Perforation has always been a dreaded complication of
endoscopy [32], with three different underlying aetio-
logical mechanisms.
Mechanical
The most common mechanism is mechanical damage,
either direct injury from the tip of the endoscope or
indirect pressure from bowing ⁄ torquing of instrumenta-
tion. Forceful insertion or blind advancement of the
endoscope, as practised in slide-by or mucosal advance-
ment techniques, increase the risks of perforation [44].
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Adhesions from previous pelvic disease or abdominal
surgery are further risk factors [45]. Instruments passed
through endoscopic channels, such as dilators, biopsy
forceps and brushes, can also cause perforation by direct
trauma.
Pneumatic
Perforation can result from increased insufflation or
creation of an isolated colonic segment with high
intraluminal pressure [46]. A particular risk is when the
tip of the endoscope is in a diverticulum, resulting in high
local pressure. Overzealous insufflation can cause mucosal
tears, which can progress to transmural perforation [47].
Thermal
Thermal damage from diathermy and electrocautery can
perforate the colon, with the clinical presentation
depending on the current intensity and duration. A
full-thickness burn resulting in free perforation can occur
at the base of the stalk or opposite a large polyp touching
the opposite bowel wall, hence transmitting the current
[48].
The site of colonic perforation is variable, but the
most common site is the sigmoid colon, which is usually
tortuous, redundant, and may be relatively fixed in the
pelvis because of previous operations or adhesions.
Furthermore, sigmoid diverticular disease makes the
examination difficult and increases the risks. Approxi-
mately 66% of perforations are in the recto-sigmoid, 13%
in the caecum and 7% each in the ascending, descending
and transverse colon [49]. Thermal perforations are more
common in the thin-walled right colon. Pneumatic
perforations are again commonly seen in the right colon
and caecum. This is in accordance with the Laplace law
(tension is directly proportional to the radius of the
cylinder). Hence, the thin-walled and wider colonic
lumen on the right increases the risk of perforation.
Inflammatory bowel disease, therapeutic steroids,
malignancy, diverticular disease, irradiation, infection
and previous abdominal surgery are important risk factors
for colonic perforation [50–53]. Though operator expe-
rience is a risk factor, the learning curve is difficult to
determine. One report suggested that endoscopists who
have performed < 400 colonoscopies may have a higher
risk of colonic perforation [54].
Clinical presentation
Symptoms and signs of iatrogenic colonic perforation
vary from asymptomatic to frank peritonitis and depend
upon the site, size and mechanism of perforation [50].
The amount of peritoneal contamination, the underlying
colonic pathology, the quality of bowel preparation and
the overall clinical condition of the patient also affect the
presentation [37]. Patients can be divided into three
broad groups based on the time to presentation.
A Immediate Perforation is diagnosed at colonoscopy.
Visualizing fat, mesenteric vessels or
small bowel is confirmatory. Difficulty in
maintaining insufflation is suggestive of
perforation [55]. Sudden onset of severe
abdominal pain is an ominous sign.
B Early Postprocedural abdominal pain, nausea and
vomiting, abdominal distension, tenderness and
guarding are suggestive of perforation. Fever,
tachycardia and leucocytosis raise suspicion [56].
C Delayed The symptoms and signs described above can be
delayed for up to 72 h (and beyond) in some
patients. Delayed presentation is more common
after therapeutic colonoscopy with thermal
injury. There has been one report of perforation
9 weeks after colonic biopsy [57].
A high index of suspicion is required to make the
clinical diagnosis of postcolonoscopy perforation. Pain
and abdominal tenderness are suggestive, and an erect
chest and abdominal X-ray film may confirm the
diagnosis (extraluminal gas under the hemidiaphragm
on an erect chest X-ray or under the anterior abdom-
inal wall on a left lateral decubitus view; Fig. 2).
However, the absence of visible free air does not rule
out perforation [58]. In some cases, a retroperitoneal
perforation may be seen as air around the psoas muscle
and ⁄ or kidneys, and clinically there may be surgical
emphysema. Other features include pneumomediasti-
num, pneumothorax or pneumopericardium [59–61].
Computed tomography scan is much more sensitive
than plain X-rays and can be helpful to establish, or to
refute, the diagnosis [61] (Fig. 3).
Management
Most clinical experience in management of colonic
trauma comes from war injuries, where traditionally
colonic trauma involved colonic resection and proximal
diversion. However, an important difference between
colonoscopic perforation and traumatic warfare injuries is
bowel preparation in the former, which reduces the faecal
and bacterial load in the colon [62,63].
The optimal management of colonoscopic perfora-
tion remains debatable, with proponents of conservative
and operative management [64–66]. Conservative man-
agement comprises bowel rest, intravenous fluids,
broad-spectrum antibiotics and serial observations.
The choice of treatment is influenced by the site, size
and mechanism of perforation, the underlying colonic
pathology, general condition of the patient, adequacy
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of bowel preparation and the timing of diagnosis
[31,48,67,68].
Variable selection criteria for conservative manage-
ment have been suggested, with suggestions that patients
with localized signs, good general condition and either
small or retroperitoneal perforations can be managed
conservatively [44]. Distal obstruction, inadequate bowel
preparation or failure to improve with conservative
management is indication for surgical intervention. Some
have suggested that thermal colonic injuries can be
managed conservatively [66,69], but there is concern that
delayed surgery, after failed conservative treatment, may
be associated with a higher morbidity and mortality
attributable to increased bacterial contamination. Within
8 h of injury, a perforation can be safely managed by
primary closure, provided there is little contamination
and the bowel preparation is adequate. Segmental colonic
mobilization is usually required to achieve a tension-free
repair. Resection with primary anastomosis is an alterna-
tive, especially in the presence of concomitant disease. A
colostomy is optimal in an unstable patient in the
presence of heavy contamination [65]. A suggested
algorithm for managing endoscopic perforation is out-
lined in Fig. 4.
Recently, laparoscopic assessment, diagnosis and suc-
cessful management of colonoscopic perforation has been
reported [70,71]. Colonoscopic perforations are amena-
ble to laparoscopic repair as the bowel is prepared, the
perforation is recognized early and the contamination
usually contained. Primary colonic suture repair, wedge
resection using a stapler and colonic resection with
anastomosis can be carried out laparoscopically with a
reduced morbidity and shortened hospital stay [72,73].
Increasing experience in endoscopic techniques and
advances in endoscopic instruments have facilitated
management of iatrogenic colonic perforations. More
recently, an alternative endoluminal technique, using
endoscopic clips, has been described in a few selected
patients [74,75].
Barium enema
Double-contrast barium enema achieves higher caecal
examination rates than colonoscopy and hence provides
reliable assessment of the right colon. It also comple-
ments the information obtained at colonoscopy [76], and
is a useful adjunct in situations where a complete
colonoscopy is impossible resulting from patient-related
factors or technical reasons. Double-contrast barium
enema provides a road map of the colon and is helpful
in localizing the site of a colonic lesion [77,78]. How-
ever, the National Polyp study from the USA reported
conflicting results [79]. The sensitivity of DCBE (as
compared with colonoscopy) was 32% for polyps
< 0.5 cm, 53% for polyps 0.6–1 cm and 48% for polyps
larger than 1 cm [79].
Barium enema is a safe and reliable diagnostic test,
though complications can occur. Perforation is the most
serious complication, and in some earlier studies had a
mortality > 50% [36,80,81]. Intraperitoneal perforation
can result in peritonitis and sepsis complicated by the
development of dense adhesions as barium acts synergis-
tically with the effects of faecal peritonitis [36,82].
Extraperitoneal perforation can result in sepsis, cellulitis
and abscess formation [83].
The reported perforation rate with DCBE is around
0.02–0.24% [36,80,84–87]. The first case of barium
peritonitis was reported in 1916 by Hullo et al. [88]. The
clinical picture can vary from retroperitoneal emphysema
to frank barium peritonitis [89]. Four mechanisms of
colonic injury are suggested, namely direct trauma from
Figure 2 Erect chest X-ray showing free air under both hemi-
diaphragms, following iatrogenic colonic perforation at rigid
sigmoidoscopy.
Figure 3 Computed tomographic scan demonstrating free
intra-abdominal air following colonoscopic perforation.
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the catheter tip [90,91], overinflation of the rectal
balloon, recent colonic instrumentation ⁄ biopsy [92–94]
and the presence of mucosal disease [84,94]. Inflation of
a retention balloon in a stricture or inflamed rectum is
also hazardous.
Experimental studies on cadavers have shown that
intraluminal pressures in the range of 50–109 mmHg can
result in bowel perforation, with caecal perforation, at
lower pressures [46,95]. During DCBE, manual squeez-
ing of the enema bag (which is on average 1 m above the
table) can produce a pressure of 150 mmHg. Further-
more, if a closed segment is created (for example with a
competent ileocaecal valve) the pressure generated can be
even higher.
Fry et al. [96] reported five patients involved with
iatrogenic colonic perforation in 2200 barium enema
examinations. Perforations were recognized immediately
in all the patients involved with iatrogenic colonic
perforations. Two patients had emergency surgery and
three were managed conservatively. There was no mor-
tality. Hakim et al. [86] reported five perforations in
13 000 barium enema examinations, a rate of 0.04%.
Three patients required surgical intervention. They con-
cluded that intraperitoneal perforation, or severe presa-
cral barium extravasation, was best managed surgically.
Nonoperative management was successful in contained
localized perirectal perforations [86]. However, in such
perforations, repeated proctosigmoidoscopic examination
is necessary for detection of the spreading perirectal
sepsis. Kewenter and Brevinge used DCBE for screening
CRC and reported no major complications in 1986
patients [97]. In an important study by Blakeborough
et al. [98], UK radiologists were surveyed for barium
enema complications over a 3-year period, including all
patients having DCBE regardless of the indication. The
risk of major complications was 1 in 10 000, with 30
perforations in 738 216 examinations (perforation rate of
1 in 25 000).
The risk of perforation after DCBE can be reduced by
adherence to general principles, such as performing
Suspected colonic
perforation
Free intraperitoneal air Subcutaneous
emphysema
CT scan/contrast
study
Contained leak/no
leak
Free intraperitoneal
leak
Generalized peritonitis Localised peritonitis/asymptomatic
Successful Deteriorate
Laparoscopy/
laparotomy
Normal Injury 
Limited damage
No colonic pathology 
Primary repair
Major damage
Colonic pathology
Minimal soiling
Major soilage
Delayed presentation
Serious comorbidity
Colectomy & anastomosis Colectomy & anastomosisand diversion
Gross soilage/-faecal
peritonitis/-unstable
Colectomy and colostomy
Erect
chest
X-ray
Figure 4 Algorithm for the management of colonoscopic perforations.
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proctoscopy and ⁄ or sigmoidoscopy beforehand, careful
placement of the catheter and balloon inflation, using the
minimal hydrostatic pressure necessary to complete the
test, appropriate attention to distending pressure while
fluoroscopically monitoring colonic filling [86], and
avoiding DCBE in patients with florid colitis and other
acute abdominal conditions. If a perforation is suspected,
the rectal balloon should be kept in place to drain the
contrast through the catheter. Aggressive surgical man-
agement is usually indicated in the treatment of barium
colonic perforation [99,100]. Colonic resection with a
Hartmann’s procedure may be required, or the perfora-
tion may be exteriorized as a colostomy. In selected stable
patients with minimal contamination, a primary repair or
resection and anastomosis can be performed [54]. Con-
servative management is feasible in a selective group of
patients, when the presentation is with retroperitoneal
emphysema, or with pneumoperitoneum, with minimal
barium extravasation, in the absence of underlying
colonic mucosal disease [89,101,102].
Computed tomographic colonography
Computed tomographic colonography, or virtual colo-
noscopy, involves spiral CT colonic scanning with com-
puter software-generated high-resolution, multi-
dimensional views of the colon. Computed tomographic
colonography was first described over 15 years ago as a
rapid and noninvasive test for colonic imaging [103], and
the first virtual colonoscopy video was presented in 1994
[104]. Subsequent improvements in scanner technology
and other refinements have culminated in CTC being
increasingly used in clinical practice.
Until recently, CTC has mainly been used in colonic
investigation after failed or incomplete colonoscopy.
Conventional colonoscopy fails to image the entire colon
in about 5% of cases. In five series, a total of 143 patients
with obstructing colonic tumour and ⁄ or having incom-
plete colonic evaluation were safely assessed with CTC
[105]. Computed tomographic colonography has the
advantage of providing a complete examination, even in
obstructed cases, detecting synchronous cancers and
polyps and also staging liver and lungs for metastatic
disease [106–109]. Its role as a primary screening tool in
CRC has been evaluated [110], and studies have shown
comparable sensitivity and specificity for CTC and
colonoscopy for detection of lesions more than 10 mm
in diameter [111,112]. Morrin et al. [113] have reported
an overall staging accuracy of 81% for CTC in diagnosing
CRC and found it to be more reliable than barium enema
in proximal colonic assessment in obstructing cancers.
Computed tomographic colonography has attracted sig-
nificant medical and media attention for primary screen-
ing of bowel cancer because of its perceived higher
accuracy and patient preference [114,115].
Computed tomographic colonography requires bowel
preparation and insertion of a rectal tube with air
insufflation to the maximum tolerable volume the patient
can withstand. Images are taken in supine and prone
positions. With new scanners, the whole colon can be
examined in one breath hold with a higher temporal and
spatial resolution, faster reconstruction time and lower
radiation dose [116]. Computed tomographic colono-
graphy has the added advantage of examining other
abdominal organs, vessels and soft tissues. However,
these extra colonic findings, often labelled incidentalo-
mas, may require extra work up and pose management
dilemmas [117]. In a Danish study by Pederson et al., in
asymptomatic patients screened for CRC, CTC identified
extra colonic findings in 65% of patients [118]. Further
work up was required in 12%, and 3% underwent surgery.
This high prevalence of extra colonic findings may make
CTC a problematic primary screening tool for CRC for
ethical and economic reasons.
Serious complications with CTC are infrequent. Case
reports of colonic perforation are emerging [119,120].
Sonsa et al. have reported nine perforations in 24 365
patients (0.036%) undergoing CTC [121]. A recent
survey of UK radiologists reported 13 serious adverse
reactions (mainly vasovagal episodes, angina and allergic
reactions to the contrast) and nine luminal perforations in
17 067 CTC examinations [122]. Interestingly, of these
nine perforations, six were asymptomatic and only one
required a laparotomy.
The underlying mechanisms for colonic perforation
include trauma at rectal intubation, overinsufflation
and ⁄ or previous microperforation as a result of incom-
plete or difficult colonoscopy. Avoidance of rectal cath-
eters and use of automated insufflation systems with
carbon dioxide may reduce the incidence of serious
adverse events [123]. However, it is pertinent to note
that CT is exquisitely sensitive for extraluminal gas, and
detection of asymptomatic (subclinical) perforations with
CTC will be higher compared with conventional colo-
noscopy and DCBE. In the UK, in a CTC survey by
Burling et al. [122], 50% of patients were asymptomatic
and found to have free intraperitoneal gas on subsequent
formal reporting after the patient had left the X-ray unit.
Bowel preparation is currently a prerequisite for both
colonoscopy and CTC. However, as CTC does not
require sedation, is quicker than colonoscopy and more
likely to provide a complete colonic evaluation, CTC is
generally more acceptable for patients. In a recent patient
survey, more than 70% of patients preferred CTC to
conventional colonoscopy for further follow-up exami-
nation [124].
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Recent developments in colonic assessment include
the use of high-resolution video capsule endoscopy,
which will allow a detailed colonic mucosal examination
[125,126]. Future advances in CTC technology involve
novel techniques such as labelling of the residual stool
and fluid, combined with electronic subtraction of the
tagged material [127]. This virtual bowel preparation and
computer-aided diagnosis will be a major breakthrough
when its accuracy has been improved and validated, as it
may obviate the need for bowel preparation for CTC
[128,129].
Discussion
This review highlights that adequate colonic imaging is
invasive, with attendant risks, particularly perforation.
Colonoscopy continues to be the optimal technique in
many patients because of diagnostic and therapeutic
superiority for mucosal pathology. As a consequence,
often secondary to therapeutic interventions, perforation
remains an infrequent, though potentially life-threaten-
ing and almost certainly under-reported complication.
Mandatory reporting of complications in endoscopy
databases would provide more accurate information, at
least on immediate adverse events, though recording of
delayed complications will continue to be problematic as
many will be treated at centres remote form the proce-
dure.
This review is biased in that only studies published in
the English language were included. However, it has
been reported that excluding trials published in languages
other than English generally has little effect on summary
treatment effect estimates [130]. Nevertheless, ideally
comprehensive literature searches followed by a careful
assessment of trial quality are required to assess the
contribution of all relevant trials, independent of lan-
guage of publication. Most published literature on
endoscopy complications has been retrospective, from
large centres, and often reflects complication rates
reported by experienced endoscopists in high-volume
centres. These reports are unlikely to reflect the true risk
in the typical, often low-volume, community-based
setting.
Additionally, the incidence of iatrogenic perforation is
likely to increase because of more CRC screening
programmes and increasing public awareness of early
warning signs, such as rectal bleeding. A recent estimate
in the UK suggests that around 12 patients will die
annually as a consequence of colonoscopy-related adverse
events with the introduction of a national screening
programme [131]. The risk of perforation varies directly
with the difficulty of the colonoscopy. While the wider
application of CTC as a diagnostic tool might suggest
that the incidence of iatrogenic colonic perforation
should diminish, this may not materialize, as colonoscopy
continues to be needed for difficult cases and for
therapeutic interventions. This, together with an increase
both in colonic imaging and overenthusiastic attempts to
achieve full colonic assessment, is likely to result in an
overall increase in incidences of iatrogenic perforation.
Iatrogenic colonic perforation remains a serious event
and requires prompt diagnosis, assessment and manage-
ment to reduce the potentially lethal outcome, sometimes
in healthy, disease-free individuals participating in screen-
ing programmes. Awareness of the risks and a high index
of suspicion continue to be required.
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Introduction
In contrast to traditional open abdominoperineal resection 
(APR), the abdominal part of the laparoscopic-assisted 
APR is performed in a minimally invasive manner, thus 
avoiding laparotomy. The early experiences with and fea-
sibility of this procedure have been reported since the late 
nineties [1]. Short-term advantages of laparoscopy have 
been confirmed for non-locally advanced rectal cancers in 
a recent meta-analysis [2]. Consistently, a shorter hospital 
stay and a trend towards fewer postoperative complica-
tions were demonstrated in favour of laparoscopic-assisted 
APR in another meta-analysis [3]. Further advantages such 
as less blood loss have also been reported [4]. The limita-
tions of laparoscopy in the lower rectum in patients with 
advanced disease infiltrating the sphincter or levator ani 
often necessitate a combined approach, where the recto-
anal part is operated on using a conventional open tech-
nique. This approach seems to offer the advantages of each 
method, namely, a faster recovery and uncompromised 
radicality. With regard to the intermediate- and long-term 
outcomes of laparoscopic-assisted APR, sound clinical 
data are sparse, mainly due to ignorance about selection 
bias. The scope of this study was to compare the short- and 
intermediate-term outcomes of open versus laparoscopic 
APR while avoiding selection bias using propensity score 
matching.
Abstract 
Purpose To compare the short- and intermediate-term 
outcomes of open versus laparoscopic abdominoperineal 
resection (APR) for low rectal cancer.
Methods Elective open and laparoscopic APRs were 
identified in a prospective database and were 1:1 propensity 
score-matched for age, ASA grade, tumour stage and type 
of neoadjuvant therapy. The short- and intermediate-term 
outcomes were compared.
Results From January 2003 until June 2013, a total of 
135 APRs (87 open, 48 laparoscopic) were identified and 
matched (n = 96, standardised mean difference of covari-
ates <0.25). The thirty-day mortality, R0 rate, lymph nodes 
harvested and reoperations were similar. The length of the 
hospital stay was shorter in the laparoscopic group [10 ver-
sus 14 days, p = 0.004 (Mann–Whitney U test), Bonfer-
roni-corrected significance level = 0.0083]. The median 
follow-up was 4.6 (IQR: 2.0–6.0) years. The overall and 
recurrence-free 3-year survival rate estimates (Kaplan–
Meier method; 95 % CI in brackets) were 71 % (59–86) 
and 57 % (44–73) in the open group versus 78 % (66–92) 
and 72 % (60–87) in the laparoscopic group, respectively 
[p = 0.167 and p = 0.186 (log-rank test), respectively]. 
The 3-year cumulative incidence of recurrence was 27 % 
(15–40) in the open group and 16 % (8–29) in the laparo-
scopic group [p = 0.359 (Gray’s test)].
Conclusions Compared to open APR, laparoscopic APR 
provided a shorter length of hospital stay while showing no 
 * Manfred Odermatt 
 manfred.odermatt@gmx.ch
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Methods
Study design and setting
This is a retrospective, comparative analysis of a prospec-
tive database using propensity score matching. The study 
was performed in the colorectal unit of Queen Alexandra 
Hospital, UK, which is a community-based hospital cover-
ing a population of approximately 600,000 that performs 
200–300 colorectal cancer resections per year. The hospital 
is one of the national training centres for laparoscopic sur-
gery (LAPCO) in the UK [5]. The period of patient recruit-
ment lasted from January 2003 to June 2013. Laparoscopic-
assisted APR was introduced in early 2005. The eligibility 
criteria for patient inclusion were elective open or laparo-
scopic-assisted APRs with curative intent for low rectal 
cancers in adult patients (≥18 years). The reasons for APR 
were low rectal cancers infiltrating the sphincter or levator 
ani and those which did not allow distal tumour clearance 
by anterior resection alone or by means of intersphincteric 
resection. Laparoscopic-assisted APR was defined as a 
procedure where the abdominal part of the operation was 
performed laparoscopically and the perineal part was per-
formed openly (referred to as laparoscopic APR). Controls 
were defined as abdominoperineal resections where both 
the abdominal and perineal parts of the operation were per-
formed openly (open APR).
Controls were matched to cases using propensity scores 
which were obtained by a multivariable logistic regression 
analysis. The covariates for this regression analysis were 
the patient age, ASA (American Society of Anesthesiolo-
gists) grade, AJCC (American Joint Committee of Cancer) 
tumour stage and type of neoadjuvant therapy; the endpoint 
(dependent variable) was the choice of procedure (open 
versus laparoscopic APR). The matching ratio was 1:1 (one 
control for each case), where the controls were chosen from 
a redundant pool of open APRs. The matching method was 
the “nearest neighbour” method without discards and a 
specified calliper distance. The postoperative pathway fol-
lowed the principles of enhanced recovery since 2005 for 
both open and laparoscopic cases [6]. However, modifica-
tion towards a more liberal and individualised use of these 
principles was observed during the study period. The dis-
charge criteria were tolerance of solid food, adequate pain 
control with oral analgesics, ability to mobilise as preop-
eratively, and a lack of evidence of untreated surgical or 
medical conditions [7]. Competency in stoma self-care was 
the aim for all patients, and was achieved by nurses provid-
ing instructions before and after surgery unless disabilities 
did not allow this care.
Variables
The baseline variables were the gender, age, ASA grade, 
BMI (body mass index), AJCC tumour stage and type of 
neoadjuvant or adjuvant therapy. The quantitative vari-
ables were treated as continuous and were not recast as 
categorical variables. Neoadjuvant therapy comprised a 
short- or long-course regimen which was recommended to 
the patient on the grounds of a multidisciplinary team deci-
sion, taking into account the pathology and staging char-
acteristics, as well as clinical factors defined according to 
national guidelines (National Cancer Intelligence Network, 
UK, and National Institute for Health and Care Excellence, 
UK). The short-term outcome variables were the mortality 
within 30 days after surgery, reoperation within 30 days 
after surgery or during the same admission, the length of 
hospital stay after surgery, R stage, and number of har-
vested lymph nodes. The intermediate-term outcome vari-
ables were the 3-year overall and recurrence-free survival, 
as well as the 3-year cumulative incidence of recurrence. 
Recurrences were categorised into local or distant. Local 
recurrences were defined as any detectable loco-regional 
disease at follow-up after primary resection occurring 
either alone or in conjunction with distant recurrence [8]. 
The overall survival was defined as the time (days) after 
surgery until death from any cause (recurrence censored). 
The recurrence-free survival was defined as the time after 
surgery until death or recurrence. Patients not experiencing 
recurrence or death during the observation time were cen-
sored. The date for censoring was the last check date for 
recurrence or death for each individual patient.
All of the baseline variables were considered as poten-
tial confounders regarding the surgeon’s choice of opera-
tion (open versus laparoscopic). This was the rationale 
behind including most of the baseline variables in the 
regression analysis to quantify their impact on the choice 
of the surgical method. An advantage of propensity score 
matching over exact matching is that it can account for all 
of the candidate confounding variables by making use of 
information from the entire pool of potential controls. On 
the other hand, exact matching will usually account for 
only a small number of confounding variables and makes 
no use of information in the non-matched pool. Although 
the body mass index is a potentially relevant predictor, the 
facts that the values were missing in 29 % of the cases and 
that the missing values were disproportionately more com-
mon in the open group did not allow their inclusion in the 
regression analysis because their imputation, deletion or 
interpolation may have introduced further bias.
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Data sources
The data were sourced from a prospective database of the 
colorectal unit. The preoperative cancer diagnosis was 
obtained by endoscopic biopsy. Information about the 
height of the tumour and its relationship to the mesorec-
tal fascia, levator ani and sphincter was obtained by MRI 
(magnetic resonance imaging) and, in selected cases, by 
transanal endoscopic ultrasound. Metastases were excluded 
by CT (computed tomography) scans of the chest, abdomen 
and pelvis. Information about the neoadjuvant or adjuvant 
treatment was obtained from notes made by the multidisci-
plinary team (MDT) at a meeting in which all rectal cancer 
patients were enrolled routinely before and after surgery 
since 1999.
The intraoperative data were collected using a standard-
ised form giving information about the type of operation. 
The pathological staging, as well as the number of har-
vested lymph nodes, was extracted from pathology reports. 
No standardised template for lymph node harvesting was 
used. All patients were followed up after 6–8 weeks, 
6 months and 12 months. They were then followed up on 
a yearly basis for 5 years. During this period, two colonos-
copies and two CT scans were arranged to detect local and 
distant recurrences. Furthermore, all patients were followed 
up by a virtual follow-up clinic where patients were regu-
larly contacted by specialist nurses, or patients could call 
in themselves if they developed new symptoms necessitat-
ing further investigation(s). Patients discharged from active 
follow-up were monitored by passive follow-up consisting 
of yearly checks of the death registries. The data collection, 
data quality management and passive follow-up were per-
formed by a full-time research assistant.
Study size
The study size was the result of the total number of lapa-
roscopic APR cases for whom an equal number of eligible 
open control cases were matched.
Surgical technique and pathological assessment of the 
specimen
The laparoscopic top-end part of the operation was per-
formed in a standardised fashion. A 12 mm camera port at 
the umbilicus, two 5 mm ports bilateral to the rectus mus-
cle sheath, and a 12 mm port 3 cm medial to the anterior 
superior iliac spine on the right side were placed. Occa-
sionally, the left working port site was used to create the 
stoma opening. The inferior mesenteric artery was divided 
centrally at about 1 cm from its origin. The left colic artery 
was not normally preserved, although this topic is under 
debate. Medial to lateral mobilisation of the left colon was 
performed as much as necessary to create a tension-free end 
colostomy. Therefore, a complete take down of the splenic 
flexure was not necessary in most cases. The inferior mes-
enteric vein was divided at the border of the pancreas. Dis-
section continued downward along the mesorectal plane 
while taking care not to injure the hypogastric nerves. In 
cases with cylindrical (extralevator) excision, the top-end 
dissection stopped at the height where the nerve fibres from 
the lateral side walls joined the mesorectum (T-junction).
In conventional and intersphincteric APR, laparoscopic 
dissection was carried out down to the top of the anal canal. 
Conventional APR with wide excision to avoid negative 
tumour margins was performed in most cases. Frozen sec-
tions were not routinely utilised in these cases. Extraleva-
tor APR, which has recently been shown to decrease the 
perforation and local recurrence rates, was not a standard 
practice during most of the study period [9]. A standardised 
extralevator APR was only applied in some patients in the 
late study period. The pathological assessment of the speci-
mens included grading and pTNM staging of the tumour, 
as well as R staging. The distance of the tumour to the cir-
cumferential margin, as well as tumour perforation, was not 
consistently recorded in the database throughout the study 
period. As the open perineal procedure was performed sim-
ilarly in both groups, a comparison of the endpoints was 
considered to be acceptable.
Statistical analysis
All analyses were performed according to the intention 
to treat (ITT) principle. Conversions from laparoscopy to 
open surgery during the abdominal part of the operation 
were kept in the laparoscopic group for the analysis. Quan-
titative variables were summarised using the medians and 
ranges and were compared between groups via the Mann–
Whitney U test. Categorical variables were summarised 
using absolute numbers and percentages, and were com-
pared via a Chi-squared or Fisher’s exact test, as appropri-
ate. However, statistical significance testing to compare 
the baseline characteristics of groups in the propensity 
score-matched samples has been widely criticised in the 
statistical literature, and the statistical significance of test-
ing has therefore been limited to outcome variables [10]. 
As the influence of one predictor (open versus laparoscopic 
APR) was tested on six short-term outcomes (mortality, 
reoperation, length of hospital stay, R stage, lymph nodes 
harvested, and recurrence), the Bonferroni-corrected alpha 
significance level was required to be 0.0083 to control for 
type 1 errors (false discoveries).
The first step of the propensity score analysis was a 
multiple logistic regression analysis that was performed to 
obtain the propensity scores. The second step was the 1:1 
“nearest neighbour” matching. The resulting differences in 
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the baseline variables between the case and control groups 
were estimated as standardised mean differences. Addition-
ally, the effect of matching was quantified by the imbalance 
measure (L1 statistic) reported by Iacus, King and Porro 
[11]. A decrease in this measure after matching indicates 
an increase in the balance. The absolute value of this num-
ber, however, does not correlate linearly with the degree of 
balance. For the propensity score matching, the PS match 
version 1.0 plug-in developed by Felix Thoemmes was 
implemented in the SPSS 19 software program (Statistical 
Package for Social Science, IBM® SPSS® Statistics). The 
potential median follow-up was estimated using the inverse 
Kaplan–Meier method [12]. The cumulative incidence of 
recurrence was analysed using the Gray method, account-
ing for death as a competing risk [13]. Survival curves were 
estimated using the Kaplan–Meier method [14]. Group 
comparisons of the estimated survival curves were made 
using the log-rank test. It was considered appropriate to 
run the analyses using the pooled cases and control groups, 
rather than using the individual matched pairs [10]. This 
is because propensity score matching does not guarantee 
that the individual pairs of matched subjects will be well 
matched on the full set of baseline covariates, only that 
the groups of individuals with similar propensity scores 
will have similar covariate distributions. Unless otherwise 
stated, the SPSS Version 20 and R version 2.15.1 software 
programs were used for the statistical analyses.
Results
From January 2003 to June 2013, a total of 135 elective 
APRs [87 (64.4 %) open and 48 (35.6 %) laparoscopic 
cases] were performed with curative intent. The first lapa-
roscopic APR was performed in February 2005. Two lap-
aroscopic cases were converted to open surgery, but were 
kept in the laparoscopic group for further analysis. The 
48 laparoscopic cases were matched to an equal number 
of open cases, resulting in a collective study of 96 cases. 
After matching, none of the included covariates or their 
interactions showed a standardised mean difference larger 
than 0.25 (|d| > 0.25) between the groups, which was con-
sidered to be a good balance [10]. In addition, the L1 sta-
tistic, an imbalance measure proposed by Iacus, King and 
Porro, decreased from 0.619 before matching to 0.604 after 
matching, indicating an improvement in the balance. The 
baseline characteristics of the two groups after matching 
are summarised in Table 1. The open APR group tended 
to have more patients who received long-course neoadju-
vant therapy than the laparoscopic group (33 versus 25 %). 
The short- and intermediate-term outcomes are shown in 
Table 2. With respect to the short-term outcomes, postop-
erative 30-day mortality, R0 rate, harvested lymph node 
count and number of reoperations were similar between 
the groups. The length of the hospital stay was signifi-
cantly shorter in the laparoscopic group [10 versus 14 days, 
p = 0.004 (Mann–Whitney U test), Bonferroni-corrected 
alpha significance level = 0.0083].
The median follow-up was 4.58 (interquartile range 
2.00–6.00) years. Due to the fact that laparoscopic APRs 
were performed later during the observation period, the fol-
low-up of the laparoscopic group was significantly shorter, 
with the median being 6.00 (IQR 3.17–8.17) years in the 
open group and 3.58 (1.71–5.17) years in the laparoscopic 
APR group (p < 0.001, log-rank test). Therefore, only the 
3-year survival and cumulative incidence of recurrence 
rates were calculated from the estimated survival curves.
With respect to the intermediate-term outcomes, abso-
lute recurrences were observed in 13 open (four local, nine 
distant) and nine laparoscopic (four local, five distant) cases 
(p = 0.549, Fisher’s exact test). The 3-year cumulative 
incidence of recurrence, corrected for death as a competing 
Table 1  Baseline characteristics of patients undergoing open versus 
laparoscopic abdominoperineal rectal resection after 1:1 propensity 
score matching
Open Laparoscopic
Gender
 Male 29 (60.4 %) 25 (52.1 %)
 Female 19 (39.6 %) 23 (47.9 %)
Age [median (range)], years 73.5 (25–90) 73.5 (42–92)
ASA grade
 1 5 (10.4 %) 6 (12.5 %)
 2 34 (70.8 %) 27 (56.3 %)
 3 9 (18.8 %) 15 (31.2 %)
BMIc [median (range)] 25.5 (20–36) 27.5 (18–52)
AJCC tumour stage (7th edition)
 1 13 (27.1 %) 16 (33.3 %)
 2 12 (25.0 %) 14 (29.2 %)
 3 23 (47.9 %) 18 (37.5 %)
T stage
 1 2 (4.2 %) 3 (6.2 %)
 2 13 (27.1 %) 19 (39.6 %)
 3 29 (60.4 %) 22 (45.8 %)
 4 4 (8.3 %) 4 (8.3 %)
N stage
 0 25 (52.1 %) 30 (62.5 %)
 1 12 (25.0 %) 11 (22.9 %)
 2 11 (22.9 %) 7 (14.6 %)
Neoadjuvant therapy
 None 27 (56.2 %) 24 (50.0 %)
 Short-course 5 (10.4 %) 12 (25.0 %)
 Long-course 16 (33.3 %) 12 (25.0 %)
Adjuvant chemo(radio)therapy 8 (16.7 %) 7 (14.6 %)
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event, was 27.1 % (15.3–40.2) in the open group and 17 % 
(8.0–29.0 %) in the laparoscopic group (p = 0.359, Gray’s 
test). The cumulative incidence plot is shown in Fig. 1. 
The overall and recurrence-free 3-year survival estimates 
(Kaplan–Meier) were 71 % (59–86) and 57 % (44–73) ver-
sus 78 % (66–92) and 72 % (60–87) in the open and laparo-
scopic groups, respectively, with no significant differences 
observed [p = 0.167 and p = 0.186 (log-rank test), respec-
tively]. The overall- and recurrence-free survival curves are 
shown in Fig. 2.
Discussion
With respect to the short-term outcomes, laparoscopic 
APR provided a significantly shorter length of hospital stay 
compared to open APR. With respect to the intermediate-
term outcomes, no statistically significant difference in 
the cumulative incidence of recurrence or the overall- and 
recurrence-free survival was found.
With regard to the length of the hospital stay, similar 
results have been reported in other comparative case series 
[15–20]. Only Araujo et al. reported no significant associa-
tion between the length of stay and surgical method [21]. 
In our study, the discharge criteria were achieved earlier in 
the laparoscopy group, although the available data did not 
allow a comparative analysis to be performed to find out 
which discharge criteria were influenced the most by lapa-
roscopy. In a randomised controlled study (LAFA study) by 
Vlug et al., laparoscopy proved to be the only independ-
ent factor that significantly influenced the length of hospi-
tal stay after colonic surgery [22]: There was no significant 
difference in hospital stay between patients receiving open 
surgery plus fast-track management and those who were 
treated laparoscopically without fast-track management. 
Combining laparoscopy with fast-track management led 
to a significant acceleration of the recovery by achieving 
earlier pain control, tolerance of solid food, passage of fla-
tus or bowel opening, mobilisation, and acceptance of dis-
charge by the patient. In a meta-analysis by Aziz et al. that 
compared open and laparoscopic surgery for rectal cancer, 
there was also a significant reduction in the time to stomal 
function, first bowel movement and length of hospital stay; 
in the subgroup containing patients who underwent abdom-
inoperineal excisions, wound infection and the requirement 
of additional postoperative intravenous analgesics were 
also significantly reduced [23]. A shorter hospital stay and 
its economic impact is a common argument in favour of the 
laparoscopic approach in spite of the technique being more 
expensive, since it is often associated with a longer opera-
tion [15–17, 19, 24]. However, as expertise in laparoscopic 
surgery increases, the length of the operation is expected to 
become shorter.
In the past, open operations were often most commonly 
used for patients with high risk factors or those needing 
multi-visceral resections. This led to a selection bias result-
ing in patients with higher morbidity or more advanced 
Table 2  The short- and intermediate-term outcomes
a Fisher’s exact test
b Chi-square test
c Mann–Whitney U test
d Gray’s test
e Log-rank test
Open Laparoscopic p
n = 48 n = 48
30-day mortality 2 (4.2 %) 1 (2.1 %) 1.000a
Reoperation 3 (6.2 %) 2 (4.2 %) 1.000a
 Stoma revision 1 (2.1 %) 2 (4.2 %)
 Haemostasis 1 (2.1 %) 0 (0.0 %)
 Wound debridement 1 (2.1 %) 0 (0.0 %)
Length of stay [median 
(range)] in days
14 (3–123) 10 (3–43) 0.004c
R stage 0.563b
 R0 40 (83.3 %) 42 (87.5 %)
 R1 8 (16.7 %) 6 (12.5 %)
Lymph nodes harvested 
[median (range)]
11.5 (2–21) 12 (0–65) 0.857c
Recurrence 0.549a
 Local recurrence 4 (8.3 %) 4 (8.3 %)
 Distant recurrence 9 (18.8 %) 5 (10.4 %)
3-year cumulative incidence 
of recurrence
27 % (15–40) 17 % (8–29) 0.359d
3-year overall survival rate 71 % (59–86) 78 % (66–92) 0.167e
3-year recurrence-free sur-
vival rate
57 % (44–73) 72 % (60–87) 0.186e
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Fig. 1  The cumulative incidence of recurrence (Gray)
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tumours being in the open group, which was associated 
with more complications and longer hospital stays. A retro-
spective analysis of the National Surgical Quality Improve-
ment Program’s (NSQIP) Participant User File demon-
strated how patient selection differed by approach [25]. In 
our study, the comparability of the groups was improved by 
propensity score matching. Thus, the individual risk profile 
and tumour characteristics known at the moment of method 
selection were taken into account. By matching open APR 
to laparoscopic cases, all of the included open APRs could 
also have been treated by laparoscopy (for the abdominal 
part). In fact, as there were surgeons who did not preferen-
tially perform laparoscopic APRs, many of the open APR 
cases would have been suitable for a combined laparo-
scopic procedure, which would have resulted in a shorter 
hospital stay.
The overall postoperative mortality rate (4.2 % in the 
open group and 2.1 % in the laparoscopic APR group) was 
similar between the two groups. In previous studies, the 
perioperative mortality was found to be independent of the 
surgical approach [3]. In the CLASSIC trial, the postopera-
tive mortality after colorectal surgery was 5 % in the open 
group and 4 % in the laparoscopic group [26]. Although 
our results could be a type 2 (false negative) error due to 
the small sample size, the absolute risk difference of post-
operative mortality of only 2.1 %, with three death events 
in both groups, seems to exclude a clinically relevant dif-
ference. Careful management in a specialised high-volume 
unit may also have the potential to further decrease mortal-
ity. So far, the inferiority of either approach with regard to 
postoperative mortality has not been demonstrated.
In terms of the postoperative complications, a systematic 
review of eight publications comparing open and laparo-
scopic APR found significantly fewer early postoperative 
complications in the laparoscopic group [3]. In our study, 
we only looked at the reoperation rate for surgical compli-
cations graded as 3b according to the Clavien–Dindo clas-
sification [27]; no statistically significant difference in the 
incidence of such complications was found. The discrep-
ancy with the cited study could again be due to a patient 
selection bias, which was insufficiently addressed by most 
previous studies. Cases with any risk factors, such as mul-
tiple previous operations in the pelvis, elderly patients at 
risk of not tolerating the pneumoperitoneum and advanced 
tumour characteristics with potential involvement of adja-
cent structures, are still more likely to make the surgeon 
choose an open procedure. Although the factors defining 
the patient’s risk profile were limited in our study, the selec-
tion bias was minimised by addressing a set of important 
variables predicting the surgical risk and prognosis. Thus, 
open operations that would have been unlikely to qualify 
for laparoscopy were excluded, and the tendency for more 
high-risk patients to be in the open group was minimised.
The completeness of resection and lymph node harvest 
are considered to be important quality markers for colo-
rectal tumour surgery, as they correlate with the prognosis 
[28, 29]. In a multivariable analysis, positive lymph nodes 
were found to be the most important independent predic-
tor for local recurrence [30]. Better local control of rec-
tal cancer seems to effectively reduce the development of 
distant metastases [31]. In our study, both groups showed 
similar R0 rates and lymph node counts. This, in accord-
ance with other investigations, failed to establish any sta-
tistically significant differences in open versus laparoscopic 
APR with regard to the lateral and distal margin clearance 
and number of harvested lymph nodes [25, 32]. There was 
only one recently published study in which significantly 
more lymph nodes were harvested in the laparoscopic 
p = 0.167
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group, with no difference in the circumferential margins 
or distal clearance [16]. The limitations of this finding in 
that study were the small number of cases (19 laparoscopic 
versus 47 open APRs), and the fact that the selection bias 
was not sufficiently addressed. Other factors, such as integ-
rity of the mesorectal fascia and the lack of coning in the 
lower rectum, may be better quality markers for assessing 
the surgeon’s performance, and have been proven to influ-
ence the quality control by a multidisciplinary team [33]. 
Unfortunately, in our cohort, no standardised specimen 
evaluation protocol was consistently implemented over the 
study period, so the R stage and lymph node count were the 
only surrogates showing the comparable level of surgical 
success in both groups.
The high proportion of R1 resections (14.6 %) in our 
study reflects the fact that conventional APR was mainly 
performed. In the meta-analysis by Stelzner et al. [9], 
which compared conventional and extended APR, the cir-
cumferential margins were similarly positive in 15.4 % 
of cases in the conventional group (versus 9.6 % in the 
extended APR group) [9]. From today’s perspective, the 
surgical technique used may have been inadequate in many 
of the included cases, because extralevator APR is now 
considered the standard of care for advanced very low 
rectal cancers. However, as extralevator APR can also be 
combined with a top-end laparoscopic procedure, the short-
term advantages found in this study should be transferable.
We found no evidence that the intermediate-term over-
all or recurrence-free survival was affected by the type of 
surgery. There was a non-significant decrease in the 3-year 
recurrence-free survival in the open group compared to the 
laparoscopic APR group, which may be explained by more 
nodal-positive patients in the open group. With respect to 
the local tumour clearance, both groups had an open per-
ineal approach with similar R0 rates (83 % in the open 
group and 87 % in the laparoscopic APR group, p = 0.56). 
Although it can be difficult to identify the ideal height 
where the use of abdominal mesorectal dissection has 
to be discontinued, there were no signs that laparoscopy 
adversely influenced the radicality of resection. Oncologi-
cal dissection in the correct plane and a high tie has proven 
to be feasible by both open and laparoscopic surgery. In 
a recent meta-analysis of 14 randomised controlled tri-
als comparing open and laparoscopic rectal resections that 
including 2114 subjects (1111 laparoscopic cases), the 
length of the specimen and circumferential resection mar-
gin were similar, as were the 3-year overall and disease-
free survival [34].
The cumulative incidence of recurrence was similar in 
both groups. Loco-regional pelvic recurrence is still one of 
the main problems associated with advanced rectal cancers, 
even after introduction of mesorectal excision [35]. After 
abdominoperineal resections, recurrence rates well beyond 
15 % have been reported [36]. In this study, a recurrence 
developed in 27.1 % of the patients (8.3 % loco-regional) 
in the open group and in 18.7 % (8.3 % loco-regional) in 
the laparoscopic APR group, demonstrating that similar 
loco-regional control could be achieved by both methods. 
In the systematic review by Stelzner et al., local recurrence 
rates of 11.9 and 6.6 % were found in the conventional and 
extended APR groups, respectively [9].
In the present study, there was a discrepancy between the 
high R1-resection rate (N = 14; 14.6 %) and the relatively 
small number of local recurrences (N = 8; 8.3 %). There 
may be several reasons to explain this. First, all patients 
with positive resection margins received adjuvant treat-
ment, potentially leading to a complete regression of the 
residual tumour in some cases, as was shown in other series 
reporting complete clinical responses to radiochemother-
apy [37]. Second, some of the tumours may have had early 
systemic manifestations not amenable to curative resection, 
and therefore treatment with palliative chemotherapy may 
have prevented the growth of microscopic tumour residu-
als. Third, the follow-up period may have been too short 
in some patients to develop clinically relevant local tumour 
recurrences. Many other studies also have shown a discrep-
ancy between microscopically positive margins and the 
number of recurrences [9].
The difference in the incidence of distant metastases 
may be explained by the fact that more patients in the open 
group (33 versus 25 %) needed neoadjuvant long-course 
therapy due to more advanced local tumours or unfavour-
able tumour features at the time of diagnosis. Furthermore, 
the follow-up time in the open group was significantly 
longer than that in the laparoscopic group. This is impor-
tant, because recurrences of rectal cancer generally still 
occur at a later point in time than those of colon cancer 
[35]. However, since recurrence after 3 years of follow-up 
was a rare event in our study, laparoscopic APR did not 
seem to adversely affect the time to loco-regional or distant 
recurrence.
This study has limitations due to its retrospective nature 
and the relatively small sample size. As selection bias 
was addressed by propensity score matching, leading to 
the exclusion of patients unsuitable for laparoscopy, the 
conclusions are only valid for selected patients. The lack 
of further details about the surgical technique and patho-
logical assessment may also require a cautious interpreta-
tion of the results. Keeping this in mind, performing the 
abdominal procedure laparoscopically in APR seems to 
reduce the length of hospital stay, while not compromising 
survival or time to recurrence. This benefit should also be 
present when extralevator instead of conventional APR is 
performed to further reduce the number of positive margins 
and the rate of local recurrence in patients with advanced 
very low rectal cancers.
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Laparoscopic cholecystectomy has become the gold stan-
dard for treatment of symptomatic gall stone disease.1
Recently, this has also gained acceptance as the surgical
treatment for acute cholecystitis. The traditional teaching
has been a two-stage treatment for acute cholecystitis with
an initial conservative management followed by an interval
laparoscopic cholecystectomy.2 This has been based on the
experience of increased conversion and complication rate
with early cholecystectomy in acute cholecystitis which
overshadow all the advantages of the laparoscopic approach
making this inefficient and unsafe.3 The conversion rates for
elective laparoscopic cholecystectomy range from 3–7%.4,5
However, in the presence of acute inflammation, higher con-
version rates of up to 30% have been reported.6,7
Timing of surgery in acute cholecystitis has been controver-
sial. Several studies have reported favourable outcomes
with a low conversion rate if patients are operated within
96 h of admission.8–10 After that window period, surgeons
have opted for interval cholecystectomy after a period of 6–8
weeks.8
Larger surgical centres have published their successful
management of acute cholecystitis with urgent laparoscop-
ic cholecystectomy.11 We set out to discover if similar out-
comes were reproducible in a district general hospital. The
aim of this study was to determine the conversion rate and
the risk of major complications with laparoscopic cholecys-
tectomy for acute cholecystitis and to compare the results
with the published data from specialist centres.
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ABSTRACT
INTRODUCTION Laparoscopic cholecystectomy has become the gold standard for treatment of symptomatic gall stone disease.
However, its place remains controversial in the management of acute cholecystitis due to a high reported incidence of bile
leaks and conversion rate. Tertiary referral centres have reported good results. We present a series of cases after the introduc-
tion of an urgent cholecystectomy pathway in a district general hospital.
PATIENTS AND METHODS A practice of urgent cholecystectomy for acute cholecystitis was introduced by three consultant gen-
eral surgeons. All prospective patients having an urgent laparoscopic cholecystectomy for acute cholecystitis, over an 8-month
period were entered into a database. A dedicated ultrasound service was instituted to provide prompt diagnosis in these
patients. Their demographic details, operative findings, laboratory results were recorded in a prospective database. Timing of
ERCP, postoperative complications and conversion rate and hospital stay were also noted.
RESULTS There were 64 patients in the study with a median age of 51 years (range, 21–84 years). There were 21 males and
43 females. All patients underwent laparoscopic cholecystectomy during the index admission. Eleven patients had pre-opera-
tive ERCP and 12 patients had on-table cholangiogram. There were no conversions. Postoperative ERCP was required in six
patients. The median time interval between admission and operation was 3 days (range, 2–7 days). There were two bile leaks
but no common bile duct injury. There were two cases of superficial wound infection. One patient required re-operation for
small bowel obstruction secondary to a port site hernia.
CONCLUSIONS Urgent laparoscopic cholecystectomy for acute cholecystitis is a feasible treatment option in a district general
hospital. A safe practice can be ensured by adherence to a care pathway and a multidisciplinary, consultant-delivered service.
Urgent cholecystectomy service can be provided safely in a district general hospital with outcomes comparable to previously
published literature.
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Patients and Methods
All consecutive patients admitted with acute cholecystitis
over an 8-month period (January–September 2006) were
included in this study. An urgent cholecystectomy pathway
was introduced led by three consultant general surgeons at
a district hospital. The aim was to offer emergency surgery
for acute cholecystitis. A dedicated fast-track ultrasound
service for all patients admitted with the provisional diag-
nosis of acute cholecystitis provided confirmation of the
diagnosis within 24 h of admission. Abdominal ultrasound
scans were carried out on the day of admission or next
morning if patients were admitted out-of-hours. All patients
with proven gall stones and acute cholecystitis were booked
on the emergency list and a laparoscopic cholecystectomy
was performed. We aimed to compare the results with other
published studies and the primary end-points were conver-
sion rate, bile leak, bile duct injury and other postoperative
complications.
For the purpose of this study, diagnosis of acute cholecys-
titis was based on the presence of right upper quadrant pain
with or without fever, with evidence of raised inflammatory
markers, i.e. white cell count (WCC) and/or C-reactive pro-
tein (CRP), presence of ultrasonographic abnormalities (gall
stones, thick-walled gall bladder, pericholecystic fluid collec-
tion, positive Murphy’s sign). There was no specific on-call
rota for this service but, between the three consultants, a reg-
ular service was provided over the week days. Weekends
were, however, difficult to cover but patients admitted over
the weekend were considered for surgery on Monday if they
had proven gall stone disease. Two specialist registrars also
participated in this service; however, they were supervised at
all times. All data were entered into a prospective database.
Demographic details, operative findings and laboratory
results for all these patients were recorded. Timing of endo-
scopic retrograde cholangiopancreatography (ERCP), postop-
erative complications and conversion rate and hospital stay
were also noted. All patients with acute cholecystitis were
offered urgent cholecystectomy. The option of conservative
management with interval cholecystectomy was also discussed;
however, all of these patients opted for urgent surgery.
The standard technique for laparoscopic cholecystecto-
my was used with a 10-mm optical umbilical port, 12-mm
epigastric port and two 5-mm ports in the right upper quad-
rant and right iliac fossa, respectively. Additional ports were
used where necessary for retraction of the abdominal vis-
cera. Gall bladder was extracted in a bag through the
umbilical port. A subhepatic drain was placed in all cases.
Tense gall bladder was decompressed by pushing a 5-mm
trocar through the fundus of the gall bladder and irrigating
with normal saline (Fig. 1). A combination of sharp and
blunt dissection using a sucker was used to dissect the
Calot’s triangle. A selective policy for on-table cholan-
giogram was adopted especially in cases where the anato-
my was difficult to define or there was suspicion of ductal
calculi. Postoperative ERCP was performed in patients with
bile duct stones and those who developed postoperative bile
leak. Bile leak was defined clinically as a persistent leak of
bile through the subhepatic drain. Chest infection was diag-
nosed on the basis of three or more of the findings includ-
ing cough, phlegm, shortness of breath, chest pain, temper-
ature above 38ºC, and pulse rate above 100 beats per
minute. Wound infection was defined using the CDC crite-
ria for surgical site infections.12
Results
Over the period of 8 months, 64 patients underwent an urgent
cholecystectomy for acute cholecystitis. There were 21 males
and 43 females with a median age of 51 years (range, 21–84
Median age 51 years
(range) (21–84 years)
Sex Male 21
Female 43
Median interval between
admission and operation 3 days
(range, 2–7 days)
Median interval between
onset of symptoms and operation 5 days
(range, 2–11 days)
Previous admission
No admission 17
One admission 29
Two admissions 13
More than two admissions 5
Table 1 Patient demographics
Figure 1 Operative picture of decompression of gall bladder with
use of suction irrigation.
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years). Male to female ratio was 1:2. The demographic details
are given in Table 1. The median values for WCC and CRP
were 14 and 21, respectively (Table 2).
Eleven patients underwent pre-operative ERCP. These
patients had deranged liver function tests with evidence of
dilated common bile duct on ultrasound scan. On-table
cholangiogram was carried out in 12 patients. Six patients
were found to have ductal calculi. In two patients, the com-
mon bile duct was cleared at the time of cholecystectomy.
The rest required postoperative ERCP. Laparoscopic chole-
cystectomy was completed successfully in all patients and,
hence, there were no conversions to open procedure. The
median operating time was 75 min. Postoperative ERCP was
required in six patients. In four patients, the purpose was to
remove the ductal stones. Two patients had postoperative
bile leak and, as a result, investigated with ERCP. No major
bile duct injury was identified. There was leakage from the
cystic duct stump in one case and the other patient had an
accessory cystic duct. In both cases, a stent was placed at
ERCP and the leak was controlled effectively. Operative
details are shown in Table 3.
A dedicated ultrasound service was provided for these
patients and 64% (41 of 64) of these patients had ultra-
sonography performed on the day of admission. The medi-
an time interval between admission and operation was 3
days (range, 2–7 days). The median time from onset of
symptoms to surgery was 5 days (range, 2–11 days). Overall,
73% of patients had previous admissions with similar symp-
toms (29 had one prior admission, 13 had two and 5 had
more than two previous admissions).
There were two cases of wound infection. One patient
was re-admitted because of a strangulated port site hernia
and required re-operation for small bowel obstruction. Five
patients developed chest infection postoperatively and all
were managed successfully with antibiotics and chest phys-
iotherapy. Other complications are shown in Figure 2. The
median hospital stay was 4 days (range, 3–10 days).
Discussion
Open cholecystectomy was the gold standard for treatment
of gall stone disease for more than a century since the first
operation performed by Carl Langenbuch in 1882.13
Laparoscopic cholecystectomy was introduced in the late
1980s and rapidly became the treatment of choice because
of its efficacy and advantages over open cholecystectomy
particularly in terms of rapid recovery, smaller incision and
earlier return to work.4,7,14,15 Acute cholecystitis was once
thought to be a relative contra-indication for laparoscopic
cholecystectomy, because of the higher complications rate,
prolonged operative time and increased conversion
rates.2,16,17 However, with increasing experience of the sur-
geons with laparoscopic procedures and advances in the
imaging techniques and operating instruments, laparoscop-
ic cholecystectomy is finding increasing application in the
setting of acute cholecystitis.18 Many authors consider this
as a treatment of choice for acute cholecystitis,19,20 and sev-
eral studies have shown comparable mortality rates with
significantly less morbidity.21–23
White cell count (WCC) (×106/l) 14 (9.9–19.1)
C-reactive protein (CRP) (mg/l) 21 (10–360)
Bilirubin (µmol/l) 11 (6–119)
Alkaline phosphatase (ALP) (U/l) 117 (66–1058)
Amylase (U/l) 41 (30–301)
Median values, range in parentheses.
Table 2 Laboratory findings in patients with acute
cholecystitis
Median operative time 75 min
(range, 45–120 min)
Conversion to open 0
On-table cholangiogram 12
Ductal calculi 6
Number of ports used
Standard four ports 59
Extra port for retraction 5
ERCP
Pre-operatively 11
Postoperatively 6
Table 3 Operative findings
Figure 2 Postoperative complications after laparoscopic cholecys-
tectomy for acute cholecystitis.
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Traditionally, acute cholecystitis has been managed in
two stages – an initial conservative management followed
by interval cholecystectomy 6–8 weeks later.2 However, with
limited resources and pressure on the waiting lists in the
NHS, these patients often have to wait for an average of 3–4
months.24 Furthermore, almost 15% of these patients
require emergency cholecystectomy and another 25% will
have a re-admission prior to elective surgery.25,26 Prompt
laparoscopic surgery for acute cholecystitis reduces re-
admission rates and enables the patient to return to normal
activity and work, whilst limiting the morbidity from their
gall bladder disease. Sobolev et al.27 have shown that, in
patients on the waiting list for laparoscopic cholecystecto-
my, the relative risk for an emergency cholecystectomy
increases by 3-fold after 20 weeks. Early cholecystectomy
can reduce the hospital stay and prevent these complica-
tions.7,28 Recently, several reports from specialist centres
have shown favourable results with laparoscopic cholecys-
tectomy for acute cholecystitis.8,9,11,15,20,25
Despite the evidence of efficacy and benefits to the
patient with laparoscopic cholecystectomy for acute chole-
cystitis, general surgeons in the UK have been reluctant to
use this approach. Only 15–20% of surgeons have adopted
the policy of urgent cholecystectomy during the index
admission.29,30 The perceived risk of higher complications
(particularly bile duct injury and conversion rates) may be
responsible for the unpopularity of early laparoscopic
cholecystectomy. Other possible contributory factors could
be the delays caused by availability of emergency operating
lists and the radiology investigations, which essentially
means that the surgeons miss the ‘window of opportunity’
for surgical intervention.11,30 It is interesting to note that the
timing of surgery in acute cholecystitis has remained con-
troversial. Surgical intervention after the first 96 h of onset
of symptoms has been reported as difficult due to significant
adhesions,21,31 and is associated with a higher conversion
rate.9 The conversion rates for elective laparoscopic chole-
cystectomy are 4–5%.32 However, the average reported rates
for laparoscopic cholecystectomy in acute cholecystitis are
between 10–30% and can be much higher in patients with
empyema or gangrenous gall bladder.7,33 Higher conversion
rates are seen in male patients, old age, very thickened gall
bladder, very high inflammatory markers and limited expe-
rience of the surgeon.15
There were no conversions in our series; however, we
believe that conversion to open procedure is inevitable in
laparoscopic management of acute cholecystitis, but the
conversion rate should kept around 10% in order to achieve
the maximum benefit of an urgent cholecystectomy service.
Patients were operated at variable times after their admis-
sion (median interval between admission and operation
was 3 days). Most of the time, the delays were for logistical
reasons, especially access to the operating theatre lists. We
did not find any association between the timing of surgery
and the complication rate. Similar findings have been
reported by studies from high-volume centres.11,34
Bile leak and bile duct injury are the two most feared
complications of laparoscopic cholecystectomy for acute
cholecystitis. The risk of bile duct injury is between
0.3–1.3%.17,35 The reported incidence for bile leaks after
laparoscopic cholecystectomy for acute cholecystitis is
around 0.25% for elective laparoscopic cholecystectomy but
rises to 2–3% in the presence of acute inflammation.9,36 We
had two patients with bile leak (3.1%) but without any
major bile duct injury: this compares favourably with the
published literature.
Laparoscopic exploration of the common bile duct has not
been standard practice at our institution due to the lack of
equipment and expertise. Patients suspected of having com-
mon bile duct stones based on abnormal liver function tests,
dilated common bile duct and evidence of ductal calculi
underwent pre-operative ERCP. Intra-operative cholan-
giogramwasmainly used in cases with difficult anatomy in the
Calot’s triangle. In six patients, this confirmed the presence of
ductal stones. All these patients had normal liver function tests
and no evidence of biliary dilatation on ultrasound scanning.
With increasing interest in laparoscopic common bile duct
exploration, two patients had choledochoscopy and removal of
stones. The other four patients underwent uneventful recovery
after laparoscopic cholecystectomy and then had an ERCP to
clear the duct. There were no complications in these patients:
in particular, no bile leaks were observed. Magnetic resonance
cholangiopancreatography (MRCP) was not used in any of
these patients.
This study is not without limitations. It is not a randomised
study and we did not have a comparative group. This is a case
series with relatively small numbers, which describes our
experiencewith laparoscopic cholecystectomy for acute chole-
cystitis. We have been able to show that the favourable results
published from high-volume and tertiary care centres are
reproducible in a district hospital setting. The key factor is
adherence to a specific care pathway and a consultant-led
service. Emergency laparoscopic cholecystectomy for acute
cholecystitis is safe. Its importance will increase due to an ever
increasing patient expectation and knowledge. This approach
will minimise re-admission rates and morbidity allowing
patients to return to work faster.
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Laparoscopic Versus Open Appendectomy: the Risk
of Postoperative Infectious Complications
Muhammad Najm Khan, FCPS, FRCS (Glasg.), Tony Fayyad, MD,
Tom D. Cecil, MD, FRCS, Brendan J. Moran, MD, FRCS
ABSTRACT
Background: Despite the reported advantages of laparo-
scopic appendectomy (LA), ongoing debate exists about a
possible increase in postoperative infectious complication
rates especially intraabdominal infections and wound in-
fection, unless wound protection is utilized.
Methods: All consecutive appendicectomies (open and
laparoscopic) performed over 4 months were included in
this prospective study. Demographic details, operative
time, time to conversion, infective postoperative compli-
cations, and delay in discharge were recorded. The pa-
tients were divided into 2 groups, laparoscopic (LA) and
open appendectomy (OA).
Results: A total of 134 appendicectomies were per-
formed, 80 in the LA group and 54 in the OA group.
Twenty-six (19.4%) appendices were perforated at the
time of operation. The median patient age was 24 years
(range, 7 to 63). Patients included 71 females and 63
males. Operating time in the LA group was longer with a
median duration of 51.3 minutes (range, 35 to 100) com-
pared with 40.6 minutes (range, 30 to 95) in the OA group.
An extraction bag was used in 59/71 (83%) LA patients.
Wound infection was recorded in 6 patients (5/54 in OA
and 1/80 in LA). The site of wound infection was the port
of specimen extraction in the laparoscopic group, and an
extraction bag was not used. Wound infection delayed
hospital discharge by an average of 2 days. Intraabdomi-
nal abscess formation complicated the outcome in 2 pa-
tients (1 in the LA group and 1 in the OA group).
Conclusion: Wound infection is less common in LA than
in OA, and an extraction bag is recommended. Intraab-
dominal infection rates do not appear to be increased,
though the numbers in this study are relatively small. The
longer operating time is minimal given the better results,
and LA is the optimal approach to the diagnosis and
management of acute appendicitis.
Key Words: Appendectomy, Laparoscopic surgery,
Wound infection, Intraabdominal abscess.
INTRODUCTION
Laparoscopic surgery has gained in popularity and found
application in almost every surgical speciality. The first
experimental laparoscopy was performed by Dr. George
Kelling in 1901 in a dog. He used a cystoscope to peer into
the abdomen of a dog after first insufflating the peritoneal
cavity with air. Since then, laparoscopic surgery has pro-
gressed in practically all branches of surgery with ever-
increasing extensions of the boundaries to the most com-
plex surgical procedures in select cases.
The management of many diseases has benefited from the
application of the laparoscopic approach. Laparoscopic
appendectomy is one such procedure increasing in pop-
ularity since initially reported by Semm in 1983.1 Several
studies have shown the advantages of laparoscopic sur-
gery in terms of shorter hospital stay, rapid postoperative
recovery, and better pain control.2–4 However, there have
been concerns about the risk of infectious complications,
particularly the development of intraabdominal abscess
and superficial wound infection. This risk is significantly
increased in cases of perforated appendicitis.5,6
The purpose of this study was to assess the comparative
incidence of superficial wound infection and intraabdomi-
nal abscess in patients undergoing appendectomy by
open or laparoscopic surgery for suspected acute appen-
dicitis.
METHODS
This prospective comparative study was carried out in a
district general hospital. All consecutive patients admitted
with right iliac fossa pain who had an open or laparo-
Colorectal Surgery, Royal Hampshire County Hospital, Hampshire, UK (Mr Khan).
General Surgery, North Hampshire Hospital, Hampshire, UK (Dr Fayyad).
North Hampshire Hospital, Hampshire, UK (Dr Cecil).
North Hampshire Hospital, Hampshire, UK (Dr Moran).
Presented as an oral presentation at the 10th World Congress of Endoscopic
Surgery, Berlin, Germany, September 13–16, 2006.
Address reprint requests to: Muhammad Najm Khan, FCPS, FRCS (Glasg.), Specialist
registrar, Colorectal surgery, Royal Hampshire County Hospital, Romsey Road,
Winchester, SO22 5DG, Hampshire, UK.
© 2007 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. Published by
the Society of Laparoendoscopic Surgeons, Inc.
JSLS (2007)11:363–367 363
SCIENTIFIC PAPERS
	   224	  
	  
	  
	  
	  
scopic appendectomy as an emergency were included.
No randomization was carried out. The choice between
open and laparoscopic approach was decided by the
operating surgeon after discussion with the patient.
Data were collected in a specifically designed ProForma,
where the patient demographic details, operative findings,
conversion to open surgery, and postoperative complica-
tions were recorded. Operative time and hospital stay
were recorded. The main emphasis was on the develop-
ment of infectious complications, ie, wound infection and
intraabdominal abscess formation. CDC definitions of nos-
ocomial surgical site infections were used for the purpose
of defining wound infection.7 They are shown in Table 1.
Intraabdominal abscesses were diagnosed with ultra-
sound scan, CT scan, or both of these, in patients with
suspected symptoms and signs. Patients were divided into
2 groups, Laparoscopic (LA) and Open (OA). The chi-
square test was used for statistical analysis. A P value of
!0.05 was considered statistically significant.
A standard technique for laparoscopic appendectomy was
used with a 10-mm optical trocar in the infra-umbilical
position. The Hasson technique was used for establishing
pneumoperitoneum. Two 5-mm ports were used, one in
the left iliac fossa and the other in the suprapubic position.
Tripolar cutting forceps (ACMI Corporation, Southbor-
ough, MA, USA) were routinely used for dissection, as
they helped to speed up the procedure. The appendix
base was tied and divided between 2 endo-loops (Ethi-
con, UK) with laparoscopic scissors. An extraction bag
was used in 59/71 laparoscopic cases. The appendicular
stump was not buried routinely. In the case of perforation,
a careful washout was performed.
Open appendectomy was performed through a gridiron
incision in the right iliac fossa by muscle splitting and
peritoneal incision. The appendix was divided at the base,
and the stump was gently buried. The wound was closed
in layers. In patients with a perforated appendix, perito-
neal wash out with normal saline was performed.
The severity of appendicitis was graded perioperatively
as:
1-catarrhal when the appendix was inflamed without ne-
crosis or perforation,
2-gangrenous when tissue necrosis was present,
3-perforated when a visible perforation was in the appen-
dix with free pus.
All patients had prophylactic antibiotics at induction (ce-
furoxime 1.5 g and metronidazole 500 mg). Patients with
catarrhal appendicitis had 3 further doses, and those with
a gangrenous or perforated appendix had a 5-day course
of antibiotics.
RESULTS
This study included 134 patients. There were 63 males and
71 females with a median age of 24 years (range, 7 to 63).
Of these 134 patients, 85 (63.4%) had acute appendicitis,
27/134 (20.1%) appendices were perforated, and 22/134
(16.4%) were normal on histological examination. There
were 80 patients in the LA group and 54 in the OA group;
however, 9 patients had a conversion to an open proce-
dure. The distribution of cases among these groups is
shown in Table 2.
The median operating time was 51.3 minutes (range, 35 to
100) for the laparoscopic group and 40.6 minutes (range,
30 to 95) for the open group. Figure 1 shows a compar-
ative graph for the median operating times between the 2
groups. There was one (1.2%) superficial wound infection
in the laparoscopic group. There were 5 wound infections
(9.2%) in the open group (P"0.05).
Grades of appendicitis were similar in the 2 groups
though more perforated appendices occurred in the open
surgery group. In the LA group, there were 53 inflamed
appendices, 12 perforated appendices, and 15 normal
appendices. In the OA group, 32 inflamed, 15 perforated,
and 7 normal appendices were removed.
One patient in the open group and one in the LA group
Table 1.
Criteria for Superficial Incisional Surgical Site Infection7
I. Infection occurs within 30 days after the procedure, and
infection involves only skin or subcutaneous tissue of the
incision.
II. At least one of the following:
1. Purulent drainage, with or without laboratory
confirmation, from the superficial incision.
2. Organisms isolated from an aseptically obtained culture
of fluid or tissue from the superficial incision.
3. At least one of the following signs or symptoms of
infection
a. pain or tenderness
b. localized swelling,
c. redness
d. heat
4. Diagnosis of superficial incisional SSI by the surgeon or
attending physician
Laparoscopic vs. Open Appendectomy: the risk of postoperative infectious complications, Khan MN et al.
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developed an intraabdominal abscess (P!0.48). Conver-
sion to an open procedure was necessary in 11% (9/80) of
the patients in the laparoscopic group. The reasons for
conversion are summarized in Table 3. Surgery was per-
formed by 3 consultants and 6 specialist registrars.
DISCUSSION
Appendectomy for acute appendicitis is a common emer-
gency surgical procedure.8 Open appendectomy has been
the gold standard treatment for acute appendicitis since
the description by Mc Burney in 1894.9 Although appen-
dectomy is considered a safe operation, a potential for
complications exists. Most noticeable among them are
wound infection, intraabdominal abscess, adhesions,
bowel obstruction, and pulmonary complications from
general anaesthesia.10
Since its first description in 1983, laparoscopic appendec-
tomy has gained in popularity1 with accumulating evi-
dence demonstrating the benefits of the laparoscopic ap-
proach in terms of shorter hospital stay, more rapid
recovery, and better postoperative pain control.11,12 Fur-
thermore, laparoscopy allows a complete and thorough
assessment of the abdominal cavity and increases diagnostic
accuracy, particularly in females where the rates of appen-
dectomy with normal histology have been very high.13
The development of a postoperative intraabdominal ab-
scess (IAA) after appendectomy is a rare but serious com-
plication and is associated with significant morbidity.14
Some reports15,16 have suggested an increased risk of an
intraabdominal abscess after laparoscopic appendectomy
compared with open surgery, whilst others have reported
the opposite.17
In this study, there was no difference, in that one patient
in the open group and one in the LA group developed an
intraabdominal abscess. Both were diagnosed by ultra-
sound scan at day 12 and 15 after their operation and were
managed conservatively using broad-spectrum antibiotics
Table 2.
Demographic Details and Main Outcome Measures for Laparoscopic Appendectomy and Open Appendectomy
Demographics Laparoscopic (n ! 80) Open (n ! 54)
Age 24 (range, 10 to 63) 23 (range, 7 to 63)
Sex (M:F) 28:52 35:19
Severity
Acute appendicitis 53 32
Perforated appendix 12 15
Normal appendix 15 07
Median operating time (minutes) 51.3 (range, 35 to 100) 40.6 (range, 30 to 95)
Conversion 9
Wound infection 1 5
Intraabdominal abscess 1 1
Figure 1. Comparison of operative time between the laparo-
scopic (LA) and open appendectomy (OA) groups.
Table 3.
Causes of Conversion in Laparoscopic Appendectomy
Cause No. of Cases
Failure to progress 3
Gangrenous base of appendix 2
Adhesions 2
Intraoperative bleeding 2
JSLS (2007)11:363–367 365
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initially. One patient went on to require CT-guided drain-
age. Both patients made a full recovery.
Good surgical technique and proper use of antibiotics is
crucial to reduce the incidence of postoperative intraab-
dominal abscess.14 Surgeons experienced in the laparo-
scopic technique and beyond their learning curve report
low rates of infectious complications.18 The conversion
rate in this study was 11%, similar to conversion in other
reports,19,20 though this decreases with increasing surgeon
experience.
Tate21 reported an incidence of 1.4% for the development
of intraabdominal abscess following appendectomy,
though this includes an incidence of 7.5% after surgery for
perforated appendicitis. The higher incidence in perfo-
rated appendicitis may be due to increased bacterial con-
tamination with a risk of a loose fecalith acting as a nidus
for infection.22
An advantage of laparoscopic appendectomy has been
the reduced risk of wound infection, as the inflamed
appendix is dissected and removed without direct contact
with the wound,21 especially if an extraction bag for spec-
imen retrieval is used.
This study has limitations. Patients were not randomized,
and the choice of procedure was operator dependent.
This introduces a bias in that the surgeons with experi-
ence and special interest in laparoscopic surgery were
more likely to opt for the laparoscopic approach. Surgery
was performed by varying grades of surgeons including 3
consultants and 6 specialist registrars. The incidence of
intraabdominal abscess formation was low, and to detect
a significant difference between the 2 groups would re-
quire a large number of patients in a randomized con-
trolled trial. Due to other advantages of laparoscopic ap-
pendectomy, such a trial is unlikely.
In this study, the risk of superficial wound infection is less
in the LA group and comparable to that in previous pub-
lications.23,24 A postoperative intraabdominal abscess is a
rare, though potentially serious, complication of the pro-
cedure, and this study suggests that the risks after laparo-
scopic and open appendectomy are similar.
CONCLUSION
The advantages of diagnostic laparoscopy in patients with
abdominal pain, combined with the benefits of laparo-
scopic appendectomy, suggest that all patients with sus-
pected appendicitis should be considered for laparo-
scopic appendectomy provided appropriately trained
personnel and adequate equipment are available.
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Abstract
Background To determine the impact of obtaining rou-
tine peritoneal fluid cultures during appendicectomy, on the
treatment and the clinical outcomes.
Methods The case notes of 137 consecutive patients
having appendicectomy, selected from the microbiology
database over a period of 1 year were reviewed. The
microorganisms in peritoneal cultures, selection of antibi-
otics and clinical outcomes were recorded. Patients were
subdivided into two groups; group I: uncomplicated
appendicitis and group II: complicated appendicitis.
Results The study included 137 patients with a median
age of 19 years. Cultures were obtained from 79.5% of
patients (group I: 67/84, group II: 42/53). Cultures were
positive in 28.3% (19/67) patients in group I and 69% (29/
42) in group II. Wound infection (5.6%), prolonged ileus
(7.5%) and intra-abdominal abscess (3.7%) were the re-
corded complications in group II. Antibiotics were modi-
fied in 3 out of 109 patients.
Conclusion Intra-operative peritoneal cultures during
appendicectomy do not significantly contribute towards
patient management.
Keywords Appendicitis ! Peritoneal swabs ! Culture and
sensitivity
Introduction
It is a common practice to send microbial swabs for culture
and sensitivity after any surgical procedure where pus is
drained. This may be helpful in growing an uncommon or
resistant organism and may help target antibiotic therapy
more precisely. But there are some procedures where the
value of this practice is questionable [1–3]. Traditionally,
microbiological swabs are taken for culture during appen-
dicectomy. The pathogens in appendicitis mainly comprise
of aerobic and anaerobic organisms, with Coliforms and
gram-negative anaerobes being most common [4]. How-
ever, the pathogens encountered in appendicitis are largely
predictable and sensitive to broad-spectrum antibiotics. In
this study we aimed to examine the value of obtaining
routine peritoneal swab, by determining the influence of
microbiological results on postoperative outcomes in pa-
tients undergoing appendicectomy.
Methods
A total of 137 consecutive patients who had appendicec-
tomy between August 2002 and September 2003, at a
district general hospital, were included in this retrospective
study. Data was obtained from the computerised data base
system (HISS system) and case notes were reviewed. All
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patients who had normal and non-inflamed appendix on
histology were excluded. The specific technical details of
the operative procedures were not evaluated in this study.
Results of microbial peritoneal cultures, selection of
antibiotics and clinical outcome were obtained. Patients
were subdivided into two groups based on histology. Group
I (uncomplicated appendicitis) included patients with in-
flamed appendix and group II (complicated appendicitis)
included suppurative or gangrenous appendix with perfo-
ration or abscess formation. Postoperative complications
were defined as those occurring within 30 days following
surgery.
All patients received a minimum of three doses of ce-
furoxime and metronidazole. Patients allergic to ce-
furoxime received ciprofloxacin. All patients with
gangrenous appendix, perforation or abscess received a
prolonged course of antibiotic between 3 and 5 days. All
intra-operative peritoneal swabs were taken using a single
microbial swab, transferred to the laboratory where they
were plated on to aerobic and anaerobic culture media.
Samples taken out of hours were refrigerated. The cultures
were grown on blood agar and MacConkey agar for aerobic
and anaerobic pathogens. All microbial swabs were cul-
tured in the same laboratory and sensitivity patterns were
determined using standard methods.
Results
This study comprised of 137 patients with a median age of
19 years (range 5–61). There were 59 males and 78 fe-
males. There were 84 (61.3%) patients in group I and 53
(38.6%) in group II. Microbial swabs were obtained from
109 patients (79.5%) as to include 67 patients (79.7%)
from group I and 42 patients (79.2%) from group II. Cul-
tures were positive in 28.3% (19/67) patients in group I and
69% (29/42) in group II. The positive culture rate was
directly related to the severity of inflammation (P < 0.05).
All patients received three doses of cefuroxime and
metronidazole. Patients allergic to cefuroxime received
ciprofloxacin or gentamycin. E. Coli and Bacteriodes were
the most common organisms isolated. Streptococcus Milleri
was isolated in three patients. Figure 1 explains the fre-
quency of different microorganisms cultured from perito-
neal swabs. Table 1 shows the distribution of different
microorganisms between two groups. Most of them were
sensitive to cephalosporins and Metronidazole. Table 2
explains the sensitivity patterns of these microorganisms.
All patients in group I made an uneventful recovery.
There were no complications or peri-operative deaths.
Significant complications occurred in patients in group II
patients who had suppurative/gangrenous appendicitis,
perforation or abscess. Wound infection was seen in three
patients (5.6%) and intra-abdominal abscess formation in
two patients (3.7%). Other complications included pro-
longed ileus in four patients (7.5%) and chest infection in
one patient (1.8%). Peritoneal swabs were not taken in 17
patients in group I and 11 patients in group II. No com-
plications were recorded in group I whereas among the 11
patients in group II, one wound infection and one case of
prolonged ileus was recorded.
Microbial resistance to cefuroxime was observed in five
patients. In four cases Coliforms were sensitive to cefo-
taxime and in one case enterococci were sensitive to cef-
otaxime and gentamicin. Intra operative swabs were taken
in the three patients who developed postoperative intra
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Fig. 1 Frequency of different microorganisms in culture isolates
Table 1 Distribution of different microorganisms grown from each
group
Organisms Group 1 Group 2
E. coli 09 24
Bacteriodes 08 17
Pseudomonas 01 05
Skin flora 02 01
Non-haemolytic streptococci 01 02
Total 21 49
Table 2 Sensitivity patterns of different microorganisms cultured
Microorganisms Sensitivity to
antibiotics
No of resistant organisms
(total no of organisms)
Coliforms Cefuroxime 04 (59)
Coliforms Ciprofloxacin Nil (59)
Bacteroides Metronidazole Nil (37)
Pseudomonas Cefuroxime 02 (31)
Non-haemolytic
streptococci
Cefuroxime Nil (08)
38 Ir J Med Sci (2007) 176:37–40
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abdominal abscess. In one case the microorganisms were
resistant to cefuroxime but sensitive to cefotaxime and
gentamicin. Among the six patients who developed wound
infection, swabs were taken in four patients. Coliforms
resistant to cefuroxime were cultured in one patient.
Microbial resistance to cefuroxime was also observed in
the other three patients but none of them developed any
complications.
The median hospital stay was 2 days (range 1–6) and
most of the patients were discharged before the results of
the culture pattern were known. Antibiotics were modified
in three patients; two of them had swabs taken pre opera-
tively. The decision to change antibiotics was based on
clinical condition and not on microbiology results. The
results of intra peritoneal cultures neither influenced anti-
biotic selection nor predicted the clinical outcome in both
groups of patients.
Discussion
There is a wide variation in the positive culture rate of
microbial swabs obtained during appendicectomy ranging
from 18–95% [5]. This may reflect the differences in the
inclusion of patients with normal or inflamed appendicitis
or may be related to differences in processing microbial
swabs. In particular, collection techniques and prolonged
exposure to oxygen may influence the isolation of anaer-
obes [6]. In this study coliforms and anaerobes were the
most common isolates and this is in accordance with the
international literature [7–10]. There are no significant
resistance patterns known among these organisms and they
are adequately covered by third generation cephalosporins
and metronidazole.
Infective complications contribute significantly to mor-
bidity following appendicectomy and it is related to the
degree of contamination found at operation [11]. In this
study all patients with uncomplicated appendicitis made an
uneventful recovery. Wound infection (5.6%) and intra-
abdominal abscess (3.7%) were the most common com-
plications in patients in group II. The results of microbio-
logical culture did not predict the occurrence of infective
complications. Jeffers and Pollock [12] have previously
noted that in 608 patients with acute appendicitis, not a
single patient had antibiotic therapy changed on the basis
of culture results. Other studies have observed that culture
findings can influence a change of antibiotic treatment in
7–16% of patients [9, 13]. Antibiotics were modified in
three patients on clinical grounds in this study. The results
of this study are similar to several other published studies
reporting a very limited role of taking peritoneal swabs
in the management of patients with acute appendicitis
[14–18].
This study has a limitation because of retrospective
nature and reliance on proper documentation and follow up
of patients. A prospective study is recommended to elim-
inate this bias. We did not record the operative details,
technique and grade of operating surgeon. These factors
may also have influenced the clinical outcome.
Conclusion
In current clinical practice the results of microbiological
cultures obtained during appendicectomy are not predictive
of complications. Intra-operative peritoneal cultures during
appendectomy have a limited role in the management of
these patients. The microbial flora is predictable and sen-
sitive to empirical antibiotic therapy. Instead of performing
routine cultures for peritonitis, a modified approach that
still facilitates hospital surveillance for microbial resistance
pattern should be adopted.
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Abstract
Aim Splenic flexure mobilization (SFM) is standard
practice in anterior resections. No previous studies have
compared outcomes with and without SFM in laparo-
scopic and open colorectal cancer surgery. This study
aimed to determine whether routine or selective SFM
should be advised.
Method Data were collected prospectively on all elective
anterior resections for cancer in our unit between
October 2006 and November 2009.
Results Of 263 resections, SFM data were recorded in
216; 138 were laparoscopic (32% with SFM, 3.6%
converted) and 78 open (68% with SFM). Eighty-eight
were low anterior resections (LARs) for mid-low rectal
cancers, with 54 laparoscopic (50% with SFM) and 34
open (91% with SFM). Comparing laparoscopic with
SFM to without, differences were found in the
proportion of LARs (61% vs 29%, P < 0.001), defunc-
tioning ileostomy rates (75% vs 46%, P = 0.001) and
operative time (median 255 vs 185 min, P < 0.001),
with no differences in age, gender, body mass index,
American Society of Anesthesiology score, preoperative
treatment, length of stay, lymph node yield, conversion
rate, mortality, anastomotic leakage, reoperation, read-
mission and R0 resection. No differences in outcomes
were seen between laparoscopic LARs with and without
SFM or between open resections with and without
SFM.
Conclusion Our results show no disadvantage in short-
term clinical or oncological outcomes when SFM was
avoided. Laparoscopic anterior resections with SFM take
longer. A selective approach to SFM is safe during
anterior resection (open or laparoscopic), including mid-
low rectal cancers.
Keywords Splenic flexure, colorectal cancer, anterior
resection
What is new in this paper?
There is little existing literature answering whether
routine splenic flexure mobilization is necessary, with
only two studies of open anterior resections and no
studies including laparoscopic resections. Our study
provides novel evidence that it is safe to avoid splenic
flexure mobilization in selected patients during both
laparoscopic and open resections.
Introduction
There is considerable debate as to whether it is necessary
to mobilize the splenic flexure routinely during anterior
resection. Many believe that splenic flexure mobilization
(SFM) is necessary to ensure a tension-free, well-
vascularized anastomosis [1,2]. Such surgeons hold that
the sigmoid colon should not be used in anastomoses
because it is often thick-walled, diverticular, has a poorer
blood supply than the more proximal colon, and may
have been exposed to radiotherapy. However, two case
series have shown that SFM confers no advantage with
regard to morbidity, oncological outcomes or survival in
open anterior resections [3,4].
The aim of this study was to determine the outcome of
selective SFM in laparoscopic anterior resections espe-
cially with regard to low anterior resections (LARs), in
which a total mesorectal excision is necessary, the risk of
anastomotic leakage is recognized to be highest, and in
which if SFM is to be avoided then the sigmoid colon
must be used in the anastomosis [5]. A subsidiary aim was
to examine our outcomes in open anterior resections with
and without SFM.
Method
Data regarding patient demographics [gender, age, body
mass index, American Society of Anesthesiology score
Correspondence to: Michael Marsden, Department of Colorectal Surgery, Queen
Alexandra Hospital, Portsmouth, UK.
E-mail: michael.marsden@stockport.nhs.uk
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(ASA)], clinical outcome (length of hospital stay, oper-
ative time and conversion rate if laparoscopic, if any
deaths, leaks, reoperations or readmissions occurred, and
if a temporary ileostomy was formed) and oncological
factors (tumour height, preoperative treatment with
short-course radiotherapy or long-course chemoradio-
therapy, lymph node harvest and if R0 resection achieved)
were collected prospectively on all elective anterior
resections performed for cancer in our unit between
October 2006 and November 2009. Ileostomy closure
data (closure rate and time to closure) were also collected
for all laparoscopic resections and postoperative contrast
enema anastomotic leaks were recorded for laparoscopic
LARs.
A standardized printed operation note was used for
every colonic resection with a tick box indicating whether
SFM was performed (yes ⁄ no), which was also collected
prospectively. Patients were excluded from the analysis if
this tick box was not completed.
Patients’ evaluation included colonoscopy with CT of
chest, abdomen and pelvis, or flexible sigmoidoscopy
followed by CT pneumocolon and CT chest prior to
surgery. MRI scans were routinely performed as part of
loco-regional staging for rectal carcinomas which were
defined as cancer present within 15 cm from the anal
verge. Preoperative radiotherapy was given according to
the recommendations of the weekly multidisciplinary
team meeting. In general, preoperative chemoradiother-
apy (long course) was advised for T4 rectal cancers or
those where the circumferential resection margin
(CRM) appeared threatened on MRI; short-course
radiotherapy was advised for rectal cancers that ap-
proached but did not threaten the CRM; no radiother-
apy was used where rectal cancers were considered
resectable by total mesorectal excision with a good
likelihood of clear margins.
Resections were undertaken by five colorectal sur-
geons in the department. Whilst open surgery was
performed by all the surgeons, laparoscopic resections
were undertaken by three of them. No selection criteria
were used to allocate patients to a laparoscopic or open
operation. Patients were assigned to individual surgeons
(open or laparoscopic) according to national cancer
targets and availability of operating theatre slots. A small
number of patients expressed a wish to have their
operation laparoscopically and they were accommodated
when possible. All patients were treated postoperatively in
an enhanced recovery programme.
Laparoscopic resections were undertaken using a
standard four-port technique with medial to lateral
dissection and mesorectal dissection as appropriate for
the location of the cancer. The inferior mesenteric artery
was routinely ligated and divided close to its origin.
During laparoscopic operations the splenic flexure was
mobilized if colon length was insufficient to achieve a well
perfused tension-free anastomosis; otherwise the flexure
was not mobilized. Open resections were carried out
using midline incisions and a lateral to medial approach.
The inferior mesenteric artery was routinely ligated and
divided at its origin. For LARs with mesorectal excision
the splenic flexure was generally mobilized at an early
stage in the operation. For high anterior resections
(HARs) a selective approach was used as above.
Analysis was carried out comparing resections with
SFM and those with no SFM (NSFM) for all open and
laparoscopic anterior resections, including a comparison
of open vs laparoscopic surgery. The same analysis was
carried out on all HARs (in this study defined as all left-
sided colorectal resections for cancers above 10 cm from
the anal verge which result in an anastomosis involving
the rectum) and LARs (defined as resections for mid and
low rectal cancers, 10 cm or less from the anal verge,
therefore necessitating at least a partial mesorectal exci-
sion and anastomosis to the low rectum or top of the anal
canal).
Statistical analysis was performed using either Stu-
dent’s t-test or the chi-squared test. In view of the small
size of some of the subgroups, multiple confounders
which have not been adjusted for, a sample size calcula-
tion not being appropriate and hence a possible lack of
power, we decided that statistical significance would only
be reached if the P-value was < 0.005. However, a lack of
statistical significance does not mean that there is no
difference in some results, because the lack of significance
could be due solely to a lack of power.
Results
Of 263 anterior resections performed during the study
period, SFM data were recorded in 216 and these form
the basis of this report. LAR was carried out in 88
patients (41%). Laparoscopic resections were attempted
in 138 (64%) of the patients and completed in 133
(conversion rate 3.6%).
Comparing all SFM to all NSFM patients, a higher
proportion of LARs (60% in SFM patients vs 25% in
NSFM patients, P < 0.001) was observed in the SFM
patients. There was also a higher median length of stay
(8 vs 5 days) in the SFM patients, although this did not
reach statistical significance (P = 0.026), which is prob-
ably explained by the significantly greater proportion of
open cases in the SFM group (55% of all SFM
resections were open whereas only 21% of NSFM
resections were open, P < 0.001). When all HAR
patients were compared with all LAR patients no
differences were found.
Selective use of splenic flexure mobilization M. R. Marsden et al.
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Laparoscopic anterior resections
The results for the 138 laparoscopic anterior resections
are presented in Table 1. The patients were grouped into
those undergoing HAR, LAR and all anterior resections
with and without SFM. The groups were broadly similar,
although patients requiring SFM tended to be older than
those not requiring SFM, and patients undergoing LAR
with SFM tended to have a higher body mass index than
those not requiring SFM.
Using a selective approach, SFM was necessary in 44
(32%) of all laparoscopic anterior resections, with 17 ⁄ 84
(20%) HAR and 27 ⁄ 54 (50%) LAR (P < 0.001). Lapa-
roscopic anterior resections with SFM took significantly
longer than without SFM (median 255 vs 185 min for all
laparoscopic patients, P < 0.001). The difference in
median operative times for laparoscopic LAR was insig-
nificant at only 14.5 min between SFM and NSFM
resections (260 vs 245.5 min, P = 0.03), whereas for
HAR it was significant at 45 min (210 vs 165 min,
P = 0.001).
Laparoscopic anterior resections with SFM had a
higher temporary ileostomy formation rate (75% vs 46%,
P = 0.001), but this is likely to reflect the expected higher
proportion of LARs requiring SFM (61% of SFM patients
underwent a LAR, vs 29% of NSFM patients, P < 0.001),
all of whom had an ileostomy formed. Median length of
stay was 4 days after laparoscopic HAR and 6 days after
laparoscopic LAR, and there was no difference between
SFM or NSFM groups.
The rate of clinical anastomotic leak requiring reop-
eration was 2.2% (3 ⁄ 138). There were no such leaks
among 54 patients undergoing laparoscopic LAR with or
without SFM. Readmission rates for laparoscopic anterior
resections were high (23 ⁄ 138, 17%), especially for LARs
(22%), even in the context of an enhanced recovery
programme, although these did not differ significantly
from the open group. However, the majority of the
reasons for readmission (shown in Table 1) were minor,
and therefore some of these readmissions could have been
avoided, reflect early experience in the enhanced recovery
programme, and highlight the importance of support for
enhanced recovery programme patients after discharge.
Reoperation rates were not significantly different
overall and in LARs. However, they were significantly
higher after laparoscopic HAR with SFM (3 ⁄ 17, 18%) vs
resection without SFM (1 ⁄ 67, 1.5%, P < 0.005),
although this is likely to have been affected by the small
numbers of patients requiring reoperation and in these
subgroups. The reasons for reoperation are given in
Table 1.
Preoperative treatment rates (short-course radiother-
apy or long-course chemoradiotherapy), lymph node
yield and rates of R0 resection were similar between the
groups except for an unusually high lymph node yield in
the SFM group for HAR only.
Postoperative contrast enemas for the LAR groups
(with SFM and without SFM) were carried out within a
median of 8 and 7 weeks respectively. There was no
difference in radiological anastomotic leak rate between
the two groups, with a leak rate of 4 ⁄ 27 (15%) in the
SFM group and 3 ⁄ 27 (11%) in the NSFM group.
Ileostomy closure, in those laparoscopic resections
that required a defunctioning stoma, was not affected by
the avoidance of SFM, with no delay in time to closure
and no difference in closure rates in all laparoscopic
resections and in laparoscopic LARs. Among the laparo-
scopic HAR patients, rates of ileostomy closure were
significantly lower in the SFM group (3 ⁄ 6, 50%) vs the
NSFM group (16 ⁄ 16, 100%, P = 0.002); however, this is
probably due to the small numbers of patients requiring a
stoma in these groups (only six in the SFM group).
Open anterior resections
The results for the 78 open anterior resections are
presented in Table 2. The patients were grouped into
those undergoing HAR, LAR and all anterior resections
with and without SFM. The groups undergoing open
resection were broadly comparable. Statistical comparison
between the open LAR groups is not appropriate because
the group which did not have SFM contained only three
patients.
SFM was carried out in 53 (68%) open anterior
resections, with 22 ⁄ 44 (50%) HARs and 31 ⁄ 34 (91%)
LARs (P < 0.001). Open resections with SFM also had a
higher temporary ileostomy formation rate (85% vs 44%,
P < 0.001), which again is likely to be related to the
higher proportion of LARs in the SFM group (58% vs
12%, P < 0.001).
Length of stay was a median 11 days after open
anterior resection with SFM and not significantly differ-
ent (12 days) for the NSFM group. No patient died after
open resection. The rate of anastomotic leak requiring
return to theatre was 6.4% (5 ⁄ 78). Overall, 10.2% (8 ⁄ 78)
of patients required reoperation after open resection. The
reasons are given in Table 2.
Lymph node yield and rates of R0 resection did not
vary according to whether there was SFM or not.
Preoperative treatment with radiotherapy or chemora-
diotherapy was higher, but not significantly, in the SFM
group (4 ⁄ 22 vs 0 ⁄ 22, P = 0.04). Although the numbers
are small, this may in part be due to surgeon preference or
due to radiotherapy damage to the sigmoid colon
necessitating SFM so that the descending colon can be
used in the anastomosis.
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Laparoscopic vs open anterior resection
The results following comparison of laparoscopic versus
open resection are presented in Table 3. The rate of SFM
was significantly higher following open compared with
laparoscopic resection whether assessed overall or after
HAR or LAR. The rate of SFM during open LAR was
91% vs 50% during laparoscopic resection (P < 0.001).
Open resections tended to have a higher rate of
preoperative oncological treatment (13% vs 5%) and
temporary ileostomy formation (72% vs 55%), despite
the proportions of LARs being similar; however, these
differences were not significant (P = 0.04 and P = 0.02
respectively). This is likely to reflect surgeon preference
with respect to the small numbers of more difficult cases,
in particular when resection margins are threatened,
being performed open.
Despite significantly lower rates of SFM during
laparoscopic resection the rate of anastomotic leak
requiring return to theatre was 2% after laparoscopic
resection vs 6% after open resection. The open group
had significantly longer hospital stay (11 vs 4 days,
P < 0.001) and a higher, though not significant, reoper-
ation rate (10% vs 4%, P = 0.05). There was no difference
in lymph node harvest or rates of R0 resection according
to whether resections were open or laparoscopic.
Table 2 Results for open high, low and all anterior resections for cancer comparing patient groups with and without SFM.
Clinical ⁄ oncological factors
Open HARs (44) Open LARs (34)
All open (78)
SFM vs NSFMWith SFM Without SFM With SFM Without SFM
Number of patients 22 (50%) 22 (50%) 31 (91%) 3 (9%) 53 vs 25
Male 14 (64%) 14 (64%) 21 (68%) 3 (100%) 66% vs 68%
Age (years), median (range) 70 (38–86) 71.5 (42–88) 71 (30–89) 66 (60–81) 70 vs 68
Body mass index, median
(range)
27 (20–39) 27.5 (17–37) 26 (18–37) 25 (20–30) 27 vs 28
ASA 3 or 4 5 (23%) 2 (9%) 5 (16%) 3 (100%) 19% vs 20%
Tumours mid-low rectum* NA NA NA NA 58 vs 12%*
(P < 0.001)
Preoperative short-course
radiotherapy or long-course
chemoradiotherapy
4 (18%) 0 5 (16%) 1 (33%) 17% vs 4%
Temporary ileostomy* 14 (64%) 8 (36%) 31 (100%) 3 (100%) 85% vs 44%*
(P < 0.001)
Length of hospital stay
(days), median (range)
13.5 (5–48) 10 (3–45) 11 (5–67) 21 (14–34) 11 vs 12
Mortality (within 30 days of
surgery)
0 0 0 0 0
Anastomotic leak 2 (9%) 2 (9%) 1 (3.2%) 0 6% vs 8%
Reoperation (within
30 days of surgery)
3 (14%) 2 (9%) 2 (6%) 1 (33%) 9% vs 12%
Reason for reoperation 2 leaks, 1 bleed 2 leaks 1 leak, 1 abscess 1 abscess
Readmission (within
30 days of surgery)
0 3 (14%) 6 (19%) 0 11% vs 12%
Reason for readmission 1 abscess,
1 wound,
1 diarrhoea
2 abdo pain, 2
stoma (1 high
output, 1 query
obstruction), 1
wound, 1 fistula
Lymph node harvest,
median (range)
10.5 (2–31) 10.5 (2–24) 13 (4–34) 13 (13–16) 12 vs 12
R0 resection in curative
surgery
16 ⁄ 18 (89%) 21 ⁄ 21 (100%) 28 ⁄ 29 (97%) 3 ⁄ 3 (100%) 94% vs 100%
NA, not applicable.
Statistically significant differences highlighted with asterisks and P-values.
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Discussion and conclusions
The major finding of this study is that selective rather
than routine SFM is associated with excellent outcomes
in patients undergoing laparoscopic anterior resection. It
is likely that similar practice would also benefit conven-
tional open anterior resections.
Our results in laparoscopic LARs suggest that SFM
can be avoided in as many as 50% of cases. Laparoscopic
mobilization of the splenic flexure can be a complex
addition to the operation and in this unit added a median
14.5 min to the operating time. This report provides
some evidence that with appropriate selection SFM may
be avoided and that this is safe.
In LARs, if SFM is to be avoided part of the sigmoid
colon must almost always be used in the anastomosis. As
there was no increase in complication rate, in particular
anastomotic leak rate, in those laparoscopic LAR patients
in whom SFM was avoided this study suggests that it is
safe, in principle, to use the sigmoid colon for distal
colorectal or colo-anal anastomosis.
When the laparoscopic HAR patients are analysed
alone, SFM was associated with a higher rate of reoper-
ation and a higher, although not significant, rate of
anastomotic leak. It is likely that these differences have
been significantly affected by the small size of the SFM
subgroup in laparoscopic HARs (n = 17). Otherwise leak
rates were similar between all subgroups of laparoscopic
and open anterior resections. This is supported by there
being no difference in postoperative contrast enema leak
rates for laparoscopic LARs, and no difference in ileos-
tomy closure rates and time to closure for all laparoscopic
anterior resections.
Overall, our laparoscopic data favour selective rather
than routine mobilization of the splenic flexure during
anterior resection. Among previous laparoscopic reports,
Kim et al., [6] in a case series of 155 laparoscopic anterior
resections, avoided mobilizing the splenic flexure in 148
(95.5%) of the patients. Our purpose differed subtly from
that of Kim et al. [6] in that they adopted a policy of
omitting SFM, which was only required in 4.5% of
patients requiring anterior resection, associated with a
leak rate of 8.4%. Our selective approach required
considerable intraoperative judgement concerning colo-
nic vascularity and length ⁄ tension and suitability of the
bowel for anastomosis. In all, 32% of flexures were
mobilized but our rate of anastomotic leakage requiring
reoperation was only 2%. Park et al. [7] compared 119
Table 3 Results for open vs laparoscopic anterior resections, including comparisons of results for HARs and LARs.
Clinical ⁄ oncological factors
All (216) open
vs laparoscopic
HAR (128) open
vs laparoscopic
LAR (88) open vs
laparoscopic
Number of patients 78 vs 138 44 vs 84 34 vs 54
SFM rate* 68% vs 32% SFM*
(P < 0.001)
50% vs 20% SFM*
(P < 0.001)
91% vs 50% SFM*
(P < 0.001)
Male 67% vs 61% 64% vs 55% 71% vs 70%
Age (years), median 70 vs 70 70 vs 70 71 vs 71
Body mass index, median 27 vs 26 27 vs 27 26 vs 26
ASA 3 or 4 19% vs 20% 16% vs 19% 24% vs 20%
Tumours mid-low rectum 44% vs 39% N ⁄ A N ⁄ A
Preoperative short-course
radiotherapy or long-course
chemoradiotherapy
13% vs 5% 9% vs 0% 18% vs 13%
Temporary ileostomy* 72% vs 55% 50% vs 26% 100% vs 100%
Length of hospital stay (days),
median*
11 vs 4 (P < 0.001)* 11.5 vs 4 (P < 0.001)* 11 vs 6 (P < 0.001)*
Mortality (within 30 days of
surgery)
0 vs 0.7% 0 0 vs 2%
Anastomotic leak 6% vs 2% 9% vs 4% 3% vs 0%
Reoperation (within 30 days of
surgery)*
10% vs 4% 11% vs 5% 9% vs 2%
Readmission (within 30 days of
surgery)
12% vs 17% 7% vs 13% 18% vs 22%
Lymph node harvest, median 12 vs 12 11 vs 12 13 vs 11
R0 resection in curative surgery 96% vs 98% 95% vs 99% 97% vs 98%
NA, not applicable.
Statistically significant differences highlighted with asterisks and P-values.
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laparoscopic with 145 open left-sided colonic cancer
resections, all without SFM, but did not explore the
proportion of anterior resections in which SFM avoidance
was not feasible. A recent international survey of 368
surgeons performing laparoscopic total mesorectal exci-
sion revealed that the majority (71.2%) are still routinely
mobilizing the splenic flexure [8]. No previous studies
have compared the outcomes of patients with and without
SFM in laparoscopic left-sided colorectal cancer surgery as
we have done. Reviewing our results in the context of
existing literature it is probable that SFM is unnecessary in
many patients undergoing laparoscopic anterior resection
and that a rigid policy towards non-mobilization may be
associated with an unacceptably high rate of anastomotic
leak. A selective approach is therefore probably best.
In open anterior resection many surgeons favour
routine mobilization of the flexure at an early stage in
the operation, particularly for low rectal cancers [9]. It is
often considered helpful to carry out this step along with
division of the inferior mesenteric artery, the inferior
mesenteric vein and the colon before beginning the pelvic
dissection. This approach allows the divided colon and
small bowel to be packed away giving good access to the
pelvis for the rectal dissection. If there is bleeding from the
spleen it can be packed and will probably stop during the
time it takes to perform the rectal dissection [2]. Our open
results reflect this philosophy with SFM in 91% of open
LARs. However, comparing the results of selective SFM in
laparoscopic resection with the more routine SFM in open
LAR policy it is likely that SFM could have been avoided in
as many as 40% of patients in whom it was performed
during LAR. Brennan et al. reported selective mobiliza-
tion of the splenic flexure in a series of 100 open anterior
resections. SFM was required in only 16 ⁄ 58 (28%) of
LARs with no apparent compromise of anastomotic
healing, oncological radicality or long-term outcome
[3]. The same conclusion was reached by Katory et al.
[4] who analysed the results of 707 open HARs, of which
531 (75%) were deemed at surgery to require SFM.
Drawing the evidence together, routine mobilization of
the splenic flexure during open anterior resection should
probably be abandoned in favour of a selective approach.
It could be argued that to truly test the hypothesis
that SFM confers advantage (or disadvantage) we
would need to perform a prospective, randomized
trial in which the randomization point came intraop-
eratively in patients deemed not to require SFM to
achieve a tension-free, well-vascularized anastomosis.
However, it could also be argued that it is difficult
ethically to justify submitting some of the patients
deemed not to require SFM to an additional and
complex surgical step which thus far in the literature
has not been shown to provide any benefit, and in
this study has been shown to entail a significantly
longer operation (an extra 15–45 min in laparoscopic
resections with SFM) and potentially entail an
increased complication risk.
In conclusion, selective mobilization of the splenic
flexure appears to be safe and is therefore recommended
in laparoscopic and open anterior resection, including
those for mid and low rectal cancers. Mobilizing the
splenic flexure increases operative time and may not be
necessary to achieve a safe anastomosis in a large
proportion of patients.
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